<![CDATA[Jamal Dinkoui]]>https://articles.berbarianwizard.comhttps://substackcdn.com/image/fetch/$s_!oKWT!,w_256,c_limit,f_auto,q_auto:good,fl_progressive:steep/https%3A%2F%2Fsubstack-post-media.s3.amazonaws.com%2Fpublic%2Fimages%2F5d3fa302-0e99-46cb-997f-f7e78714de4d_480x480.pngJamal Dinkouihttps://articles.berbarianwizard.comSubstackTue, 03 Nov 2026 13:57:07 GMT<![CDATA[Male Sexual Function, Part 6: Semen Volume and Dry Orgasms]]>https://articles.berbarianwizard.com/p/male-sexual-function-6-semen-volume-ejaculationhttps://articles.berbarianwizard.com/p/male-sexual-function-6-semen-volume-ejaculationThu, 15 Oct 2026 16:23:01 GMTLess semen can mean the glands made less fluid. It can also mean fluid failed to enter the urethra, the tube through the penis, or travelled backward into the bladder. More frequent ejaculation and medicine changes can also reduce the amount.[1, 2] If the main change is less pleasure at orgasm, use Part 4.

Contents

  1. Understand a change in semen volume

  2. Medicines, hormones and operations

  3. Food, hydration and zinc

  4. Dry orgasm and retrograde ejaculation

  5. Supplements for low semen volume

  6. Check whether semen volume improves

Read more

]]><![CDATA[Male Sexual Function, Part 5: Refractory Period and Post-Orgasm Symptoms]]>https://articles.berbarianwizard.com/p/male-sexual-function-5-refractory-period-recoveryhttps://articles.berbarianwizard.com/p/male-sexual-function-5-refractory-period-recoveryThu, 15 Oct 2026 16:22:56 GMTThe refractory period is the time after orgasm before you can have another erection or orgasm. Libido may return before erections do, and touch may still feel uncomfortable. Flu-like illness, brain fog or exhaustion that lasts for days after orgasm is covered under post-orgasmic illness syndrome in section 8.[1, 2]

Contents

  1. Identify what limits recovery

  2. Dopamine, prolactin and the refractory period

  3. Rest, timing and sexual recovery

  4. Food and nutrients for energy and recovery

  5. When libido returns before erections

  6. Medicines for high prolactin

  7. Other brain signals involved in recovery

  8. Post-orgasmic illness syndrome

  9. Low mood after sex

  10. Choose the next step

Read more

]]><![CDATA[Male Sexual Function, Part 4: Delayed Orgasm, Reduced Sensation and Sexual Pain]]>https://articles.berbarianwizard.com/p/male-sexual-function-4-delayed-ejaculation-orgasm-sensationhttps://articles.berbarianwizard.com/p/male-sexual-function-4-delayed-ejaculation-orgasm-sensationThu, 15 Oct 2026 16:22:51 GMTYou can have good erectile function and still have delayed orgasm, genital numbness or sexual pain.[1, 2]

If you can reach orgasm during masturbation but struggle with a partner, start with section 3. For numbness, use section 4. For pain, use section 5, or section 7 if painful erections wake you from sleep. Section 2 covers changes after medication or hormones. Section 6 covers unwanted genital arousal. If the main problem is little or no semen, go to Part 6.

Contents

  1. Identify what has changed

  2. Medicines and hormone changes

  3. Sexual habits and partnered orgasm

  4. Reduced genital sensation and nerve problems

  5. Genital pain, painful ejaculation and pelvic tension

  6. Persistent unwanted genital arousal

  7. Painful erections during sleep

  8. Treatments for medication-related orgasm problems

  9. Specialist treatments for persistent orgasm difficulty

  10. Check whether orgasm and sensation improve

Read more

]]><![CDATA[Male Sexual Function, Part 3: Premature Ejaculation]]>https://articles.berbarianwizard.com/p/male-sexual-function-3-premature-ejaculationhttps://articles.berbarianwizard.com/p/male-sexual-function-3-premature-ejaculationThu, 15 Oct 2026 16:22:46 GMTIf premature ejaculation develops after years of normal control, look for what changed. If you rush because your erection is fading, treat erectile dysfunction first. Lifelong PE often benefits from practice alongside treatment that delays ejaculation without sacrificing pleasure.[1]

Start with the practice in section 2. Use the prostate, bladder, gut or hormone sections early if you have symptoms in those areas. Sections 12 and 13 explain the nerve pathways behind the treatments.

Contents

  1. Find the cause of premature ejaculation

  2. Edging, breathing and pelvic control

  3. Erection loss and rushing to ejaculate

  4. Prostate inflammation and pelvic pain

  5. Bladder urgency and urinary treatments

  6. Gut symptoms, food triggers and oral health

  7. Histamine, food reactions and ejaculation control

  8. Hormones and premature ejaculation

  9. Calming options for tension and poor sleep

  10. Supplements that may delay ejaculation

  11. Medicines for ejaculation control

  12. Brain signals and the ejaculation reflex

  13. How GABA, glutamate and calming hormones work

  14. Activating, experimental and sedating drugs

  15. Check whether you have more control

Read more

]]><![CDATA[Male Sexual Function, Part 2: Libido and Sexual Arousal]]>https://articles.berbarianwizard.com/p/male-sexual-function-2-libido-and-sexual-arousalhttps://articles.berbarianwizard.com/p/male-sexual-function-2-libido-and-sexual-arousalThu, 15 Oct 2026 16:22:40 GMTLow libido, loss of attraction to a partner and difficulty becoming aroused can have different causes. Start with what changed and when. Notice whether physical contact still increases arousal.[1]

If libido is normal and the problem is erectile dysfunction, use Part 1.

Dopamine stimulates libido. High prolactin can reduce libido and cause erectile dysfunction, even when testosterone is normal. Oxytocin is involved in arousal and orgasm. Serotonin can delay or speed up ejaculation, depending on the receptors and nerve pathways involved. GABA and certain neurosteroids inhibit nerve activity. Androgens and estrogens support libido, and thyroid function affects both libido and ejaculation.[2, 3, 4, 5, 6, 7, 8]

Contents

  1. Where to start

  2. Food intake, energy and body composition

  3. Daylight, sleep and the body clock

  4. Stress, sexual habits and your relationship

  5. Gut symptoms and inflammation

  6. Testosterone, DHT and estradiol

  7. Prolactin, thyroid and growth-hormone disorders

  8. Neurosteroids: pregnenolone, progesterone and DHEA

  9. Sexual problems during antidepressant treatment

  10. Supporting dopamine production and function

  11. Supplements for libido, energy and sleep

  12. Peptides and drugs acting on the brain

  13. Follow-up

Read more

]]><![CDATA[Male Sexual Function, Part 1: Erectile Function and Morning Wood]]>https://articles.berbarianwizard.com/p/male-sexual-function-1-erectile-functionhttps://articles.berbarianwizard.com/p/male-sexual-function-1-erectile-functionThu, 15 Oct 2026 16:22:36 GMTPoor sleep, low energy intake, poor vascular function and hormone problems can all affect erectile function. Performance anxiety can contribute even when blood flow and hormones are normal.[1]

Contents

  1. Identify the erection problem

  2. Blood flow, nerve signals and hormones

  3. Carbs, glucose metabolism and energy for erections

  4. Sleep and morning wood

  5. Insulin sensitivity, blood sugar and excess body fat

  6. Exercise, smoking and healthy blood vessels

  7. Porn and performance anxiety

  8. Pelvic muscles and urinary symptoms

  9. Medicines and hormone changes

  10. Nutrients and plant compounds for blood flow and nerve function

  11. Medicines for erections

  12. Medicines acting on erection signals in the brain

  13. Experimental blood-flow and energy treatments

  14. Check whether erections are improving

Read more

]]><![CDATA[Male Sexual Function: Where to Start]]>https://articles.berbarianwizard.com/p/male-sexual-function-introductionhttps://articles.berbarianwizard.com/p/male-sexual-function-introductionThu, 15 Oct 2026 16:22:32 GMTYou can have high libido and still have erectile dysfunction. You can have good erectile function and still have premature ejaculation.

Dopamine stimulates libido. High prolactin can cause low libido and erectile dysfunction, even when testosterone is normal.[1, 2]

Oxytocin contributes to arousal and orgasm. Serotonin can delay or speed up ejaculation, depending on which receptors and nerve pathways it activates. GABA reduces nerve excitation, and some neurosteroids strengthen its effects. Androgens, estrogens and thyroid hormones influence libido, erections and ejaculation through their actions in the brain and other tissues.[3, 4, 5, 6, 7]

The oral microbiome affects blood-vessel function. Bacteria in the mouth convert nitrate into nitrite, which the body can use to make nitric oxide.[8] Treating gum inflammation has also improved erectile function in men with both gum problems and ED.[9]

The gut microbiome may influence sexual function through inflammation and hormone signalling. The guides cover bacterial overgrowth, endotoxin, food reactions and histamine, including their possible links with testosterone production, pelvic pain and premature ejaculation.[10, 11, 12]

These six guides progress from food, sleep, exercise and sexual habits to supplements, hormone treatments and prescription medicines. They cover more than 140 supplements, hormones, medicines and combinations, plus 21 approaches without medication.

Contents

  1. Identify your main symptom

  2. Find the guide for your symptom

  3. Food, body composition, sleep and exercise

  4. Medication and supplement side effects

  5. Porn, pressure and sexual habits

  6. Hormones in the blood and tissues

  7. Track what improves

1. Identify your main symptom

  • When it started. Worse sleep, extreme dieting, more training, a new drug or a hormone dose change.

  • When it happens. Alone, with a partner, every time or only sometimes.

  • What else changed. Libido, morning wood, erection quality, sensation, orgasm or semen volume.

  • What you’ve tried. The treatment, dose, timing, result and side effects.

If ED persists, have blood pressure, blood sugar and hormone levels tested. Pain or a sudden loss of erections or sensation needs prompt medical attention. If the problem began after a drug change, start with that change.[13]

2. Find the guide for your symptom

  • Part 1: Erectile Function and Morning Wood. Improve erectile function and morning wood through sleep, glucose metabolism, insulin sensitivity and blood flow. Includes oral health, body fat, pelvic muscles, performance anxiety, nutrients and treatments for erections.

  • Part 2: Libido and Sexual Arousal. Improve libido and arousal, from food intake, daylight, stress and sexual habits to dopamine, prolactin, thyroid function, androgens, estrogens and neurosteroids. Includes gut inflammation and the nutrients needed to produce and regulate dopamine.

  • Part 3: Premature Ejaculation. Improve ejaculation control through edging, breathing, pelvic-floor training and targeted treatments. Covers prostate and bladder symptoms, gut problems, histamine, GABA, glutamate, noradrenaline and serotonin.

  • Part 4: Delayed Orgasm, Reduced Sensation and Sexual Pain. Treat delayed or weak orgasms, genital numbness and sexual pain. Covers medication effects, sexual habits, nerve injury or compression, pelvic tension and painful erections during sleep.

  • Part 5: Refractory Period and Post-Orgasm Symptoms. Understand the refractory period, including dopamine, prolactin, energy intake and the return of libido and erections. Covers fatigue, illness-like symptoms and low mood after orgasm.

  • Part 6: Semen Volume and Dry Orgasms. Identify the causes of low semen volume or dry orgasms, including hydration, nutrient intake, medication, hormone changes and semen flowing into the bladder. Compare food, supplements and targeted treatments.

For fertility and PCT (post-cycle therapy), use my PCT, ICT and HRT guide.

3. Food, body composition, sleep and exercise

Enough food, a lean body and regular activity

Eat enough carbs and calories for your activity and training. I prioritise resistance training to build and preserve muscle, with walking for daily activity. Short HIIT sessions can fit when recovery allows. Part 1 compares their effects on glucose use and erectile function.[14, 15]

Lose excess abdominal fat gradually. If you are under-eating or overtraining and your sleep, energy and libido are getting worse, eat more and reduce the training load.[16, 17, 18]

In men with obesity and type 2 diabetes, diet and exercise helped prevent a decline in erectile function. Benefits can appear before visible abs.[16]

Daylight and sleep

Get outside in the morning, keep a steady waking time and dim the lights at night.[19] Part 2 explains daylight and the body clock.

Pay attention to sleep quality, repeated waking and how you feel the next day.[18] Loud snoring, pauses in breathing and daytime sleepiness can point to sleep apnea.[20] Part 1 covers sleep problems and missing morning wood.

4. Medication and supplement side effects

Antidepressants, antipsychotics, opioids, blood-pressure medicines and bladder treatments can affect libido, erections, orgasm or ejaculation. If symptoms follow a prescription or dose change, discuss reducing the dose or replacing the drug.[13]

Finasteride and dutasteride reduce DHT production and can cause sexual side effects. They are used for hair loss or an enlarged prostate and may be included in compounded scalp preparations.[21, 22] Sexual symptoms have also been reported with preparations containing saw palmetto.[23] If symptoms began after an optional hair-loss treatment, I would stop it before adding hormones or ED medication. Treatment for urinary symptoms may need a replacement.

If libido or erectile function declines after starting topical minoxidil for hair loss, I would stop it and see whether libido and erections recover. Sexual side effects have been reported during use.[24] Oral minoxidil prescribed for severe hypertension needs a replacement before stopping.[21, 25] Part 1 covers these treatments in detail.

5. Porn, pressure and sexual habits

I recommend stopping porn and masturbation alongside improving food, sleep and exercise.[26, 27]

For men with premature ejaculation, Part 3 explains edging and stop-start practice, including how to use pauses with a partner.

For four weeks, remove saved porn, block the sites you return to and keep your phone out of bed. Include sexual browsing on social media. If boredom or stress triggers the habit, plan another activity for that time.

Notice whether comparisons with videos or pressure to perform interfere with sex. If the habit feels difficult to control, a therapist who treats compulsive sexual behaviour can help.

6. Hormones in the blood and tissues

A blood test shows how much hormone is circulating. What happens inside a tissue also depends on its enzymes and receptors. For example, fat cells can produce different amounts of aromatase, the enzyme that makes estrogen, even when blood estradiol is similar. Excess prolactin may interfere with nitric oxide signalling in penile blood vessels. This helps explain why people with similar blood results can have different symptoms. Parts 1 and 2 examine these tissue effects in more detail.[28, 29, 30]

I suspect estradiol, or E2, can contribute to compulsive libido, particularly during androgen use. Symptoms alone cannot identify the responsible hormone. Lowering estrogen too much can reduce libido, as it did in men receiving testosterone when estrogen production was blocked.[6] Use blood tests alongside symptoms before changing hormone treatment. My guide to lowering estrogen and aromatase explains the options when E2 is elevated.

7. Track what improves

Try optional treatments one at a time. Record the dose and start date, then compare libido, erection quality, ejaculation control and orgasm after the period given in the entry. Stop an optional supplement if it causes side effects. If a prescribed treatment causes side effects, discuss a lower dose or a replacement.

Check for duplicate ingredients before combining supplements. Specific interactions are listed beside each treatment.

If one symptom improves while another persists, use the guide for the remaining problem. If a treatment has no effect despite the correct dose and schedule, reconsider the cause before adding another.

This Substack is reader-supported. To receive new posts and support my work, consider becoming a free or paid subscriber.

References

  1. Krüger TH, Haake P, Haverkamp J, Krämer M, Exton MS, Saller B, Leygraf N, Hartmann U, Schedlowski M (2003). Effects of acute prolactin manipulation on sexual drive and function in males. Methods, Figure 1 and experience/refractory ratings. Source. DOI 10.1677/joe.0.1790357. PMID 14656205.

  2. De Rosa M, Colao A, Di Sarno A, Ferone D, Landi ML, Zarrilli S, Paesano L, Merola B, Lombardi G (1998). Cabergoline treatment rapidly improves gonadal function in hyperprolactinemic males: a comparison with bromocriptine. Source. DOI 10.1530/eje.0.1380286. PMID 9539303.

  3. Behnia B, Heinrichs M, Bergmann W, Jung S, Germann J, Schedlowski M, Hartmann U, Kruger TH (2014). Differential effects of intranasal oxytocin on sexual experiences and partner interactions in couples. Source. DOI 10.1016/j.yhbeh.2014.01.009. PMID 24503174.

  4. Althof SE and colleagues (2014). An Update of the International Society of Sexual Medicine’s Guidelines for the Diagnosis and Treatment of Premature Ejaculation (PE). Definitions, treatment recommendations and dose table. Source. DOI 10.1002/sm2.28. PMID 25356302.

  5. Park-Chung M, Malayev A, Purdy RH, Gibbs TT, Farb DH (1999). Sulfated and unsulfated steroids modulate gamma-aminobutyric acidA receptor function through distinct sites. Brain Research 830:72–87. Results, Figure 2 and Table 1. Source. DOI 10.1016/S0006-8993(99)01381-5. PMID 10350561.

  6. Finkelstein JS, Lee H, Burnett-Bowie SA, Pallais JC, Yu EW, Borges LF, Jones BF, Barry CV, Wulczyn KE, Thomas BJ, Leder BZ (2013). Gonadal steroids and body composition, strength, and sexual function in men. Sexual-function results and Figure 4. Source. DOI 10.1056/nejmoa1206168. PMID 24024838.

  7. Carani C, Isidori AM, Granata A, Carosa E, Maggi M, Lenzi A, Jannini EA (2005). Multicenter study on the prevalence of sexual symptoms in male hypo- and hyperthyroid patients. Source. DOI 10.1210/jc.2005-1135. PMID 16204360.

  8. Kapil V, Haydar SMA, Pearl V, Lundberg JO, Weitzberg E, Ahluwalia A (2013). Physiological role for nitrate-reducing oral bacteria in blood pressure control. Free Radical Biology and Medicine 55:93–100. Primary abstract, oral nitrate reduction and blood-pressure results. Source. DOI 10.1016/j.freeradbiomed.2012.11.013. PMID 23183324.

  9. Eltas A, Oguz F, Uslu MO, Akdemir E (2013). The effect of periodontal treatment in improving erectile dysfunction: a randomized controlled trial. Abstract. Source. DOI 10.1111/jcpe.12039. PMID 23252455.

  10. Tremellen K, McPhee N, Pearce K, Benson S, Schedlowski M, Engler H (2018). Endotoxin-initiated inflammation reduces testosterone production in men of reproductive age. American Journal of Physiology: Endocrinology and Metabolism. DOI: 10.1152/ajpendo.00279.2017. PMID: 29183872. Experimental Results, Figures 2–3 and Discussion. Randomized challenge: 17 endotoxin, 16 placebo. Gut origin was not established.

  11. Weinstock LB, Geng B, Brandes SB (2011). Chronic prostatitis and small intestinal bacterial overgrowth: effect of rifaximin. Source. PMID 21854715.

  12. Shuyi Huang, Sijia Sun, Zhou Zhao, Dawei Gao, Wenxiu Zhang, Nianchao Zhou, Yihan Jin, Baofang Jin, Dalin Sun (2026). Associations of Gut Microbiota Composition and Fecal Metabolomic Profiles in Patients With Acquired Premature Ejaculation: A Cross-Sectional Pilot Study. Eligibility criteria and microbiome/metabolomic comparisons. Source. DOI 10.1177/15579883261493263. PMID 42813505.

  13. European Association of Urology (2026). EAU Sexual and Reproductive Health: Management of Erectile Dysfunction. Sections 5.4.1–5.4.3. Source.

  14. Jamal Dinkoui (4 March 2026). Beyond Calories, Part II: Muscle, Movement and Daily Habits. Sections on resistance training and high-intensity cardio. Article.

  15. Fisher G and colleagues (2015). High Intensity Interval- vs Moderate Intensity-Training for Improving Cardiometabolic Health in Overweight or Obese Males: A Randomized Controlled Trial. PLOS ONE 10:e0138853. Primary abstract. DOI: 10.1371/journal.pone.0138853. PMID: 26489022.

  16. Rena R Wing and colleagues (2010). Effects of weight loss intervention on erectile function in older men with type 2 diabetes in the Look AHEAD trial. Intervention and sexual-function outcomes. Source. DOI 10.1111/j.1743-6109.2009.01458.x. PMID 19694925.

  17. Zekarias K, Shrestha RT (2019). Role of Relative Malnutrition in Exercise Hypogonadal Male Condition. Case report pp. 234–235 and Table 1. Source. DOI 10.1249/mss.0000000000001783. PMID 30212398.

  18. Consensus Conference Panel and colleagues (2015). Recommended Amount of Sleep for a Healthy Adult: A Joint Consensus Statement of the American Academy of Sleep Medicine and Sleep Research Society. Consensus recommendation for adult sleep duration. Source. DOI 10.5664/jcsm.4758. PMID 25979105.

  19. National Heart, Lung, and Blood Institute (2026, accessed 12 October). Healthy Sleep Habits. Source.

  20. Patil SP, Ayappa IA, Caples SM, Kimoff RJ, Patel SR, Harrod CG (2019). Treatment of Adult Obstructive Sleep Apnea with Positive Airway Pressure: An American Academy of Sleep Medicine Clinical Practice Guideline. Good-practice statements on diagnosed obstructive sleep apnea and follow-up. Source. DOI 10.5664/jcsm.7640. PMID 30736887.

  21. MHRA (2026). Finasteride and Dutasteride – updated safety warnings for psychiatric side effects and sexual dysfunction. Advice for healthcare professionals and patients. Source.

  22. FDA (2025). FDA alerts health care providers, compounders and consumers of potential risks associated with compounded topical finasteride products. Review and discussion. Source.

  23. Firenzuoli F, Firenzuoli B, Mascherini V, Firenzuoli N, Menniti-Ippolito F, Ippoliti I, Maggini V, Gallo E, Cuomo A, Fagiolini A, Gensini GF, Firenzuoli F (2026). Can we identify a post-Serenoa syndrome (PSS)? A case series on sexual and psychiatric side effects of Serenoa repens. Methods and case histories 1 and 2, with abstract limitations. Source. DOI 10.1002/bcp.70442. PMID 41507085.

  24. Wu M, Yu Q, Li Q (2016). Differences in reproductive toxicology between alopecia drugs: an analysis on adverse events among female and male cases. Methods, Table 3 and Discussion limitations. Source. DOI 10.18632/oncotarget.12617. PMID 27738338.

  25. Pfizer (n.d.). LONITEN (minoxidil): prescribing information. Indications and patient information. Source.

  26. Banca P, Morris LS, Mitchell S, Harrison NA, Potenza MN, Voon V (2016). Novelty, conditioning and attentional bias to sexual rewards. Source. DOI 10.1016/j.jpsychires.2015.10.017. PMID 26606725.

  27. R. Porto (2016). Habitudes masturbatoires et dysfonctions sexuelles masculines. Source. DOI 10.1016/j.sexol.2016.03.004.

  28. Ahmed F and colleagues (2025). Altered Expression of Aromatase and Estrogen Receptors in Adipose Tissue From Men With Obesity or Type 2 Diabetes. Methods, Results, Figures 1–3 and Discussion. Primary paper. DOI 10.1210/clinem/dgaf038. PMID 39833659.

  29. Lim J and colleagues (2000). Human androgen receptor mutation disrupts ternary interactions between ligand, receptor domains, and the coactivator TIF2. Results, Figures 5–8 and Discussion. Primary paper. DOI 10.1210/mend.14.8.0499. PMID 10935543.

  30. Cheng X and colleagues (2025). Prolactin impairs erectile function via eNOS suppression independently of testosterone. Results 3.1–3.4 and Discussion limitations. Primary paper. DOI 10.1016/j.taap.2025.117532. PMID 40848920.

]]><![CDATA[The Fascinating World of Pheromones]]>https://articles.berbarianwizard.com/p/the-fascinating-world-of-pheromoneshttps://articles.berbarianwizard.com/p/the-fascinating-world-of-pheromonesFri, 25 Sep 2026 10:49:18 GMT
Painted meme parody: Jean Phil walks confidently toward the viewer. The woman in a black velvet dress looks back at him. Drake, in a black pinstriped suit, turns toward her with his mouth open and a questioning hand gesture as they walk the other way.

People can recognize a partner by smell. Newborns respond to smells from the breast. In lab tests, body odors can also change how someone reads a face or responds to a threat.1, 2, 3

These smells come from chemicals made by the body and by the microbes living on our skin. Scientists have identified many of the chemicals, worked out how some are made and tested how people react to them.4, 5, 6, 7

Some experiments test one chemical, such as androstadienone or hexadecanal. Others test whole samples of sweat or tears. With a mixture, the response belongs to the sample tested until its ingredients are tested separately.8, 9, 10, 11

A pheromone is a chemical released by one member of a species that causes a particular response in another. Establishing that role means checking the chemical, the response and the amount normally encountered. Human experiments need those same checks.12, 13

A chemical leaves one body, reaches another, is detected and causes a response.

Finding a chemical is the first step. Researchers also need to show how it reaches another body, how that body detects it and what happens afterward.13, 1

This Substack is reader-supported. To receive new posts and support my work, consider becoming a free or paid subscriber.

Contents

  1. What a pheromone is.

  2. How researchers identify a pheromone.

  3. Pheromones in other animals.

  4. How the body produces odor.

  5. How the nose detects odors.

  6. Body odor and sexual attraction.

  7. Body odor, fertility and hormones.

  8. Body odor and relationships.

  9. Communication beyond attraction.

  10. Perfumes, products and patents.

  11. What research has found so far.

  12. Glossary.

Find a topic

  • Steroid names: 4.2 and Glossary. Food and body odor: 4.4.

  • Androstadienone: 6.1. Androstenone and androstenols: 6.2.

  • Androsterone and ADL: 6.3. Estratetraenol: 6.4.

  • Sexual orientation: 6.5 and 8.1. Copulins: 6.6. Sexual enjoyment and arousal: 6.7. Seeing someone with a partner: 6.8.

  • Fertility: 7.1–7.2. Breastfeeding scents and adult responses: 7.3. Periods starting together: 7.4. Sperm responses: 7.5.

  • Immune genes: 8.1. Birth control: 8.2.

  • Dominance and rivalry: 8.3. Recognizing people: 8.4. Age: 8.5.

  • Newborn feeding: 9.1. Fear and happiness: 9.2–9.3. Illness: 9.4.

  • Tears and aggression: 9.5–9.6 and 6.1. Products and patents: 10.1–10.2. Personal reports: 10.3.

1. What a pheromone is

A hormone carries a message inside the body that makes it. A pheromone carries a message from one member of a species to another. Peter Karlson and Martin Lüscher introduced the word in 1959. They used it for a substance released outside the body that changes another animal’s behavior or causes a slower change in its body.12

Pheromones have many uses beyond sex. They can travel through air, water or food, or pass between animals when they touch. One chemical may do the job, or several may need to work together. How much is present, and how much of each ingredient is in a mixture, can change the result.12, 13

Smell can also give away information. A predator can use an animal’s smell to find it, even though this does the hunted animal no good. Scientists call this a cue. They use signal for a feature that evolved to help animals communicate. A signature mixture is a combination of chemicals that helps identify a particular animal, often because others have learned its smell.13

The same body fluid can carry several kinds of information. Some of its chemicals may be common to a species. Others may change with the animal’s condition. The overall smell may also be familiar enough to identify that animal. Recognizing someone by smell does not require each person to have a pheromone unique to them.13, 1

An animal’s reaction to a pheromone can change with its age, physical condition, experience and the other smells around it.13, 14, 15

2. How researchers identify a pheromone

Researchers begin with a response they can measure, such as a newborn animal searching for milk. They test natural samples, separate the ones that cause the response and keep testing their smaller parts. This is a bioassay, a test that uses a living response to find an active substance.13, 16, 17

Once they identify a suspected chemical, they check it against a known sample or a copy made in the lab. Removing it from the natural mixture and adding it back helps establish its role.13, 18

Schaal and colleagues did this with rabbit milk in 2003. Removing the chemicals that escape from milk into the air weakened newborn rabbits’ head and mouth movements toward a nipple. Adding 2-methylbut-2-enal, or 2MB2, brought those movements back.16

Rabbit milk caused newborn rabbits to search for a nipple and try to take it into their mouths. Removing the chemicals that enter the air weakened these movements. Adding 2MB2 brought them back.

The steps in Schaal and colleagues’ rabbit-milk experiment. The symbols show what was removed and added, without representing exact amounts or the size of the response.16

The rabbits responded before their first feed, although exposure before birth was possible. More 2MB2 did not always produce a stronger response. The amount matters, especially when comparing a lab test with what an animal normally encounters.16, 13

A receptor is a protein that responds to certain chemicals. Giving silkmoths another moth species’ receptor made them begin mating behavior in response to that species’ chemical. This worked when the receptor was placed in cells normally detecting the silkmoth’s sex pheromone. Placing it in other smell cells did not produce the same behavior. The cells receiving the chemical, and the signals they send onward, help determine the response.19

In human experiments, a control is a comparison sample without the ingredient being tested. Unused pads reveal odors from the collection material. Changing sample order helps account for practice or fatigue. Keeping people unaware of which sample they receive reduces the influence of expectations. Tests with new people and in other labs check whether a finding holds up.7, 20, 21

Statistical significance means a result passes a chosen test of how surprising the data would be if there were no effect, given the test’s assumptions. It says little on its own about how large or useful the effect is. A null finding means the test did not find enough evidence for the expected effect. Small studies can miss real changes.20

Researchers also need to measure exposure. The amount dissolved in a bottle differs from the amount reaching a nose. Evaporation, airflow, distance and the delivery device all affect that journey.13, 21

3. Pheromones in other animals

Argentine ants followed trails made from two chemicals found in their natural trails. Adding a little of a third suspected trail chemical made the ants respond more strongly. Both the mixture and where it was placed on the ground helped guide them.17

One smell can change how an animal reacts to another. Honeybees attacked a moving dummy more often when an alarm chemical called isoamyl acetate was present. Some flower smells, including linalool, reduced the attacks. The result depended on which flower chemical was used and how the alarm sample was prepared.14

Male mouse urine contains a protein called darcin. Female mice encounter it when they investigate and touch the urine. Tests with a copy made in the lab showed that darcin helps make the scent attractive to females. Contact with it also helped females learn to recognize the smell of a particular male’s urine from a distance.15

Pregnenolone and androstenedione attract female red-bellied newts ready to breed. Toyoda’s team identified both steroids in fluid released by pieces of a male scent gland. In water tests with eight females per test, the females spent more time near sponges containing 0.4 nanograms of either steroid. When the team applied both steroids together with sodefrin, a peptide released by males, the electrical response in smell tissue exceeded the separate responses added together. Pregnenolone has a direct role in this courtship system, where the chemicals travel through water.22 An earlier report from the same team found that blocking the females’ nostrils removed their preference for pregnenolone and androstenedione.23

4. How the body produces odor

Several kinds of glands contribute to body odor. Eccrine glands make much of the watery sweat that cools us. Apocrine glands, found in places such as the armpits, release sweat with a different mix of ingredients. Sebaceous glands make skin oil, also called sebum. Fluids from the mouth, breasts and genitals contain other chemicals. Each part of the body also has its own mix of microbes.1

An armpit sample tells us about only one part of a person’s smell. Breath, hair, clothing and other skin areas can carry different chemicals. Some easily enter the air. Others mostly stay on the skin or fabric. Chemicals that enter the air are called volatile.1, 24

Tears, breath, saliva, skin, sweat, breasts during breastfeeding and genital fluids provide different mixtures of chemicals.

Each part of the body releases a different mixture. The breast label refers to research during breastfeeding. These are sources of body chemicals. A chemical found there still needs testing before it can be called a pheromone.1, 24, 2

A 2021 review collected reports of 2,746 chemicals from human breath and body samples. A separate skin review listed 822 chemicals across 29 studies. These lists overlap. They include substances made by the body, substances made by microbes and substances picked up from food, products or the environment. The reviews counted chemicals found in samples. They did not test each one for a response in another person.25, 26

In 2024, Diana Owsienko and colleagues compared underarm samples from 18 children aged 0–3 and 18 aged 14–18. The older group’s samples contained odor patterns matching androstenone and alpha-androstenol, two of the steroids studied in human scent. Neither was detected in the younger group’s samples. Several acids also remained detectable after greater dilution in the older samples. The researchers pooled samples from several children for each analysis, so these findings describe group differences.27

4.1. How skin bacteria produce odor

Some strong armpit smells start as chemicals that barely smell at all. The body releases these starting materials, called precursors. Certain skin bacteria take them in and turn them into strong-smelling chemicals.5, 6

One example is 3M3SH, a strong-smelling chemical that contains sulfur. In the material released onto the skin, it is attached to two amino acids, the small units used to build proteins. A skin bacterium called Staphylococcus hominis takes in this linked molecule. One enzyme, a protein that speeds up a chemical reaction, removes the amino acid glycine. A second enzyme frees the smell-producing part from the remaining amino acid, cysteine. Researchers have identified these enzymes as ShPepV and ShPatB.5, 6, 28

A bacterium takes in a linked molecule. It removes the amino acid glycine. The enzyme ShPatB then frees the smell-producing chemical 3M3SH from the remaining amino acid, cysteine.

One way bacteria produce armpit odor. Cys and Gly mean cysteine and glycine, two amino acids. The shapes show which parts are attached. Other products of the reactions are left out.5, 6

Not all skin bacteria do this. In the enzyme study, another common skin bacterium, Staphylococcus epidermidis, could not process the starting material in the same way. The kinds of bacteria present matter, as well as their total number.6

The gene ABCC11 helps control which substances pass out of cells. Different versions of this gene affect how much of certain odor starting materials reaches the armpit. This changes what the bacteria have available to work with.29, 30

Experiments also explain an earlier step. The ABCC11 protein moved a larger, linked form of 3M3SH in a lab test. A human enzyme called GGT1 cut off one part, leaving the two-amino-acid form that bacteria can use. The researchers found GGT1 in human sweat glands too. This links human gland chemistry with the later bacterial reactions on the skin.31

Two other important armpit smells come from acids called HMHA and 3M2H. The body releases them attached to the amino acid glutamine. Certain bacteria have an enzyme that cuts this link and releases the acids. Different bacteria have different tools, so the starting chemicals and the species living on the skin both affect the final smell.32

Having different amounts of a chemical does not mean everyone reads it as a male or female scent. In a study published in 2025, 2,716 museum visitors smelled lab-made samples of HMHA and 3M3SH, called MSH in that paper. Women rated MSH as slightly more feminine than HMHA. Men made no clear distinction between them. Ratings varied widely, and smells people liked more were more often described as feminine. The study measured how people described the two smells.33

4.2. Steroids with similar names

Several chemicals studied as possible pheromones are steroids. Their atoms form a set of connected rings. Androstenone, androstenols and androstadienone belong to a group called 16-androstenes. They share a double bond, a particular link between two carbon atoms. Their other chemical features differ.34, 35

These names refer to different compounds:

  • Androsterone and androstenone are two different chemicals.

  • Androstadienone, or AND, differs from androstenedione, a starting material for other hormones.

  • 3α-androstenol and 3β-androstenol have the same parts arranged differently.

  • Androstadienol, or ADL, can serve as a starting material for other 16-androstenes.36, 35

The α and β symbols are the Greek letters alpha and beta. They describe which way part of a molecule points. That small difference can change how a receptor or enzyme responds to it. Results for one form cannot simply be applied to the other.18, 13

Androsterone has two oxygen atoms. Androstenone has one and a double bond in its smallest ring. Their similar names identify different molecules.

Each corner or unlabeled line end stands for a carbon atom. Most hydrogen atoms are left out. O stands for oxygen. These molecules have different bonds and oxygen-containing parts, so they can act differently in the body.36

4.3. How the body makes these steroids

Pregnenolone can become steroid odor chemicals. Researchers measured its conversion into ADL in material from human testicles. In lab-grown cells, the human enzyme CYP17A1 performed this reaction, with more ADL produced when the helper protein cytochrome b5 was added.37, 38

Further tests with human enzymes traced ADL to AND, then androstenone and 3α-androstenol. 5α-reductase type 2, also called SRD5A2, carries out the AND-to-androstenone step.35

Human enzyme experiments connect pregnenolone to ADL, then AND, androstenone and 3α-androstenol. Each arrow names the enzyme that performs that step.

A production route tested with human enzymes in lab-grown cells. ADL means androstadienol, and AND means androstadienone. Cytochrome b5 helps the first reaction. Other chemical helpers are NAD+ for the second step and NADPH for the last two. The diagram does not measure how much a living person produces.38, 35

For more on the enzyme in this diagram, see my guide to 5α-reductase. It covers the factors that change its activity, with human, animal and cell findings identified separately.

The body also attaches sulfate groups to steroids. Labows and colleagues found androsterone sulfate and DHEA sulfate in fresh drops from seven men’s armpit glands. Heating these samples during analysis created additional odor chemicals. Those products came from the measuring process.39

Armpit bacteria can break down androsterone sulfate. Gower’s team found free androsterone and small amounts of AND or androstenone, depending on the bacterial strain. They measured the products without identifying every enzyme involved. In the body, SULT2A1 can add sulfate to DHEA. Cell tests showed that increasing DHEA eventually stopped producing a matching increase in the reaction rate.40, 41

Skin cells make and change hormones too. With the necessary enzymes, DHEA can become androstenedione, then testosterone, which can become DHT or estradiol. These hormones act within the skin. Tracing their contribution to scent requires measuring what reaches the surface and enters the air.42, 1

Hormone-derived material does reach the skin. In 1970, Brooksbank tracked labeled pregnenolone and progesterone in one man for 36 hours. He recovered labeled pregnenolone, DHEA, androstenedione and related steroids. Small armpit pads recovered about as much label as a much larger collection from the rest of the body. Most armpit label was in steroids with sulfate groups attached.43

Later studies measured testosterone, estradiol and progesterone in sweat. Muir’s team found all three on men’s and women’s faces after exercise. Among 13 men, levels were much higher in armpit sweat. Another 72 men provided armpit testosterone and estradiol measurements. The team could not collect enough women’s armpit sweat for that comparison.44

Elliott’s follow-up enrolled 73 men, with 49 completing all four visits. Men with higher armpit testosterone or estradiol readings tended to stay higher across visits. Estradiol readings were higher when a female researcher collected the samples. Only one researcher of each sex took part, so other differences between them could explain this result.45

Both studies used antibody tests that also react to related chemicals. The testosterone test, for example, responded strongly to DHT. The proposed transfer of hormones through skin contact was not measured, nor was attraction caused by it.44, 45

Sweat contains cortisol and cortisone too. Alvi’s team measured both in 50 volunteers, checking their identities against reference samples. Runyon’s team measured them and four breakdown products in four people during exercise. Both studies measured what left the body in sweat.46, 47

One study connected changing steroid levels with odor ratings. Shah’s team measured 16 steroids in shirts worn by ten men receiving hormone suppression for prostate cancer. After three months, androsterone and 5α-androstane-3,17-dione had fallen. Scent attractiveness, masculinity and strength ratings stayed similar. Of the 100 raters, 50 were women, all using hormonal contraception. The chemical measurements came from fabric extracts, not inhaled air.48

4.4. Food and body odor

What a person eats can change how their body odor smells to others. In a small experiment, 17 men followed a diet with red meat and a diet without it, each for two weeks. Thirty women rated their armpit samples. Ratings favored the samples from the meat-free period. The difference passed the researchers’ statistical test when they counted each woman’s ratings separately, but not when they counted each man’s average score separately. With only 17 men providing the smells, the result leaves considerable room for differences between people.49

Garlic produced another useful comparison. Fialová and colleagues tested armpit samples after men ate garlic and after a comparison meal. The first experiment found no clear change. A second used more garlic and found slightly higher attractiveness and pleasantness ratings. A third used garlic capsules and again found higher attractiveness ratings, but no clear change in pleasantness. The women smelled armpit samples in jars. They did not smell the men’s breath or meet them. These experiments show why the body area and the way a sample is collected matter.50

4.5. Collecting odor from skin and air

A pad pressed against skin collects a different sample from a material held above the skin to trap chemicals in the air. Collecting that surrounding air is called headspace sampling. These methods can produce different lists of chemicals from the same body area.51, 52, 53

Finding a chemical on a pad does not tell us how much reaches someone nearby. Nor does the chemical present in the largest amount necessarily contribute the most to the smell. It also matters how easily it enters the air and how sensitive the person smelling it is.13, 53

4.6. Other routes to body odor

Skin oil reacts with air to make new smells. Squalene reacts with ozone to form smaller chemicals, including geranylacetone and 6-MHO, without an enzyme. In a 2025 chamber study with three men, researchers collected breath separately to measure what left the skin. Clothing and oil left on clothes affected these emissions.54

Another part of skin oil, sapienic acid, can react with ozone to form decanal. The enzyme FADS2 makes sapienic acid from palmitic acid. Sapienic acid and palmitoleic acid have bonds in different positions, so their breakdown can produce different odor chemicals.55, 56

Hormones can change the material available for these reactions. In human oil-gland cells grown in the lab:57, 58

  • CRH, a hormone involved in stress, increased fat content and briefly increased activity of the gene for 3β-HSD, an enzyme used in steroid production.57

  • IGF-1, a hormone involved in growth, increased fat production, including squalene, and the protein SREBP-1, which helps control that production. Insulin also changed fat production, with different effects at the two concentrations tested.58

Thyroid hormones affect skin oil in people. A study of 50 patients, including 38 women, found less forehead oil in those with an underactive thyroid. In 20 measured again after thyroxine treatment, oil output rose but remained below normal. An overactive thyroid showed no clear increase. The study measured oil quantity, without testing its smell or effect on attraction.59

Skin bacteria also use sweat. Hara’s team traced lactate through pyruvate and a short-lived intermediate to diacetyl, a chemical involved in scalp, foot and armpit odor. Bacterial enzymes perform the earlier steps. The final step can happen through a reaction with oxygen.60

Some bacteria supply other species with the ingredients they need. In mouth-bacteria experiments, one species supplied ornithine, an amino acid. Another used it to increase methanethiol, a sulfur chemical in bad breath. Blocking ornithine transport removed the increase.61

A similar partnership produces putrescine, associated with vaginal odor. A 2025 study examined bacterial proteins in samples from 29 women, with and without bacterial vaginosis. Separate culture tests showed one species making ornithine from arginine and another turning it into putrescine. Growing them together increased production. Attraction was not tested.62

Urine carries odor chemicals both free and with other groups attached. Enzyme treatment of samples from eight women and six men released much more indole, guaiacol and vanillin. These attached forms provide material from which further reactions can release odor.63

An applied ingredient can change on skin too. Rohto reported that odorless sodium 4-hydroxyundecanoate released sweet-smelling γ-undecalactone in a seven-person skin test. Lab tests also found conversion with skin acids or the fat-splitting enzyme lipase. This was a perfume ingredient applied to skin, rather than a study of the body’s own lactone production.64

Producing an odor therefore depends on the starting chemicals, the cells and microbes processing them, and exposure to air. An enzyme’s name alone cannot tell us how much scent someone will release.38, 31, 60, 62, 54, 42

5. How the nose detects odors

Smell begins when chemicals reach a small area high inside the nose called the olfactory epithelium. Nerve cells there have receptors that react to chemicals in the thin layer of mucus. This starts electrical signals in the cells.65

Those signals travel to the olfactory bulb, a part of the brain that first sorts smell information. Other brain areas help us recognize the smell and connect it with memories, feelings and what is happening around us. One chemical can activate several kinds of receptor, and one receptor can react to several chemicals. The combination helps the brain tell smells apart.65, 1

Chemicals in the air reach receptors inside the nose. Nerve signals then travel to the olfactory bulb and other parts of the brain.

Chemicals reach the nose. Nerves carry the signals to the brain. This diagram shows how smell works in general. It does not identify a separate system for human pheromones.65, 1

A smell can cause a response through nerve signals without showing that the chemical entered the blood or reached the brain itself. Another nerve, the trigeminal nerve, detects sensations such as stinging, irritation and cooling in the nose. This matters when experiments use strong amounts of a chemical that might also irritate the nose.65, 21, 24, 66

5.1. Why people smell the same substance differently

People can smell the same chemical differently because their receptors respond differently. Keller and colleagues studied one receptor called OR7D4. Different versions of its gene changed how the receptor reacted to androstenone and AND in the lab. Those versions were also linked to differences in people’s smell tests. Some people needed more of the chemical to notice it and found its smell less unpleasant.7

The weakest amount someone can reliably smell is their detection threshold for that chemical. A person can smell most things normally yet struggle with one particular chemical. This is called specific anosmia. The result depends on the amount used and how the test is done.7, 66

In a 2025 study, 68 people initially could not smell androstenone well enough to pass the study’s test. After about two months of repeatedly smelling it, 49 passed and 19 still did not. The researchers found no clear link between the OR7D4 gene version tested and who learned to smell it.66

After repeatedly smelling androstenone, 49 of 68 people passed the smell test and 19 did not.

Gillmeister and colleagues’ 2025 study. The chart shows how many people in the main group could smell androstenone well enough to pass the test after training.66

Only five people trained with samples that did not contain androstenone, making the comparison group much smaller. This limits how firmly the study can credit the chemical exposure for the improvement. Still, a first smell test may not predict what someone can smell after repeated practice.7, 66

Researchers have also identified a receptor for the armpit acid HMHA. In a 2026 study, HMHA activated the human receptor OR52E8 in cells. The team used an engineered version of the receptor to study how the chemical fits into it. This adds a specific detection step to the chemistry of armpit odor.67

People vary in how strongly they smell these acids. In a 2019 study, some participants could not detect HMHA or 3M2H within the concentrations tested. Among women in Madagascar, those estimated to be in their fertile days rated HMHA as stronger. Their pleasantness ratings were similar. The study compared different women, so it did not follow each woman through her cycle.68

5.2. The vomeronasal organ

Many other animals have a small structure inside the nose called the vomeronasal organ, or VNO. It detects chemicals from other animals. Some adults have a small opening or structure in this area, but finding it has not shown that humans have a working system like those animals do. Some chemicals proposed as human pheromones can be detected through our ordinary sense of smell.1, 7

The debate includes experiments that delivered chemicals directly to this area. In 1998, Monti-Bloch and colleagues tested a lab-made steroid called pregna-4,20-diene-3,6-dione, or PDD. In the hormone experiment, ten men received PDD and a comparison liquid on separate days. The researchers reported lower LH and testosterone during PDD exposure. The chemical was delivered through a probe inside the nose over six hours. This tests a particular chemical and delivery method, while the route from the nasal tissue to the hormone response remains to be mapped.69

In one experiment, researchers temporarily blocked the area thought to contain the human VNO. This did not change the measured responses to AND compared with a procedure that left it unblocked. Tests of OR7D4 also show that an ordinary smell receptor can detect AND and androstenone.70, 7

A pheromone does not have to work through a VNO. What matters is whether one member of a species naturally releases a chemical that causes a particular response in another.12, 13

Women with one version of the VN1R1 gene scored higher on a questionnaire about casual sex in a 2017 study. The authors found a related result in a second group, but it depended on how they compared gene versions and accounted for relationship length. The study compared genes and reported behavior, without testing a smell or identifying an active chemical.71

5.3. Smells people do not notice

People can react to a smell without saying they noticed it. Researchers can check this by asking them to pick the odd sample out of several choices. If they repeatedly choose correctly, they can tell the samples apart even if they say they cannot smell a difference.21

Researchers sometimes add clove or musk to both the test sample and the control to hide a smell difference. This added scent can have effects of its own. They need to check that people cannot reliably tell the two samples apart.72, 73, 74

A 2014 experiment with moving dots tested AND and estratetraenol, or EST, using a 500-micromolar liquid mixture. That number describes how much chemical was dissolved in the liquid. It does not tell us how much people breathed in or whether someone’s skin would release a similar amount.75

Researchers need to measure both whether people notice a smell and whether it changes their reactions. A smell people do not notice is not necessarily more powerful.21

5.4. Hormones change the response to a smell

The person smelling an odor brings their own hormone state to the encounter. Fleming’s team studied 63 women after childbirth. Among 23 first-time mothers with both measurements, higher saliva cortisol went with more pleasant ratings of their own baby’s shirt. The link did not appear in mothers who had given birth before.76

Experiments with nasal sprays test whether giving a hormone changes the response. Maier’s team gave oxytocin or placebo to 58 people, including 30 women, before they smelled stress and exercise sweat from 30 men. With placebo, stress sweat made women see more fear in slightly fearful faces. Oxytocin reduced that bias and reduced the amygdala’s response to stress sweat in both sexes. Some men’s behavioral results came from exploratory comparisons. The oxytocin was given to the people smelling the sweat.77

Across five experiments with 216 men, Chen’s team tested oxytocin and vasopressin during AND or EST exposure. Men judged whether a walking figure made of dots looked male or female. With EST, a lower oxytocin dose increased the response in men reporting more social difficulties. A higher dose removed it. Men with fewer difficulties showed another pattern. Vasopressin did not produce the same changes. These were tests of movement judgments after hormone administration, without measuring natural oxytocin levels or attraction.78

Insulin can change odor detection too. A 2018 nasal-spray experiment with 30 adults found reduced sensitivity to n-butanol in 14 women, all taking the contraceptive pill. Men showed no change, and neither group changed its response to peanut odor. A 2019 study found improved n-butanol detection in 33 men. The studies used different doses and designs. They tested the ability to smell.79, 80

5.5. Tests with hormones themselves

Researchers have also put hormones directly in contact with smell tissue. Progesterone, estradiol and pregnenolone reduced responses to an odor mixture in tissue from female mice’s noses. Pregnenolone was applied in liquid. The authors considered whether its conversion to progesterone contributed to the effect.81

Testosterone activates TRPM8, a protein that lets charged particles cross a cell’s surface. Tests used purified protein, and researchers also found TRPM8 in the mouse smell system. Experiments linked the protein to mating, aggression and interest in urine. Those tests involved whole urine or encounters between mice, so they did not isolate testosterone released by another mouse as the cause.82

A human experiment tested testosterone, progesterone, estradiol and cortisol directly inside eight men’s and eight women’s noses. At the tested amount, responses resembled the control: electrical activity in the nose and skin, heart rate and breathing. Attraction was not measured. This was a small, single-blind study with authors working for or advising the sponsor.83

6. Body odor and sexual attraction

Several chemicals became candidates for human pheromones because of their structure, their effects in other animals or earlier scent claims. Researchers then tested people’s responses. Tristram Wyatt favors starting with a response to something people naturally release, such as sweat, and working backward to find the chemical responsible.84, 1

Testing a chemical on its own shows what it can do in that experiment. Measuring natural release and exposure helps establish when the same effect could occur in daily life.13, 9

Six selected human experiments tested AND, androstenone, alpha-androstenol, androsterone, EST and copulin mixtures. Results include higher ratings, photo-dependent changes and findings with no clear difference.

Examples of attraction and social judgments. Each row summarizes a different test. The following sections give the methods, comparisons and other findings for each chemical.72, 85, 86, 87, 88, 89, 90

Whole body odor has also been tested. In a 2004 Chinese study, 40 men and 42 women smelled shirts worn by three men and three women. Of the 82 receivers, 49 preferred the opposite-sex sample when choosing between male and female odors. The rest preferred the same-sex sample or made no choice. With only six scent donors, individual differences could strongly affect the result. No single chemical was tested.91

6.1. Effects of androstadienone

At three speed-dating events, women who smelled androstadienone, or AND, rated men as more attractive overall. Their choices to meet again showed no clear overall change. The groups were small and unequal in size, and results varied between events. Unilever funded the work.72

Women who smelled AND gave men higher attractiveness ratings overall. The study found no clear overall difference in choices to meet again.

The speed-dating study measured both ratings and choices to meet again. Only the ratings showed a clear overall increase.72

The result depends on what people are asked to do. A 2017 study found no clear AND or estratetraenol effect on judgments of a face’s gender, attractiveness or likely unfaithfulness. A larger 2024 study found no clear AND effect on generosity or money-sharing with people at different levels of familiarity.73, 92

AND has changed cortisol, a hormone involved in energy use and stress, in opposite directions in different settings. Wyart’s team found higher cortisol after women smelled pure AND from a jar, compared with a similar-smelling yeast sample. They saw this in 21 women and again in another 27. Chung’s team found lower cortisol in 31 women doing timed arithmetic under critical feedback. They used dissolved AND on a pad, with musk in both samples. Delivery, comparison smells and the situation differed between the teams.8, 74

The person running the test may matter too. Among 37 women, mood improved with AND when a man ran the session, but the same pattern did not appear with a woman. Male-face ratings and attention did not improve. With only one experimenter of each sex, their individual manner could also explain the difference.93

A 2023 experiment tested punishment choices in 206 young heterosexual Han Chinese men and women. They smelled AND through a device at the nose before responding to an opponent they believed was the same sex. Men chose less aggressive punishments in two tasks. Women gave stronger punishments after provocation, with no clear increase in the other task. The study plan was not publicly recorded beforehand, and menstrual-cycle timing relied on the women’s reports.94

6.2. Androstenone and the androstenols

Androstenone occurs in human armpit samples and fluid from apocrine sweat glands. The receptor OR7D4 helps explain why people smell it differently.4, 7

In one older study, 14 women remaining from a larger group found androstenone less unpleasant around estimated ovulation. They still rated it unpleasant on average. Their ability to detect faint amounts did not clearly change. Another paper with competition and aggression in its title measured smell detection and ratings. A later correction changed a sensitivity statement and hormone-group labels. Aggressive behavior was not tested.95, 96, 97

Robin Tan’s doctoral study tested 103 women. Those smelling an androstenone mixture drank more alcohol-free beer during a taste test than those smelling water. Ratings of men’s photos and distance from a seat supposedly reserved for a man showed no clear change. The mixture contained propanediol, which was absent from the water control, so the solvent changed along with the steroid.85

3α-androstenol improved face ratings in a 2022 experiment with 32 heterosexual adults, sixteen of each sex. They sniffed the chemical in alcohol or alcohol alone before rating opposite-sex faces. Average scores were 4.17 versus 3.52 out of seven. The roughly two-second sniff came from a vial containing 1 mg per mL. Participants also found this sample stronger and more pleasant. The conscious smell experience therefore changed too. The experiment tested alpha-androstenol, and cannot establish the same effect for 3β-androstenol, its beta form.86, 36

An older necklace experiment found that women wearing 3α-androstenol later reported more conversations with men. It relied on their recollections, tested many questionnaire answers and contained some inconsistent reporting.98

In a toilet-stall experiment, men used selected stalls less often during the week when androstenol was applied to their doors. Androsterone produced no similar pattern in a different week. Fixed test order, untracked repeat visitors and amounts far above natural release make this a poor guide to ordinary contact.99

6.3. Androsterone and androstadienol

Androsterone changed how women judged men’s photos in a 1992 experiment. Maiworm and Langthaler studied 102 women using androsterone, androstenol and two control conditions. They applied a solution above the upper lip before the women rated five photos. Neither the women nor the researchers giving the tests knew which solution was used.87

The direction depended on the photo. With androsterone, one man’s average attractiveness score was 66.6 out of 100, compared with 51.8 in the group given no treatment. Another man’s score was 9.2, compared with 22.5. The authors reported both differences as statistically significant. They also used an alcohol-only control. For these two attractiveness scores, the table marks differences against no treatment, not against alcohol alone.87

Some other judgments changed against the alcohol control. One man was rated warmer and more lovable with androsterone. Another was rated less sexy. Androsterone affected impressions in this experiment, but the changes differed across the five photos. The authors recorded pill use and cycle timing without giving the group results needed to say that women on the pill were specifically repelled by androsterone.87

Androsterone also acts inside the body. Zolkowska and colleagues injected it into mice and measured protection against experimentally induced seizures. This is a measured nervous-system effect after a drug entered the animal’s body. Smelling androsterone released by another person is a different route of exposure.100

Researchers have followed androstadienol, or ADL, as it changes into other steroids in lab experiments. These reactions explain part of the production route shown in section 4.3.37, 38, 35

6.4. Effects of estratetraenol

The body can make estratetraenol, or EST. Human placental tissue converted AND into EST in a 1963 lab study. Researchers later identified it in late-pregnancy urine, checking it against a known sample and its chemical fingerprint. Most was attached to another chemical group and had to be freed with an enzyme. These findings concern production and urine content. They do not measure airborne exposure from skin.101, 102, 1

EST has changed some visual judgments. In 2014, AND and EST affected whether people saw a walking figure made of dots as male or female. Results differed by sex and sexual orientation. The later face study found no clear effect on gender or attractiveness ratings, using a different visual task.75, 73

Original walking-dot stimuli, showing seven body shapes and frames from the moving figures.

The actual figures used in the 2014 experiment. The top row shows the range from more female to more male body shapes. The lower rows show movement over time. SD is the paper’s unit for steps along the body-shape range, not a probability that a person is male or female. Original Figure 1 from Zhou and colleagues.75

Oren’s team tested a highly concentrated EST sample in two experiments. Among 56 men, it improved overall accuracy in judging relationships shown in videos. The result for intimate relationships alone did not remain clear after accounting for the number of comparisons. Another 64 men chose photos for an album about emotions. EST increased ratings for pictures of things touching, including objects as well as people, without a clear change across all pictures. Neither task measured romantic feelings toward a partner.103

The authors used a high concentration because natural exposure was unknown. A related paper tested cooperative decisions, possibly with some of the same participants.103, 104

Another study asked men to view an erotic image briefly now or wait to see it longer. Each completed the task with EST and a comparison scent. Among the 76 men analyzed, choices to wait rose from 42% to 47%. A separate measure of how waiting reduced the image’s value showed no clear change. Nineteen of the original 95 men were excluded, including seven who always chose the same option.88

With the comparison scent, men chose to wait for a longer view of an erotic image on 42 percent of trials on average. With EST, the figure was 47 percent.

Average shares of choices to wait, from 0% to 100%. Each man completed both conditions. The task concerned viewing an image.88

6.5. Sexual orientation and brain responses

Brain scans have found different responses to AND in groups of men and women with different sexual orientations. A 2014 review describes experiments where changing the amount of AND also changed the apparent difference between men and women. Some older reports used the same comparison participants, so they include fewer separate groups of people than the number of papers might suggest.105

These scans describe average brain responses in the groups studied. They cannot tell us a particular person’s sexual orientation or what that person desires.105, 21

6.6. Copulins and vaginal acid mixtures

Copulins is a name for mixtures of short-chain acids found in vaginal fluid. Examples include acetic, propanoic and butanoic acids. In 1975, Michael and colleagues analyzed hundreds of samples collected across 86 menstrual cycles, including samples from women taking the pill. The amounts varied widely between women and with the collection method.106

Later teams tested lab-made versions of these mixtures on men. A 2016 study of 100 men found a difference in how desirable the men thought they were. The change in their ratings of women’s faces was too uncertain to count as a clear effect. Their reported efforts to keep a partner from becoming involved with someone else, called mate guarding, did not change. The study did not measure testosterone.89

A larger follow-up tested 231 men with four different sample conditions. It found no clear increase in efforts to find sexual partners, self-rated desirability, the expected changes in partner preferences or risk taking. The overall face ratings moved in the opposite direction to the predicted improvement.90

An older trial followed 62 couples through three menstrual cycles. They received an acid mixture or comparison treatments under coded labels. The study found no clear effect on sexual behavior or desire. A later analysis found a favorable result in a small subgroup when repeated days were counted separately. That result did not hold when each couple was counted as one unit.107

The acids themselves are known. The experiments used different recipes and ways of delivering them, with mixed results on attraction and sexual behavior.106, 89, 90, 107

6.7. Smell, arousal and sexual enjoyment

People with a more sensitive sense of smell reported more pleasant sexual experiences in a 2018 study by Bendas, Hummel and Croy. The researchers tested 70 adults with a rose-like scent and asked about their sex lives. Women who detected fainter smells also reported reaching orgasm during a larger share of sexual encounters. Sensitivity had no clear link to sexual desire, how often people had sex or how long it lasted. This was a comparison of existing differences between people. No body odor or pheromone was given to them.108

Wisman and Shrira collected women’s armpit sweat while the women were sexually aroused and while they were in a neutral state. Men then smelled the samples. In two of three experiments, they rated the arousal samples as more attractive. The third result was less clear. Other tests asked men how aroused they felt and measured their responses to photographs.11

McCarthy and colleagues checked the results in 2021 and found an error in the calculation of how large the effects were. The actual average differences in smell ratings were 0.18 to 0.27 points on seven-point scales. They also pointed out other inconsistencies in the original report.109

The changes were small, and the tests used whole sweat samples. They cannot identify which ingredient caused the change in ratings or show how it would affect a sexual encounter.11, 109

6.8. Seeing a man with a partner

Seeing a man with an attractive partner can change how another woman rates him. Liu and Zheng tested whether AND affected this response in two experiments published in 2026. Women first rated men’s faces, then saw the men paired with women and rated them again. Each participant did the task with AND under her nose and with a comparison scent on separate days.110

Original photo examples: a man alone, the same man beside a woman, and the man alone again, with ratings before and after the pair.

Women rated their romantic interest in a man, saw him beside a woman presented as his partner, then rated him again. These are the photo examples printed in the paper. The arrows show task order. Adapted from Figure 1 of Liu and Zheng, using its original photographs.110

In the first experiment, involving 54 women, the average increase in interest was about 0.55 points with the comparison scent and 0.12 with AND, on a seven-point scale. The difference was larger among women who reported less competition with other women. A second experiment with 50 women added a task that encouraged feelings of competition. The AND effect depended on that task and the women’s existing sense of competition. These experiments measured changes in ratings after viewing pictures. Some participant totals and statistical values in the paper do not agree, so its detailed subgroup results need particular care.110

7. Body odor, fertility and hormones

Hormones can matter on both sides of a scent experiment. A woman’s hormone levels may be linked to her body odor. The person smelling it has their own hormone levels, which may affect their response. Researchers can also test whether the odor changes those levels. For that last question, they need to compare the change after the odor with the change after a control sample.111, 96, 8, 112

Hormones are measured in the person giving the odor and the person smelling it. To test an odor effect on hormones, compare the before-to-after change in an odor session with the change in a control session.

The sample giver’s hormone levels, the receiver’s starting levels and the receiver’s change after exposure are separate measurements. A change after an odor is only part of the comparison. Hormones can also change during the control session.111, 96, 8, 112

Men’s hormone levels can also be linked to the impressions their odor gives. In a Russian study published in 2012, 77 women smelled sweat samples from 29 men. Among women estimated to be near ovulation, sweat from men with higher testosterone and lower cortisol received higher ratings for reliability. That link did not appear in the group tested later in the cycle. The researchers measured the men’s hormones in saliva. The women smelled their sweat, and cycle timing was estimated from calendar dates.113

7.1. Body odor during the menstrual cycle

Men sometimes prefer a woman’s odor collected near ovulation, but the size and consistency of that preference vary. Gildersleeve’s team collected two armpit samples from each of 41 women, using urine tests to help confirm timing. Men chose the near-ovulation sample as more attractive on 56% of trials and distinguished the samples better than chance. The attraction result was less clear when each woman providing scent was counted separately, rather than each man rating it.114

Lobmaier’s team found higher scent-attractiveness ratings in women with higher estradiol and lower progesterone near their fertile days. This compared different women. Mei’s team took repeated samples from each woman, with hormone and ovulation tests. Average ratings changed near ovulation, but a woman’s hormone changes did not clearly predict her smell ratings. Men were also poor at identifying her fertile days from one sample.111, 115

A woman can smell attractive throughout her cycle. To find out whether her scent changes near ovulation, researchers need samples from her at different times.111, 115, 51

One study compares samples from different women. Another collects repeated samples from each woman during her cycle.

Comparing women and measuring a woman’s changes over time answer different questions. The dots illustrate the methods, without representing participant numbers.111, 115, 51

Zetzsche’s 2024 study combined repeated armpit samples, hormone measurements, ovulation tests, chemical analysis and smell ratings. It found no clear fertile-day improvement in attractiveness or the expected chemical changes.51

Ohgi’s team reported a positive result in 2025 with different collection methods. They identified geranylacetone, myristic acid and palmitoleic acid in connection with samples near ovulation. All three are outside the steroid group. Adding them to a lab-made armpit odor improved some ratings. Small further experiments tested mood, body reactions and face ratings.52

Many chemical comparisons were tested, increasing the chance of accidental findings, and the authors reported a related patent interest. The experimental blend also needs comparison with the amount men normally smell. Collection methods may explain part of the disagreement between the two teams.52, 51

A 2025 study examined odor from the vulva, the area around the vaginal opening. Ratings did not clearly improve during fertile days. Chemical patterns depended on the analysis and compliance with collection instructions. It used the same women as Zetzsche’s armpit study, adding a second body area within that group.116, 51

7.2. Hormone changes after smelling body odor

Studies of men’s testosterone after they smell women’s body odor have produced mixed results. Tarumi and Shinohara used samples from five women and reported effects for some body areas. Roney and Simmons found no testosterone effect after confirming when the women ovulated and repeatedly measuring men’s saliva. Another study of scents from fertile days found none of the expected hormone or psychological changes.117, 118, 119

Preti and colleagues gave 18 women a mixture of men’s armpit samples to smell, along with a control whose smell was masked. The order varied between sessions. The average wait until the next release of luteinizing hormone, or LH, was 47 minutes after the men’s samples and 59 minutes after the control. The number and size of these hormone releases, and the starting LH level, showed no clear difference.120

LH helps control reproduction. The body releases it in repeated bursts, often called pulses. The large rise around ovulation is different from the timing of one pulse. Preti’s result concerns a 12-minute difference in that timing. The team tested the combined armpit samples, so identifying the ingredient behind the change would need a further test.51, 120

Shinohara and colleagues also measured LH pulses in studies involving 11 and 20 women. They tested androstenol or armpit extracts. In the 20-woman study, the results depended on when in the sample-givers’ cycles the armpit material had been collected.121, 122

7.3. Scents from breastfeeding women

Jacob and colleagues studied whether scents collected during breastfeeding affected other women’s menstrual cycles. The samples came from the armpits and breasts of 26 nursing mothers and could also contain their babies’ saliva. Women in the experiment wiped the samples, or a comparison liquid, under their noses several times a day for two cycles. In the main analysis of 47 women, cycle lengths became more spread out in the scent group. Women who began with longer cycles tended to keep longer cycles, while those with shorter cycles tended to keep shorter ones.123

Spencer and colleagues reported sexual-diary results from the same larger experiment. Women receiving the collected scents reported increased sexual desire and more days with sexual fantasies. Sexual activity did not clearly increase. These papers describe overlapping participants, so they add different measurements from one research project.124, 123

The cycle analysis excluded women whose starting cycles fell outside the study’s chosen range. The diary analysis also excluded some missing or extreme values. Both results concern repeated application of collected fluids under the nose. Neither paper identifies a single ingredient responsible for the changes or shows that ordinary contact with a nursing mother has the same effect.123, 124

7.4. Menstrual cycles in women living together

Menstrual synchrony is the idea that women who live together or spend time close to one another begin getting their periods at the same time. A 1971 dormitory study tracked when women’s periods started. In 1998, Stern and McClintock tested armpit extracts collected at different points in women’s cycles. That experiment compared extracts containing a mixture of chemicals.125, 126

Yang and Schank followed 186 women in 29 dormitory groups. Their periods did not stay aligned beyond what would be expected by chance. Cycles of different lengths naturally bring period dates closer together and then further apart. Matching dates can happen without one woman’s body changing another’s cycle.127

A change in the timing of one LH pulse would need to produce repeated changes across whole cycles to explain periods staying aligned. The synchrony studies have not established that chain or identified a chemical that causes it.126, 127, 1

7.5. How reproductive fluids act on sperm

Progesterone released by cells around the egg acts directly on human sperm through fluid. It lets more calcium enter through CatSper, a channel in the sperm’s surface, and changes tail movement.128, 129

Jeschke’s team tested 15 steroids, including pregnenolone, testosterone, DHEA, estradiol, estrone and cortisol. All caused calcium entry, with widely different strengths. Responses disappeared in sperm lacking a working CatSper channel. Progesterone and 17-hydroxyprogesterone were strongest. The team also tested fluid from around eggs, chiefly a pooled sample from four women undergoing fertility hormone treatment. At the much greater dilution expected in the reproductive tract, they judged progesterone likely to explain most of the fluid’s effect.130

Semen contributes prostaglandins, chemical messengers that also activate CatSper. Zinc held the response down. Diluting a mixture of zinc and prostaglandin E1 first strengthened the calcium response, then weakened it with further dilution.130

Wehrli’s team screened 90 steroids and examined ten active examples more closely, including pregnenolone, testosterone, epiandrosterone and deoxycorticosterone. They increased calcium inside sperm and reduced the response to progesterone added later. The ten did not change overall swimming measures.131

How progesterone starts the response remains disputed. Miller’s team proposed in 2016 that it activates ABHD2, an enzyme that breaks down a fat-like substance holding CatSper down. Edwards’s team used more selective ABHD2 blockers in 2026, and sperm still responded to progesterone. This challenges that proposed enzyme step.128, 129

These are direct effects of hormones in reproductive fluids. Attraction through smelling them was not tested.130, 131

8. Body odor and relationships

8.1. Immune genes and partner preference

Some partner-choice research focuses on genes that help the immune system recognize what belongs in the body. They form a group called the major histocompatibility complex, or MHC. In humans, this group is called HLA. One idea is that smell helps people choose partners with a useful difference in these genes.132, 1

In the 1995 T-shirt experiment, Wedekind and colleagues asked 49 women to smell shirts worn by men with similar or different HLA types. The 31 women who were not taking the pill rated the smells of men with different HLA types as more pleasant. The 18 pill users showed a preference in the other direction in one analysis, though it was less clear when each woman was counted separately.133

A 2018 experiment included smells from both partners and strangers. Among the 24 women who were not using hormonal contraception, scents from men who shared more of the tested HLA types received lower attractiveness ratings. The 28 women using hormonal contraception and the 47 men showed no clear preference based on this similarity.134

Researchers have tested several versions of the idea. A person might prefer someone with different gene versions, a wider variety of versions or a particular combination. Studies also measure different things: whose smell people like, how satisfied couples are or which gene combinations actual couples have.132

A review combined results from several studies and examined these questions separately. Overall, it found no clear link between having different MHC genes and the preferences or relationship outcomes measured. Some individual studies found links, but the combined results do not give a reliable rule for choosing a compatible partner by smell.132

A Brazilian study published in 2026 included 20 heterosexual and 20 non-heterosexual men who rated other men’s armpit odors. The non-heterosexual men gave the male scents higher attractiveness ratings. HLA similarity did not explain those ratings, though more similar HLA types were associated with stronger-smelling samples. The paper draws on Silva’s earlier thesis, so the thesis and article share research rather than providing two independent tests.135

Milinski and colleagues added HLA-related peptides, small chains of amino acids, to people’s own armpit odor. Among 17 nonsmokers tested while free of a cold, people preferred the altered scent that matched their HLA type. They were judging which smell suited them. The researchers knew which peptides they had added, but did not measure how much would naturally pass from one person to another.136

8.2. Birth control, smell and face preferences

In one study, 37 women who started taking the pill and 60 comparison women repeated smell-preference tests over time. After starting the pill, the women’s preferences shifted toward men whose immune genes were more similar to their own, relative to the comparison group. The women chose for themselves whether to start the pill. Beforehand, the study found no general preference for men with different HLA genes.137

This study followed women starting the pill. It did not follow women stopping it or test androsterone. Its group result cannot predict how one woman will feel about her partner’s smell.137

Another study gave women weekly smell tests. Thirteen pill users had a test during their scheduled break from active pills. On those days, they were less able to tell body odors apart than during weeks when they took active pills. Across the study as a whole, pill users and women who did not take the pill performed similarly.138

Telling two body odors apart is different from noticing a very faint smell. Some other studies tested the faintest amount women could detect. These different tests of smell can give different results.138, 139

Thorne and colleagues studied 32 women, half of whom took the pill. Women rated male faces and fictional characters more favorably overall when a combined sample of men’s armpit odor was present. Pill use did not clearly change the effect on face ratings, and pill users also gave higher scores to some characters. The study was small, used few visual examples and compared the scent with a room without added odor. Even so, it found positive responses among pill users, which goes against the idea that they generally dislike male scent.140

Average face ratings were 2.13 out of 5 without added odor and 3.80 with male armpit odor. Lines show standard deviations of 0.38 and 0.42.

Ratings from all 32 women, including 16 pill users. Each woman completed both odor conditions. Dots show averages. The short lines show the spread reported for each condition, expressed as one standard deviation. Redrawn from the numbers in Thorne and colleagues’ Results section.140

A 2026 study tested 98 women twice, including 47 pill users. It found no overall difference between pill users and other women in detecting, identifying or telling smells apart. Some smaller groups differed depending on the pill and how it was taken. These were tests of ordinary smells. They did not test attraction to men’s body odor or a response to androsterone.141

The pill has also been studied through the faces women choose. In 2013, Little and colleagues let women adjust men’s faces on a computer until they looked most attractive. Among 18 women who started the pill, preference for a more masculine face fell relative to 37 women who stayed off it. The women chose whether to start the pill themselves.142

The same male face altered toward a less masculine shape on the left and a more masculine shape on the right.

The male-face examples from Little and colleagues’ Figure 1. Women adjusted face shape along a range between the two versions. These images show what the researchers meant by facial masculinity.142

A separate comparison in the same paper included 170 couples. Half the women had been taking the pill when their relationship began. Their partners’ faces were judged less masculine on average than those of the other group. The pictures below are computer-altered examples built from the two groups’ average face shapes. The couples were already together when studied, so this comparison cannot show how the pill changed any one woman’s choice.142

Four computer-altered male faces based on the partners of pill users and nonusers. The lower pair deliberately exaggerates the shape difference.

The original face panels from Figure 2. The left column uses the shape associated with partners of pill users, the right with partners of nonusers. The top row uses +50% shape changes. The authors exaggerated these to +200% in the bottom row to make the difference easier to see. These percentages describe image editing, not hormone levels.142

A later study by Jones and colleagues followed 30 women who started the pill and 15 who stopped. It found no drop in preference for masculine male faces during pill use. The 2013 pattern therefore did not carry over to this later group. These experiments tested visual preferences. They did not measure the men’s scent or testosterone.143, 142

8.3. Dominance and responses to other women

In 2025, researchers measured men’s testosterone and asked other people to rate the smell of shirts the men had worn. Men with higher testosterone were judged as more dominant. Higher testosterone had no clear link to ratings of sexiness, a pleasant smell, or being worthy of respect and admiration. A correction to the paper clarified which university had recruited the participants.144, 145

An earlier study also found no clear link between men’s testosterone and how attractive their body odor smelled. Seeming dominant, seeming attractive and acting aggressively are different things. The 2025 study measured impressions from shirt smells. It did not measure androsterone or watch men interact aggressively.146, 144

Experiments with a named chemical give a different kind of evidence. Banner and Shamay-Tsoory tested 64 men with AND and a comparison scent on separate days. Men with higher social anxiety rated male faces as slightly more dominant with AND. Their average rating rose from 4.82 to 5.06 on a nine-point scale. Men with lower social anxiety showed no clear change. The chemical altered how one group judged the faces.147

Rivalry has also been studied in women. In a 2026 experiment, 52 women read a story in which another woman was interested in the same man. With AND, they rated the other woman as more flirtatious and said they were slightly more likely to share negative information about her. The average likelihood score rose from 3.00 to 3.19 on a seven-point scale. Positive and neutral gossip scores did not clearly change. These were answers about an imagined situation, and the negative information was specifically about sex and fidelity.148

A different 2026 study, by Nehls and colleagues, tested 33 women with body odors collected from other women during menstruation, near ovulation or during pregnancy. While smelling pregnancy samples, participants chose a greater preferred distance from women shown in photos than while smelling either of the other body-odor samples. Their attractiveness ratings did not change. The distance was a choice on a screen. The photos showed different women from those who gave the odors.149

The researchers tested the collected odors as mixtures. Hormone measurements helped identify the donors’ and participants’ reproductive states. The experiment did not isolate progesterone, estradiol or another hormone as the chemical responsible.149

8.4. Recognizing people by smell

A worn shirt carries body odor along with smells from the fabric, soap and perfume. Researchers have tested whether partners, mothers and babies, and children who know each other can recognize one another by smell. These tests ask whether a scent is familiar. Attraction tests ask whether someone likes it.1, 150

With relatives, both shared genes and time spent together may matter. A familiar family smell could come from similar body chemistry, from learning someone’s smell, or both. Researchers need comparisons that separate these explanations.13, 1

A partner’s smell has also been tested during sleep. Hofer and Chen asked 155 people to sleep with shirts used as pillow covers, including a shirt worn by their partner. Wrist monitors estimated how much of their time in bed they spent asleep. Across the three groups studied, the average improvement with the partner’s scent was about two percentage points. The first group showed the clearest result. Neither of the two later groups showed a clear improvement on its own, including the group that compared partner odor with a stranger’s odor. The experiment tested the whole familiar scent.151

A partner’s scent does not always feel calming. In a 2026 lab study, people who smelled their romantic partner’s odor reported more stress and had a higher heart rate. Their cortisol did not fall.152

8.5. Body odor and smell at different ages

Sweat glands, hormones and experience change with age. Much human scent research uses young adults, so studies of children and older people add information those experiments cannot supply. Soaps, perfumes, culture and expectations affect people’s experience of odor too.1, 24, 21

Among 219 Czech children aged ten to fifteen, 109 named someone who smelled good. Within that group, those further through puberty more often named other young people than adults. Their answers included perfume and deodorant.153

A 2026 study followed 276 women through pregnancy and after birth with repeated questionnaires. Disgust ratings for situations involving body odor were highest early in pregnancy and lowest seven to eight weeks after birth.154

Among 2,086 Americans aged 62 to 90, AND detection was linked to aspects of social and sexual life. This compared existing differences between people, without testing whether AND exposure changed their lives.155

Japanese research also describes the sweet-smelling γ-decalactone and γ-undecalactone, or lactones C10 and C11. A Rohto patent reports higher amounts in clothing samples from younger women in a group of 50. Separately, 52 adults gave women’s photos higher youthfulness, femininity and attractiveness ratings with a perfume containing the lactones than without fragrance. That comparison cannot isolate each lactone’s contribution.156

In a 2025 menopause study, a difference in faint-odor detection disappeared after accounting for age. Some differences in identifying smells remained. Sexual responses were not tested.157

Detecting faint odors, recognizing someone and finding their smell attractive are separate abilities. A result in one age group does not describe all three across life.1, 105, 155

9. Communication beyond attraction

9.1. Smell between parents and babies

Newborns respond to several smells associated with feeding. Montgomery’s glands, the small glands around the nipple, release fluid during breastfeeding. When Doucet’s team held samples near babies’ noses, their breathing and mouth movements changed, suggesting a role in early feeding responses.2

Other experiments traced particular chemicals. Contreras’s team found eight fatty acids in amniotic fluid, the liquid around a baby before birth, and in early and later milk. Nineteen newborns made longer sucking movements when smelling amniotic fluid or a lab-made mixture of the acids than comparison samples.158

Gutiérrez-García’s team tested each acid separately in 12 newborns. Myristic acid produced longer sucking and sniffing movements than the other acids, salt water, vanilla or the solvent. Samples were held near the nose for 30 seconds, and two people scored recordings without knowing the sample used.159

These babies had already fed, so familiarity before birth or during feeding could contribute. Sleep state was not recorded in the 2017 study. Both studies measured movements, rather than milk intake. They also leave a separate question about which ingredients cause the response to Montgomery’s gland fluid.158, 159, 2

Androstenone solutions produced some negative facial responses or shorter positive movements in a study of 81 newborns. The main scorer knew the samples used, and the preparation contained a second, weaker odor. The experiment tested these solutions, without removing androstenone from milk to check its role there.160

Parents respond to children’s odors too. Two 2024 brain-scan studies included 78 women. Younger children’s odors produced stronger responses in areas linked to pleasure and reward. Some connections between brain areas differed with motherhood, and certain connections were stronger when mothers smelled their own young child than an unfamiliar child.161

A University of Tokyo patent reports tests in 133 mothers whose youngest child was three to five. Two infant-odor mixtures produced larger urinary oxytocin increases than three comparison conditions. The smaller mixture contained 2-pentylfuran, 2-pyrrolidone, acetophenone, phenylacetaldehyde and nonanal. The inventors measured urine oxytocin, without testing childcare behavior.162

A 2025 Japanese study gave 27 mothers a 14-compound infant-odor mixture while they heard babies’ cries and happy sounds. After accounting for multiple comparisons, the main brain-response test showed no clear odor effect. A further analysis found a difference linked to ratings of cries. The ratings themselves did not change.163

An Iranian trial followed 78 mothers with babies in intensive care for five days. Watching a video of their baby, with or without smelling the baby’s worn hat, reduced reported anxiety and increased expressed milk compared with receiving a plain hat. Adding the odor showed no clear extra benefit over the video alone.164

9.2. Body odor during fear

Sweat collected during fear can change other people’s responses to faces and threats. A 2017 meta-analysis, which combined 26 experiments, found an overall pattern of responses. The tasks and collection methods differed. A change in attention or face judgment need not mean the person consciously feels afraid. Movement, warmth and sweat volume can change during fear too.3, 21

Researchers have tested particular chemicals. In a 2023 study, the main sweat results failed to match predictions recorded before analysis. Later patterns in smaller groups led to a test of palmitic acid, also called hexadecanoic acid, in 33 women. It made them slightly more likely to label mixed fear-disgust faces as fearful than the other conditions combined. The acid occurred in neutral sweat too, and the test used an added amount. Its contribution at natural body-odor levels needs a separate comparison.165

A 2025 study collected sweat from 12 women during anxiety-provoking dental treatment and a neutral night at home. Strong odor ingredients included decanoic acid, lauric acid, myristic acid and HMHA. Lauric acid and HMHA stayed detectable at greater dilution in anxiety samples. Myristic acid showed the reverse. These were measures of odor strength in extracts, not exact amounts in fresh sweat, and HMHA’s identity was tentative.166

After smelling the anxiety sweat, 36 men and women detected a fainter rose-like smell than after an unused pad. The difference from neutral sweat was unclear, and a second test odor showed no improvement. Collection duration and setting also differed between the sweat samples. The receiver test used the whole mixture, so it cannot assign the response to one acid.166

A 2026 preprint measured chemicals above the armpits of 37 adults during frightening virtual scenes. Stronger fear responses went with more acetic, butyric, caproic and caprylic acids, octanal and acetone. Sulcatone, decanal, geranylacetone and citraconic anhydride showed the reverse pattern. Some identities were tentative because similar chemicals can overlap in the measurements. Everyone saw the neutral scene first, allowing time effects to contribute. Other people’s responses to this mixture were not tested.167

9.3. Body odor during happiness

In 2015, de Groot and colleagues asked 35 women to smell sweat from nine men who had watched happy, frightening or neutral films. Sweat collected during the happy films caused facial-muscle activity that the authors interpreted as smiling. In a separate test, it did not make the women judge neutral symbols more positively.168

This was an early study looking for possible effects. The smiling result depended partly on how the researchers handled differences in muscle activity between women. All men watched the film types in the same order, so the order could also have affected their sweat. Unilever partly funded the work. The tests measured immediate reactions during the session.168

9.4. Illness can change body odor

In a 2023 experiment, people received either a bacterial substance called lipopolysaccharide, which causes inflammation, or salt water as a control. Other people then smelled their body-odor samples. They rated the samples collected after inflammation as slightly less pleasant.169

The researchers also found a change in 6-methyl-5-hepten-2-one after accounting for the many chemicals they had compared. They tested the collected odor as a whole, so this chemical change does not explain the less pleasant ratings by itself. They measured ratings of samples, without watching whether people avoided an ill person.169

9.5. Experiments with human tears

Smelling tears has changed sexual responses and retaliation in several experiments. Gelstein’s team collected tears from crying women in 2011. Twenty-four men rated women’s photos as less sexually attractive after smelling tears than salt water, without seeing anyone cry.170

Other experiments reported lower arousal and testosterone. Brain areas first identified by their response to sexual images were less active during sad films after tears than salt water. Some hormone and arousal findings, however, came from separate before-and-after tests. A decrease after tears alone does not establish that it differs from the change after salt water.170, 171

A Korean team directly compared those changes in 2012. Sixteen men provided usable testosterone measurements on separate tear and salt-water mornings. Blood testosterone fell 28.6% after tears and 14.0% after salt water, a statistically significant difference. Four of the original 20 men’s samples were excluded because of damage. Appetite and food intake did not change.112

The attraction finding has been harder to repeat. Gračanin’s team ran three studies with 75, 150 and 28 men, finding no clear overall reduction in attractiveness ratings. Their images, tasks and some methods differed. Noam Sobel disputed those methods and found decreases after reanalyzing one face and one subgroup. These were selected parts of the same data, rather than new independent experiments.171, 172

In 2023, men played a game against someone they believed was stealing their money. They could retaliate by taking money from the opponent without keeping it. Among 25 men analyzed, retaliation per theft was lower after smelling women’s tears than salt water.10

Four human smell receptors also responded to tears in lab-grown cells. The tests show detection of ingredients within the mixture, without identifying which ingredient explains the game result. The authors proposed that tears could protect babies, but their experiment measured adult men’s retaliation and did not test infant care.10

9.6. Hexadecanal and aggression

Hexadecanal, or HEX, is a different chemical from hexadecanoic acid. Mishor and colleagues tested it in 127 people. After a game with an unfair opponent, participants chose how loudly to blast noise at that person. Compared with their respective control groups, men who smelled HEX chose quieter noise and women chose louder noise.9, 165

The authors suggested that HEX might help protect babies. That idea went beyond the experiment, which involved a game. The team did not study parents caring for babies. The study also left open how much HEX people normally release and breathe in.9

Men retaliated less often for each theft in a game after smelling tears. In a separate HEX experiment, men chose quieter noise punishments and women chose louder ones. Each result compares the chemical sample with its own control.

Two studies using different samples and tasks. The tear experiment counted revenge responses for each theft. The HEX experiment measured the noise volume chosen by 127 people. The arrows show the order of events. The results describe the direction of change, without comparing its size across the studies.10, 9

10. Perfumes, products and patents

People can still recognize someone’s body odor after perfume has been added. Fragrance experiments have tested both this recognition and how pleasant the combined smell is. A pheromone claim would need a test of the specific response the chemical is said to cause.150

Deodorants and antiperspirants can change the mix of armpit microbes. A study that counted these microbes did not measure attraction, so it cannot tell us which product makes someone smell more attractive.173

10.1. Studies of pheromone products

Two small trials asked people to keep diaries of their sex lives. In Cutler and colleagues’ 1998 study, 38 men finished a trial using aftershave with either a test additive or a comparison additive under coded labels. Men using the test additive more often reported an increase in days when they had sex or slept beside a partner. Several other diary measures showed no clear difference.174

McCoy and Pitino studied 36 women who finished a similar trial using a perfume additive or a comparison additive. Some diary measures involving a partner, including sex, favored the test product. The number of approaches and casual dates did not clearly differ.175

These trials reported benefits for some parts of the participants’ sex lives. Confidence is limited by the small groups, people leaving the trials, differences between groups at the start, and the many diary measures tested. The suppliers were also involved. Each study used a different formula, and neither published its full chemical recipe. Their results apply to those products and cannot identify which ingredient produced the changes.174, 175

10.2. Pheromone patents

Patents document ingredients, experiments and proposed uses. Their value depends on what the inventors actually tested. Several examples show the range:176, 177

  • US5272134A, the Berliner fragrance patent, reports electrical responses from electrodes inside the nose. It did not test the attractiveness of someone wearing the fragrance.176

  • WO2025013888A1 covers fragrance mixtures linked to the menstrual cycle. It belongs to the same research program as the geranylacetone and fatty-acid paper in section 7.1. The patent and paper are not independent confirmations.177, 52

  • WO2009003935A1, Andrea Büttner’s application, describes repeated vaginal sampling in three women. It identifies acids, sulfur compounds, vanillin and fruity or floral odor chemicals. Proposed uses concern sperm movement and sexual stimulation, but the worked examples test collection and chemical identity.178

  • US20090117163A1, Alexandra Fede’s application, proposes scent-releasing capsules for clothes or jewelry. It lists steroids and copulins, without a controlled trial of the claimed attention, mood or attraction effects. One ingredient is called androstenediol while its chemical name describes androstenol.179

  • EP3462875A1 tests hormones as rodent attractants. Progesterone alone and a progesterone–estradiol mixture reportedly increased male mouse captures. Estradiol alone did not. Testosterone drew female mice toward a treated chamber in a lab test. These are mouse results.180

  • US8679507B2, Moshe Shifrine’s Testosterone olfaction, reports increased saliva testosterone after ten men applied truffle extract above the lip for several nights. With no control group, possible skin absorption and other extract ingredients, it does not isolate an effect of smelling testosterone.181

One invention may appear under several patent numbers and languages. Japanese, international and Spanish filings can describe the same work.176, 182, 183, 184

Japanese reviews also discuss plant fragrances with proposed pheromone-like effects. Their effects on people are a separate topic from chemicals released by humans.185, 186

10.3. What people report after using hormones

Personal reports can describe changes that formal experiments have not yet tested. In a 2026 Bioenergetic Forum discussion, one man described more pleasant armpit odor and more attention from women after using several hormone products. His account included testosterone and related steroids, along with other supplements and changes in his routine. Several things changed together. The post records his experience, but it does not isolate which change affected his smell or the way people responded to him.187

Other reports focus on odor itself. In a Reddit discussion about progesterone, the original poster and two people replying described stronger body odor after starting it. One said the change went away after stopping. Another reported that it settled after a doctor added a different medicine. These accounts describe changes during hormone treatment. They contain no measurement of the chemicals leaving the skin or test of attraction in someone else.188

These reports give researchers concrete observations to investigate: changes in smell, changes in the chemicals leaving the skin and changes in other people’s responses. The user’s own mood and behavior may change too. A calmer manner or more eye contact could affect an interaction without a change in scent. These accounts are not instructions to use hormones.187, 188

11. What research has found so far

Human scent can affect how people experience each other. The examples include recognizing someone familiar, responding to threat, judging a face and a newborn’s movements toward feeding. Those responses have different purposes, even when they all begin at the nose.1, 3, 147, 2, 159

The chemistry is equally varied. Skin cells and microbes make and change odor chemicals. Air can change them again. The person smelling them brings their own receptors, hormone state and experience. Together, these findings explain why measuring one hormone gives only part of the information needed to understand someone’s scent and its effects.5, 6, 54, 42, 7, 77

For attraction, the response matters as much as the chemical’s name. A higher rating, a change in arousal and a decision to meet again are separate outcomes. The speed-dating experiment measured two of them and found different results. Keeping those distinctions makes it possible to say clearly what a chemical changed.72, 8

People already use smell to recognize, approach and respond to one another. Research is giving those everyday experiences chemical detail: what the body releases, how another person detects it and which part of the encounter changes.1, 7, 147, 2

12. Glossary

  • Semiochemical: A chemical that affects how living things interact. Pheromones are one kind.13

  • Kairomone: A chemical that helps a different species, as when a predator uses another animal’s smell to find it.13

  • Releaser / primer: A releaser effect is a fairly quick change in behavior. A primer effect is a slower change in the body, such as development. These names describe the response in a particular setting.13

  • AND: Short for androstadienone. A steroid tested for effects on hormones, smell and social behavior. Section 6.1.36, 8

  • ADL: Short for androstadienol. A steroid that can be changed into other 16-androstenes. Section 6.3.35

  • Androsterone / androstenone: Two different steroids with similar names. Their chemical drawings are in section 4.2.36

  • Androstenols: Steroids whose alpha and beta forms have the same parts arranged differently. Section 6.2.36

  • EST: Short for estratetraenol. A chemical tested as a possible human pheromone. Section 6.4.103

  • Copulins: A name for mixtures of short-chain acids found in vaginal fluid. Section 6.6.106

  • HEX: Short for hexadecanal. A different chemical from hexadecanoic acid, also called palmitic acid. Section 9.6.9, 165

  • HLA / MHC: A group of genes that helps the immune system recognize what belongs in the body. MHC is the general name, and HLA refers to the human form. Section 8.1.132

  • LH: Luteinizing hormone. It helps control reproduction and is released in repeated bursts. Section 7.2.120

  • OR7D4: A smell receptor that reacts to androstenone and AND. Section 5.1.7

  • VNO: Vomeronasal organ. A small structure inside the nose that detects chemicals from other animals in many species. Its role in adult humans remains uncertain. Section 5.2.1

  • Headspace: The air around a source of smell. Collecting it gives a different sample from touching a pad to the skin. Section 4.5.53

  • Precursor / enzyme: A precursor is a starting material for another chemical. An enzyme is a protein that speeds up a chemical reaction. Section 4.1.5, 6

  • Specific anosmia: Difficulty smelling one particular chemical while being able to smell other things. Section 5.1.66

  • Between-person / within-person: A comparison of different people, or repeated measurements of the same person. Section 7.1.111, 115

  • Significant / null finding: A result that passes a chosen statistical test, or one that does not provide enough evidence for the expected effect. These terms alone do not tell us how large or useful an effect is. Section 2.20

References

  1. Tristram D. Wyatt (2014). On the scent of human attraction: human pheromones?. DOI: 10.1017/CBO9781139030748.015. Chapter 13, pp. 275–303. Recognition pp. 278–281, production pp. 284–291, receptors pp. 291–295 and candidates pp. 295–302.

  2. Doucet S, Soussignan R, Sagot P, Schaal B (2009). The secretion of areolar (Montgomery’s) glands from lactating women elicits selective, unconditional responses in neonates. DOI: 10.1371/journal.pone.0007579. PMID: 19851461. Results pp. 2–3, Figure 1 and Methods pp. 7–9.

  3. de Groot JHB, Smeets MAM (2017). Human Fear Chemosignaling: Evidence from a Meta-Analysis. DOI: 10.1093/chemse/bjx049. PMID: 28981822. Methods, overall synthesis, heterogeneity and limitations.

  4. Gower DB, Holland KT, Mallet AI, Rennie PJ, Watkins WJ (1994). Comparison of 16-androstene steroid concentrations in sterile apocrine sweat and axillary secretions: interconversions of 16-androstenes by the axillary microflora--a mechanism for axillary odour production in man?. DOI: 10.1016/0960-0760(94)90082-5. PMID: 8142319. Methods and Results, induced apocrine secretions, skin extracts and bacterial transformations.

  5. Minhas GS, Bawdon D, Herman R, Rudden M, Stone AP, James AG, Thomas GH, Newstead S (2018). Structural basis of malodour precursor transport in the human axilla. DOI: 10.7554/elife.34995. PMID: 29966586. Results, precursor transport and structural analyses.

  6. Rudden M, Herman R, Rose M, Bawdon D, Cox DS, Dodson E, Holden MTG, Wilkinson AJ, James AG, Thomas GH (2020). The molecular basis of thioalcohol production in human body odour. DOI: 10.1038/s41598-020-68860-z. PMID: 32719469. Results, Figures 1–3 and 6, and Discussion.

  7. Keller A, Zhuang H, Chi Q, Vosshall LB, Matsunami H (2007). Genetic variation in a human odorant receptor alters odour perception. DOI: 10.1038/nature06162. PMID: 17873857. pp. 468–472, Figures 1–4 and online Methods.

  8. Wyart C, Webster WW, Chen JH, Wilson SR, McClary A, Khan RM, Sobel N (2007). Smelling a single component of male sweat alters levels of cortisol in women. DOI: 10.1523/jneurosci.4430-06.2007. PMID: 17287500. Methods, cortisol time course and second-sample experiment.

  9. Mishor E, Amir D, Weiss T, Honigstein D, Weissbrod A, Livne E, Gorodisky L, Karagach S, Ravia A, Snitz K, Karawani D, Zirler R, Weissgross R, Soroka T, Endevelt-Shapira Y, Agron S, Rozenkrantz L, Reshef N, Furman-Haran E, Breer H, Strotmann J, Uebi T, Ozaki M, Sobel N (2021). Sniffing the human body volatile hexadecanal blocks aggression in men but triggers aggression in women. DOI: 10.1126/sciadv.abg1530. PMID: 34797713. Results, aggression experiments. Discussion, natural exposure and ecological limits.

  10. Agron S, de March CA, Weissgross R, Mishor E, Gorodisky L, Weiss T, Furman-Haran E, Matsunami H, Sobel N (2023). A chemical signal in human female tears lowers aggression in males. DOI: 10.1371/journal.pbio.3002442. PMID: 38127837. Results, aggression task, receptor assays and imaging. Discussion, ecological and receptor-causation limits.

  11. Wisman A, Shrira I (2020). Sexual Chemosignals: Evidence that Men Process Olfactory Signals of Women’s Sexual Arousal. DOI: 10.1007/s10508-019-01588-8. PMID: 32026223. Experiments 1–3 Methods and Results, Table 1, General Discussion and footnotes.

  12. Karlson P, Lüscher M (1959). ‘Pheromones’: a new term for a class of biologically active substances. DOI: 10.1038/183055a0. PMID: 13622694. Nature 183, pp. 55–56, definition and proposed classification.

  13. Tristram D. Wyatt (2014). Pheromones and Animal Behavior: Chemical Signals and Signatures. DOI: 10.1017/CBO9781139030748. ISBN: 9780521112901. Second edition. Chapter 1, pp. 1–2, 6–7 and 13–16. Chapter 2, pp. 49–56. Chapter 13, pp. 275–303.

  14. Nouvian M, Hotier L, Claudianos C, Giurfa M, Reinhard J (2015). Appetitive floral odours prevent aggression in honeybees. DOI: 10.1038/ncomms10247. PMID: 26694599. Results, Table 1, Methods and Discussion.

  15. Roberts SA, Simpson DM, Armstrong SD, Davidson AJ, Robertson DH, McLean L, Beynon RJ, Hurst JL (2010). Darcin: a male pheromone that stimulates female memory and sexual attraction to an individual male’s odour. DOI: 10.1186/1741-7007-8-75. PMID: 20525243. Results, recombinant-protein experiments and Figures 7 and 10. Methods pp. 17–20.

  16. Schaal B, Coureaud G, Langlois D, Giniès C, Sémon E, Perrier G (2003). Chemical and behavioural characterization of the rabbit mammary pheromone. DOI: 10.1038/nature01739. PMID: 12840760. Nature 424, pp. 68–72, especially Figures 2–4 and removal/add-back experiments.

  17. Choe DH, Villafuerte DB, Tsutsui ND (2012). Trail pheromone of the Argentine ant, Linepithema humile (Mayr) (Hymenoptera: Formicidae). DOI: 10.1371/journal.pone.0045016. PMID: 23028739. Results, Table 1, Figures 3–4 and Methods.

  18. Kenji Mori (2010). Chemical Synthesis of Hormones, Pheromones and Other Bioregulators. DOI: 10.1002/9780470669228. ISBN: 9780470697245. Chapter 4, §§4.1–4.3, pp. 107–111.

  19. Sakurai T, Mitsuno H, Haupt SS, Uchino K, Yokohari F, Nishioka T, Kobayashi I, Sezutsu H, Tamura T, Kanzaki R (2011). A single sex pheromone receptor determines chemical response specificity of sexual behavior in the silkmoth Bombyx mori. DOI: 10.1371/journal.pgen.1002115. PMID: 21738481. Results pp. 2–7, Figure 3 and Table 1. Methods pp. 7–8.

  20. Wyatt TD (2020). Reproducible research into human chemical communication by cues and pheromones: learning from psychology’s renaissance. DOI: 10.1098/rstb.2019.0262. PMID: 32306877. §§5–8, reproducibility, preregistration and future study design.

  21. Idan Frumin, Noam Sobel (2013). An Assay for Human Chemosignals. DOI: 10.1007/978-1-62703-619-1_27. ISBN: 9781627036184. Chapter 27, pp. 373–394. Design pp. 382–388 and methodological notes pp. 388–392.

  22. Fumiyo Toyoda and colleagues. The abdominal gland of the male red-bellied newt generates steroids that act synergistically with sodefrin as a courtship pheromone (2026). Physiology & Behavior 312, 115347. Methods 2.7–2.10, Results 3.1–3.4, Figures 1–3 and Table 1. PMID: 41990986. Source.

  23. Fumiyo Toyoda. 有尾両生類における性フェロモンの作用機構の解明 [The Action of the Sex Pheromones in Urodele] (2013-05-31). KAKENHI project 22570075, final research report. Japanese original, English abstract and sections 3–4. Source.

  24. Loos HM, Schaal B, Pause BM, Smeets MAM, Ferdenzi C, Roberts SC, de Groot J, Lübke KT, Croy I, Freiherr J, Bensafi M, Hummel T, Havlíček J (2025). Past, Present, and Future of Human Chemical Communication Research. DOI: 10.1177/17456916231188147. PMID: 37669015. Terminology, pp. 21–22, social recognition, pp. 24–25, and research roadmap, pp. 33–34. Online 2023, final issue 2025.

  25. Natalia Drabińska, Cheryl Flynn, Norman Ratcliffe, Ilaria Belluomo, Antonis Myridakis, Oliver Gould, Matteo Fois, Amy Smart, Terry Devine, Ben de Lacy Costello (2021). A literature survey of all volatiles from healthy human breath and bodily fluids: the human volatilome. DOI: 10.1088/1752-7163/abf1d0. PMID: 33761469. Review abstract, Methods and compartment summaries.

  26. Anuja Mitra, Sunyoung Choi, Piers R Boshier, Alexandra Razumovskaya-Hough, Ilaria Belluomo, Patrik Spanel, George B Hanna (2022). The Human Skin Volatolome: A Systematic Review of Untargeted Mass Spectrometry Analysis. DOI: 10.3390/metabo12090824. PMID: 36144228. Methods, Results and supplementary Table S3.

  27. Diana Owsienko, Lisa Goppelt, Katharina Hierl, Laura Schäfer, Ilona Croy and Helene M. Loos (2024). Body odor samples from infants and post-pubertal children differ in their volatile profiles. Communications Chemistry 7, 53. Results, Table 1 and Methods, “BO donors.” PMID 38514840. Original source.

  28. Reyme Herman, Bethan Kinniment-Williams, Michelle Rudden, Alexander Gordon James, Anthony J Wilkinson, Barry Murphy, Gavin H Thomas (2024). Identification of a staphylococcal dipeptidase involved in the production of human body odor. DOI: 10.1016/j.jbc.2024.107928. PMID: 39454956. Results, ShPepV enzyme assays and pathway figures.

  29. Martin A, Saathoff M, Kuhn F, Max H, Terstegen L, Natsch A (2010). A functional ABCC11 allele is essential in the biochemical formation of human axillary odor. DOI: 10.1038/jid.2009.254. PMID: 19710689. pp. 529–540, donor Table 1 and precursor tables.

  30. Harker M, Carvell AM, Marti VP, Riazanskaia S, Kelso H, Taylor D, Grimshaw S, Arnold DS, Zillmer R, Shaw J, Kirk JM, Alcasid ZM, Gonzales-Tanon S, Chan GP, Rosing EA, Smith AM (2014). Functional characterisation of a SNP in the ABCC11 allele - effects on axillary skin metabolism, odour generation and associated behaviours. DOI: 10.1016/j.jdermsci.2013.08.016. PMID: 24076068. pp. 23–30, Methods §§2.1–2.8, Tables 1–2 and Discussion.

  31. Tim Baumann, Sophia Bergmann, Thomas Schmidt-Rose, Heiner Max, Annette Martin, Bernd Enthaler, Lara Terstegen, Dorothea Schweiger, Hubert Kalbacher, Horst Wenck, Gabriele Jedlitschky, Zorica Jovanovic (2014). Glutathione-conjugated sulfanylalkanols are substrates for ABCC11 and γ-glutamyl transferase 1: a potential new pathway for the formation of odorant precursors in the apocrine sweat gland. DOI: 10.1111/exd.12354. PMID: 24533866. Results, ABCC11 transport assays, GGT1 conversion and gland staining.

  32. Andreas Natsch, Roger Emter (2020). The specific biochemistry of human axilla odour formation viewed in an evolutionary context. DOI: 10.1098/rstb.2019.0269. PMID: 32306870. Sections 1–6 and N-AGA structural analysis.

  33. Camille Ferdenzi, Géraldine Coppin, Christophe Bousquet, Sylvain Delplanque (2025). The perception of gender in two allegedly sex-specific body odor compounds MSH and HMHA. DOI: 10.1038/s41598-025-26457-4. PMID: 41309809. Scientific Reports 15, 42447. Methods and Results, participant selection and odor ratings.

  34. Kwan TK, Kraevskaya MA, Makin HL, Trafford DJ, Gower DB (1997). Use of gas chromatographic-mass spectrometric techniques in studies of androst-16-ene and androgen biosynthesis in human testis; cytosolic specific binding of 5alpha-androst-16-en-3-one. DOI: 10.1016/s0960-0760(96)00162-8. PMID: 9182868. pp. 139–145, Table 3 and Figure 3.

  35. Isabelle Dufort, Penny Soucy, Lucille Lacoste and Van Luu-The (2001). Comparative biosynthetic pathway of androstenol and androgens. DOI: 10.1016/s0960-0760(01)00057-7. PMID: 11457660. Methods and Results, expressed human enzymes and sequential steroid conversions.

  36. National Center for Biotechnology Information. PubChem compound registry. Androsterone, androstenone, 3α-androstenol, 3β-androstenol. Compound identity and synonym records, plus 2D structures for androsterone and androstenone. Accessed 11 and 14 September 2026.

  37. Weusten JJ, Smals AG, Hofman JA, Kloppenborg PW, Benraad TJ (1987). The sex pheromone precursor androsta-5,16-dien-3 beta-ol is a major early metabolite in in vitro pregnenolone metabolism in human testicular homogenates. DOI: 10.1210/jcem-65-4-753. PMID: 3654919. pp. 753–756, especially Figure 3.

  38. Soucy P, Lacoste L, Luu-The V (2003). Assessment of porcine and human 16-ene-synthase, a third activity of P450c17, in the formation of an androstenol precursor. Role of recombinant cytochrome b5 and P450 reductase. DOI: 10.1046/j.1432-1033.2003.03508.x. PMID: 12631293. pp. 1350–1355, Figures 2–6.

  39. John N. Labows, George Preti, Erhard Hoelzle, James Leyden and Albert Kligman (1979). Steroid analysis of human apocrine secretion. Steroids 34, 249–258. Collection methods and results on pp. 251–257. Original source.

  40. Gower DB, Mallet AI, Watkins WJ, Wallace LM, Calame JP (1997). Capillary gas chromatography with chemical ionization negative ion mass spectrometry in the identification of odorous steroids formed in metabolic studies of the sulphates of androsterone, DHA and 5alpha-androst-16-en-3beta-ol with human axillary bacterial isolates. DOI: 10.1016/s0960-0760(97)00075-7. PMID: 9449209. pp. 81–89, Methods, Table 2 and Figures 2–4.

  41. Heidi M. Laderoute (2015). The Metabolism of Androstenone and Other Steroid Hormone Conjugates in Relation to Boar Taint. Chapter 4, printed pp. 59–82, especially methods pp. 61–63 and Table 4.3.

  42. Zouboulis CC, Chen WC, Thornton MJ, Qin K, Rosenfield R (2007). Sexual hormones in human skin. DOI: 10.1055/s-2007-961807. PMID: 17326004. pp. 85–87, skin steroid metabolism and cell-specific enzyme activity.

  43. B. W. L. Brooksbank (1970). Labelling of steroids in axillary sweat after administration of 3H-delta-5-pregnenolone and 14C-progesterone to a healthy man. DOI: 10.1007/BF02114166. PMID: 4249154. Experientia 26, 1012–1014. Collection methods and product table, p. 1013.

  44. Cameron C. Muir and colleagues. Enzyme Immunoassay of Testosterone, 17β-Estradiol, and Progesterone in Perspiration and Urine of Preadolescents and Young Adults: Exceptional Levels in Men’s Axillary Perspiration (2008). Hormone and Metabolic Research 40, 819–826. Methods and assay validation, Results of studies 1–2, Table 2 and Discussion. Source.

  45. Brittney Elliott, Cameron Muir and Denys deCatanzaro. Sources of variance within and among young men in concentrations of 17β-estradiol and testosterone in axillary perspiration (2017). Physiology & Behavior 173, 23–29. Methods 2.1–2.5, Results 3.2–3.4, Tables 1, 3–4 and Discussion. Source.

  46. Alvi SN, Abuhdeeb K, Hammami MM (2022). Sweat Cortisol and Cortisone Determination in Healthy Adults: UHPLC-MS/MS Assay Validation and Clinical Application. DOI: 10.1155/2022/3133640. PMID: 36483476. Methods and Results, assay validation and 50 volunteer sweat samples.

  47. J. Ray Runyon, Min Jia, Michael R. Goldstein, Perry Skeath, Leif Abrell, Jon Chorover, Esther M. Sternberg (2019). Dynamic Behavior of Cortisol and Cortisol Metabolites in Human Eccrine Sweat. DOI: 10.36001/ijphm.2019.v10i3.2707. pp. 2–4, methods; pp. 7–8, results and conclusion.

  48. Syed Imran Ali Shah and colleagues. Gonadal suppression alters axillary steroid secretions in men, but does that affect olfactory social signaling? (2021). Journal of Men’s Health 17(3), 69–76. Methods 2.1–2.3, Results 3.1–3.3 and Tables 1–2. Source.

  49. Havlíček J, Lenochová P (2006). The effect of meat consumption on body odor attractiveness. DOI: 10.1093/chemse/bjl017. PMID: 16891352. pp. 747–752, Methods, Results and Discussion.

  50. Fialová J, Roberts SC, Havlíček J (2016). Consumption of garlic positively affects hedonic perception of axillary body odour. DOI: 10.1016/j.appet.2015.11.001. PMID: 26551789. pp. 9–13, Methods, Results, Table 1 and Discussion.

  51. Zetzsche M, Weiß BM, Kücklich M, Stern J, Birkemeyer C, Widdig A, Penke L (2024). Combined perceptual and chemical analyses show no compelling evidence for ovulatory cycle shifts in women’s axillary odour. DOI: 10.1098/rspb.2023.2712. PMID: 39043247. Methods, Results, chemical-profile and perceptual models.

  52. Ohgi N, Shirasu M, Ogura Y, Hirasawa Y, Okamoto M, Kawamura R, Takikawa H, Touhara K (2025). Human ovulatory phase-increasing odors cause positive emotions and stress-suppressive effects in males. DOI: 10.1016/j.isci.2025.113087. PMID: 40948555. Methods, chemical screening, blend evaluations and competing interests.

  53. Brémond Bostoen V, Richard Ortegón S, Barthès N, Buatois B, Nicolè F, Steyer D, Dormont L, Ferdenzi C (2025). ABOV: A Novel System of Direct Headspace Skin Sampling to Study Human Body Odor. DOI: 10.1007/s10886-025-01581-7. PMID: 40056297. Methods and Results, above-skin sampling, donor profiles and cross-center comparison.

  54. Yuekun Qu, Ziwei Zou, Charles J Weschler, Yingjun Liu, Xudong Yang (2025). Influence of Temperature, Humidity, Personal Hygiene, and Clothing on the Ozonolysis of Skin Oil at the Skin’s Surface: Self Regulation. DOI: 10.1021/acsenvironau.5c00073. PMID: 40979464. Methods, Results on clothing and hygiene, Discussion.

  55. Jessica L. Zung and Carolyn S. McBride (2025). Sebaceous origins of human odor. Current Biology 35, R303–R313. Sections on fatty acid production and oxidation, Figures 2–3. Scientific review. Original source.

  56. Lan Ge, Joel S. Gordon, Charleen Hsuan, Kurt Stenn and Stephen M. Prouty (2003). Identification of the delta-6 desaturase of human sebaceous glands: Expression and enzyme activity. Journal of Investigative Dermatology 120, 707–714. Results and Figures 1, 4–6. Original source.

  57. Christos C. Zouboulis and colleagues (2002). Corticotropin-releasing hormone: An autocrine hormone that promotes lipogenesis in human sebocytes. Proceedings of the National Academy of Sciences 99, 7148–7153. Methods, Results and Figures 3–5. PMID 12011471. Original source.

  58. Terry M. Smith, Zhaoyuan Cong, Kathryn L. Gilliland, Gary A. Clawson and Diane M. Thiboutot (2006). Insulin-like growth factor-1 induces lipid production in human SEB-1 sebocytes via sterol response element-binding protein-1. Journal of Investigative Dermatology 126, 1226–1232. Results, Figures 2–5 and lipogenesis methods. Original source.

  59. S. K. Goolamali, D. Evered and Sam Shuster (1976). Thyroid disease and sebaceous function. British Medical Journal 1, 432–433. Patients and methods, Results and Figures 1–3. Original source.

  60. Takeshi Hara, Hiroshi Matsui, Hironori Shimizu (2014). Suppression of microbial metabolic pathways inhibits the generation of the human body odor component diacetyl by Staphylococcus spp. DOI: 10.1371/journal.pone.0111833. PMID: 25390046. Culture methods, Figures 1 and 4–6, Results and Discussion.

  61. Takeshi Hara, Akito Sakanaka, Richard J Lamont, Atsuo Amano, Masae Kuboniwa (2024). Interspecies metabolite transfer fuels the methionine metabolism of Fusobacterium nucleatum to stimulate volatile methyl mercaptan production. DOI: 10.1128/msystems.00764-23. PMID: 38289043. Results on co-culture, ornithine, arcD deletion and methionine metabolism.

  62. Elliot M Lee, Sujatha Srinivasan, Samuel O Purvine, Tina L Fiedler, Owen P Leiser, Sean C Proll, Samuel S Minot, Danijel Djukovic, Daniel Raftery, Christine Johnston, David N Fredricks, Brooke L Deatherage Kaiser (2025). Syntrophic bacterial and host–microbe interactions in bacterial vaginosis. DOI: 10.1093/ismejo/wraf055. PMID: 40576334. Metaproteomics methods, Results and bacterial co-culture experiments.

  63. Wagenstaller M, Buettner A (2013). Quantitative determination of common urinary odorants and their glucuronide conjugates in human urine. DOI: 10.3390/metabo3030637. PMID: 24958143. Sections 2.1–2.2, 3 and 4.1–4.9.

  64. Rohto Pharmaceutical (2023). An odorless lactone precursor changes into lactone on the skin. Original Japanese research report, 8 November 2023. Results 1–2, Figures 1–2 and ingredient notes. Corporate research report. Original source.

  65. Marie-Annick Persuy, Guenhaël Sanz, Anne Tromelin, Thierry Thomas-Danguin, Jean-François Gibrat, Edith Pajot-Augy (2015). Mammalian Olfactory Receptors: Molecular Mechanisms of Odorant Detection, 3D-Modeling, and Structure–Activity Relationships. DOI: 10.1016/bs.pmbts.2014.11.001. §§1.2–1.3, printed pp. 5–9: receptor expression, combinatorial detection and nerve transmission to the olfactory bulb.

  66. Gillmeister A, Nagai MH, Margot C, Meesa P, Matsunami H, Hummel T (2025). Olfactory training in specific anosmia to androstenone and its association with genetic variations of OR7D4. DOI: 10.1016/j.ibneur.2025.06.017. PMID: 40687083. Methods §§2.1–2.5, Results §§3.1–3.3, Figures 2–4 and Discussion §4.1.

  67. Chulwon Choi, Hyeonsung Byeon, Juho Lee, Hong Geun Lee, Chaok Seok, Hee-Jung Choi (2026). Structural basis of the sweat odorant HMHA recognition by the human odorant receptor OR52E8. DOI: 10.1038/s42003-026-10317-6. PMID: 42162228. Results, native-receptor functional assays and engineered-receptor structure.

  68. Camille Ferdenzi, Harilanto Razafindrazaka, Nicolas Baldovini, Daphnée Poupon, Denis Pierron, Moustafa Bensafi (2019). Influence of gender and culture on the perception of acidic compounds of human body odor. DOI: 10.1016/j.physbeh.2019.112561. PMID: 31178171. Methods 2.1–2.2 and Results 3.1–3.2.

  69. Monti-Bloch L, Diaz-Sanchez V, Jennings-White C, Berliner DL (1998). Modulation of serum testosterone and autonomic function through stimulation of the male human vomeronasal organ (VNO) with pregna-4,20-diene-3,6-dione. DOI: 10.1016/s0960-0760(98)00025-9. PMID: 9699878. pp. 237–242, Methods, endocrine crossover experiment and Discussion.

  70. Frasnelli J, Lundström JN, Boyle JA, Katsarkas A, Jones-Gotman M (2011). The vomeronasal organ is not involved in the perception of endogenous odors. DOI: 10.1002/hbm.21035. PMID: 20578170. Vomeronasal occlusion and sham experiments, Results and Discussion.

  71. S. Henningsson and colleagues (2017). A missense polymorphism in the putative pheromone receptor gene VN1R1 is associated with sociosexual behavior. Translational Psychiatry 7, e1102. Results, Tables 1–3 and limitations on pp. 3–5. Original source.

  72. Saxton TK, Lyndon A, Little AC, Roberts SC (2008). Evidence that androstadienone, a putative human chemosignal, modulates women’s attributions of men’s attractiveness. DOI: 10.1016/j.yhbeh.2008.06.001. PMID: 18601928. pp. 598–600, Methods, Results and Figures 1–3.

  73. Hare RM, Schlatter S, Rhodes G, Simmons LW (2017). Putative sex-specific human pheromones do not affect gender perception, attractiveness ratings or unfaithfulness judgements of opposite sex faces. DOI: 10.1098/rsos.160831. PMID: 28405372. Methods §§2.1–2.3, Results and Discussion.

  74. Chung KC, Peisen F, Kogler L, Radke S, Turetsky B, Freiherr J, Derntl B (2016). The Influence of Menstrual Cycle and Androstadienone on Female Stress Reactions: An fMRI Study. DOI: 10.3389/fnhum.2016.00044. PMID: 26909031. Methods, Results and cortisol analyses.

  75. Zhou W, Yang X, Chen K, Cai P, He S, Jiang Y (2014). Chemosensory communication of gender through two human steroids in a sexually dimorphic manner. DOI: 10.1016/j.cub.2014.03.035. PMID: 24794295. Methods, point-light walker experiments and Discussion.

  76. Alison S. Fleming, Meir Steiner and Carl Corter (1997). Cortisol, Hedonics, and Maternal Responsiveness in Human Mothers. Hormones and Behavior 32, 85–98. Odor tests, Table 1 and results on pp. 89–92. PMID 9367716. Original source.

  77. Ayline Maier, Dirk Scheele and colleagues. Oxytocin reduces a chemosensory-induced stress bias in social perception (2019). Neuropsychopharmacology 44, 281–288. Published online 2018. Methods, Results and Figures 2–5. PMID: 29703998. Source.

  78. Kepu Chen, Yuting Ye, Nikolaus F. Troje and Wen Zhou. Oxytocin modulates human chemosensory decoding of sex in a dose-dependent manner (2021). eLife 10, e59376. Experiments 1–5, especially Experiments 3–5 and Figures 4–5. Source.

  79. R. Rodriguez-Raecke, Y. F. Brünner and colleagues. Odor Sensitivity After Intranasal Insulin Application Is Modulated by Gender (2018). Frontiers in Endocrinology 9, 580. Participants, olfactory tests, Results and Figure 2. Source.

  80. S. Edwin Thanarajah, V. Hoffstall and colleagues. The role of insulin sensitivity and intranasally applied insulin on olfactory perception (2019). Scientific Reports 9. Research Design and Methods, Results and Figures 1–4. 36 recruited, 33 analyzed. Source.

  81. Ninthujah Kanageswaran and colleagues. Modulatory Effects of Sex Steroids Progesterone and Estradiol on Odorant Evoked Responses in Olfactory Receptor Neurons (2016). PLOS ONE 11, e0159640. Methods, Figure 6 and Discussion. PMID: 27494699. Source.

  82. Adithya Mohandass and colleagues. TRPM8 as the rapid testosterone signaling receptor: Implications in the regulation of dimorphic sexual and social behaviors (2020). The FASEB Journal 34(8), 10887–10906. Methods 2.1, Results 3.3, 3.5–3.6 and Figures 3, 5–6. PMID: 32609392. Source.

  83. Luis Monti and colleagues. Effect of fasedienol (PH94B) pherine nasal spray and steroidal hormones on electrogram responses and autonomic nervous system activity in healthy adult volunteers (2024). Human Psychopharmacology 39(2), e2892. Methods, Results and sponsor disclosures. PMID: 38193849. Source.

  84. Wyatt TD (2015). The search for human pheromones: the lost decades and the necessity of returning to first principles. DOI: 10.1098/rspb.2014.2994. PMID: 25740891. §§2, 4 and 6, criteria, steroid candidates and discovery methods.

  85. Robin Tan (2017). The Effect of Androstenone as a Mating Prime on Drinking and Approach Behavior. PhD dissertation, University of South Florida. Methods, pp. 12–22. Results, pp. 24–29. Table 2, p. 53. The main text and Table 2 give different t-values for beer consumption, both with a reported p-value of 0.03.

  86. Alan A. Beaton, Lowri Jones, David Benton, Gareth Richards (2022). Judgements of attractiveness of the opposite sex and nostril differences in self-rated mood: The effects of androstenol. DOI: 10.1016/j.biopsycho.2021.108237. PMID: 34864067. Author manuscript PDF pp. 8–15, Methods and Results, Table 1.

  87. R. E. Maiworm and W. U. Langthaler. Influence of Androstenol and Androsterone on the Evalulation of Men of Varying Attractiveness Levels (1992). Chemical Signals in Vertebrates 6, pp. 575–579. Complete chapter, Methods, Table 1 and Discussion. Source.

  88. Wu Y, Wei R, Ou J, Shen B, Ye Y (2022). Estratetraenol increases preference for large sexual reward but not impulsivity among heterosexual males. DOI: 10.1016/j.yhbeh.2022.105266. PMID: 36152381. pp. 2–4, Methods §§2.1–2.6 and Results §§3.1–3.3, Figure 2.

  89. Williams M, Jacobson A (2016). Effect of Copulins on Rating of Female Attractiveness, Mate-Guarding, and Self-Perceived Sexual Desirability. DOI: 10.1177/1474704916643328. Methods and Results, face ratings, self-perceived desirability and mate guarding.

  90. Megan N. Williams; Coren Apicella (2017). Synthetic Copulin Does Not Affect Men’s Sexual Behavior. DOI: 10.1007/s40750-017-0083-y. Methods, Results and Discussion, four-condition experiment.

  91. Sun Yuefen (孙月芬), Hu Peicheng (胡佩诚) (2004). 人类体味的异性偏好现象初探 [A preliminary study of opposite-sex preferences for human body odor]. Chinese Journal of Human Sexuality 13(10), printed pp. 8–9. Methods and results tables. Title translated from Chinese.

  92. Lu J, Ye Y, Wu Y (2024). Little evidence that androstadienone affects social distance-dependent prosocial behaviour: a pre-registered study. DOI: 10.1098/rsos.240004. PMID: 39076351. Methods and Results, social-discounting experiment.

  93. Lundström JN, Olsson MJ (2005). Subthreshold amounts of social odorant affect mood, but not behavior, in heterosexual women when tested by a male, but not a female, experimenter. DOI: 10.1016/j.biopsycho.2005.01.008. PMID: 16242537. pp. 198–203, Methods §§1.1–1.7, Results §§2.1–2.3 and Discussion.

  94. Wu Y, Wei R, Nan Y, Hu Y, Ye Y (2023). Androstadienone modulates human aggression in a sex-dependent manner. DOI: 10.1093/scan/nsad006. PMID: 36790105. Participants, olfactory stimuli, aggression tasks, Results Figure 2 and Discussion.

  95. Hummel T, Gollisch R, Wildt G, Kobal G (1991). Changes in olfactory perception during the menstrual cycle. DOI: 10.1007/bf01958823. PMID: 2065768. Methods and Results, cycle-phase pleasantness and detection thresholds.

  96. Lübke KT, Pause BM (2014). Sex-hormone dependent perception of androstenone suggests its involvement in communicating competition and aggression. DOI: 10.1016/j.physbeh.2013.10.016. PMID: 24184511. pp. 136–141, Methods, Results and Discussion. Read with the separately listed corrigendum.

  97. Katrin T. Lübke; Bettina M. Pause (2014). Corrigendum to “Sex-hormone dependent perception of androstenone suggests its involvement in communicating competition and aggression” [Physiol Behav 123 (2014) 136-141]. DOI: 10.1016/j.physbeh.2014.02.001. pp. 52–53, corrected abstract statement and figure labels.

  98. Cowley JJ, Brooksbank BW (1991). Human exposure to putative pheromones and changes in aspects of social behaviour. DOI: 10.1016/0960-0760(91)90264-6. PMID: 1892794. Methods and Tables 2a–2b, necklace exposure and recalled verbal exchanges.

  99. Gustavson AR, Dawson ME, Bonett DG (1987). Androstenol, a putative human pheromone, affects human (Homo sapiens) male choice performance. DOI: 10.1037/0735-7036.101.2.210. PMID: 3608426. pp. 210–212, Method, Table 1, Results and Discussion.

  100. Dorota Zolkowska and colleagues. Anticonvulsant potencies of the enantiomers of the neurosteroids androsterone and etiocholanolone exceed those of the natural forms (2014). Psychopharmacology 231, 3325–3332. Animal methods, Results and Table 1. Source.

  101. Knuppen R, Breuer H (1963). Biogenese von Östratetraenol beim Menschen [Formation of estratetraenol in humans]. DOI: 10.1530/acta.0.0420129. PMID: 14033886. pp. 129–134, Methods, Results and Discussion.

  102. Thysen B, Elliott WH, Katzman PA (1968). Identification of estra-1,3,5(10),16-tetraen-3-ol (estratetraenol) from the urine of pregnant women (1). DOI: 10.1016/s0039-128x(68)80052-2. PMID: 4295975. pp. 73–85, urine collection, hydrolysis, chemical identification and Discussion.

  103. Oren C, Peled-Avron L, Shamay-Tsoory SG (2019). A scent of romance: human putative pheromone affects men’s sexual cognition. DOI: 10.1093/scan/nsz051. PMID: 31309986. Experiments 1–2, Methods and Results.

  104. Oren C, Shamay-Tsoory SG (2019). Women’s fertility cues affect cooperative behavior: Evidence for the role of the human putative chemosignal estratetraenol. DOI: 10.1016/j.psyneuen.2018.10.028. PMID: 30408723. pp. 50–59, Experiments 1–2. Participant independence from the related project is unconfirmed.

  105. Krajnik J, Kollndorfer K, Nenning KH, Lundström JN, Schöpf V (2014). Gender effects and sexual-orientation impact on androstadienone-evoked behavior and neural processing. DOI: 10.3389/fnins.2014.00195. PMID: 25132813. Neuronal correlates of AND, concentration dependence, sexual orientation, Figure 1 and Table 2. Review, not a new experiment.

  106. Michael RP, Bonsall RW, Kutner M (1975). Volatile fatty acids, “copulins”, in human vaginal secretions. DOI: 10.1016/0306-4530(75)90007-4. PMID: 1234654. Methods and Results, vaginal acid sampling across 86 cycles.

  107. Naomi M. Morris, J Richard Udry (1978). Pheromonal influences on human sexual behaviour: an experimental search. DOI: 10.1017/s0021932000011573. PMID: 565359. pp. 147–157, especially Tables 1–2 and couple-level analyses.

  108. Bendas J, Hummel T, Croy I (2018). Olfactory Function Relates to Sexual Experience in Adults. DOI: 10.1007/s10508-018-1203-x. PMID: 29721723. PDF pp. 2–6, Method, Results, Table 1 and Discussion.

  109. McCarthy RJ, Erickson JM, Hu X, Pawirosetiko JS, Tarleton HL, Thomas CL, Tillery MG, Sagarin BJ (2021). Broad Agreement, But Notes of Caution With the Implications of Sakaluk’s (2020) Critique of Wisman and Shrira (2020). DOI: 10.1007/s10508-021-01929-6. PMID: 33594531. Sections on effect-size calculation, Table 1, Conclusion and footnotes 1–4.

  110. Ludan Liu, Lijun Zheng (2026). Androstadienone reduces women’s mate-choice copying: The moderating role of intrasexual competition. DOI: 10.1016/j.psyneuen.2025.107717. PMID: 41353996. Psychoneuroendocrinology 184, 107717. Experiments 1–2, Methods and Results. Published online 3 December 2025.

  111. Lobmaier JS, Fischbacher U, Wirthmüller U, Knoch D (2018). The scent of attractiveness: levels of reproductive hormones explain individual differences in women’s body odour. DOI: 10.1098/rspb.2018.1520. PMID: 30209229. Methods and Results, between-donor hormone and attractiveness models.

  112. Oh TJ, Kim MY, Park KS, Cho YM (2012). Effects of chemosignals from sad tears and postprandial plasma on appetite and food intake in humans. DOI: 10.1371/journal.pone.0042352. PMID: 22870321. PLOS ONE 7(8), e42352. Study protocol, Results and Figure 5, including four exclusions from the hormone analysis.

  113. M. L. Butovskaya, E. V. Veselovskaya, V. V. Rostovtseva, N. B. Selverova and I. V. Ermakova (2012). Механизмы репродуктивного поведения человека: ольфакторные маркеры мужской привлекательности [Mechanisms of human reproductive behavior: Olfactory markers of male attractiveness]. Журнал общей биологии 73(4), 299–314. Full supplied article, methods pp. 303–305 and hormone/cycle results p.308. Linked page gives the journal abstract. Published page numbers checked against the full PDF.

  114. Gildersleeve KA, Haselton MG, Larson CM, Pillsworth EG (2012). Body odor attractiveness as a cue of impending ovulation in women: evidence from a study using hormone-confirmed ovulation. DOI: 10.1016/j.yhbeh.2011.11.005. PMID: 22137971. pp. 158–165, Methods, Results, Tables 1–3 and Discussion.

  115. Mei M, Grillot RL, Abbey CK, Emery Thompson M, Roney JR (2022). Does scent attractiveness reveal women’s ovulatory timing? Evidence from signal detection analyses and endocrine predictors of odour attractiveness. DOI: 10.1098/rspb.2022.0026. PMID: 35259990. Methods, Results, within-donor models and signal-detection analyses.

  116. Madita Zetzsche; Marlen Kücklich; Brigitte M. Weiß; Julia Stern; Andrea C. Marcillo Lara; Claudia Birkemeyer; Lars Penke; Anja Widdig (2025). Understanding olfactory fertility cues in humans: chemical analysis of women’s vulvar odour and perceptual detection of these cues by men. DOI: 10.1016/j.evolhumbehav.2025.106742. Methods §2, Results §3 and Table 2. Supplement §§S2 and S6–S9, especially Tables S7.2 and S9.1–S9.2.

  117. Tarumi W, Shinohara K (2020). Women’s body odour during the ovulatory phase modulates testosterone and cortisol levels in men. DOI: 10.1371/journal.pone.0230838. PMID: 32231386. Methods and Results, body-region comparisons.

  118. Roney JR, Simmons ZL (2012). Men smelling women: null effects of exposure to ovulatory sweat on men’s testosterone. DOI: 10.1177/147470491201000404. PMID: 23089078. Methods and Results, ovulation-confirmed donors and serial testosterone measurements.

  119. James R. Roney; Mei Mei; Rachel L. Grillot; Melissa Emery Thompson (2023). No effects of exposure to women’s fertile window body scents on men’s hormonal and psychological responses. DOI: 10.1016/j.evolhumbehav.2023.03.003. Methods and Results, hormonal and psychological response analyses.

  120. Preti G, Wysocki CJ, Barnhart KT, Sondheimer SJ, Leyden JJ (2003). Male axillary extracts contain pheromones that affect pulsatile secretion of luteinizing hormone and mood in women recipients. DOI: 10.1095/biolreprod.102.008268. PMID: 12606409. Methods, Results and LH-pulse latency analysis.

  121. Shinohara K, Morofushi M, Funabashi T, Mitsushima D, Kimura F (2000). Effects of 5alpha-androst-16-en-3alpha-ol on the pulsatile secretion of luteinizing hormone in human females. DOI: 10.1093/chemse/25.4.465. PMID: 10944511. Methods and Results, eight-hour LH observations in 11 women.

  122. Shinohara K, Morofushi M, Funabashi T, Kimura F (2001). Axillary pheromones modulate pulsatile LH secretion in humans. DOI: 10.1097/00001756-200104170-00005. PMID: 11303754. Methods and Results, donor-phase extracts and LH pulsatility.

  123. Jacob S, Spencer NA, Bullivant SB, Sellergren SA, Mennella JA, McClintock MK (2004). Effects of breastfeeding chemosignals on the human menstrual cycle. DOI: 10.1093/humrep/deh057. PMID: 14747191. pp. 422–429, Methods, participant flow Figure 1, Results and Discussion.

  124. Spencer NA, McClintock MK, Sellergren SA, Bullivant SB, Jacob S, Mennella JA (2004). Social chemosignals from breastfeeding women increase sexual motivation. DOI: 10.1016/j.yhbeh.2004.06.002. PMID: 15325237. pp. 362–370, Methods, Results and Discussion.

  125. McClintock MK (1971). Menstrual Synchrony and Suppression. DOI: 10.1038/229244a0. PMID: 4994256. Dormitory observations and reported menstrual timing.

  126. Stern K, McClintock MK (1998). Regulation of ovulation by human pheromones. DOI: 10.1038/32408. PMID: 9515961. Methods and Results, donor-phase extracts and cycle timing.

  127. Yang Z, Schank JC (2006). Women do not synchronize their menstrual cycles. DOI: 10.1007/s12110-006-1005-z. PMID: 26181612. Methods, group analyses and Discussion of chance convergence.

  128. Miller MR, Mannowetz N, Iavarone AT, Safavi R, Gracheva EO, Smith JF, Hill RZ, Bautista DM, Kirichok Y, Lishko PV (2016). Unconventional endocannabinoid signaling governs sperm activation via the sex hormone progesterone. DOI: 10.1126/science.aad6887. PMID: 26989199. Science 352, pp. 555–559, Figures 1–4 and main text.

  129. Edwards M, Amaral A, Carter EM, Arnolds O, Vester K, Thrun A, Wigren E, Homan E, Ribera P, Bentley K, Haraldsson M, Theo-Emegano N, Loppnau P, Szewczyk MM, Cao MA, Barsyte-Lovejoy D, Dittmar N, Hans A, Weber M, Münchow J, Zhu WF, Temme L, Brenker C, Strünker T, Sundström M, Todd MH, Edwards AM, Lesche R, Gileadi O, Tredup C (2026). ABHD2 activity is not required for the non-genomic action of progesterone on human sperm. DOI: 10.1093/humrep/deag085. PMID: 42212558. Materials and methods, sperm calcium and hyperactivation assays; Results, Figure 4; Discussion.

  130. Janice K. Jeschke, Cristina Biagioni and colleagues. The Action of Reproductive Fluids and Contained Steroids, Prostaglandins, and Zn²⁺ on CatSper Ca²⁺ Channels in Human Sperm (2021). Frontiers in Cell and Developmental Biology 9, 699554. Results, Tables 1–2, Figures 1–7 and Discussion. PMID: 34381781. Source.

  131. Lydia Wehrli, Ioannis Galdadas and colleagues. The action of physiological and synthetic steroids on the calcium channel CatSper in human sperm (2023). Frontiers in Cell and Developmental Biology 11, 1221578. Results, Table 1, Figures 2–6 and 9, and sperm-motility results. PMID: 37547474. Source.

  132. Havlíček J, Winternitz J, Roberts SC (2020). Major histocompatibility complex-associated odour preferences and human mate choice: near and far horizons. DOI: 10.1098/rstb.2019.0260. PMID: 32306884. Separate analyses of odor preferences, relationship outcomes and genomic partner similarity.

  133. Wedekind C, Seebeck T, Bettens F, Paepke AJ (1995). MHC-dependent mate preferences in humans. DOI: 10.1098/rspb.1995.0087. PMID: 7630893. pp. 245–248, Methods, Results and Figures 1–2.

  134. Sorokowska A, Pietrowski D, Schäfer L, Kromer J, Schmidt AH, Sauter J, Hummel T, Croy I (2018). Human Leukocyte Antigen similarity decreases partners’ and strangers’ body odor attractiveness for women not using hormonal contraception. DOI: 10.1016/j.yhbeh.2018.10.007. PMID: 30339817. pp. 145–149, Methods §§2.2–2.6, Results and Discussion.

  135. da Silva LNO, de Paiva Costa TP, Castro FN (2026). Influence of Human Leukocyte Antigen on Olfactory Sexual Attraction in Non-Heterosexual Brazilian Men. DOI: 10.1007/s10508-025-03372-3. PMID: 42062644. pp. 1481–1489, Methods, Results and thesis provenance statement.

  136. Milinski M, Croy I, Hummel T, Boehm T (2013). Major histocompatibility complex peptide ligands as olfactory cues in human body odour assessment. DOI: 10.1098/rspb.2012.2889. PMID: 23345577. Methods and Results, administered peptide-ligand experiments.

  137. Roberts SC, Gosling LM, Carter V, Petrie M (2008). MHC-correlated odour preferences in humans and the use of oral contraceptives. DOI: 10.1098/rspb.2008.0825. PMID: 18700206. Methods, longitudinal analyses and Discussion.

  138. Endevelt-Shapira Y, Pinchover L, Perl O, Bar E, Avin A, Sobel N (2020). Women Have Reduced Ability to Discriminate Body Odors During the Withdrawal Period of Oral Contraception. DOI: 10.1007/s12078-019-09273-9. PMID: 32968473. Results, active-use and withdrawal comparisons.

  139. Lundström JN, McClintock MK, Olsson MJ (2006). Effects of reproductive state on olfactory sensitivity suggest odor specificity. DOI: 10.1016/j.biopsycho.2005.07.001. PMID: 16084006. Methods and Results, detection-threshold comparisons.

  140. Frances Thorne, Nick Neave, Andrew Scholey, Mark Moss and Bernhard Fink (2002). Effects of putative male pheromones on female ratings of male attractiveness: influence of oral contraceptives and the menstrual cycle. PMID: 12195229. Printed PDF pp. 299–305, especially Methods, Results and Figures. PubMed lists pp. 291–297.

  141. Patrícia Maria Rodrigues Gonçalves and colleagues (2026). Olfactory perception and wellbeing across hormonal contraceptive users and menstrual cycle phases. DOI: 10.3389/fnhum.2026.1646597. PMID: 41710213. Frontiers in Human Neuroscience 20, 1646597. Methods, Results and tables comparing contraceptive groups.

  142. Little AC, Burriss RP, Petrie M, Jones BC, Roberts SC (2013). Oral contraceptive use in women changes preferences for male facial masculinity and is associated with partner facial masculinity. DOI: 10.1016/j.psyneuen.2013.02.014. PMID: 23528282. Psychoneuroendocrinology 38(9), 1777–1785. Experiments 1–2, Figures 1–2 and Discussion. Original face panels reproduced as labeled excerpts.

  143. Jones BC, Hahn AC, Fisher CI, Wang H, Kandrik M, Han C, Fasolt V, Morrison D, Lee AJ, Holzleitner IJ, O’Shea KJ, Roberts SC, Little AC, DeBruine LM (2018). No Compelling Evidence that Preferences for Facial Masculinity Track Changes in Women’s Hormonal Status. DOI: 10.1177/0956797618760197. PMID: 29708849. Psychological Science 29(6), 996–1005. Methods and Results on the 45 women who changed pill use, printed pp. 997 and 1001.

  144. Marlise K. Hofer; Tianqi Peng; Jennifer C. Lay; Frances S. Chen (2025). The role of testosterone in odor-based perceptions of social status. DOI: 10.1016/j.evolhumbehav.2025.106752. Methods, Results and mixed-model analyses. See the separately listed corrigendum.

  145. Marlise K. Hofer; Tianqi Peng; Jennifer C. Lay; Frances S. Chen (2026). Corrigendum to “The role of testosterone in odor-based perceptions of social status” [Evolution and Human Behavior, Volume 46 (2025) 106752]. DOI: 10.1016/j.evolhumbehav.2025.106792. Complete recruitment clarification, p. 1. Online 2025, issue 2026.

  146. Markus J. Rantala; C.J. Peter Eriksson; Anssi Vainikka; Raine Kortet (2006). Male steroid hormones and female preference for male body odor. DOI: 10.1016/j.evolhumbehav.2005.11.002. Methods, Results and odor-rating figure.

  147. Banner A, Shamay-Tsoory SG (2018). Effects of androstadienone on dominance perception in males with low and high social anxiety. DOI: 10.1016/j.psyneuen.2018.05.032. PMID: 29859341. Accepted manuscript, PDF pp. 7–18, especially Results §3.3.

  148. Wu Y, Niu C, Zheng L (2026). Chemosignals Shape Women’s Self-Reported Engagement in Negative Gossip and Their Perception of Flirtatiousness of Romantic Rivals. DOI: 10.1007/s10508-026-03482-6. PMID: 42340626. pp. 1859–1865, Methods, Table 1, Results and Discussion.

  149. Nehls S, Losse E, Salloum Sleibi I, Armin M, Habel U, Chechko N (2026). From female to female: Communication via chemosignals. DOI: 10.1073/pnas.2528625123. PMID: 41950097. PNAS 123(15), e2528625123. Main paper p. 3, Figure 2, methods pp. 6–7, and supporting appendix Tables S1–S4.

  150. Allen C, Havlíček J, Roberts SC (2015). Effect of fragrance use on discrimination of individual body odor. DOI: 10.3389/fpsyg.2015.01115. PMID: 26300812. Methods and Results, fragrance and individual-odor discrimination.

  151. Marlise K. Hofer and Frances S. Chen (2020). The Scent of a Good Night’s Sleep: Olfactory Cues of a Romantic Partner Improve Sleep Efficiency. Psychological Science 31, 449–459. Main results and supplements SOM-R, Samples 1–3, and SOM-U, Results Removing Sample 1 Data. Complete author manuscript and supplements checked. PMID 32163721. Original source.

  152. Spengler FB, Doerflinger JT, Noel JA, Ditzen B, Freiherr J, Heinrichs M (2026). Smelling the romantic partner’s natural body odor increases psychological and autonomic but not cortisol stress responses. DOI: 10.1038/s41598-025-27639-w. PMID: 41535314. Methods, Results, subjective stress, heart rate and cortisol outcomes.

  153. Lenka Martinec Nováková, Dagmar Plotěná and Jan Havlíček (2017). Age and Pubertal Status-Related Changes in Reports of Perception of Personal Odors. Perception 46(3–4), 484–497. Methods, Results, Table 4 and Discussion. PMID 28056656. Original source.

  154. Michał M. Stefanczyk, Daniela Dlouhá, Jan Havlíček, Kamila Nouzová and Šárka Kaňková (2026). Body odor disgust sensitivity during pregnancy and the postpartum period: a longitudinal study. Evolution and Human Behavior 47(4), 106855. Methods, Results, Figure 1 and Limitations. Original source.

  155. Kern DW, Kaufmann GT, Hummer TA, Schumm LP, Wroblewski KE, Pinto JM, McClintock MK (2023). Androstadienone sensitivity is associated with attention to emotions, social interactions, and sexual behavior in older U.S. adults. DOI: 10.1371/journal.pone.0280082. PMID: 36638090. Study 1 and Study 2 Methods and Results, especially the observational NSHAP sample aged 62–90.

  156. Rohto Pharmaceutical (assignee) (2023). Composition for supplementing the body odor of young women. Japanese patent JP7199495B2, published 5 January 2023. Tests 1 and 3, paragraphs 0093–0102, PDF pp. 16–18, Figure 7 on p. 29. Original Japanese text checked. Original source.

  157. Atalay F, Yavuz Z, Kars A, Yaşar M (2025). Is there a relationship between olfactory dysfunction and duration of menopause?. DOI: 10.14639/0392-100x-n3174. PMID: 41178485. Methods, Results and age-adjusted comparisons in Table II.

  158. Carlos M. Contreras, Ana G. Gutiérrez-García and colleagues (2013, online 2012). “Amniotic fluid elicits appetitive responses in human newborns: fatty acids and appetitive responses.” Developmental Psychobiology 55:221–231. DOI: 10.1002/dev.21012. PMID: 22315200. Locator: Methods, Table 1, behavioral Results and Discussion. Author-uploaded full text consulted through automatic text extraction.

  159. Ana Gloria Gutiérrez-García, Carlos M. Contreras and Cynthia Díaz-Marte (2017). “Myristic acid in amniotic fluid produces appetitive responses in human newborns.” Early Human Development 115:32–37. DOI: 10.1016/j.earlhumdev.2017.08.009. PMID: 28886572. Locator: Methods 2.2–2.5, p. 33. Results 3.1–3.5 and Figure 1, p. 34. Figure 2 and Discussion, p. 35. Complete paper consulted.

  160. Helene M. Loos, Sébastien Doucet, Robert Soussignan, Constanze Hartmann, Karine Durand, Ralf Dittrich, Paul Sagot, Andrea Buettner, Benoist Schaal (2014). Responsiveness of Human Neonates to the Odor of 5α-Androst-16-en-3-one: A Behavioral Paradox?. DOI: 10.1093/chemse/bju041. pp. 695–700, participants, stimuli, facial scoring, results and discussion.

  161. Laura Schäfer and colleagues (2024). The scent of cuteness: neural signatures of infant body odors. Social Cognitive and Affective Neuroscience 19, nsae038. Participants and Results, brain activation and functional connectivity. PMID 38850226. Original source.

  162. Kazushige Touhara, Yukei Hirasawa, Masako Okamoto and Mika Shirasu (2023). Method for producing a secretion promoter and secretion promoter. University of Tokyo patent application JP2023022459A, published 15 February 2023. Original Japanese examples, paragraphs 0026–0050, Tables 2–5 and Figure 4. Later grant JP7788135B2 belongs to the same family. Original source.

  163. Wanhshuyao Sun and colleagues (2025). Effects of Infant Odors on Maternal Brain Responses to Pleasant and Unpleasant Infant Vocalizations: An fNIRS Study. Keio University graduate bulletin 99, 53–67. Original Japanese methods and results, pp. 55–62, Table 1 and Figure 7. No DOI listed. Original source.

  164. Shahla Shafaati Laleh and colleagues (2026). The Effect of Watching Infant Video With or Without Smelling an Infant-Scented Hat With Infant Scent on Anxiety, Milk Volume, Stress, and Attachment in Mothers of Hospitalized Infants in the Neonatal Intensive Care Unit: A Randomized Controlled Trial. Health Science Reports 9, e72468. Results, Tables 2–3 and Discussion. PMID 42088997. Original source.

  165. de Groot JHB, Haertl T, Loos HM, Bachmann C, Kontouli A, Smeets MAM (2023). Unraveling the universality of chemical fear communication: evidence from behavioral, genetic, and chemical analyses. DOI: 10.1093/chemse/bjad046. PMID: 37944028. Preregistered sweat hypotheses, exploratory subgroup analyses and the subsequent HDA experiment.

  166. Annkatrin Wunder, Nele Bürkel, Imke Guder, José I. Zorzin, Christiane Mühle, Helene M. Loos, Jessica Freiherr (2025). Enhanced sensitivity to odors due to chemosignals associated with anxiety. DOI: 10.1038/s42004-025-01512-3. PMID: 40301685. Communications Chemistry 8, 129. Results, odor thresholds and chemical analysis. Methods and Supplementary Information.

  167. T. Bruderer, A. Greco and colleagues (2026). A time-resolved axillary volatile fingerprint of human fear. bioRxiv, version 2. Preprint, not peer reviewed. Tables 1–2, chemical assignments on p. 10, study limits on pp. 15–17 and methods on pp. 18–27. Original source.

  168. de Groot JH, Smeets MA, Rowson MJ, Bulsing PJ, Blonk CG, Wilkinson JE, Semin GR (2015). A sniff of happiness. DOI: 10.1177/0956797614566318. PMID: 25870406. pp. 686–698, Methods, receiver Results, Tables 1–2, Figure 6 and Discussion.

  169. Gordon AR, Lundström JN, Kimball BA, Karshikoff B, Sorjonen K, Axelsson J, Lekander M, Olsson MJ (2023). Human scent as a first-line defense against disease. DOI: 10.1038/s41598-023-43145-3. PMID: 37794120. Methods, Results: Body odor perception and Chemical composition of body odor, and Discussion.

  170. Gelstein S, Yeshurun Y, Rozenkrantz L, Shushan S, Frumin I, Roth Y, Sobel N (2011). Human tears contain a chemosignal. DOI: 10.1126/science.1198331. PMID: 21212322. Main article, face ratings, psychophysiology, testosterone and imaging experiments.

  171. Gračanin A, van Assen MALM, Omrčen V, Koraj I, Vingerhoets AJJM (2017, online 2016). Chemosignalling effects of human tears revisited: Does exposure to female tears decrease males’ perception of female sexual attractiveness?. DOI: 10.1080/02699931.2016.1151402. PMID: 26954726. Cognition and Emotion 31(1), 139–150. Study 1–3 methods and results, pp. 141–147, Tables 2–4.

  172. Sobel N (2017, online 2016). Revisiting the revisit: added evidence for a social chemosignal in human emotional tears. DOI: 10.1080/02699931.2016.1177488. PMID: 27196115. Cognition and Emotion 31(1), 151–157. Response and reanalysis, Figure 1f–g and Table 1.

  173. Urban J, Fergus DJ, Savage AM, Ehlers M, Menninger HL, Dunn RR, Horvath JE (2016). The effect of habitual and experimental antiperspirant and deodorant product use on the armpit microbiome. DOI: 10.7717/peerj.1605. PMID: 26855863. Methods and Results, product-use intervention and axillary microbial communities.

  174. Cutler WB, Friedmann E, McCoy NL (1998). Pheromonal influences on sociosexual behavior in men. DOI: 10.1023/a:1018637907321. PMID: 9494686. Methods, diary outcomes and Discussion.

  175. McCoy NL, Pitino L (2002). Pheromonal influences on sociosexual behavior in young women. DOI: 10.1016/s0031-9384(01)00675-8. PMID: 11897264. Methods, diary outcomes and supplier disclosure.

  176. David L. Berliner (1993). Fragrance compositions and other compositions which contain human pheromones. Examples 16–17, nasal electrical responses, and family information.

  177. World Intellectual Property Organization, publication WO2025013888A1 (2025). Fragrance composition and menstrual cycle marker. Description, experimental examples and bibliographic data. Japanese-origin international patent application.

  178. Andrea Büttner (2009-01-08). Vaginal odorants. Description, Examples and Table 1, printed pp. 17–24; claims pp. 25 onward.

  179. Alexandra Fede (2009-05-07). Composition and Method for the Application of Human Synthetic Pheromones Using Substance Slowly Releasing Technological Bio Capsule in form of Drops in Clothing, Underwear, Jewels and Like. Patent application US20090117163A1. Description, chemical list and capsule design. Claims.

  180. Stephen J. Takács, Regine Gries and Gerhard Gries. Compositions and methods comprising pheromone compounds androstenone, testosterone, progesterone and estrogen (2019-04-10). European patent application EP3462875A1. Experiments 12 and 21–23, paragraphs 0097–0098 and 0114–0116. Source.

  181. Moshe Shifrine. Testosterone olfaction (2014-03-25). United States patent US8679507B2, Example 1 and Table 1. Source.

  182. バーリナー，デイビッド　エル． (1994-12-08). ヒトフェロモンを含有する芳香組成物および他の組成物. Japanese description and patent-family information. Same family as US5272134A.

  183. Clive L. Jennings-White, David L. Berliner, Nathan W. Adams, Luis Bloch-Monti (2007-05-01). Esteroides como estimuladores neuroquimicos del ovn para aliviar los sintomas de pms. Spanish national translation, description and patent-family data.

  184. David L. Berliner, Nathan William Adams, Clive L. Jennings-White (2004-07-01). Esteroides de androstano utiles como iniciadores del cambio de la funcion hipotalamica humana, composiciones farmaceuticas y procedimientos asociados. Spanish description, claims and patent-family data.

  185. 篠原 一之, 樽見 航 (2019). 新たな健康戦略としての「機能性香料」の提案—ヒトフェロモン等価物の応用—. DOI: 10.11469/koshohin.43.191. Discussion of proposed functional fragrances and human-pheromone analogues. Japanese-language review.

  186. 篠原 一之, 西谷 正太 (2012). 嗅覚：フェロモンなどの匂いを介したコミュニケーション. DOI: 10.11469/koshohin.36.303. Olfactory pathways and proposed human chemical communication. Japanese-language review.

  187. Bioenergetic Forum participant (2026-02-24). 11KT (11 keto testosterone): reply describing body odor and social attention. Public personal account, reply dated 24 February 2026. Accessed 20 September 2026.

  188. Reddit participants (accessed 2026-09-20). Can prog increase body odor?. Public personal accounts, original post and replies. Exact posting date not verified.

This Substack is reader-supported. To receive new posts and support my work, consider becoming a free or paid subscriber.

]]><![CDATA[What Lowers Estrogen and Aromatase Activity: Natural Methods and Medical Treatments]]>https://articles.berbarianwizard.com/p/what-lowers-estrogen-and-aromatasehttps://articles.berbarianwizard.com/p/what-lowers-estrogen-and-aromataseFri, 18 Sep 2026 21:32:57 GMTTestosterone and estrogen are closely linked in men. The body converts some testosterone into estrogen, and estrogen helps regulate how much testosterone the testes produce.[1][2]

Estrogen can build up when production rises or the liver and gut remove less of it. Its effects also depend on how strongly a tissue responds.[3][4][5][6][7]

Food intake, body fat, sleep, thyroid function, digestion and hormone use can all change this balance. Reducing production, improving removal and limiting a tissue’s response are different ways to approach an estrogen problem.[8][9][10][3][4][11]

Contents

  1. How estrogen works.

  2. Checking a possible estrogen problem.

  3. What changes estrogen production and removal.

  4. Comparing the options.

  5. Practical plan and doses.

  6. Supplements and other nonprescription options.

  7. Food and gut health.

  8. Vitamins, extracts, and other supplements.

  9. Steroid hormones and androgen-to-estrogen ratios.

  10. Prescription treatments.

  11. Study doses and experimental amounts.

  12. Research chemicals and patents.

  13. Checking results and special situations.

Read more

]]><![CDATA[What Raises or Lowers SHBG, and What Should You Do About Your Result?]]>https://articles.berbarianwizard.com/p/what-raises-or-lowers-shbg-guide-for-menhttps://articles.berbarianwizard.com/p/what-raises-or-lowers-shbg-guide-for-menSat, 12 Sep 2026 00:38:01 GMTStart with sections 1–4 to understand your result and decide what to check. Use the catalogue when you want the evidence for a particular drug or supplement.

Sections 6–7 answer common questions and explain follow-up. The appendices give the detailed science and further examples.

Interpret SHBG together with free testosterone, symptoms and the medicines or steroids you take. The same SHBG result can mean different things in a healthy man, a man with thyroid disease and a man taking steroids.[1][2][3]

Contents

  1. What SHBG does.

  2. Blood tests and ranges.

  3. Natural men: high, low or in-range SHBG.

  4. Testosterone and AAS.

  5. Drugs, supplements, foods and habits.

  6. Common questions.

  7. Recording changes and checking again.

Appendices: Other human populations. Cell and animal experiments. Detailed science. Glossary. Further blood-test examples and health findings.

Read more

]]><![CDATA[What Lowers Prolactin: ~300 Research Papers, 200+ Options]]>https://articles.berbarianwizard.com/p/what-lowers-prolactinhttps://articles.berbarianwizard.com/p/what-lowers-prolactinThu, 10 Sep 2026 09:24:03 GMTContents

  1. What prolactin does

  2. Where prolactin comes from

  3. Testing prolactin

  4. Why prolactin is high

  5. Sleep, food, exercise and other daily influences

  6. Sex, orgasm and recovery

  7. Which options deserve priority

  8. Medicines: doses and results

  9. Thyroid treatment and hormones

  10. Supplements and herbs studied in people

  11. Animal and cell studies: herbs, nutrients and other compounds

  12. Peptides and treatments that block prolactin in tissues

  13. Surgery and treatment of aggressive tumors

  14. Treatment steps for common situations

  15. Follow-up and stopping treatment

  16. The aim of treatment

Compound index

Read more

]]><![CDATA[What Raises 5-Alpha-Reductase: Results from Human, Animal, and Cell Studies]]>https://articles.berbarianwizard.com/p/what-raises-5-alpha-reductasehttps://articles.berbarianwizard.com/p/what-raises-5-alpha-reductaseFri, 28 Aug 2026 12:40:56 GMT5-alpha-reductase, shortened to 5AR, is usually introduced as the enzyme that turns testosterone into dihydrotestosterone, or DHT. That description leaves out most of its biology.

The same enzyme family begins the path from progesterone to 5-alpha-dihydroprogesterone and allopregnanolone. It helps make THDOC from deoxycorticosterone. It acts on several routes that can lead to DHT, and it helps the body break down cortisol, corticosterone, and aldosterone. SRD5A3 also helps make dolichol, a fat-like molecule that cells use to attach sugar tags to new proteins.[S1][S2][S3][S7][S8][S9][S212]

5-alpha metabolism matters across all of these hormone systems. DHT carries a strong androgen signal. Allopregnanolone and THDOC affect GABA-A receptors, which help control how strongly nerve cells respond. The cortisol and aldosterone branches change how the body processes adrenal hormones. Broad inhibition can affect several steroid families at once.[S1][S2][S5][S7]

High blood DHT does not automatically mean that the body made more 5AR. DHT can rise because testosterone rose, because less DHT was removed, because DHT was taken directly, or because testosterone was applied to skin that converts a large share of it before it reaches the blood. A convincing result needs a direct conversion test, a useful product-to-starting-hormone comparison, or a urine measure that shows more steroid taking the 5-alpha path.

The strongest human findings involve thyroid state, recovery from severe under-eating, and one controlled comparison of a high-carbohydrate diet with a very-high-protein diet. Several smaller hormone studies also found a shift. Most supplement and herb studies measured only a final hormone, one tissue, an animal, or cells in a dish. Those results say less about conversion across the human body.

The practical order starts with low energy intake, too little carbohydrate, confirmed thyroid problems, and medically high prolactin. Resistance training has a direct human result inside muscle. Creatine has one positive blood-ratio trial, followed by a later trial that found no change. Direct DHT can start the positive feedback loop described later. It comes last and needs medical monitoring because it also changes the hormone being measured. Most other popular claims stop at animal tissue, cells, a higher starting hormone, or a higher final hormone without proof of faster conversion.

No standard blood test diagnoses “low 5AR” in a healthy adult, and there is no accepted ideal DHT-to-testosterone ratio for everyone. Rare inherited deficiencies are separate medical conditions. Pregnancy, breastfeeding, adolescence, fertility treatment, prostate disease, liver disease, and prescribed hormone use need their own clinical decisions.[S1][S4][S17]

Overview of the androgen, progesterone, deoxycorticosterone, glucocorticoid, and dolichol pathways that use 5-alpha-reductase enzymes.
Figure 1

Contents

  • 1. What 5-alpha-reductase does

  • 2. How to know whether conversion increased

  • 3. What raised whole-body conversion in humans

  • 4. How hormones and tissues control 5AR

  • 5. Nutrients, supplements, and hormone precursors

  • 6. Food, training, light, sleep, and sexual habits

  • 7. Herbs, plant extracts, and gut bacteria

  • 8. Practical protocol

  • 9. Study doses and measurement reference

Read more

]]><![CDATA[Male Gynecomastia: Causes, Diagnosis, Treatment, Surgery, and Recurrence]]>https://articles.berbarianwizard.com/p/male-gynecomastia-guidehttps://articles.berbarianwizard.com/p/male-gynecomastia-guideTue, 11 Aug 2026 23:07:13 GMT

A tender disc under the nipple, a soft chest after weight gain, and a puffy areola can look similar in a mirror. They can come from different tissues. One may be proliferating gland. Another may be fat over a small normal gland. A third may reflect loose skin, scar, swelling, or the shape of the pectoral muscle. The distinction determines the next step.

Gynecomastia is benign growth of male breast glandular tissue. Many causes can produce it. Pseudogynecomastia describes breast enlargement dominated by fat without the characteristic glandular proliferation. Mixed presentations are common. Current European and Italian guidelines begin with history and physical examination because a hormone value cannot establish which of these structures is present.[S1][S2]

The tissue also has a history. Human pathology shows heterogeneous ductal and stromal patterns. Some specimens appear more proliferative. Others contain denser fibrosis. These patterns help explain why tissue that began or enlarged within six months can behave differently from adult tissue present beyond six to twelve months. A calendar still cannot identify an individual’s histology or guarantee response.[S3]

Blood tests remain useful. They can reveal hypogonadism, hyperthyroidism, hyperprolactinemia, an hCG signal, liver or kidney disease, and other contexts that change management. They also have clear limits. Serum testosterone, estradiol, prolactin, DHT, or a testosterone-to-estradiol ratio does not measure local enzyme activity, receptor abundance, receptor function, or the tissue’s accumulated response. A normal result today cannot erase an earlier exposure.

Treatment can aim to prevent new growth, relieve pain, stop progression, shrink the gland, or correct the chest contour. Studies need to state which result they measured because less tenderness says little about how much gland remains. Lower estradiol alone does not show that the gland became smaller. Surgery can improve the contour while an endocrine cause still needs care.

Diagnosis also starts with the presentation. A typical, symmetric, central presentation often needs no imaging. An indeterminate mass or a suspicious presentation follows a different route based on age and examination. Hard or eccentric tissue, visible or measurable unilateral enlargement over days to weeks, nipple retraction or spontaneous discharge, skin ulceration or dimpling, enlarged axillary nodes, and a testicular abnormality leave the observation-and-drug pathway and enter diagnostic assessment. No validated centimeter-per-week cutoff separates benign from malignant growth. The American College of Radiology makes this presentation-based distinction explicit.[S4]

Trials are only one layer of the treatment record. Patents reveal local-delivery ideas and proposed combinations. Forums reveal nonresponse, adverse effects, mechanism switches, and the practical preference for raloxifene in bodybuilding. Human studies still control claims about efficacy. The other layers now shape the protocol and show where its certainty changes.

The time labels are fixed throughout this guide. Recent adult disease means documented onset or enlargement within six months. Structurally established adult disease means tissue present beyond six to twelve months. Persistent after cause correction means tissue still present after at least six months of observation following correction of the identified cause. Rapid enlargement means visible or measurable change over days to weeks. Early postoperative means the first six weeks. These are decision anchors, not histology tests.

Figure 1. Treatment is chosen from the tissue, timing, cause, and the result the patient needs.[S1][S2][S3][S6]

Contents

Part I. Identify the tissue
1. Male breast anatomy.
2. Gland, fat, skin, scar, and muscle.
3. Tissue change over time.
4. Clinical grade and structural anatomy.

Part II. Explain the biology
5. Estrogenic stimulation and androgenic opposition.
6. Serum values and breast-tissue exposure.
7. Local steroid metabolism.
8. DHT and other 5-alpha-reduced steroids.
9. Prolactin, progesterone, and progestins.
10. Growth factors, inflammation, and fibrosis.

Part III. Find the cause
11. Physiological life stages.
12. Obesity, weight change, nutrition, and recovery.
13. Hypogonadism and genetic conditions.
14. Thyroid, liver, kidney, and systemic disease.
15. Tumors and urgent endocrine causes.
16. Medication-induced gynecomastia.
17. TRT, AAS, fertility treatment, and changing exposure.
18. Idiopathic disease after complete evaluation.

Part IV. Diagnose and classify
19. Urgent features and malignant differentials.
20. The exposure and symptom timeline.
21. Physical examination.
22. Targeted laboratory evaluation.
23. Imaging and biopsy.
24. Final diagnostic classification.

Part V. Choose the treatment objective
25. Prevention, pain relief, growth arrest, regression, and removal.
26. Observation and cause correction.
27. Objective reassessment.

Part VI. Medical treatment
28. SERMs.
29. Aromatase inhibitors.
30. DHT and historical androgen treatment.
31. Danazol, mesterolone, and older strategies.
32. Dopamine agonists.
33. Cause-specific medical paths.
34. Treatment safety and stopping rules.

Part VII. Supplements and nonstandard treatment
35. Supplements linked to estrogen metabolism.
36. Diet and metabolic claims.
37. Topical and physical approaches.
38. Patent claims.
39. Forum, Reddit, and social evidence.

Part VIII. Surgery
40. Surgical indications.
41. Anatomy-selected operations.
42. Adequate excision and contour preservation.
43. Evaluating a surgeon and operative plan.
44. Complications and recovery.
45. Limits of the surgical outcome literature.

Part IX. Residual tissue, recurrence, and treatment failure
46. Residual gland, fat, scar, skin, and contour.
47. Medical nonresponse and changing diagnosis.
48. Early postoperative swelling and scar maturation.
49. New gland growth after renewed exposure.
50. Revision evaluation and long-term follow-up.

Part X. Gradual intervention protocols and common paths
Protocol 0. Establish a usable baseline.
Protocol 1. Remove the active cause and observe.
Protocol 2. Treat a recent active gland with one SERM.
Protocol 3. Consider DHT as a separate mechanism.
Protocol 4. Switch mechanisms after DHT or SERM failure.
Protocol 5. TRT, AAS, hCG, and bodybuilding exposure.
Protocol 6. Historical reserve treatments.
Protocol 7. Stop endocrine trials when the problem is structural.
51. Adolescents.
52. Adults with a recent tender lump.
53. Long-standing stable disease.
54. Obesity and major weight change.
55. TRT and AAS exposure.
56. Fertility treatment.
57. Medication-associated disease.
58. Prostate-cancer antiandrogen treatment.
59. Confirmed endocrine or systemic disease.
60. Postoperative concern about recurrence.

Part XI. Evidence limits and reference tools
61. Evidence hierarchy.
62. Material disagreements.
63. Unresolved questions.

Conclusion. Treatment follows tissue, timing, cause, and goal
Appendix A. Urgent-feature checklist
Appendix B. Exposure and symptom timeline template
Appendix C. Laboratory interpretation framework
Appendix D. Medication-causality worksheet
Appendix E. Treatment-evidence summary
Appendix F. Surgery consultation checklist
Appendix G. Postoperative finding and recurrence taxonomy
Appendix H. Glossary

Read more

]]><![CDATA[The TESTOSTERONE Kabbalah]]>https://articles.berbarianwizard.com/p/the-testosterone-kabbalahhttps://articles.berbarianwizard.com/p/the-testosterone-kabbalahThu, 06 Aug 2026 12:19:41 GMT

The first Testosterone Kabbalah reached almost 10 million views. I kept studying the subject after I published it. This is the version I wanted to be able to write then.

They control everything. They stole your testosterone. Your testosterone was promised to them 3,000 years ago.

The joke hides a real problem. Men are taught to treat testosterone as a number that can be pushed upward. The blood value is only the visible output of a timed biological system. Circadian rhythm, sleep, energy availability, thyroid state, reproductive signaling, Leydig-cell function, mitochondrial cholesterol transport, steroid enzymes, liver handling, local conversion, and receptor response all shape the result.

A low result tells you what was present in that blood sample. It does not tell you why. Luteinizing hormone, or LH, follicle-stimulating hormone, or FSH, sex hormone-binding globulin, or SHBG, free testosterone, prolactin, sleep timing, health, and exposure history help locate the cause. A normal total-testosterone result can still coexist with impaired fertility, weak tissue response, sexual dysfunction, or poor recovery.

Everything depends on identifying the part of the system that limits the result. Once that is clear, the order of action becomes much easier.

This article is completely free. Subscribe to receive future articles directly in your inbox.

Contents

  • Opening. Testosterone boosters, diagnosis, and the systems map

    • Before the map: what testosterone boosters actually change

      • Human evidence, animal evidence, product identity, adulteration, and the difference between symptom relief, temporary output, and restoration

      • Fadogia, Bulbine, Tongkat ali, ashwagandha, shilajit, fenugreek, zinc, boron, Tribulus, Butea superba, akarkara, D-aspartic acid, and complex formulas

      • Products that target LH, estrogen, DHT, free testosterone, libido, erections, or training performance

    • Start here: find the limiting layer

      • Define the problem, record the changed context, screen urgent findings, and decide whether to stabilize, test, or escalate

    • The Testosterone Kabbalah systems map

      • Timing, sleep, nutrition, thyroid function, mitochondria, cholesterol transport, reproductive signaling, steroid enzymes, liver and gut handling, tissue conversion, and receptor action

  • Part I. How the system works

    • 1. A testosterone result has several layers

      • Production, blood concentration, binding, local conversion, receptor response, symptoms, fertility, and durable function

    • 2. Testosterone rises through sleep cycles

      • Sleep onset, slow-wave sleep, REM, continuity, circadian timing, testing time, and the distinct clocks of pituitary hormones

      • Sleep opportunity, airway resistance, apnea, nasal obstruction, allergies, mouth taping, nasal strips, nasal rinsing, and sleep tracking

    • 3. Retinal light, dopamine, and blue light

      • Morning and daytime outdoor light, evening blue-rich light, retinal dopamine, circadian contrast, bromantane, and seasonal context

    • 4. Energy availability

      • Calorie intake, glycogen, fasting, dieting, illness, training load, and low energy availability

    • 5. Nutrition, body composition, and the supplement reference

      • Evidence hierarchy, the original Ray Peat sample food pyramid, energy context, carbohydrate, protein, gelatin, dietary fat, cholesterol, and PUFA

      • Salt, thiamine, iodine, selenium, magnesium, zinc, vitamins A, D, E and K, P5P, glycine, taurine, TMG, inositol, and other layer-specific tools

      • Supplements arranged by circadian rhythm and sleep, thyroid function, mitochondrial energy, prolactin and estrogen, gut function, liver clearance, body composition, fertility, and testicular function

      • Orange juice flavanones, raw carrot salad, white button mushrooms, bamboo shoots, intestinal tolerance, aromatase, estrogen handling, insulin resistance, adiposity, and SHBG

    • 6. Training and recovery

      • Resistance training, aerobic work, intervals, endurance, adaptation, recovery signals, and deloading

    • 7. Thyroid and metabolic state

      • Thyroid output, mitochondrial respiration, metabolic capacity, binding proteins, transport, and peripheral T4-to-T3 conversion

    • 8. Steroid production

      • Brain-to-testis signaling, Ray Peat’s hierarchy, LH and Leydig cells, FSH and Sertoli cells, cholesterol supply, StAR transport, and mitochondrial conversion

      • Pregnenolone, the delta-5 and delta-4 routes, testosterone synthesis, and intratesticular testosterone

    • 9. Liver, gut, serotonin, prolactin, illness, and stress

      • SHBG, hormone metabolism and clearance, bile, endotoxin, gut serotonin, motility, inflammation, glucocorticoids, and active illness

      • Prolactin, dopamine, pornography, compulsive masturbation, sexual context, and the difference between repeated novelty and partnered sex

    • 10. Conversion, transport, and tissue response

      • Pregnenolone, progesterone, DHT, 5-alpha-reductase, estradiol, aromatase, SHBG, free testosterone, androgen receptors, symptoms, and tissue function

  • Part II. Read the laboratory pattern

    • 11. Laboratory interpretation

      • A valid baseline, matched collection conditions, the core laboratory set, and the difference between serum testosterone, intratesticular testosterone, metabolites, and tissue action

      • LH beside testosterone, the LH-to-testosterone relationship, INSL3, Leydig-cell capacity, FSH, prolactin, estradiol, SHBG, thyroid markers, and fertility testing

      • Seven endocrine patterns, from central suppression and primary testicular failure to binding-protein discordance, exogenous exposure, and persistent symptoms with valid androgen values

    • 12. Causes, exposures, and age

      • Testicular, pituitary, hypothalamic, medication, substance, environmental, occupational, and anabolic-androgenic steroid causes

      • Aging as accumulated metabolic, sleep, exposure, illness, and behavioral burden rather than an isolated mechanism

  • Part III. Restore the system

    • 13. The natural restoration plan

      • Gate 1. Validate and classify: Complete the intake, standardize measurement, confirm persistence, and locate the limiting layer

      • Gate 2. Stabilize circadian rhythm and sleep: Fix wake timing, build day-night light contrast, protect complete sleep cycles, and screen airway and sleep disruptors

      • Gate 3. Restore energetic and metabolic conditions: Reconstruct the energy history, correct under-fueling, reduce excess adiposity without crash dieting, and correct defined nutrient needs

      • Gate 4. Adjust training and remove suppressors: Match training to recovery, review drugs and hormones, stop compulsive habits, and treat active illness or gut disease

      • Gate 5. Retest, decide, and preserve options: Hold the intervention long enough, repeat matched testing, escalate unresolved patterns, and define the medical branch when needed

    • 14. Daily and weekly practice

      • Light, meals, training, sleep, airway care, supplements, symptom tracking, and the weekly review

    • 15. Monitor the result

      • Process measures, outcome measures, reassessment intervals, comparable testing conditions, several levels of success, and predefined failure criteria

    • 16. Pattern-based troubleshooting

      • Poor sleep, obesity and low SHBG, energy deficit, high LH, low LH with high prolactin, persistent symptoms with normal testosterone, suppressed LH with high testosterone, and numerical improvement without functional recovery

    • 17. Where the natural approach ends

      • Persistent central, testicular, fertility, structural, medication-related, or systemic disease patterns that require direct medical assessment

  • Final decision and reference material

    • The final decision rule: Locate the first weak layer, change the smallest useful variable, and judge durable function under matched conditions

    • References: Studies, patents, official Ray Peat articles, and official Georgi Dinkov articles

Before the map: what testosterone boosters actually change

A product sold as a testosterone booster may act on testosterone, another hormone, a binding protein, blood flow, arousal, stress, sleep, training performance, or nothing measurable. Those outcomes are often sold under the same name.

Five different effects need separate labels.

  1. Deficiency correction replaces something the body lacks. Zinc can help when zinc deficiency is limiting reproductive function. More zinc after sufficiency does not keep raising testosterone.[1]

  2. Signal stimulation pushes an instruction sent to the testes. A substance that raises luteinizing hormone, usually shortened to LH, increases testicular demand while it is present. The effect depends on the Leydig cells being able to answer.

  3. Measurement change alters the relationship between total and free testosterone. Sex hormone-binding globulin, or SHBG, carries testosterone in blood. Lower SHBG can make calculated free testosterone look higher without increasing production.

  4. Symptom change improves libido, erections, mood, or training through another pathway. Better blood flow can improve an erection while testosterone remains unchanged.

  5. Temporary output raises a value during use. Durable restoration means that the limiting cause has improved and the system still works after the push is removed. Most booster trials never test that question.

A booster can push the output while leaving the machinery unchanged.

Human evidence, animal evidence, and product evidence

Product identity matters. The label on the bottle is only the beginning. Plant species, plant part, extraction method, standardized constituent, dose, and product authenticity all matter.

Tongkat ali, longjack, and Malaysian ginseng refer to Eurycoma longifolia. Physta and LJ100 are named root extracts. Evidence from either extract applies to that preparation, not every tongkat powder.

The same rule applies across the list. Akarkara, akalkara, and pellitory refer to Anacyclus pyrethrum. Ashwagandha is Withania somnifera. Fenugreek is Trigonella foenum-graecum. Testofen and Furosap are named fenugreek seed extracts. Maca is Lepidium meyenii. Shilajit is a variable mineral-organic material, and PrimaVie is a purified branded ingredient. These distinctions decide whether a study tested the product in the reader’s hand.

The human record is small. A 2021 review found 32 randomized herbal trials covering 13 plants. Nine trials reported a significant testosterone increase, and only six were judged at low risk of bias.[2] A later review included 52 studies. Most products did not raise total testosterone. Its possibly effective label required only one positive study. The studies behind that category were small, industry-funded, and at high risk of bias. Only eight of the 52 studies reported adverse effects. These trials measured output during treatment. They left durable recovery after withdrawal unanswered.[3]

Products with no convincing human restoration evidence

Fadogia agrestis became popular from a short rat experiment that raised testosterone and sexual behavior. A later study gave rats an aqueous stem extract at the same doses for 28 days. It changed several testicular measures at every dose. Testicular glutamate dehydrogenase, used in that paper as a marker of mitochondrial injury, fell as the dose rose. Ten days after withdrawal, several measures were still abnormal, especially at 50 and 100 mg/kg.[4][5] The published evidence remains animal-only, with a testicular safety signal and no controlled human efficacy or long-term safety trial.

Bulbine natalensis also rests on rat studies of an aqueous stem extract. After seven days, 25 and 50 mg/kg raised testosterone, LH, FSH, and mating success. At 100 mg/kg, testosterone fell and mating success was worse. A separate 14-day study found altered liver and kidney markers and mild tissue damage.[6][7] The dose reversal and organ findings prevent any safe human dose from being derived from these experiments.

Akarkara improved sexual behavior and accessory-organ measures in rats given a petroleum-ether root extract.[8] The evidence applies to that laboratory extract in rats. Ordinary root powder has no controlled human testosterone trial behind it.

Tribulus terrestris has been tested in men. Controlled trials found no reliable increase in testosterone, androstenedione, or LH.[9][10] A 2025 review found no consistent androgen effect across ten studies.[11] Some sexual-function studies reported improvement. An erectile or libido result remains a different endpoint from testosterone production.

Butea superba has a small erectile-dysfunction trial, one case report of very high dihydrotestosterone, and a later erectile trial whose first active batch was suspected of containing a phosphodiesterase-5 inhibitor.[12][13][14] Dihydrotestosterone is shortened to DHT. It is a potent androgen made from testosterone in many tissues. This record supports neither dependable endocrine restoration nor routine use.

I found no useful effect from Butea superba, Tongkat ali, Fadogia agrestis, Bulbine natalensis, or Akarkara in my own use. That experience led me to audit these products more carefully. Human trials and toxicology determine the published conclusion.

Products with limited or extract-specific human signals

Tongkat ali has the strongest human testosterone signal among the frequently marketed herbs. A 2022 meta-analysis found a higher average total testosterone result, with the clearest signal in men classified as hypogonadal.[15] Most studies used a named standardized extract. Samples were small, follow-up was short, and free testosterone, LH, follicle-stimulating hormone, symptoms, and persistence after stopping were reported less consistently.

One twelve-week Physta trial in older men increased total testosterone. The free-testosterone result was less clear, and the manufacturer funded the study and employed two authors.[16] A short trial in young men increased total and free testosterone and estradiol without changing LH or follicle-stimulating hormone.[17] Tongkat ali is conditional, extract-specific support. It is the wrong tool for sleep apnea, pituitary disease, primary testicular failure, or continued androgen suppression.

Ashwagandha uses several non-equivalent extracts, including KSM-66, Sensoril, and Shoden. One small crossover trial in overweight men found higher salivary testosterone and dehydroepiandrosterone sulfate, usually shortened to DHEA-S. Fatigue, vigor, sexual well-being, and estradiol did not improve beyond placebo.[18] The result applies to that extract, group, and endpoint.

Fenugreek trials use Testofen, Furosap, and other standardized seed extracts. A 2024 randomized trial found no significant pooled advantage over placebo for plasma total testosterone or the free-testosterone index. Salivary testosterone changed, and one dose comparison affected the index.[19] Culinary fenugreek is a different preparation and should not inherit the extract claim.

Purified shilajit raised total and free testosterone in one ninety-day trial of healthy men aged 45 to 55.[20] The claim belongs to that purified ingredient and that population. Independent replication, contaminant control, long-term safety, and persistence remain limited. Raw or unpurified material is a separate product.

These findings support product-specific conclusions. They give no reason for a default stack.

Nutrients only help when the nutrient is limiting

Correct a real deficiency. Zinc, magnesium, vitamin D, iodine, selenium, vitamins A and E, and B vitamins support normal physiology. Deficiency can impair health and reproductive function. Replacement can remove that constraint.

Sufficiency changes the rule. High-dose zinc can cause copper deficiency. Too much iodine or selenium can damage thyroid function. Fat-soluble vitamins can accumulate. Magnesium may help sleep or correct low intake without directly restoring testosterone. Randomized vitamin D trials have not shown a reliable testosterone increase in men who started with normal testosterone.[21]

Small studies do not create a protocol. Boron has changed SHBG or steroid measurements in small, short studies. That is a measurement signal, not evidence of durable production or clinical benefit. ZMA combines zinc, magnesium, and vitamin B6. It inherits the same deficiency logic.

A nutrient enters the plan when diet, symptoms, disease, or measurement establishes a plausible need. A broad micronutrient stack makes it harder to learn which input mattered.

A one-month high-output experiment

In 2013, Georgi Dinkov described a self-experiment built after two years of reading and testing. The first account named 140 grams of protein per day. The daily total was split into two servings of 20 grams of whey, 20 grams of casein, and 30 grams of gelatin, followed by orange juice. The supplement list gave 30 milligrams of zinc, 5 milligrams of vitamin B6, 2,000 milligrams of mixed tocopherols, 3,500 milligrams of branched-chain amino acids, and magnesium without a stated dose.

Georgi Dinkov reported total testosterone above the laboratory’s upper measurement limit of 1,500 ng/dL. No laboratory report, baseline panel, control period, or independent replication accompanied the post. The result remains a self-experiment.

In 2014, Georgi Dinkov described the month in more detail. He said his usual diet was high in protein and sugar and that many of his foods supplied substantial cholesterol. The expanded account added 15 grams of taurine, 6 to 7 grams of aspirin, 2,500 milligrams of mixed tocopherols, 45 milligrams of vitamin K2 as MK-4, 30 milligrams of zinc, 10 milligrams of vitamin B6, and 1,500 milligrams of thiamine. It also included branched-chain amino acids at a dose he did not remember, 1,500 milligrams of tyrosine with each branched-chain amino-acid dose, 200 to 400 milligrams of caffeine, and niacinamide that sometimes reached 8 grams per day.

The two accounts differ. The later account gives 2,500 rather than 2,000 milligrams of vitamin E, 10 rather than 5 milligrams of vitamin B6, and no exact branched-chain amino-acid dose. Those differences matter. They cannot be silently combined into one precise recipe.

The logic of the experiment is more useful than the final number:

  • Substrate and energy. Sugar supplied carbohydrate. Thiamine and niacinamide were used to push glucose oxidation and cellular energy. Caffeine raised metabolic drive. Cholesterol supplied one source of steroid substrate.

  • Amino-acid balance. Gelatin lowered the relative tryptophan and cysteine load of the protein mixture. Branched-chain amino acids compete with tryptophan for transport into the brain. They also compete with tyrosine, which explains why tyrosine was added. Vitamin B6 supports aromatic amino-acid decarboxylation. The intended direction was less serotonin, more dopamine, and less prolactin.

  • Stress and steroidogenic conditions. Aspirin, vitamin E, taurine, vitamin K2, magnesium, and zinc were used to change prostaglandin signaling, lipid oxidation, inhibitory signaling, mineral status, and the environment in which steroidogenesis occurs.

Every layer changed at once. The result therefore belongs to the combined state. It cannot identify which ingredient mattered, whether the value would persist after stopping, or whether a man with a different limiting layer would respond.

Georgi Dinkov later called the expanded schedule “not a healthy schedule” and said it was done purely as an experiment. That warning is justified. Aspirin at 6 to 7 grams per day can cause salicylate toxicity, bleeding, acid-base disturbance, and kidney injury. Niacinamide at several grams per day can cause dose-dependent adverse effects, including gastrointestinal and liver injury. Very high vitamin E can further inhibit platelet function when combined with aspirin.[22][23][24] Caffeine can also damage the sleep foundation this article places first.[25]

This experiment shows how several metabolic and signaling layers can be pushed together. The natural protocol below excludes it.

Products that target LH, estrogen, DHT, or free testosterone

  • LH. D-aspartic acid is marketed as an LH signal. In a twelve-week randomized trial of resistance-trained men, it did not improve total testosterone, free testosterone, estradiol, body composition, or training outcomes.[26]

  • Estradiol. Aromatase-oriented products try to reduce conversion of testosterone into estradiol. Estradiol is an estrogen that men also need for bone, body composition, sexual function, and hormonal feedback.[27] Lowering it can raise LH and testosterone during use by weakening feedback. That is hormone manipulation. It can create a new deficiency while the original cause remains.

  • DHT, prolactin, and receptors. Products sold as DHT boosters, 5-alpha-reductase boosters, prolactin reducers, or androgen-receptor sensitizers must be judged by the human outcome they produce. An enzyme change matters only when it improves the relevant function without creating a new hormonal problem.

  • Prescription stimulation. Drugs that raise LH, activate the LH receptor, lower prolactin, or inhibit aromatase can be useful for defined medical patterns. They need a diagnosis, monitoring, and a fertility plan. They are not natural restoration tools.

Libido, erections, performance, and laboratory spikes

  • Sexual function. Maca improved symptom scores in one randomized trial without a significant advantage for total or free testosterone.[28] That can still be a useful sexual outcome. It remains separate from endocrine restoration.

  • Blood flow and performance. Arginine, citrulline, yohimbine, horny goat weed, and products containing phosphodiesterase-5-like compounds mainly target blood flow or arousal. Creatine has established performance uses. In one crossover study of 20 young rugby players, testosterone did not change. DHT rose from 0.98 to 1.53 nmol/L after seven days of loading and remained at 1.38 nmol/L after 14 days of maintenance.[29] Treat that as one short serum finding. A reproducible DHT or tissue-effect protocol requires replication.

  • Training. Hard resistance exercise, sprints, and intervals can cause short hormone changes. Training improves strength, fitness, insulin sensitivity, and body composition. The brief post-workout rise does not explain chronic muscle growth or restored baseline testosterone.[30][31]

  • Cold and sun exposure. Cold showers, ice baths, testicular icing, and genital sun exposure lack controlled human evidence for durable restoration. Daylight reaching the eyes has a clear role in setting circadian rhythm. Deliberate ultraviolet exposure of the genitals adds skin risk without an established hormonal protocol.

  • Porn and compulsive sexual behavior. Remove pornography during a natural-restoration trial. Stop edging and long sessions. Pause or reduce masturbation when it weakens sleep, attention, libido, erections, or partnered arousal. Orgasm produces an acute prolactin rise, so repeated sessions repeatedly recreate that post-orgasm state. Rat sexual-exhaustion experiments found temporary, region-specific changes in brain androgen receptors after prolonged copulation.[32][33][34][35] Human cue-conditioning and sexual-function data give an independent reason to remove the behavior.[36][37]

Complex formulas and adulterated products

Unknown formulas produce unknown explanations. A proprietary complex combines several uncertain ingredients, often at undisclosed doses. If the result changes, the active component remains unknown.

Product identity can fail more dramatically. In one analysis, 74 of 91 supplements sold as natural sexual enhancers contained sildenafil, tadalafil, or an unapproved analogue.[38] A separate chemical analysis of 44 products sold as selective androgen-receptor modulators found that only 23 contained a selective androgen-receptor modulator. Seventeen contained another unapproved drug, 11 contained a substance absent from the label, and only 18 matched the labeled amount.[39]

An unexpectedly strong result can come from an undeclared drug rather than the herb on the label.

Evidence table for marketed testosterone boosters

Figure 1. Recovery means that the product repairs the failing layer and that the improvement remains after the product is removed.

The test for a real restoration claim

A higher testosterone result can be temporary. Restoration requires the limiting layer to improve and the result to persist after withdrawal.

Before using a product or tactic, write down:

  1. The symptom or laboratory pattern being treated.

  2. The biological layer thought to be limiting.

  3. The exact product, extract, or exposure.

  4. The human evidence for that population and endpoint.

  5. The result that will be measured.

  6. The safety, interaction, and fertility risks.

  7. The stopping rule.

  8. What should remain improved after withdrawal.

When the limiting layer is unknown, the product is an experiment on the output.

Start here: find the limiting layer

Diagnosis locates the weak link. Begin with the symptoms that carry the most androgen information, then use the timeline and laboratory pattern to separate the causes. Fatigue, low mood, poor concentration, weight gain, and weak training progress remain useful context, but carry little diagnostic weight alone.

Start with four checks:

  1. Define the change from your own baseline. Record the symptom, when it began, whether it is constant or intermittent, and how much it affects daily life.

  2. Check whether the change fits androgen function. Loss of libido, fewer spontaneous or morning erections, reduced testicular volume, delayed puberty, infertility, hot flushes, loss of body hair, and reduced shaving frequency carry more androgen information than fatigue alone.[40][41]

  3. Record what changed before the symptom. Review sleep, shift work, weight, food intake, training load, illness, pain, medication, alcohol, opioids, hormones, anabolic steroids, head injury, testicular injury, and fertility plans.

  4. Choose urgent care, laboratory testing, or stabilization. Sudden severe testicular pain, a testicular mass, a severe new headache with visual change, or serious systemic illness bypasses self-directed optimization.

Define the problem before ordering a panel

Use three symptom groups.

Sexual and reproductive changes include libido, spontaneous erections, erectile reliability, ejaculation, testicular change, fertility, and breast symptoms. These are the most useful starting signals, though each still has non-androgen causes.

Physical and recovery changes include strength, muscle loss, bone injury, anemia, reduced work capacity, slow recovery, and a simultaneous fall in training performance. These become more informative when several change together.

General symptoms include fatigue, low mood, irritability, poor concentration, sleepiness, and reduced initiative. Keep them in the record. Do not let them carry the diagnosis alone.

For every symptom, record the direction of change, the date it began, and the context. A lifelong low libido is a different problem from a sharp decline after an anabolic-steroid cycle. Poor recovery during a severe cut is different from progressive weakness with a testicular mass.

Mark the context that changed

Build a simple twelve-month timeline. Include:

  • Sleep timing, snoring, witnessed breathing pauses, travel, and shift work.

  • Weight, waist, dieting, fasting, appetite, and food restriction.

  • Training volume, intensity, endurance work, injuries, and deloads.

  • Acute or chronic illness, pain, fever, gut symptoms, and major stress.

  • Every prescription, supplement, hormone, prohormone, selective androgen-receptor modulator, and recreational drug.

  • Head injury, testicular injury, infection, surgery, chemotherapy, and radiation.

  • Puberty, previous fertility, current fertility goal, and anabolic-steroid history.

The sequence often identifies the first branch. Symptoms that follow sleep fragmentation point toward timing and airway work. Symptoms that follow rapid weight loss and rising training load point toward low energy availability. Low testosterone after androgen use begins in the suppression branch. A long fertility history with small testes or high follicle-stimulating hormone begins in the testicular branch.

Diagnostic intake and decision sequence

Figure 2. Define the change, screen urgent findings, record the context, and then choose stabilization, matched laboratory testing, or direct medical assessment. The figure is a decision sequence, not a symptom score.

Decide whether to stabilize, test, or escalate

Stabilize first when a temporary confounder clearly dominates and no red flag is present. Examples include acute febrile illness, several nights of severe sleep loss, an unusual endurance event, or an active crash diet. Correct the condition, allow recovery, and then test under representative conditions if symptoms remain.

Test now when sexual or reproductive symptoms persist, when several physical signs move together, when a previous result was low, when fertility is at risk, or when medication or hormone exposure could have suppressed the system.

Seek direct assessment when the history suggests a pituitary, testicular, genetic, medication-related, or serious systemic cause. Lifestyle work can continue when safe. It should not delay the cause-specific evaluation.

This first pass narrows the question. Laboratory testing later in the article separates low production, weak central signaling, testicular resistance, altered binding, exogenous suppression, and symptoms that are probably coming from another system.

The Testosterone Kabbalah

The Kabbalah is a map of dependencies. No knowledge of religious Kabbalah is needed to use it.

A vertical path runs through the middle. It starts with the conditions that let cells work, then follows cholesterol into the mitochondrion, through steroid production, into testosterone, and finally into tissue action. Side nodes show the systems that supply timing, fuel, instructions, transport, and clearance.

The map prevents a common mistake. A man can have enough cholesterol and still have weak LH signaling. He can have strong LH and damaged Leydig cells. He can have adequate testosterone in blood and poor sleep, vascular erectile dysfunction, low free testosterone, or impaired fertility. Every layer has to carry its part of the system. Raising one downstream number leaves failure elsewhere untouched.

How to read each part of the map

Timing comes first. Light reaching the retina sets the central circadian clock. Sleep supplies the cycles during which testosterone normally rises. An obstructed airway can fragment those cycles.

Food supplies energy and raw material. Protein, carbohydrate, fat, vitamins, and minerals support the tissues involved. The body can make cholesterol from carbon supplied by any macronutrient. High fat intake is unnecessary for that purpose.

Thyroid and mitochondria provide working capacity. Thyroid hormone helps regulate metabolic activity. Mitochondria are small structures inside cells that turn fuel into usable energy and host the first regulated step of steroid production.

The brain and pituitary provide instructions. The hypothalamus is a control region in the brain. It signals the pituitary gland, which releases LH and follicle-stimulating hormone, usually shortened to FSH. LH tells Leydig cells in the testes to make testosterone. FSH supports Sertoli cells and sperm production. Together, this is the hypothalamic-pituitary-gonadal axis, shortened to the HPG axis.

Cholesterol must reach the correct place. Steroidogenic acute regulatory protein, shortened to StAR, moves cholesterol to the inner mitochondrial membrane. The enzyme CYP11A1 then converts it into pregnenolone, the first steroid in the pathway.

Later enzymes finish production. Pregnenolone can pass through several intermediates before becoming testosterone. Enzyme activity, cellular energy, reducing power, and testicular health determine how much material moves through the pathway.

Blood transport changes the measured result. The liver makes SHBG, a protein that carries testosterone. Liver health and metabolic state can change SHBG and therefore change how total and free testosterone relate.

Tissues decide the final signal. 5-alpha-reductase converts testosterone to DHT. Aromatase converts it to estradiol. Receptors in each tissue respond to the hormones that reach them. The blood value cannot describe every local conversion.

Gut and liver remain supporting systems. The gut handles digestion, absorption, immune exposure, serotonin production, and microbial metabolites. The liver makes binding proteins and clears steroid hormones. These are defined functions rather than vague detox claims.

Body composition and suppressive exposures modify the network. Excess adipose tissue can lower SHBG, increase aromatase, worsen insulin resistance, and contribute to sleep apnea. Severe underfeeding can also suppress reproductive signaling. Illness, medication, previous androgen use, and training that exceeds recovery can interrupt several nodes at once.

The cobalt path in the figure marks production from cholesterol transport to tissue action. Gray lines show support or context. The smaller LH node represents the immediate testicular instruction. It is essential without being the whole system.

The Testosterone Kabbalah systems tree

Figure 3. Cobalt follows the regulated steroid pathway. Gray marks timing, energy, metabolic support, transport, clearance, and lower-weight modifiers. The smaller reproductive node separates LH action on Leydig cells from FSH support of Sertoli cells.

Part I. How the system works

1. A testosterone result has several layers

Testosterone exists at several biological levels at once:

  1. Leydig cells make it.

  2. A blood sample measures it.

  3. SHBG and albumin carry it.

  4. Tissues convert it to DHT or estradiol.

  5. The androgen receptor receives the signal.

  6. The signal contributes to libido, fertility, blood production, bone, muscle, mood, and body composition.

Each layer can move independently.

Laboratory testosterone is one output. The final androgenic signal is the wider result. A higher blood value can still coexist with poor sleep, low energy availability, thyroid disease, inflammation, vascular erectile dysfunction, or weak tissue response.

Production, concentration, and action

Production means how much the testes secrete over time. Concentration means how much a laboratory finds in one sample. Action means what happens inside a tissue.

Concentration changes when production changes, but also when SHBG, clearance, plasma volume, sampling time, or the assay changes. Tissue action varies again with local conversion, receptor function, tissue health, and other hormones.

This explains several common mismatches:

  • Low total testosterone with low SHBG can coexist with a smaller change in free testosterone.

  • Normal total testosterone with high SHBG can coexist with low free testosterone.

  • Exogenous testosterone can produce a high serum concentration while suppressing LH, FSH, intratesticular testosterone, and sperm production.

  • Normal testosterone can coexist with erectile dysfunction from vascular disease, medication, neuropathy, anxiety, sleep loss, or relationship context.

  • Acute illness or underfeeding can lower testosterone without permanent testicular failure.

Aim for better function and a stable, healthy system. Do not chase the highest serum number.

2. Testosterone rises through sleep cycles

Circadian rhythm sets the clock. It is the body’s internal timing system, running on a cycle of roughly twenty-four hours. Outdoor light reaching the eyes is one of its main environmental setters.[42][43]

Sleep supplies the cycles. Testosterone starts rising after sleep begins. In healthy young men, it reaches a high level around the first rapid eye movement, or REM, period and stays elevated until waking.[44][45] Fragmentation can delay that rise. Selective loss of slow-wave sleep can also lower the morning result.[46][47]

Sleep deprivation lowers testosterone. The clearest adverse evidence comes from total sleep deprivation.[48] Severe repeated restriction has also lowered daytime testosterone in a controlled study.[49]

Cycles are not fixed ninety-minute blocks. Their length varies within the same person and across the night. Slow-wave sleep is usually concentrated earlier. REM periods become longer later. Cutting the last part of the night removes REM-rich sleep. Fragmenting the first part damages slow-wave sleep.

Protect complete cycles. Allow enough time for sleep and reduce avoidable awakenings. Judge the result through morning function, daytime alertness, symptoms, and matched laboratory tests.

Build the sleep window around enough complete cycles and a reasonably stable wake time. Shift work, travel, parenting, illness, and chronotype can move the clock. The standard remains adequate opportunity, intact cycles, regular timing, and alignment with daylight.

Sleep cycles and the nocturnal testosterone rise

Figure 4. Testosterone starts rising after sleep onset. Slow-wave sleep is heavier early in the night. REM periods lengthen later. Fragmentation and a shortened night remove different parts of the cycle.

Circadian rhythm and testing

The circadian clock places sleep and hormone rhythms in time. Sleep provides the stages and continuity.

Light can shift the clock without opening an obstructed airway. Extending the sleep window cannot fully repair repeated night-shift misalignment.

A blood draw at 8:00 a.m. can mean different things in a day worker, a night worker, and a man who slept from 4:00 a.m. to noon. Record:

  • Wake time on the day of the test.

  • Sleep start and duration for the preceding nights.

  • Whether the schedule was typical.

  • Recent night shifts or travel across time zones.

  • Acute illness, severe training, fasting, or caloric restriction.

  • Time of the blood draw relative to waking.

In the HORMONIT night-work study, androgen and melatonin timing shifted later, while individual sex steroids followed different patterns.[50] The sampling plan has to account for that shift.

Pituitary hormones do not share one clock

Each pituitary hormone has its own timing.

LH is pulsatile. Researchers sampled twenty healthy men every ten minutes and found LH intervals ranging from 30 to 480 minutes. A daily LH pattern appeared across the group, while FSH showed no clear daily rhythm.[51] One isolated LH result may catch a pulse, a trough, or the interval between them.

Prolactin and growth hormone follow sleep closely. Thyroid-stimulating hormone, or TSH, reflects both sleep and circadian timing. Cortisol follows the circadian clock more strongly.[52]

In a small crossover study, ten young men followed a later sleep-and-meal schedule for three weeks. Free testosterone and prolactin fell, and several measured twenty-four-hour rhythms became much flatter.[53] The experiment moved sleep and meals together, so its result belongs to the shifted schedule as a whole.

Melatonin is also time-dependent. Retinal light remains the main environmental signal for the central clock. Melatonin can shift circadian phase, but the effect depends on timing. In one 3 mg study, doses taken during the first half of habitual sleep produced little phase shift.[54][55]

Melatonin changes one timing signal. The schedule, sleep pattern, symptoms, and matched laboratory results show whether the wider hormonal rhythm is working.

Sleep opportunity and common disruptors

Time in bed is not time asleep. A useful sleep window includes the sleep itself, the time needed to fall asleep, and ordinary brief awakenings.

Build from the wake time. Choose a workable wake time and count backward far enough to complete the night. When spending longer in bed only creates more wakefulness, persistent insomnia may require cognitive behavioral therapy for insomnia.

Caffeine depends on dose and timing. It can reduce total sleep time, sleep efficiency, and deep sleep.[25] Find the latest dose that leaves sleep unchanged, then leave some margin.

Alcohol can trade faster sleep onset for a worse second half of the night. It can also worsen sleep-disordered breathing.[56]

Pain, reflux, nocturia, nicotine, stimulants, heat, noise, and a partner’s schedule can all break sleep cycles. Find the main disruptor before reaching for a sleep supplement.

Restless legs syndrome deserves its own check. The pattern is an urge to move the legs that begins or worsens at rest, improves with movement, and is usually worse in the evening. Clinically important restless legs can delay sleep and cause repeated disruption. Review ferritin and transferrin saturation with a clinician, untreated apnea, alcohol, caffeine, and medicines that can aggravate the condition. This includes some antihistaminergic, serotonergic, and antidopaminergic drugs.[57] Iron is not a blind sleep supplement. Its use depends on the iron studies and the clinical pattern.

Sleep continuity and the airway

Enough time in bed will not compensate for an airway that keeps closing.

Look for loud snoring, witnessed pauses, gasping, dry mouth, morning headaches, nocturia, unrefreshing sleep, and daytime sleepiness. Obstructive sleep apnea, shortened to OSA, is associated with lower testosterone, especially when disease is severe.[58] Obesity contributes. Lean men can also have apnea through jaw structure, tonsils, or nasal obstruction.

Nasal allergies can fragment sleep. Pollen, dust mites, animal dander, mold, smoke, infection, reflux, and structural narrowing can all block the nose, so treatment should follow the cause.

Use this order:

  1. Reduce the known allergen or irritant.

  2. Use a saline rinse when it helps rhinitis. Use only distilled, sterile, or previously boiled and cooled water.[59][60]

  3. Try a nasal strip when the nasal valve is narrow. It may improve airflow. It does not treat obstructive sleep apnea.[61]

  4. Seek examination for persistent obstruction, recurrent sinus disease, enlarged tonsils, or a deviated septum.

  5. Get a sleep study when apnea signs are present.

A true food allergy or reflux can worsen congestion in some people. Treat a suspected food as relevant when the reaction repeats under similar conditions. “Starch” is too broad to serve as a diagnosis.

Mouth-taping evidence is small, and obstruction or sleep apnea makes the practice unsafe.[62] Open the nose and rule out apnea first.

Nasal breathing tools and airway limits

Figure 5. Rinse and nasal strips can help selected nasal problems. Mouth taping is not an apnea treatment and should never be used through an obstructed nose.

Continuous positive airway pressure, or CPAP, treats diagnosed apnea but does not reliably raise testosterone on its own.[63] Its purpose is to keep the airway open and improve breathing, oxygenation, and sleep quality.

3. Retinal light, dopamine, and blue light

Light reaching the retina is the main environmental signal for the central clock. Specialized retinal cells respond strongly to short wavelengths and send that timing information to the brain.[64]

You need thyroid, you need the amino acid tyrosine, and you need your retina to be exposed to light.

Tyrosine is a dopamine precursor, and tyrosine hydroxylase controls the rate-limiting step in catecholamine synthesis. Bright light can stimulate dopamine synthesis inside the retina.[65][66]

Outdoor light supports testosterone through more than one route. It anchors circadian rhythm, supports retinal dopamine, and protects sleep. In the hypothalamus, dopamine restrains pituitary prolactin. When prolactin remains pathologically high, GnRH and LH can fall, followed by testosterone, libido, erections, and fertility.[42][43][67][64][65]

Where bromantane fits

Bromantane, also called Ladasten, connects to this dopamine discussion through a different compartment. Outdoor light begins with photons at the retina. Bromantane acts inside central catecholamine pathways.

The rat response changed by brain region and time. In adult male rats given 50 mg/kg orally, tyrosine-hydroxylase messenger RNA in the ventral tegmental area peaked at 220% of control after 90 minutes. In the hypothalamus, the same transcript first fell to 66% at 30 minutes, then rose to 212% at 90 minutes. Hypothalamic tyrosine-hydroxylase protein was about twice the control level after two hours. In the striatum, the transcript fell to about 20% at 30 minutes and returned to control by two hours, while the protein did not rise. Nucleus-accumbens L-3,4-dihydroxyphenylalanine, or L-DOPA, and dopamine were about three times control at two hours. Hippocampal L-DOPA and dopamine showed a similar threefold peak at 90 minutes.[68]

A separate microdialysis experiment followed five freely moving male rats after 100 mg/kg orally. Extracellular dopamine in the dorsal striatum peaked at 553% of baseline after two hours and remained between 240% and 355% through eight hours. At eight hours, the dopamine metabolites 3,4-dihydroxyphenylacetic acid, or DOPAC, and homovanillic acid, or HVA, had fallen to 68% and 60% of baseline. Tetrodotoxin almost stopped spontaneous dopamine release and only partly suppressed the bromantane response, which points to more than one release mechanism.[69]

In the gene-expression experiment, a 588-gene whole-brain macroarray identified 15 initial candidates 90 minutes after 50 mg/kg orally. Quantitative PCR supported 12 changes. The largest reported shifts included carboxypeptidase H falling to 10% of control, synapsin I to 42%, gamma-aminobutyric acid transporter 3, or GAT3, to 60%, the APC tumor-suppressor transcript rising to 221%, cytoplasmic actin to 180%, and the retinoblastoma transcript, Rb, to 176%. The authors treated GAT3 and carboxypeptidase H as possible pharmacological targets. They treated several other changes as compensatory or neuroplastic responses.[70]

In rat hippocampal slices, 10 micromolar bromantane converted weak short-term potentiation into a long-lasting form. Blocking protein synthesis prevented the effect. A D1/D5 antagonist given during induction also prevented the conversion. Starting the antagonist 40 minutes after induction did not. This supports a dopamine- and protein-synthesis-dependent synaptic mechanism in that preparation.[68]

The two routes should be read separately:

  • Outdoor light: Retinal photoreception, circadian timing, and dopamine production inside the retina.

  • Bromantane: Pharmacological regulation of dopamine synthesis and signaling inside selected brain regions.

The androgen route is indirect. Hypothalamic dopamine restrains prolactin. Pathologically high prolactin can suppress GnRH, LH, testosterone, libido, erections, and fertility. These bromantane papers stop upstream. They contain no prolactin, GnRH, LH, testosterone, or retinal-dopamine measurement.[68][71]

Treat bromantane as central dopaminergic pharmacology. It cannot replace daytime outdoor light and it sits outside the default natural protocol. The milligram-per-kilogram values above describe rat experiments. They are not human dosing instructions. Bromantane is a CNS-active drug. Product identity, medication interactions, sleep timing, and the clinical context matter.

Daylight contains plenty of blue light, which supports alertness and circadian anchoring during the day. Exposure to the same spectrum at night can suppress melatonin and delay sleep timing.[42][43][64]

Use a strong day-night contrast:

  • Get outdoor light after waking when feasible.

  • Work in a bright environment during the day.

  • Dim the environment as sleep approaches.

  • Reduce bright screens near the face at night.

  • Keep the bedroom dark.

Someone trying to delay an unusually early clock may need morning light later. Clinicians may also use evening light deliberately for some circadian disorders. Timing determines whether light advances or delays the clock.

Calibrate.day turns wake time into a simple light and wind-down schedule. Use it to organize timing. Circadian phase measurement and sleep diagnosis belong to clinical assessment.

Daytime retinal light and nighttime blue-rich light

Figure 6. Daytime retinal light supports circadian timing and retinal dopamine. Hypothalamic dopamine affects the reproductive axis separately through prolactin control.

Retinal light and skin exposure act through different routes. Correct vitamin D deficiency for its established indications. In men who begin with normal testosterone, supplementation trials show no reliable testosterone increase.[21] Set skin exposure by latitude, season, skin type, and medical risk instead of a universal number of minutes.

Seasons change the comparison

Male hormone results can vary across the year. Two large observational datasets found seasonal variation in testosterone and placed the peak in different parts of the year.[72][73] Latitude, temperature, activity, sleep, illness, body composition, and laboratory timing all shape the comparison.

Record the season when comparing tests taken many months apart. Keep the laboratory, wake context, and sampling method as similar as possible. Treat season as a comparison variable, never as an explanation for a persistent low result with symptoms.

4. Energy availability

Reproductive output responds to food intake, expenditure, stored energy, illness, and stress. One man may need more food while another needs slow fat loss. The starting state determines the intervention.

Low energy availability

Energy availability means the food energy left for normal physiology after exercise. Male studies do not support one universal cutoff. Use the man’s weight trajectory, intake, training, recovery, symptoms, and hormone pattern.

During contest preparation, testosterone in one bodybuilding case study fell from 9.22 to 2.27 ng/mL and recovered after the competition.[74] The athlete had combined a long deficit, very low body fat, and high training demand.

Short trials have produced different results. In one randomized crossover, six exercising men completed four days at about 16 kcal/kg fat-free mass/day. Leptin and insulin fell, but testosterone and free triiodothyronine, or T3, did not.[75] Two other trials found lower testosterone at their lowest intake.[76][77] Severe restriction presents a real risk. The size and timing of the response vary, and a four-day experiment cannot define chronic adaptation.

Look for a pattern that includes several of the following:

  • Unplanned or rapid weight loss.

  • Persistent hunger or rigid food restriction.

  • Falling performance despite high effort.

  • Cold intolerance.

  • Loss of morning erections or libido.

  • Irritability, sleep disruption, or waking hungry.

  • Recurrent injury.

  • Training volume that rose while food intake stayed fixed.

  • A testosterone decline that followed a cutting phase.

Diagnose the pattern from weight change, intake, training, recovery, and the timing of symptoms. One isolated item carries little weight.

5. Nutrition, body composition, and the supplement reference

The evidence hierarchy for nutrition

Nutrition changes energy availability, body composition, training, sleep, liver function, thyroid function, and nutrient status. The strongest evidence supports three actions: correct a sustained deficit, reduce excess fat without crash dieting, and replace a genuine deficiency.

The trials do not identify one ideal macronutrient ratio. A 2021 analysis found lower testosterone with lower-fat diets, while a 2025 analysis that included more trials found no overall advantage for higher-fat diets.[78][79] Set the ratio from energy needs, digestion, training, body composition, and metabolic health.

Protein supports tissue repair and lean mass. Carbohydrate supports glycogen, training, and recovery. Fat supplies energy, essential fatty acids, and helps absorb fat-soluble nutrients. The useful amounts depend on the person.

Build the diet in this order:

  1. Correct an energy deficit or excess that is impairing health.

  2. Establish adequate complete protein.

  3. Supply carbohydrate and fat in amounts that support training, sleep, glucose regulation, and the intended weight trajectory.

  4. Build micronutrient sufficiency from tolerated foods.

  5. Add a supplement only when the reason, dose, expected result, and stopping rule are clear.

The original Ray Peat sample food pyramid

The diagram below keeps the original labels and placement from the widely circulated sample pyramid. I have not renamed its tiers or added foods. The image itself says that these are not structured guidelines, and it remains a third-party summary of Ray Peat’s diet rather than a diagram published by Ray Peat.

Inside the pyramid are fruit, fruit juice, honey, dairy, eggs, collagenous meats, non-PUFA seafood, coconut oil, butter, daily carrots, and weekly liver. PUFA sits outside it. Ray Peat’s own writing supports many of these choices,[80][81][82] though none becomes a proven testosterone intervention by appearing in the image.

Ray Peat sample food pyramid

Figure 7. The labels and placement reproduce the original sample pyramid. “These are not structured guidelines” is part of the source image. The pyramid is a third-party summary, not a diagram published by Ray Peat.

Energy context

Carbohydrates occupy the base of the pyramid. The person’s energy state determines the amount.

A lean athlete who loses weight, morning erections, performance, and warmth during a hard cut may need more food and less training. A sedentary man with visceral fat, insulin resistance, low SHBG, and apnea may need gradual fat loss. Both patterns can lower testosterone through different routes.[74][83][84]

Use regular meals when long gaps lead to under-eating, waking hunger, poor training, or overeating. Meal frequency serves energy stability and adherence rather than a universal testosterone target.

Carbohydrate: source, amount, and purpose

Ray Peat favored ripe fruit, fruit juice, honey, and easily digested carbohydrates. Juice can be useful when appetite is low or expenditure is high. Whole fruit provides more fiber and chewing. Potatoes, rice, and other starches also belong when they improve satiety, digestion, or adherence.

Evaluate the carbohydrate pattern through:

  • Stable training and recovery.

  • Sleep without hunger or reflux.

  • Good digestion.

  • The intended weight and waist trend.

  • Appropriate glucose control when metabolic disease is present.

For testosterone, current human evidence does not rank fruit sugar above a tolerated, energy-matched starch. Choose the source by digestion, sleep, training, glucose control, and body composition.

Protein: complete sources and complementary gelatin

Choose complete protein sources that digest well. Ray Peat often favored milk, cheese, eggs, shellfish, low-fat fish, and ruminant meat, with liver in a smaller role.

Gelatin or collagen supplies glycine and can complement a diet heavy in muscle meat,[82] but it cannot replace complete protein.

Shellfish supply zinc, copper, and selenium. Eggs supply protein and choline. Liver is dense in vitamin A, copper, B vitamins, and iron, so the amount has to account for the rest of the diet.

A workable protein pattern has five features:

  • Intake supports lean mass, training, and recovery.

  • The diet remains energetically adequate.

  • Protein selection does not create persistent digestive symptoms.

  • Kidney, liver, allergy, or metabolic conditions are respected.

  • The plan does not depend on one food that the person cannot tolerate.

Dietary fat, cholesterol, and PUFA

Polyunsaturated fatty acids are shortened to PUFA. The first article favored saturated fats and strict PUFA avoidance. Ray Peat preferred lower-PUFA foods and stable cooking fats,[81] while the human testosterone evidence supports a much narrower claim.

Some studies report lower testosterone with very low fat intake. A newer analysis of trials found no overall advantage for higher-fat diets.[78][79]

The body can make cholesterol from carbon supplied by carbohydrate, fat, and protein. Dietary cholesterol contributes to that pool, alongside cholesterol made inside the body, circulating lipoproteins, lipid droplets, and cell membranes.[85][86][87][88] Steroid production does not require forcing fat intake upward.

Four constraints matter when setting fat intake:

  1. Keep total fat high enough for nutritional adequacy and food tolerance.

  2. Keep total energy aligned with the intended weight trajectory.

  3. Minimize repeatedly heated or oxidized oils and the ultra-processed foods that carry them.

  4. Choose cooking fats and whole-food fat sources that fit cardiometabolic risk, digestion, and preference.

The source pyramid names coconut oil and butter, while my first article also named dairy fat, cocoa butter, and ruminant fat. They can be used when they fit the person and the diet. Keep PUFA low without chasing literal zero. Complete elimination is impractical.

Minerals, vitamins, and dose

The first article named calcium, salt, magnesium, thiamine, niacinamide, riboflavin, biotin, vitamin K2, vitamin E, zinc, selenium, iodine, choline, taurine, glycine, and creatine. Separate them into three categories.

Required nutrients. Calcium, magnesium, potassium, sodium, iodine, selenium, zinc, B vitamins, and fat-soluble vitamins serve established physiological functions. An adequate diet should cover them because deficiency can impair general and reproductive health.

Context-dependent additions. Creatine can support repeated high-intensity performance. Gelatin or glycine can complement the protein pattern. Choline-rich foods contribute to ordinary nutrient sufficiency. Coffee can remain in the diet when caffeine leaves sleep intact. None guarantees a rise in testosterone.

Dose-sensitive compounds. Iodine, selenium, zinc, vitamin A, vitamin E, niacinamide, and salt can cause harm when the dose exceeds the person’s need or conflicts with disease or medication. Salt intake has to reflect sweat loss, climate, blood pressure, kidney function, and treatment context. Caffeine timing has to protect sleep.[25]

Salt and the stress-hormone loop

Salt acts upstream of testosterone by changing the amount of hormonal compensation required to maintain circulation and sodium balance.

When sodium intake or effective blood volume falls, the kidneys release renin. Renin drives angiotensin II and aldosterone. Aldosterone conserves sodium, while sympathetic activity helps defend pressure and circulation. Across controlled diet studies, lower sodium increased renin, aldosterone, noradrenaline, and adrenaline on average.[89]

Ray Peat placed serotonin and prolactin inside the same loop. Sodium restriction can increase serotonin and sympathetic activity. Serotonin can increase prolactin. Prolactin can promote urinary sodium loss. Continued sodium loss then creates more demand for renin, aldosterone, and adrenaline.[90]

This explains the anti-prolactin role of adequate salt. Salt does not block the prolactin receptor. It reduces one of the conditions that can sustain serotonin, prolactin, and stress-hormone compensation. Ray Peat also connected sodium with sodium-potassium ATPase activity, fuel use, carbon-dioxide production, heat, and sleep. In this model, adequate salt supports the energetic state that keeps the stress system quiet.[90]

Cortisol needs precise wording. In a 630-person crossover intervention, liberal sodium increased 24-hour urinary free cortisol while producing a small decrease in morning serum cortisol. More cortisol in urine can reflect greater excretion rather than greater exposure inside tissues.[91] A single urinary or morning value cannot describe the whole cortisol rhythm.

Salt also sits beside thyroid, progesterone, and estrogen in this model. Progesterone opposes aldosterone signaling. Hypothyroidism and a high estrogen-to-progesterone state can favor sodium loss. Salt supports the resulting physiology without acting as a direct anti-estrogen drug.[90]

Use appetite, food intake, sweat loss, climate, blood pressure, kidney function, heart function, and medication together. A man losing sodium through heat, endurance work, diarrhea, or a low-salt diet has a different problem from a man with salt-sensitive hypertension, edema, kidney disease, heart failure, or a drug that changes sodium handling.

Thiamine and the energy layer

Thiamine becomes thiamine diphosphate, a cofactor for pyruvate dehydrogenase, alpha-ketoglutarate dehydrogenase, branched-chain alpha-ketoacid dehydrogenase, and transketolase.[92] That places vitamin B1 between food and usable energy.

Pyruvate dehydrogenase converts pyruvate into acetyl-CoA. Alpha-ketoglutarate dehydrogenase keeps the citric-acid cycle moving. Together they let carbohydrate support adenosine triphosphate, or ATP, production and carbon dioxide. Steroidogenic cells need ATP and reducing power to transport cholesterol and run steroid enzymes. When thiamine-dependent metabolism is constrained, the same LH signal reaches a Leydig cell with less energetic capacity.

The dopamine link follows the same logic. Tyrosine and vitamin B6 sit closer to dopamine synthesis, while thiamine supports the energy, redox state, and mitochondrial function needed by dopaminergic neurons. Thiamine supports the terrain in which dopamine is made and released. Dopamine agonists act directly at dopamine receptors. Thiamine works through metabolism.

The gut adds another route. Enteric nerves and intestinal smooth muscle require ATP. Pyruvate-derived acetyl-CoA also supplies the acetyl group used to make acetylcholine, a major signal for intestinal movement. A 2026 genetic study of 268,606 people linked stool frequency with vitamin B1 transport and metabolism. Dietary thiamine intake tracked with stool frequency in the accompanying nutritional analysis.[93] Better transit can reduce prolonged fermentation, constipation, and the gut burden that feeds endotoxin and peripheral serotonin signaling. Georgi Dinkov had already placed thiamine in this gut-motility context.[94]

Georgi Dinkov groups thiamine, niacinamide, and biotin around glucose oxidation.[95] A separate Georgi Dinkov article on testicular energy metabolism places aspirin and niacinamide in the same direction.[96] Together, these inputs aim at parts of the downstream metabolic state associated with T3: stronger glucose oxidation, better mitochondrial throughput, and less reliance on stress metabolism. T3 still has its own receptor-mediated actions.

Thiamine acts upstream of testosterone. It removes an energetic bottleneck when intake, absorption, transport, or enzyme activity is limiting. Once those enzymes are working normally, adding more B1 is a different intervention. Gram doses are pharmacological and should not be confused with ordinary nutritional sufficiency.

Zinc shows why context matters. A small 1996 study induced marginal zinc deficiency in four young men and supplemented nine marginally deficient older men. Testosterone fell during restriction and rose during repletion.[1] The result supports correcting deficiency, not giving high-dose zinc to men who already have enough.

Use the same rule here. Food history, clinical risk, and laboratory assessment can identify a real deficiency. Correct one defined problem at a time.

The supplement map: match the tool to the layer

A useful supplement has a named job. It corrects a shortage, treats a defined condition, or improves a measured function that is limiting the network. The name on the bottle is not enough. Form, dose, route, strain, timing, starting state, and endpoint decide what the evidence means.

Use this section as a reference by limiting layer. The ordered protocol in Part III determines whether any item belongs in the plan.

Use five evidence classes:

  1. Deficiency correction. A nutrient restores a function that low intake, poor absorption, loss, or disease had constrained.

  2. Condition-specific treatment. A product helps a defined phenotype such as antibiotic-associated diarrhea, irritable bowel syndrome with diarrhea, or documented male-factor infertility.

  3. Functional support. A product improves sleep, bowel function, training performance, or another upstream input without directly raising testosterone.

  4. Preliminary hormone signal. A small or uncontrolled human study moves a hormone but does not establish durable restoration.

  5. Mechanism only. A cell or animal experiment explains a possible route. It does not establish the same outcome in men.

Every supplement enters through one layer. Judge it by that layer before judging testosterone.

Layer 1. Circadian rhythm and sleep

Glycine can support sleep and improve the amino-acid balance of a diet heavy in muscle meat. In a small crossover study of people dissatisfied with their sleep, 3 grams before bed improved subjective sleep quality and shortened the latency to sleep and slow-wave sleep. It did not change the proportion of sleep spent in each stage.[97] Glycine can be tested when it is tolerated. It does not repair apnea, nasal obstruction, pain, late bright light, or circadian misalignment.

L-theanine is another optional sleep aid. A recent systematic review found small improvements in selected subjective sleep outcomes across a mixed literature. Evidence for pure L-theanine was thinner than the marketing suggests.[98] It can support a wind-down routine when it is tolerated. It cannot replace light timing, complete cycles, or treatment of an airway problem.

Gelatin and collagen supply glycine. They can complement muscle meat and increase total glycine intake. Their effect depends on the amount actually consumed. They do not replace complete protein.

Melatonin can shift circadian timing and help selected sleep problems when timing and dose fit the problem.[99] It cannot replace daytime light, darkness at night, complete sleep cycles, or an open airway.

Epithalon, also called Epitalon, is the experimental tetrapeptide AEDG. Its relevant placement is the circadian branch. An experiment in old female rhesus monkeys changed the evening melatonin response and the cortisol rhythm.[100] A recent review describes a wider experimental literature.[101]

My overall response to Epithalon was positive. I did not preserve the preparation, route, dose, timing, cycle length, concurrent inputs, or raw sleep measurements.

Other public reports around Epithalon repeatedly mention deeper sleep, vivid dreams, clearer mornings, and easier circadian adjustment. Some instead describe transient sleep disruption, paradoxical stimulation, or difficulty waking. These reports identify possible response patterns. They provide no estimate of response frequency. Baseline state, light timing, concurrent drugs, preparation, dose, and product identity remain unresolved.

The practical route is circadian. Better melatonin and cortisol timing can improve sleep continuity, morning energy, metabolic control, and the nocturnal environment in which testosterone production occurs. Judge Epithalon by sleep timing, ease of waking, body temperature, next-day energy, and measured rhythm when available. Its placement here is circadian support, not direct LH stimulation.

Epithalon stays outside the default natural restoration plan until a specific question, a credible preparation, medical oversight, measurable endpoints, and a stopping rule justify the experiment.

Layer 2. Thyroid production and mineral sufficiency

Iodine is a raw material for T4 and T3. Selenium is built into the deiodinases that activate and inactivate thyroid hormone. Iron supports thyroid peroxidase. Zinc and vitamin A also participate in thyroid physiology. A systematic review of 57 human studies found that thyroid and iodine status are influenced by this wider micronutrient setting, while the randomized evidence did not support treating every association with more supplementation.[102]

The causal order is simple. An iodine shortage can limit hormone production. A selenium shortage can limit deiodinase function. Correcting either shortage can remove that bottleneck. Once iodine supply and selenoprotein activity are adequate, adding more does not keep pushing the thyroid forward.

Iodine has a narrow practical role. Review iodized salt, dairy, eggs, seafood, seaweed, thyroid disease, thyroid antibodies, and drugs that alter thyroid function. Concentrated kelp and iodine drops can move intake far beyond food-level exposure. Excess iodine can trigger hypo- or hyperthyroid patterns, especially in susceptible thyroids.[103]

Selenium needs the same restraint. Food intake, geography, malabsorption, thyroid diagnosis, and total supplemental exposure matter. In a 412-person randomized trial of autoimmune hypothyroidism, selenium and placebo produced equal improvement in quality of life.[104] Selenium is essential. Routine high-dose selenium is a different claim.

Myo-inositol becomes relevant here when the target is thyroid responsiveness. It supplies substrate to phosphoinositide signaling used downstream of TSH-receptor activation. In a randomized double-blind study, 46 women with autoimmune subclinical hypothyroidism completed six months of treatment. TSH fell from 4.4 to 3.1 mIU/mL with 600 milligrams of myo-inositol plus 83 micrograms of selenomethionine. TSH did not change with selenomethionine alone.[105]

The lower TSH is best read as reduced compensatory demand. When the thyroid responds better, the pituitary can maintain the system with less stimulation. The finding applies to myo-inositol plus selenium in women with autoimmune subclinical hypothyroidism. LH and FSH still require their own paired target hormones and clinical context.

Iron matters here only when deficiency is documented. Ferritin must be read with inflammation, transferrin saturation, blood count, symptoms, bleeding, and iron-overload risk. Blind iron can create a new oxidative and infectious burden.

Lactoferrin sits beside iron because it binds the mineral and can change its handling instead of simply delivering a large elemental dose. In a trial of 80 children with inflammatory bowel disease and iron-deficiency anemia, 100 milligrams per day for three months improved hemoglobin, serum iron, transferrin saturation, and ferritin. Interleukin-6, or IL-6, and hepcidin also fell. The response was stronger and better tolerated than ferrous sulfate in that population.[106] Lactoferrin is not a replacement for iron therapy in every cause of anemia.

Apolactoferrin is lactoferrin with very little iron attached. Its low iron saturation leaves more iron-binding capacity unoccupied. Native lactoferrin, apolactoferrin, and iron-saturated hololactoferrin are not the same preparation. Their iron saturation changes their physical behavior and can change the purpose of the product.[107] Check the label for iron saturation, dose, and intended target instead of treating every lactoferrin product as interchangeable.

Copper also requires context, especially after prolonged high-dose zinc.

Layer 3. Mitochondrial energy and recovery

Magnesium supports ATP handling, nerve and muscle function, glucose metabolism, and many enzyme systems. The first question is the amount of elemental magnesium. The second is intestinal tolerance. The salt attached to it matters, but it does not create a special testosterone pathway.

  • Magnesium citrate is well absorbed and can loosen stool. In a randomized crossover study in healthy men, citrate produced greater serum and urinary magnesium responses than oxide.[108]

  • Magnesium oxide supplies more elemental magnesium by weight and works as an osmotic laxative. Its absorption is lower than citrate in direct comparisons. It can still be the right form when constipation is part of the problem.

  • Magnesium glycinate or bisglycinate is often chosen when citrate is too laxative. A glycinate label does not prove a separate testosterone effect.

  • Magnesium chloride, lactate, gluconate, and aspartate are soluble oral forms. Choose among them by elemental dose, tolerance, cost, and the clinical use behind the product.

  • Magnesium malate, taurate, orotate, and L-threonate attach magnesium to different carriers. Claims about energy, the heart, or the brain require evidence for the complete compound. They cannot inherit a testosterone claim from magnesium itself.

  • Magnesium carbonate and hydroxide are used mainly in antacid or laxative products. Their purpose and elemental dose should be read from the complete label.

  • Magnesium sulfate is mainly a medical or laxative form. Intravenous magnesium is a drug treatment for specific conditions.

  • Topical magnesium chloride oil, creams, sprays, flakes, and Epsom-salt baths can feel more noticeable than an oral capsule. That practical response matters. A person may prefer the topical route for local muscle tension, cramping, relaxation, or sleep. The amount that crosses intact skin is not predictable from the product label or the sensation, and the human absorption literature remains limited.[109]

Correcting magnesium deficiency can remove a sleep or neuromuscular constraint. Across the sleep literature, observational associations are common and randomized results remain inconsistent.[110] Choose oral, topical, or bowel-active forms by the target and tolerance. When systemic deficiency is suspected, follow the intake, losses, symptoms, and laboratory context rather than estimating absorption from how strongly a product feels.

Kidney function sets the safety boundary. Reduced renal clearance can turn supplemental magnesium or magnesium-based laxatives into hypermagnesemia.[111]

Thiamine, riboflavin, niacinamide, magnesium, and lipoate support different steps in carbohydrate oxidation and mitochondrial redox handling. Biotin supports carboxylase reactions. Vitamin K2 as MK-4 has separate electron-carrier and steroidogenic hypotheses, but its testosterone evidence remains preclinical.[112] These compounds belong together only at the level of energy production. A shortage in one cannot be diagnosed from a testosterone result alone.

Taurine participates in bile-acid conjugation, osmoregulation, calcium handling, and neural signaling.[113] It was part of Georgi Dinkov’s one-month experiment. That combined self-experiment cannot isolate taurine as the reason testosterone rose.

Creatine monohydrate supports repeated high-intensity work and training quality. Its role here is performance and recovery. One small study changed the DHT-to-testosterone relationship, but that result has not made creatine a dependable DHT or testosterone treatment.[29]

Pinealon is the experimental tripeptide EDR. Its primary placement is brain metabolism, gene regulation, neuronal stress, and neurodegenerative models.[114] My overall response was positive, but I did not preserve the preparation, route, dose, timing, cycle length, concurrent inputs, or raw measurements. Reports of changed sleep or dreams can follow a change in brain function. They do not make Pinealon a sleep supplement or a sedative.

Pinealon fits under brain metabolism. It stays outside the default natural restoration plan until a specific question, a credible preparation, medical oversight, measurable endpoints, and a stopping rule justify the experiment.

Methylene blue is different. It is a drug-like redox compound, not another B vitamin. In experimental systems it can accept electrons from NADH and pass them to cytochrome c, creating an alternative route around blocked parts of the respiratory chain.[115] That mechanism explains why it appears in mitochondrial protocols. It does not establish a routine testosterone dose or a general need.

Methylene blue also inhibits monoamine oxidase A. Combining it with serotonergic drugs can cause serotonin toxicity.[116] Product purity, dose, medication interactions, and diagnosis decide whether it belongs anywhere. It stays outside the default natural protocol.

Layer 4. Prolactin, estrogen, and steroid signaling

Zinc can restore testosterone when zinc deficiency is the limiting problem.[1] It also supports spermatogenesis, immune function, and many enzymes. In a small acute experiment, oral zinc lowered basal prolactin in healthy adults.[117] That result supplies a direct anti-prolactin route. It does not show that chronic high-dose zinc treats persistent hyperprolactinemia. Chronic high doses can lower copper status. Read zinc beside diet, copper exposure, blood count, gastrointestinal disease, and the reason it is being used.

Vitamin B6 and its active coenzyme form, pyridoxal 5′-phosphate, or P5P, support amino-acid metabolism. Aromatic amino-acid decarboxylase uses P5P to make dopamine from L-DOPA. The same enzyme also makes serotonin from 5-hydroxytryptophan.[118] P5P therefore supports the dopamine route that restrains prolactin, but it is not a selective dopamine switch. Pyridoxine blunted the prolactin rise caused by exercise in one experiment, and a very small series of selected women with hyperprolactinemia reported responses.[119][120] A separate intravenous study in nine patients with hyperprolactinemia found no prolactin reduction.[121] Correct inadequate B6 and use the route when the clinical setting fits. Persistent hyperprolactinemia still requires diagnosis. Repeated high supplemental exposure can cause sensory neuropathy.[122]

Vitamin A supports epithelial differentiation and retinoic-acid signaling in spermatogenesis.[123] Liver, eggs, dairy, and carotenoid-rich foods contribute to status in different forms. Retinol is fat soluble and high supplemental doses can injure the liver.[124]

Vitamin D matters for bone, mineral handling, immune function, and deficiency correction. A randomized trial in healthy men did not produce a reliable testosterone increase.[21] Correct deficiency for its own reasons. Do not make testosterone the promise.

Vitamin E protects susceptible membrane lipids from oxidation. Ray Peat placed it more broadly as an estrogen antagonist because lipid peroxidation, inflammation, prostaglandins, and estrogen signaling can reinforce one another.[125] In one eight-week trial in 24 men receiving hemodialysis, vitamin E lowered prolactin but did not change free testosterone, LH, or FSH.[126] This supports an oxidative-stress and prolactin route in uremia. The wider anti-estrogen model is mechanistically coherent, but the dose and starting state still matter. Mixed tocopherols are not interchangeable with one isolated tocopherol, and very high doses can impair platelet function, especially beside aspirin.[24]

Vitamin K supports normal coagulation and bone-related proteins. For an androgen-focused K2 supplement, I prefer MK-4. MK-4 raised testosterone in rats and testis-derived tumor cells.[112] In contrast, an eight-week trial of 90 micrograms of MK-7 in women with PCOS found lower DHT relative to placebo, with no difference in total testosterone.[127] The trial did not measure 5-alpha-reductase itself, so the mechanism remains unresolved. The direction of the DHT result is enough for me to keep MK-7 out of a DHT-focused protocol. MK-4 is the preferred form here, while its direct testosterone evidence remains preclinical.

The other B vitamins remain part of the energy and blood-forming layers. Riboflavin, niacinamide, biotin, folate, and B12 should be corrected when diet, disease, medication, or measurement shows a reason. High-dose niacinamide is pharmacology, and high-dose biotin can distort thyroid, gonadotropin, prolactin, vitamin D, and other immunoassays that use biotin-based detection.[128] Tell the laboratory about every supplement before endocrine testing.

Layer 5. Gut barrier, motility, serotonin, and endotoxin

Zinc carnosine, enteric lactoferrin, riboflavin, and butyrate address different parts of this layer.

Zinc L-carnosine is a defined compound used for mucosal protection. In a small randomized crossover experiment, 10 healthy volunteers took 37.5 milligrams twice daily before indomethacin exposure. Zinc L-carnosine prevented the increase in small-bowel permeability seen with indomethacin alone.[129] That is a direct intestinal-barrier result. It is not the same intervention as ordinary zinc, and it does not show a testosterone effect.

Layer 2 covered lactoferrin as an iron-regulating protein. Its gut use raises a different issue: formulation. Enteric coating protects more of the protein from early gastric digestion and delivers it farther into the intestine. In one small eight-week trial of 26 adults with abdominal obesity, 300 milligrams per day of enteric-coated bovine lactoferrin reduced visceral-fat area more than placebo.[130] The study was too small to make lactoferrin a general fat-loss or testosterone product. Ordinary powders and non-enteric capsules cannot borrow an enteric-coated result.

Use enteric-coated lactoferrin when intestinal delivery is the target. Use an iron-defined lactoferrin or apolactoferrin preparation when iron handling is the target. The label must identify which intervention is actually being used.

Riboflavin, or vitamin B2, connects the gut and mitochondrial branches. In the randomized RIBOGUT trial, 50 or 100 milligrams per day for two weeks increased fecal butyrate without a gross change in microbial composition.[131] Riboflavin therefore offers one route for supporting microbial redox exchange and butyrate production. The trial did not test testosterone.

Butyrate is a short-chain fatty acid normally produced when colonic bacteria ferment suitable carbohydrate and fiber. Colon cells use it as fuel. Oral sodium butyrate is a delivery tool when endogenous production or colonic exposure is the target. Microencapsulation matters because free butyrate is absorbed early and has a strong odor and taste.

In a 66-person randomized trial, microencapsulated sodium butyrate added to standard IBS treatment reduced the frequency of selected symptoms. It did not produce a broad reduction in symptom severity.[132] Use sodium butyrate for a defined bowel target, such as an irritable-bowel-syndrome symptom pattern. It has no direct testosterone role.

Probiotics are strain-specific.

A bacterial species name is not a product specification. The strain, viable dose, formulation, storage, duration, and host condition are part of the intervention.

Saccharomyces boulardii is a probiotic yeast. CNCM I-745 is a named clinical strain and must remain on the product record when that is what was used. Across preparations identified as S. boulardii, a meta-analysis of 21 randomized trials found that antibiotic-associated diarrhea fell from 18.7 percent to 8.5 percent.[133] Antibiotics do not kill this yeast, while antifungal drugs can. It is inappropriate for critically ill or severely immunocompromised patients and for people with central venous catheters because fungemia has been reported.[134]

Heyndrickxia coagulans GBI-30, 6086, commonly still labeled Bacillus coagulans GBI-30, 6086 or BC30, has human evidence for bowel function. In a randomized trial of 111 adults with functional gastrointestinal complaints, one billion viable cells per day for four weeks improved selected stool and constipation outcomes.[135] The strain and viable count are part of the result. It did not test testosterone.

Limosilactobacillus reuteri ATCC PTA 6475 is the strain behind the famous testosterone claim. It preserved testicular size and testosterone in mice through an immune pathway.[136] A twelve-week double-blind trial then tested the same strain in healthy men aged 55 to 65. Neither the low nor high dose raised testosterone.[137] A later ten-person open-label pilot also found no meaningful change in sex hormones after twelve weeks, although body-fat, blood-pressure, and inflammatory measures moved.[138] The human endocrine results do not reproduce the mouse testosterone result.

Other L. reuteri strains have other jobs. BM36301 preserved testicular and endocrine measures in aged mice, but it has no comparable human testosterone trial.[139] DSM 17938 improved selected symptoms and bowel habit in a randomized adult functional-constipation trial.[140] NCIMB 30242 is a bile-salt-hydrolase-active strain that lowered LDL cholesterol in a trial of hypercholesterolemic adults.[141] Those results do not transfer between strains. A mixed product that merely says L. reuteri has not identified the intervention.

Many other L. reuteri strains exist. Each requires its own human endpoint. Species-level marketing cannot fill in missing strain data.

The first article also named Lactiplantibacillus plantarum, Lactobacillus acidophilus, Lacticaseibacillus rhamnosus PB01, Lacticaseibacillus paracasei, and a commercial Mega Acidophilus blend. I grouped them too loosely. The male-hormone leads for L. plantarum with inulin and for L. acidophilus came from metabolically injured rats.[142][143] PB01, also identified as DSM 14870, raised reproductive hormones and improved sperm kinematics in normal-weight and diet-induced-obesity mice.[144] Those are useful strain leads. They are not human testosterone results.

The L. paracasei claim and the Mega Acidophilus brand claim are weaker because the original list did not preserve a verified male human trial or a stable, complete strain specification. A changing brand formula is not a scientific identity. Neither belongs in a testosterone protocol until the exact strain and human endpoint are established.

Ginger and gut serotonin signaling.

Ginger acts through gut motility and 5-HT3 signaling. Gingerols and shogaols modulate the 5-HT3 receptor-channel complex in cell and isolated-tissue experiments.[145] This is a receptor-level anti-serotonin route. It does not mean that ginger lowers all serotonin in the body.

The human gastrointestinal signal is clearer. In a randomized crossover experiment in 24 healthy adults, 1.2 grams of ginger accelerated gastric emptying and increased antral contractions.[146] Ginger can therefore be tested when upper-gut motility, nausea, or meal tolerance is the target. Its testosterone literature remains largely experimental and cannot carry the decision by itself.

Thymoquinone and black seed.

Nigella sativa seed oil, a standardized thymoquinone-rich oil, and isolated thymoquinone are three different preparations. A randomized trial gave 68 infertile men 2.5 milliliters of Nigella sativa seed oil twice daily for two months and reported better semen parameters. The abstract did not report a testosterone endpoint.[147]

Isolated thymoquinone has separate human work in metabolic disease. In a randomized trial added to metformin, it improved glucose endpoints in type 2 diabetes.[148] That result belongs to glucose control in that population. It does not convert isolated thymoquinone into a male fertility or testosterone treatment.

Use black seed products only when the complete preparation and endpoint match. Whole seed, seed oil, standardized oil, and isolated thymoquinone cannot inherit one another’s evidence.

Binders treat a named intestinal problem.

Enterosgel, or polymethylsiloxane polyhydrate, has randomized human evidence for irritable bowel syndrome with diarrhea, or IBS-D. In a 440-person trial, the responder rate was 37.4 percent with Enterosgel and 24.3 percent with placebo.[149] This supports a time-limited IBS-D treatment. It does not show that Enterosgel removes systemic endotoxin or raises testosterone. The study also included company employees among its authors.

Diosmectite shortened recovery from acute watery diarrhea in a randomized adult trial.[150] It is an acute-diarrhea tool, not part of a daily hormone protocol.

Activated charcoal belongs mainly to selected acute poisonings. It adsorbs many medications, can cause constipation, and carries an aspiration risk.[151] Daily charcoal can remove the drugs and nutrients the rest of the plan depends on.

Bentonite, zeolite, and modified citrus pectin are often sold as toxin or endotoxin binders. They have no credible human evidence for restoring testosterone. Product contamination and drug binding add practical risk. They remain outside this protocol.

Take any intestinal adsorbent away from medication only under product-specific medical guidance. Stop when the defined gastrointestinal indication has ended.

Layer 6. Liver, bile, methylation, insulin, and body composition

TUDCA, or tauroursodeoxycholic acid, is a bile acid with pharmacological effects. A four-week randomized trial in 20 obese insulin-resistant adults used 1,750 milligrams per day and improved liver and muscle insulin sensitivity by about 30 percent. It did not improve adipose-tissue insulin sensitivity or the measured markers of endoplasmic-reticulum stress.[152] This is a metabolic result in a selected population. TUDCA belongs after the diagnosis of a liver, bile, or insulin-resistance problem. It is not a generic liver detoxifier.

Choline supports phosphatidylcholine production, membrane structure, acetylcholine synthesis, and export of fat from the liver. A placebo-controlled trial in patients receiving long-term parenteral nutrition showed that correcting choline deficiency reversed associated liver abnormalities.[153] Eggs, dairy, meat, fish, and other foods can cover much of the need. Choline supplements make sense when diet or a defined liver and nutrient question establishes the target.

Coffee has relevant liver evidence. A meta-analysis of 11 observational studies linked coffee consumption with lower odds of fatty liver and liver fibrosis.[154] That association does not prescribe a universal number of cups. Caffeine taken late enough to shorten or fragment sleep can work against the main objective of this article. Use coffee only when the dose, timing, pulse, digestion, and sleep remain favorable.

Trimethylglycine, or TMG, is also called betaine and enters two layers. In the liver it donates a methyl group to remethylate homocysteine. In training it acts as an osmolyte and may change the endocrine response to hard work.

The testosterone signal is human. In a randomized crossover trial of 43 adult CrossFit practitioners, three weeks at 2.5 or 5 grams per day raised total testosterone by 7.0 percent on average. The response varied widely. Placebo did not change testosterone, and body composition did not change.[155] A second crossover study gave 10 adolescent male handball players 2.5 grams per day for 14 days. After a high-intensity resistance session, the betaine condition produced higher total testosterone and a higher testosterone-to-cortisol ratio, with lower cortisol.[156] In a 14-week trial of 29 professional youth soccer players, testosterone and the testosterone-to-cortisol ratio rose in the betaine group during the season, while testosterone fell late in the season in the placebo group. Lean mass and body fat did not differ between groups.[157]

These studies place TMG in the training and recovery branch. They used athletes, and two used adolescents. They do not establish a treatment for clinical low testosterone. The adult CrossFit result was modest, variable, and short.

The prediabetes trial shows the liver boundary. High-dose betaine lowered homocysteine, left clamp-measured insulin sensitivity unchanged, and raised total cholesterol.[158] Four controlled feeding studies found the same tradeoff at 6 grams per day: lower homocysteine with higher LDL cholesterol and triglycerides.[159] Use TMG for a measured methylation or homocysteine problem, or as a defined training experiment with matched labs. Permanent daily use requires the same clear target and follow-up.

Betaine hydrochloride is a gastric-acid product. Its acid-support effects cannot substitute for TMG’s methyl-donor and osmolyte evidence.

D-chiro-inositol connects insulin signaling, mitochondrial glucose oxidation, and aromatase. D-chiro-inositol-containing glycans can regulate glycogen synthase and mitochondrial pyruvate-dehydrogenase phosphatase.[160] D-chiro-inositol also reduced expression of CYP19A1 aromatase in primary human granulosa cells.[161] That experiment used ovarian cells, but its direction matches the male blood data.

The first male pilot gave 10 men 1 gram of D-chiro-inositol daily for one month.[162]

  • Testosterone rose by 23.4 percent.

  • DHEAS rose by 13.8 percent.

  • Epiandrosterone rose by 39 percent.

  • Estrone fell by 85 percent.

  • Estradiol fell by 14.4 percent, although that change missed statistical significance.

  • The testosterone-to-estradiol ratio rose by 36 percent.

  • LH, FSH, and inhibin B did not change.

A second pilot studied 10 insulin-resistant men aged 65 to 75 with symptomatic low testosterone. They took 600 milligrams twice daily for 30 days.[163]

  • Testosterone rose from 222.8 to 262.8 ng/dL.

  • Androstenedione rose from 0.43 to 0.88 ng/mL.

  • Estradiol fell from 42.24 to 34.15 pg/mL.

  • Estrone fell from 128.59 to 93.59 pg/mL.

  • Elevated LH moved from 12.61 to 9.76 mIU/mL.

  • The homeostatic model assessment of insulin resistance, or HOMA-IR, fell from 5.41 to 3.52.

  • Grip strength and self-reported erectile function improved.

The pattern is biologically coherent. Less aromatase expression could preserve more androgen substrate. Better insulin signaling and glucose oxidation could improve the energy available to Leydig cells. In the older group, the rise in testosterone occurred beside a fall in previously elevated LH, which is consistent with less compensatory drive.

The evidence still comes from two one-month studies with 10 men each and no placebo group. D-chiro-inositol is promising for the combined pattern of low testosterone, high aromatization, insulin resistance, or high LH relative to testosterone. It does not yet deserve a settled place in the default protocol. Treat it as a measured experiment. Record testosterone, estradiol, estrone when available, LH, glucose control, waist, libido, erections, and adverse effects before and after. Do not suppress estradiol blindly or continue indefinitely without reassessment.

Layer 7. Fertility and testicular function

Semen quality, intratesticular testosterone, serum testosterone, erections, and pregnancy are different endpoints. A fertility supplement should be judged by semen analysis and couple-level outcomes.

Myo-inositol has a separate fertility record. A double-blind trial in men with idiopathic infertility reported improvements in sperm concentration, total count, progressive motility, and acrosome reaction.[164] That result concerns semen and fertility. It does not make myo-inositol a universal testosterone supplement.

A randomized trial in 468 infertile men tested selenium, N-acetylcysteine, their combination, or placebo for 26 weeks. The active groups improved several semen measures, and the paper reported changes in testosterone and inhibin B.[165] The result applies to men with infertility in that protocol. Selenium and N-acetylcysteine are not automatic additions for a fertile man with adequate selenium status.

Coenzyme Q10, L-carnitine, and acetyl-L-carnitine act on redox handling and sperm energy metabolism. Trials in idiopathic male infertility have reported improvements in selected semen measures.[166][167] The endpoint remains fertility. A semen response cannot be rewritten as restoration of the whole testosterone network.

Large stacks can fail even when every ingredient has a plausible mechanism. The MOXI randomized trial combined vitamins C and E, selenium, carnitine, zinc, folate, and lycopene in men with male-factor infertility. It did not improve semen parameters, pregnancy, or live birth over placebo.[168]

Outside the core layers. Thymic and immune experimentation

Vilon is the experimental dipeptide KE. Its main literature concerns thymic and immune regulation.[169] It does not map directly onto a core Kabbalah layer. My own response was unusually strong recovery and training drive. That experience is relevant to recovery, but it cannot identify whether the change came through immune, stress, neuroendocrine, or another route.

Before another experimental peptide cycle can support a practical protocol, record:

  • The exact product, batch, certificate of analysis, and storage conditions.

  • The preparation, route, dose, timing, frequency, and cycle length.

  • The sleep schedule, light exposure, diet, training, illness, drugs, hormones, and other supplements used at the same time.

  • The target chosen before use, such as sleep continuity, wake time, dream recall, cognition, recovery, training performance, immune markers, LH, prolactin, or testosterone.

  • Baseline measurements, repeated measurements during use, adverse effects, and the result after withdrawal.

Vilon stays outside the default natural restoration plan until a specific question, a credible preparation, medical oversight, measurable endpoints, and a stopping rule justify the experiment.

This is the practical rule for the entire map:

  1. Name the limiting layer.

  2. Choose the form or strain studied for that layer.

  3. Record the starting value or symptom.

  4. Change one main variable when possible.

  5. Define the reassessment date and stop rule.

  6. Keep pharmacological doses and disease treatments out of the default natural protocol.

Intestinal tolerance and Ray Peat’s fiber tools

The original article kept three fiber tools in view: raw carrot salad, well-cooked white button mushrooms, and well-boiled bamboo shoots. This version also restores the orange-juice flavonoid route. The four foods do different jobs. Mushrooms act most directly on aromatase in experimental systems. Carrot and bamboo mainly change bowel handling. Orange juice supplies absorbed citrus flavanones with experimental aromatase activity.

Orange juice flavanones

Orange juice supplies the flavanone glycosides hesperidin and narirutin. Digestion and the microbiota release hesperetin and naringenin, and both aglycones appear in human plasma and urine after juice intake.[170]

The anti-estrogen route is aromatase. Naringenin inhibited human aromatase in an enzyme system, but it did not reduce aromatase activity in one human endometrial stromal-cell model.[171][172] Hesperetin inhibited the growth of aromatase-expressing tumors in an ovariectomized mouse model, while naringenin was inactive in that experiment.[173] The models disagree on naringenin and agree that the compound, tissue, and preparation matter.

Orange juice therefore belongs as a repeatable food-level source of bioavailable flavanones, energy, potassium, and carbohydrate. Its flavanones supply a plausible anti-aromatase route. They do not turn a glass of juice into a pharmaceutical aromatase inhibitor. Use an amount that supports energy and digestion without crowding out complete protein or causing gastrointestinal problems.

Raw carrot salad

Ray Peat used raw carrot as a bowel-protective, anti-estrogen food.[174] The causal route begins in the liver. The liver conjugates estrogens and sends part of them into bile. Intestinal bacteria can deconjugate some of that material. Slow transit leaves more time for reabsorption. Faster transit and greater stool output move more material out.

A small 1979 study gave five people 200 grams of raw carrot at breakfast each day for three weeks. Serum cholesterol fell by 11 percent. Fecal bile-acid output rose by 50 percent, fecal fat rose by 30 percent, and stool weight rose by 25 percent. Neutral-steroid excretion did not change.[175] This directly supports a bile and bowel effect. It did not measure estrogen or testosterone.

A later controlled study gave 24 women enough raw, frozen, blanched, or canned carrot to provide 15 grams of carrot fiber per day. Every preparation increased stool bulk. The carrot fiber was also highly fermented, and fecal bile-acid excretion did not increase.[176] Preparation, background diet, dose, and the person therefore matter. Raw carrot is not uniquely nonfermentable in every intestine.

The estrogen route has separate human support. Women eating more fiber excreted more estrogen in stool in one diet comparison.[177] In a randomized intervention, faster transit produced with senna lowered selected serum estrogens. Wheat bran lowered estrone sulfate. Fecal beta-glucuronidase did not change.[178] Transit itself can matter even when one bacterial enzyme does not move.

A practical carrot salad can remain simple: grated raw carrot with salt, vinegar, and a small amount of tolerated oil. The published carrot studies did not test this exact recipe. Use it consistently enough to judge stool frequency, stool form, bloating, and comfort. Stop or change it when it increases fermentation, constipation, or irritation.

White button mushrooms: the direct aromatase route

White button mushroom is Agaricus bisporus. Cremini and portobello are later forms of the same species. Among these foods, mushrooms have the most direct experimental aromatase evidence.

The original experiment boiled 70 grams of wet vegetable in 200 milliliters of water, then filtered and concentrated the extract. White button mushroom was the strongest of seven vegetables in a human placental-microsome aromatase assay. Fifty microliters of the 7.5-fold concentrate produced about 50 percent inhibition. The kinetics were mixed, which points to more than one inhibitor or mechanism. The extract also reduced aromatase activity and testosterone-supported proliferation in aromatase-transfected breast-cancer cells.[179]

Carrot did not inhibit aromatase in that same vegetable screen. Its anti-estrogen role belongs to bowel transit and estrogen handling, not to this enzyme result. Later mushroom work reproduced aromatase inhibition in experimental cancer systems and identified several unsaturated fatty acids in an active fraction.[180]

The human data did not show a serum-androgen effect. A phase I study gave 36 men with recurrent prostate cancer between 4 and 14 grams of white button mushroom powder per day. Circulating testosterone, DHT, and DHEA did not change.[181] The concentrated extract assay and the human powder study answer different questions. A local enzyme effect does not have to produce a large change in circulating androgens.

Cooking is still the right preparation. Agaricus bisporus contains agaritine. Boiling, baking, and frying reduce its concentration to different degrees.[182] Cooking also makes a large mushroom serving easier to digest. The extract assay gives a reason to test well-cooked mushrooms consistently as food. Judge tolerance and the overall pattern over weeks. A serving cannot be expected to act like pharmaceutical suppression.

Bamboo shoots

Well-boiled bamboo shoots provide another structured fiber. In a controlled feeding study, eight healthy young women ate a fiber-free diet, a cellulose diet, and a diet containing 360 grams of bamboo shoots. Each period lasted six days. The bamboo-shoot period increased fecal volume and bowel-movement frequency.[183] The study was small and short. It measured bowel and lipid outcomes, not estrogen, endotoxin, or testosterone.

Boiling matters because fresh shoots from some edible bamboo species contain taxiphyllin, a cyanogenic glycoside. Food-chemistry analysis found less taxiphyllin after boiling and identified heat-processing markers in commercial bamboo products.[184] Use a prepared commercial product or properly boiled shoots. Bamboo shoots belong in the bowel-function branch.

How to use these foods

Consistency is required because transit and stool patterns are repeated processes.

  1. Pick one food first.

  2. Keep the preparation and amount reasonably stable.

  3. Track stool frequency, stool form, bloating, pain, and tolerance.

  4. Give the food enough repeated exposure to reveal a pattern.

  5. Stop when symptoms clearly worsen.

  6. Add the next food only after the first result is clear.

These foods support the gut and clearance layers. They do not replace treatment for constipation, diarrhea, inflammatory bowel disease, high estradiol, liver disease, or hypogonadism.

  • Keep total energy and protein adequate.

  • Investigate bleeding, weight loss, anemia, nocturnal symptoms, chronic diarrhea, severe pain, or persistent malabsorption.

  • Do not treat bloating as proof of endotoxin, high serotonin, or testosterone-degrading bacteria.

Obesity, insulin resistance, and SHBG

Obesity changes several layers at once. Lower SHBG can reduce total testosterone without an equivalent fall in free testosterone. More severe obesity may also suppress hypothalamic and pituitary signaling and produce functional hypogonadotropic hypogonadism. Sleep apnea, inflammation, insulin resistance, liver fat, medication use, and reduced activity often occur in the same person.[83]

The relationship runs in both directions. Lower testosterone can worsen body composition in some men, while excess adiposity can lower testosterone.[83][84]

The pace of fat loss matters. Weight loss can reverse obesity-associated functional hypogonadism,[84] yet aggressive dieting can suppress the same axis. Favor a gradual trend that preserves protein intake, resistance training, sleep, and recovery.

Because insulin resistance can lower SHBG, total testosterone may look disproportionately low. Measure SHBG or valid free testosterone, classify LH and FSH, and then address the metabolic pattern.

6. Training and recovery

Exercise improves health, body composition, insulin sensitivity, function, and sleep without needing to produce a chronic rise in resting testosterone.

A meta-analysis found little average change in resting testosterone after training in eugonadal men.[30] Hard sessions may produce a brief rise, but muscle protein synthesis does not depend on it.[31]

Judge training by the adaptation it produces, not by the hormone spike after the session.

Resistance training

The useful dose is the amount of work that improves performance and can be recovered from repeatedly. The greatest amount that can be survived once usually exceeds it.

Program training for adaptation:

  • Use stable exercises long enough to measure progress.

  • Add load, repetitions, range of motion, or technical control over time.

  • Keep enough hard work to create a stimulus without taking every set to failure.

  • Preserve technique, joints, tendons, and the ability to train again.

  • Cover the major movement patterns across the week.

  • Allow the trained tissue to recover before repeating the same demand.

  • Match volume and frequency to food intake, sleep, age, illness, injury, and training history.

A 2026 meta-regression covered 67 studies and 2,058 participants. More weekly volume was associated with greater hypertrophy and strength. The gain from each additional set became smaller as volume rose, especially for strength. More frequent training had little independent effect on hypertrophy after weekly volume was accounted for. It had a clearer diminishing-return relationship with strength.[185]

The models fit best when an indirect set counted as half a set. The authors still called that a heuristic. A row, for example, does not give the biceps the same work as a curl in every person and every repetition range. The fixed effects explained about one quarter of the variance, and estimates became less certain at the highest volumes. Use the curve to understand diminishing returns. Do not use it as one universal set prescription.[185]

Volume is only productive while the person can adapt to it. A program is too large when more work produces worse performance, worse tissue tolerance, or a recovery cost that persists into the next sessions. In practice, frequency distributes the weekly work. It should make the weekly dose easier to perform well.

Aerobic work, intervals, and endurance

Aerobic training supports work capacity and makes ordinary activity less costly. Easy and moderate sessions can sit beside resistance training. Hard intervals create a larger recovery demand and belong in the weekly count of hard training.

Endurance work becomes a reproductive problem when high volume is combined with inadequate energy, falling body mass, poor sleep, illness, or insufficient recovery. That combination can produce a low-testosterone pattern.[186] The solution is to review food, total load, the rate of weight change, sleep, and the laboratory pattern together. Adding a booster while the deficit continues misses the cause.

Read recovery across several signals

One weak session means little. A pattern across several domains matters more. Track:

  • Performance at the same exercises and effort.

  • Persistent soreness, joint irritation, or loss of movement quality.

  • Sleep onset, awakenings, and morning state.

  • Appetite, body weight, and the ability to maintain food intake.

  • Libido, spontaneous erections, and general motivation.

  • Illness, pain, resting pulse, and unusual fatigue.

A falling lift alone can reflect poor programming or technique. A simultaneous decline in performance, sleep, appetite, libido, and tissue tolerance points toward a recovery problem. Reduce the load, restore food and sleep, and look for illness before assuming that testosterone itself is the first failure.

Deload before failure becomes chronic

A deload is a planned reduction in training stress. It can mean fewer hard sets, lighter loading, fewer intervals, or several days away from the most demanding work. The goal is to remove accumulated fatigue while preserving the habit and the movements.

Deload when performance, motivation, sleep, and tissue tolerance deteriorate together. Resume progression when the same work again produces a normal recovery response. If several recovery markers remain poor after the load falls, training may have exposed another problem rather than caused the whole problem.

Evening exercise is not automatically bad for sleep, although very hard work close to bedtime can disturb some people.[187] Track sleep onset, awakenings, morning state, and next-day performance.

7. Thyroid and metabolic state

The HPG axis provides the direct reproductive signal. Thyroid-supported metabolism shapes how well the testes can answer that signal.

Anatomical locations in the androgen system

Figure 8. Dashed cobalt marks systemic metabolic support, not an anatomical tract. Gray shows the direct HPG signal, circulation, tissue delivery, and feedback. Liver and gut remain anatomical context.

Thyroid and mitochondria

Thyroid function changes the metabolic setting. Ray Peat argued that the pituitary is only one regulator of the thyroid system and that the liver, senses, nutrition, and stress also matter.[188] Thyroid disease can alter energy, SHBG, sex hormones, sexual function, and sperm parameters. Many of those changes improve when the thyroid disorder is treated.[189]

The useful human result comes from treating diagnosed disease. A before-after study followed forty treatment-naive men with overt primary hypothyroidism until they had remained euthyroid for six months on levothyroxine. Median testosterone rose from 162 to 441 ng/dL. Prolactin fell, sperm motility improved, and an assay-specific insulin-like factor 3, or INSL3, measure rose. The study had no untreated control, measured no free testosterone, and included only severe diagnosed hypothyroidism.[190] Its conclusion is specific: correct overt hypothyroidism. Euthyroid men have a different starting state.

Binding, transport, and peripheral conversion

Thyroid status is more than one TSH result. Thyroxine-binding globulin, or TBG, binds about three quarters of circulating thyroxine, or T4, and triiodothyronine, or T3. A change in TBG can move total thyroid-hormone values while free hormone and metabolic state remain stable.[191] This is the thyroid equivalent of reading total testosterone without its binding context.

The thyroid secretes mainly T4. About 80 percent of circulating T3 is produced outside the gland by conversion of T4.[192] D1 and D2 activate T4 to T3. D3 inactivates T4 and T3. Transporters move these hormones into cells, and local deiodinases can make tissue exposure differ from the serum result. Liver, kidney, brain, pituitary, muscle, illness, fasting, and medication can all change part of this handling.[192][193]

Read TSH with free T4, symptoms, illness, medication, and binding context. Use T3 or other tests when the clinical question justifies them. A total value changed by TBG is not a reason to force thyroid hormone, and a peripheral-conversion mechanism is not a general T3 protocol.

Thyroid hormone has no place as a general testosterone booster. Excess exposure can cause arrhythmia, bone loss, muscle wasting, anxiety, insomnia, and sexual dysfunction.[189]

Check the following:

  • Symptoms and signs compatible with thyroid disease.

  • TSH and free T4.

  • Medications, supplements, acute illness, or severe dieting that may alter the result.

  • Persistence of the testosterone pattern after diagnosed thyroid disease is treated.

Temperature and pulse add context, but neither can diagnose thyroid disease or determine a dose.

8. Steroid production

Cholesterol supplies the starting material. LH, mitochondrial transport, and enzymes determine what happens next.

Thyroid-supported metabolism and healthy mitochondria provide capacity. LH gives the Leydig cell its direct trigger. StAR moves cholesterol to the inner mitochondrial membrane, CYP11A1 converts it to pregnenolone, and later enzymes carry the pathway to testosterone.[85][86]

The brain-to-testis signal

The hypothalamic-pituitary-gonadal axis communicates in pulses. The hypothalamus releases gonadotropin-releasing hormone, or GnRH. The pituitary releases LH and FSH. LH gives Leydig cells the direct signal to make testosterone. FSH acts mainly on Sertoli cells and supports sperm production. Testosterone, estradiol, and inhibin B feed back to the brain and pituitary.[85][86][194]

The upstream pulse generator. Kisspeptin neurons sit above GnRH in the chain. In the arcuate nucleus, the KNDy network uses kisspeptin, neurokinin B, and dynorphin to help organize GnRH pulses. It integrates sex-steroid feedback with metabolic and environmental information.[195] In a small human infusion study, kisspeptin-10 increased LH and LH pulse frequency.[196] This maps the control system. Kisspeptin intervention belongs to research and specialist care.

The first diagnostic split. A low result may reflect a weak central signal or testes that cannot answer a strong one. LH and FSH help separate those patterns.[40][197]

The Kabbalah is wider than the HPG axis. The direct reproductive signal does not sit at the top of the whole map. Thyroid-supported metabolism, mitochondrial function, food, sleep, illness, and tissue integrity shape how well the testes answer it. Ray Peat described the pituitary as one part of a wider thyroid-regulating system.[188] His metabolic hierarchy surrounds the HPG signal without changing the physiology of LH.

Ray Peat’s hierarchy

“Many things, including the liver and the senses, regulate the function of the thyroid system.”[188]

Ray Peat’s official writing places thyroid, vitamin A, and low-density lipoprotein, or LDL cholesterol, among the conditions that support progesterone synthesis. It also places pregnenolone formation inside the mitochondrion.[198]

ATP supports cellular work. Reduced nicotinamide adenine dinucleotide phosphate, or NADPH, supplies the reducing power used in steroid synthesis. These are biochemical requirements, not blood targets or reasons to buy a generic mitochondrial stack.[85]

Pregnenolone sits upstream of dehydroepiandrosterone, or DHEA, progesterone, and the later steroids. The figure uses 17-OH as shorthand for 17-hydroxy.

Figure 9A preserves every item from the expanded source image. The blocker list is estrogen, non-esterified fatty acids, or NEFA, X-rays, serotonin, ultraviolet, darkness, PUFA, excess iron, prolactin, bacterial lipopolysaccharide, or LPS, carrageenan, and nitric oxide. The promoter list is thyroid, sugars, red light, vitamins A, D, E, and K2, glycine or gelatin, calcium, magnesium, caffeine, aspirin, stimulating life, some antibiotics, and saturated fats.

The source image also puts “EFA,” meaning essential fatty acids, beside PUFA.

The items in those lists carry very different levels of human evidence. Read the figure as Ray Peat’s metabolic model, not as a stack. Aspirin, thyroid hormone, antibiotics, and high-dose vitamins each require their own indication and safety review.

Ray Peat-derived factors in steroid synthesis

Figure 9A. Ray Peat’s metabolic hierarchy appears here with every item from the expanded reference. The source labels do not carry equal human evidence and should not be read as a supplement or drug protocol. The 17-OH pregnenolone intermediate is added so the DHEA branch remains biochemically correct.

The direct reproductive signal

GnRH arrives in pulses. The LH receptor activates cyclic adenosine monophosphate, or cAMP. cAMP activates protein kinase A, or PKA, which helps stimulate StAR-mediated cholesterol transport and steroid production.[85][86]

FSH acts mainly on Sertoli cells, where it supports sperm production and raises inhibin B.[194] Serum testosterone alone cannot answer a fertility question.

The cholesterol pool

Leydig cells can obtain cholesterol from several sources:

  • De novo synthesis from acetyl-CoA.

  • Uptake from circulating lipoproteins.

  • Stored cholesteryl esters in lipid droplets.

  • Mobilization from cellular membranes.

Carbohydrate, fat, and some amino acids can all supply acetyl-CoA, which the body can use to build cholesterol through the mevalonate pathway.[87][88] Cholesterol synthesis and testosterone production do not require a high-fat diet.

Dietary cholesterol supplies substrate while LH signaling, StAR transport, CYP11A1, later enzymes, and Leydig-cell health control its use.[85][86] Eat for nutritional adequacy. A dietary-cholesterol target cannot maximize the whole pathway.

The mitochondrial gate

Steroid production begins inside the mitochondrion by moving cholesterol to the inner membrane. Steroidogenic acute regulatory protein, StAR, controls much of this acute transport. Cholesterol side-chain cleavage enzyme, CYP11A1, then converts cholesterol to pregnenolone.[85][86]

A cholesterol-rich cell may still make little steroid because this step is regulated. Transport, enzyme expression, LH, mitochondrial integrity, and cofactors may each become the bottleneck.

Delta-5 and delta-4 routes

From pregnenolone, human steroid production follows related routes:

  • In the delta-5 route, pregnenolone becomes 17α-hydroxypregnenolone, then dehydroepiandrosterone, or DHEA. DHEA can reach testosterone through androstenediol or androstenedione.

  • In the delta-4 route, pregnenolone becomes progesterone, then 17α-hydroxyprogesterone, then androstenedione, then testosterone.

The main enzymes include cytochrome P450 17A1, or CYP17A1, 3β-hydroxysteroid dehydrogenase type 2, or HSD3B2, 17β-hydroxysteroid dehydrogenase type 3, or HSD17B3, and aldo-keto reductase, or AKR, family members. Their expression and cofactors determine the flow.[85]

ATP supports cellular work, while NADPH supplies reducing power for steroidogenic reactions.[85] A product labeled “mitochondrial support” neither identifies nor fixes the limiting step.

My first article also stressed glucose oxidation, carbon dioxide, redox balance, and restraint of excessive lipolysis.[80] The part worth keeping is that steroid production needs a working energy system. The ideal fuel ratio will differ between people.

Testicular steroidogenesis and downstream conversion

Figure 9B. Thyroid-supported metabolism and mitochondrial integrity set the metabolic capacity. LH supplies the immediate Leydig-cell trigger. StAR, CYP11A1, enzyme activity, reducing power, and testicular integrity determine the resulting flux.

Intratesticular testosterone

Testosterone reaches a much higher concentration inside the testis than in serum, and LH closely tracks that local steroid environment.[199] Spermatogenesis depends on the high intratesticular concentration.

In one controlled study of healthy men, exogenous testosterone lowered LH and FSH while intratesticular testosterone fell by about 94 percent.[200] Serum androgen exposure had risen as the concentration inside the testes collapsed.

That difference changes several decisions:

  • A serum testosterone result does not measure intratesticular testosterone.

  • Exogenous testosterone is not a fertility-preserving way to “restore natural production.”

  • A man who may want children needs to state that before starting androgen therapy.

  • Semen analysis answers a fertility question that serum testosterone cannot.

9. Liver, gut, serotonin, prolactin, illness, and stress

Liver, gut, immune, neurotransmitter, and stress pathways can change hormone transport, clearance, central signaling, testicular output, symptoms, and the meaning of a blood result.

Liver, SHBG, and clearance

The liver makes SHBG and metabolizes steroids. Liver disease, insulin resistance, thyroid status, and estrogen exposure can all change SHBG.[85][40]

On average, men with fatty liver have lower total testosterone and SHBG.[201] Adiposity and insulin resistance explain part of the association. Calling for a “liver detox” does not identify or treat the cause.

Review alcohol, medications, supplements, metabolic risk, liver enzymes, and imaging when indicated. Symptoms alone cannot measure estrogen clearance.

Gut and endotoxin

The gut influences nutrient absorption, bile acids, immune signaling, microbial metabolites, and illness burden.

A 2022 study identified a microbial enzyme capable of degrading testosterone.[202] The work combined isolates, animal experiments, and human associations. It establishes a mechanism worth following. Clinical use requires evidence of the organism, the enzyme, and a treatment that changes the outcome. Bloating alone supplies none of those.

Lipopolysaccharide can suppress Leydig-cell steroid production in animals.[203] A small study in overweight men also linked markers of endotoxemia with hypogonadism.[204] Together, these findings support treating diagnosed gut and metabolic disease, not rotating random antibiotics, antifungals, or probiotics.

For persistent gut symptoms, proceed conservatively:

  1. Diagnose persistent symptoms such as bleeding, weight loss, anemia, chronic diarrhea, severe pain, or nocturnal symptoms.

  2. Address celiac disease, inflammatory bowel disease, infection, constipation, reflux, or malabsorption when present.

  3. Simplify obvious dietary triggers without collapsing nutritional adequacy.

  4. Keep the diet nutritionally complete.

  5. Reassess whether testosterone changed after the underlying disease improved.

Most serotonin is made in the gut

The intestine, mainly its enterochromaffin cells, produces about 95 percent of the body’s serotonin.[205] Peripheral serotonin remains separate from brain serotonin and helps regulate gut movement, secretion, sensation, platelets, and immune signaling.

Gut microbes can alter enterochromaffin serotonin production in animal and human microbial models.[206] Build the clinical picture from symptoms, disease, medication, diet, and physiology. A generic stool label of “high serotonin” does not represent the system.

The first article treated serotonin as a broad suppressive factor. The evidence supports a more specific account:

  • Gut serotonin can affect motility, secretion, pain, and inflammation.

  • Brain serotonin and peripheral serotonin are separated by the blood-brain barrier.

  • Receptor type and tissue decide the effect.

  • In cultured rat Leydig cells, serotonin activated a 5-HT2 and CRF route that reduced cAMP and testosterone production.[207]

  • Tissue, receptor, and compartment determine what a serotonin measurement means.

That experiment did not test gut serotonin, circulating serotonin, or living men. Review constipation, diarrhea, reflux, inflammatory disease, medication effects, and diet before attaching symptoms to serotonin. A generic anti-serotonin drug protocol has no place here.

Prolactin and sexual behavior

Persistently high prolactin can suppress GnRH, lower LH and testosterone, reduce libido, impair erections, and affect fertility.[67] Include it in the diagnostic workup when the pattern points there.

Record sodium adequacy in the same history. In Ray Peat’s model, low sodium can raise serotonin and sympathetic activity, serotonin can raise prolactin, and prolactin can promote further sodium loss.[90] Adequate salt can interrupt that indirect loop when sodium depletion is present. It cannot explain away a persistently high prolactin result or replace evaluation of medication, thyroid, kidney, or pituitary causes.

Orgasm causes an acute prolactin rise after masturbation and intercourse.[32][33] Repeated sessions repeatedly recreate the acute post-orgasm period. A properly timed blood test shows whether prolactin also remains elevated between sessions.

Intercourse and masturbation create different endocrine contexts. One paper pooled three earlier laboratory datasets. It compared separate groups rather than testing the same people twice. The total sample was 19 men and 19 women. Among the men, nine were studied after intercourse and ten after masturbation while watching an erotic film. Adjusted prolactin change was 15.62 ng/mL after intercourse and 3.05 ng/mL after masturbation. The authors interpreted the roughly fivefold difference as greater satiety.[208] This is a useful acute comparison. It does not establish a chronic hormone pattern or prove that modern internet pornography caused the difference.

Oxytocin also rises during self-stimulation and orgasm.[209][210] It adds another endocrine signal to the event. The available experiments do not show that oxytocin cancels prolactin or prevents receptor adaptation.

The receptor evidence comes from rats. In the main satiety model, sexually experienced males copulated for up to four hours. They reached at least five and an average of seven ejaculations before a 90-minute period without another ejaculation marked satiety. At 24 or 48 hours, 70 percent would not mate even with a novel female. Most copulated again by 72 hours, and the review describes full behavioral recovery by day 15.[34][35]

Androgen-receptor density changed by region. One ejaculation and full satiety both lowered it in the nucleus accumbens and medial preoptic nucleus at 24 hours. Only the fully satiated rats showed a reduction in the ventromedial nucleus, and the fully satiated group had lower density than the one-ejaculation group in the medial preoptic and ventromedial nuclei. Serum testosterone was similar across groups. A separate rat experiment found that ventral-prostate androgen receptors rose after the first three ejaculations and returned to baseline after the fourth.[211] Tissue, timing, and exposure change the response. Equivalent human brain and penile data are absent.

The same caution applies to 5-alpha-reduction. The human paper used several short drug experiments with only four to seven normal men per group. During an exogenous-testosterone experiment, metoclopramide raised prolactin and removed the normal relationship between the rise in testosterone and the rise in DHT. The authors interpreted this as lower peripheral testosterone-to-DHT conversion. In a separate group of 20 men receiving chronic neuroleptics, prolactin and testosterone were inversely correlated.[212] A rat experiment found greater LH-stimulated testicular 5-alpha-reductase activity during hyperprolactinemia.[213] These findings differ because tissue, duration, and treatment differ. Pornography and masturbation were not tested.

The receptor model comes from animal tissue because human brain and penile tissue have not been measured after porn or masturbation. Treat it as a mechanistic warning. The human case for removing porn stands independently on cue conditioning, compulsive repetition, sleep disruption, partnered-arousal mismatch, and sexual function.

Porn can train a narrow arousal environment. It can present a rapid stream of highly selected bodies, acts, angles, and scenes. With a wife or girlfriend, the body, pace, feedback, emotions, and uncertainty are real. They cannot be replaced with another cue at the movement of a finger.

Small experiments in men with compulsive sexual behavior found greater preference for novel sexual images and conditioned sexual cues.[214] Another small study found greater desire but similar liking for explicit videos, with stronger activity in a cue-reactivity network that included the ventral striatum.[215] These studies support a model of conditioned attention and wanting. They did not measure dopamine release.

That conditioning can create a mismatch. The screen produces an intense, controllable sequence of cues. Partnered sex asks the nervous system to respond to one real person. In a large cross-sectional survey of young men, higher problematic-pornography scores were associated with a higher probability of erectile dysfunction, while masturbation frequency was not a significant factor in the erectile-function model.[216] The cross-sectional design establishes association rather than direction. Across the broader review, problematic use carried more information than frequency alone.[36][37]

Remove porn during restoration. Stop edging. Give partnered arousal time to become responsive to partnered cues again. Bright screens near bedtime add a separate circadian and sleep load. The photons have the same effect whether the screen contains porn, work, or a film.

Run a defined restoration trial:

  • Remove pornography completely.

  • Stop edging and long compulsive sessions.

  • Pause or reduce masturbation when it leaves libido, erections, sleep, or focus worse.

  • Keep partnered sex separate in the record. It has a different sensory, relational, and satiety context.

  • Record morning erections, partnered arousal, mood, sleep, and recovered time.

  • Measure prolactin properly when symptoms or laboratory patterns point to it.

Changing the behavior may improve function even when prolactin is normal. A persistently high result still requires medical review. Medication, hypothyroidism, kidney disease, and pituitary disease are established causes.

Inflammation and illness

Acute illness can lower testosterone, while chronic inflammatory disease can affect the HPG axis, food intake, sleep, medication use, and testicular function.[40]

Routine diagnostic testing during severe acute illness can mislead. Treat the infection, inflammatory disease, organ dysfunction, medication effect, or energy deficit first.

Stress and glucocorticoid context

Glucocorticoids act at the hypothalamus, pituitary, and testes.[217] Sustained stress can also disturb sleep, appetite, training, substance use, and relationships.

One cortisol value cannot map the whole stress system. Sleep apnea, depression, overtraining, underfeeding, thyroid disease, Cushing syndrome, adrenal insufficiency, and medication effects each require their own diagnosis.

Include sodium intake and sodium loss in that map. Restriction can raise renin, aldosterone, and sympathetic catecholamines, while sodium intake also changes cortisol excretion and the meaning of a cortisol measurement.[89][91][218]

Start by removing loads that can be identified and measured:

  • Stabilize sleep and wake timing.

  • Restore adequate food if intake is low.

  • Reduce training when performance and recovery are falling.

  • Treat pain and illness.

  • Reduce alcohol and stimulant dependence.

  • Create periods without work demand.

  • Use psychological care when anxiety, trauma, depression, or compulsive behavior is the active constraint.

10. Conversion, transport, and tissue response

Testosterone is a branch point.

Progesterone and pregnenolone

Pregnenolone follows cholesterol directly. Progesterone sits in the delta-4 route to androgens and corticosteroids.[85]

My first article described progesterone as a counterweight to estrogen and stress. Supplemental progesterone adds a hormone to that model. Dose, route, conversion, feedback, and fertility determine whether the result helps or suppresses the male androgen state.

DHT

The main conversion. 5α-reductase uses NADPH to reduce testosterone to DHT. DHT binds the androgen receptor strongly and matters in external sexual development, prostate, skin, hair follicles, and other androgen-responsive tissues.[85][219]

The name 5α-reductase covers several isoenzymes. SRD5A1 has broad expression that includes liver and non-genital skin. SRD5A2 is prominent in androgen-sensitive reproductive tissues. SRD5A3 exists as a separate enzyme, although its normal contribution to adult androgen handling is less clear.[219] Finasteride inhibits type 2 more strongly. Dutasteride inhibits types 1 and 2. The drugs therefore do not create identical tissue effects.

Alternative routes. The shortest DHT route is testosterone to DHT. Other routes also exist. In the primary backdoor pathway, progesterone-related intermediates are reduced before CYP17A1 cleavage and proceed through androsterone and androstanediol to DHT. This route bypasses androstenedione and testosterone. A second route converts androstenedione to 5α-androstanedione and then to DHT, also bypassing testosterone.[85][220]

DHT is also a starting point for other metabolites. It can be reduced to 3α-androstanediol or 3β-androstanediol and can contribute to androsterone metabolites. Some reactions are reversible. Back-conversion of 3α-androstanediol to DHT has been shown in prostate tissue and studied heavily in prostate cancer.[220] That local adaptation should not be described as a universal systemic DHT recycling loop.

The liver, kidney, and target tissues then inactivate and conjugate androgens. UGT2B7, UGT2B15, and UGT2B17 help form glucuronides for urinary or biliary elimination.[219][221][222] These metabolites can reveal parts of androgen handling that a serum DHT value misses.

Blood and tissue are different compartments. In a randomized study of healthy men, a large increase in serum DHT left intraprostatic DHT and measured androgen-regulated prostate genes unchanged over four weeks.[223] Serum DHT describes blood exposure. Tissue response requires tissue-specific evidence.

DHT production, tissue metabolism, and clearance

Figure 10. DHT can arise through testosterone reduction or routes that bypass testosterone. Local metabolites, back-conversion in selected tissues, conjugation, and clearance explain why serum DHT cannot stand in for every tissue.

The published pathway follows steroid-biochemistry reviews and human tissue studies. Claims about mood, fertility, pheromones, or a dosing protocol require their own evidence.

Because finasteride and dutasteride inhibit 5α-reductase, sexual symptoms, fertility plans, the original indication, and alternatives belong in the discussion with the prescriber. Do not stop a prescribed drug on the basis of one serum DHT result.

Estradiol

Aromatase converts testosterone to estradiol and is present in adipose tissue, which allows body composition to influence conversion. In men, estradiol supports bone, body composition, sexual function, and hormonal feedback.[85][27]

In a controlled experiment, androgen deficiency drove losses in lean mass, muscle size, and strength, while estrogen deficiency contributed to fat gain. Both deficiencies affected sexual function.[27]

The sexual result changes when a strong nonaromatizable androgen replaces testosterone. In a two-year randomized trial, pharmacological DHT suppressed testosterone, LH, FSH, and estradiol while leaving most self-reported sexual measures unchanged. Desire fell slightly, and spinal bone density declined.[224] High DHT exposure can preserve part of the sexual signal while losing estrogen-dependent bone protection. Indiscriminate aromatase suppression follows the same biological mistake.

Very high estradiol can matter in the right context. Driving it as low as possible can impair bone, lipids, sexual function, and body composition.

SHBG and free testosterone

Most circulating testosterone travels bound to SHBG or albumin, leaving a smaller fraction free.[40]

Some direct free-testosterone tests are unreliable. Equilibrium dialysis serves as a reference method, while validated calculations can help when total testosterone, SHBG, and albumin are measured accurately.[40]

Low SHBG often accompanies obesity, insulin resistance, and hypothyroidism. Hyperthyroidism, liver disease, some medications, and estrogen exposure may raise it. SHBG helps interpret the result without becoming the center of the Kabbalah.

Receptor response, symptoms, and function

Androgen action depends on receptor function, tissue exposure, local metabolism, illness, training, nutrition, and the many non-androgen causes of the same symptoms.

Routine clinical practice has no test for everyday “androgen receptor sensitivity.” Supplement claims about it usually rest on indirect or animal data.

Use symptoms and function carefully:

  • Libido is influenced by androgens, estradiol, dopamine, mood, relationship context, medications, sleep, and illness.

  • Erections require vascular inflow, smooth-muscle relaxation, intact nerves, adequate sleep, and psychological context.

  • Muscle gain requires training stimulus, food, amino acids, recovery, and time.

  • Fertility requires gonadotropins, intratesticular testosterone, Sertoli-cell function, sperm production, and unobstructed transport.

  • Energy and mood are broad outputs with many non-androgen causes.

Fatigue and mood have many causes. Libido, morning erections, gonadotropins, fertility, and matched laboratory values offer a sharper androgen picture.

Part II. Read the laboratory pattern

11. Laboratory interpretation

Hypogonadism requires compatible symptoms or signs together with consistently low testosterone. The diagnostic standard uses accurate assays and a repeated morning fasting total testosterone measurement. Free testosterone becomes useful when total testosterone sits near the lower limit or SHBG is altered.[40]

Do not diagnose hypogonadism from one result.

Laboratory interpretation patterns

Figure 11. Pair testosterone with symptoms, timing, SHBG or free testosterone, and gonadotropins.

A valid baseline

Repeat a first low result under ordinary, comparable conditions:

  • Draw after a representative sleep period.

  • Use a morning sample for men on a conventional schedule.

  • For shift workers, coordinate interpretation with sleep timing and clinician judgment.

  • Use the same reliable laboratory when possible.

  • Fast when following the diagnostic standard.

  • Avoid testing during acute illness.

  • Record medications, supplements, androgen exposure, and recent injections or gels.

  • Avoid drawing immediately after an unusual all-night event, extreme endurance session, or severe caloric depletion.

Use the reference range for that assay and laboratory.

The core laboratory set

The core workup for repeated low testosterone often includes:[40][197][67]

  • Total testosterone.

  • SHBG.

  • Albumin for calculated free testosterone, or a validated free-testosterone method.

  • LH.

  • FSH.

  • Prolactin.

Add tests according to the likely cause:

  • TSH and free T4 when thyroid disease is possible.

  • Complete blood count.

  • Comprehensive metabolic panel and liver enzymes.

  • Ferritin and transferrin saturation when iron deficiency or iron overload is possible.

  • Hemoglobin A1c or fasting glucose for metabolic risk.

  • Semen analysis when fertility is the question.

  • INSL3 when Leydig-cell capacity remains uncertain and the assay is available.

  • Pituitary hormones or imaging when secondary hypogonadism, hyperprolactinemia, headache, visual symptoms, or other pituitary deficits are present.

  • Testicular ultrasound when examination identifies a mass or structural concern.

Read LH beside testosterone

LH reflects demand. Testosterone reflects one part of output. Reading them together shows how much signal accompanies the measured result.

The favorable pattern is adequate testosterone and testicular function with less compensatory LH demand. Low LH by itself is not the goal. Low LH with low testosterone points toward a central or functional problem. Stable testosterone that requires progressively more LH points toward reduced testicular response.

A lower LH-to-testosterone ratio means that less measured LH accompanies the same testosterone. A higher testosterone-to-LH ratio expresses the same relationship in the opposite direction. Name the direction and the units because the number changes when testosterone is reported in ng/dL rather than nmol/L.

Among 8,182 young European men with a median age of 19.1 years, testosterone alone did not differ across sperm-concentration groups. Higher LH accompanied lower sperm concentration, total sperm count, motility, and percentage of normally shaped sperm. Both total-testosterone-to-LH and calculated-free-testosterone-to-LH ratios rose with the same semen measures. The pattern extended into semen values that the authors considered normal, and the LH difference became clear below roughly 70 to 80 million sperm per milliliter compared with higher categories.[225]

This was a cross-sectional association. It does not prove that lowering LH improves fertility, and it does not create a universal ratio target. It shows why a normal testosterone result can hide greater pituitary demand.

Trend the relationship. The ratio becomes more useful across repeated tests performed under similar conditions. Stable natural testosterone with rising LH suggests that the testes require more pituitary demand. Stable testosterone with repeatedly lower LH shows the same output alongside less measured demand. An LH pulse, sampling time, illness, sleep loss, or an assay change can distort any single ratio.

INSL3 and Leydig-cell capacity

INSL3 reflects Leydig-cell capacity more than immediate output. Mature Leydig cells secrete it, and its level varies less within one person than testosterone.[226][227]

A blood test measures circulating INSL3. The term INSL3 expression belongs to gene or tissue measurements.

INSL3 can add context after anabolic-steroid exposure. Former users had lower levels than controls years after cessation, even after accounting for total testosterone.[228] Testosterone may therefore recover while Leydig-cell capacity remains reduced.

Keep the proposed INSL3 cutoff inside its population and assay. A 2024 analysis proposed 0.4 ng/mL or lower as a low value in middle-aged and older men. It corresponded to the lower 95 percent boundary around age 60 to 65 in the analyzed populations. After men at or below that threshold were removed, the authors proposed a serum reference interval of 0.4 to 2.3 ng/mL for men older than 35.[227]

The number is not universal. INSL3 fell by about 14 percent per decade in the EMAS data. Plasma averaged about 10 percent below serum. Different assays produced materially different ranges. At the 0.4 ng/mL threshold, the comparison with low overall sexual function still produced 41.0 percent false positives and 24.1 percent false negatives. The paper therefore supports INSL3 as context for Leydig-cell capacity, especially when testosterone and LH tell an incomplete story. It does not support using one INSL3 result as a diagnosis.[227]

Assay access remains limited, and INSL3 belongs after the standard laboratory set. When available, read it beside testosterone, LH, testicular volume, semen analysis, specimen type, age, and the clinical question.

Pattern 1: low testosterone with low or inappropriately normal LH

Low testosterone with low or inappropriately normal LH points toward a secondary, central, or functional pattern. The pituitary signal has not risen appropriately for the low output.

Possible contexts include obesity, energy deficiency, acute or chronic illness, opioid use, hyperprolactinemia, pituitary disease, prior anabolic-steroid use, glucocorticoid exposure, severe sleep disruption, and some genetic conditions.[40][197][229][230]

The word “normal” can mislead. An LH value inside the laboratory range may be physiologically inappropriate when testosterone is low.

Pattern 2: low testosterone with high LH

Low testosterone with high LH points toward primary testicular impairment. The pituitary has increased its signal, but the testes have not produced an adequate output.

Possible causes include genetic conditions, prior orchitis, torsion, trauma, chemotherapy, radiation, advanced testicular damage, or loss of testicular tissue. FSH, examination, fertility history, and semen analysis help define the problem.[40][197]

Pattern 3: low total testosterone, low SHBG, and preserved free testosterone

Obesity and insulin resistance can produce this combination. Sometimes the result reflects a binding-protein pattern more than severe androgen deficiency. Symptoms, repeated measurements, assay quality, and metabolic context determine its significance.

The pattern gives a reason to improve metabolic health while continuing to investigate symptoms. It gives no reason to pursue the lowest possible SHBG.

Pattern 4: total testosterone near range, high SHBG, and low free testosterone

High SHBG can keep total testosterone near the laboratory range while the available fraction is low. Hyperthyroidism, liver disease, estrogen exposure, some medications, low body weight, and age can contribute to high SHBG.[40]

Confirm the free-testosterone method, then investigate the SHBG change. This is a binding pattern first. Testicular production remains a separate question.

Pattern 5: normal testosterone with high LH

This pattern has been called compensated hypogonadism. Longitudinal data show frequent reversion, so the finding marks increased pituitary demand rather than a settled diagnosis of symptomatic androgen deficiency.[197][231]

The pattern can signal reduced testicular reserve, broader health deterioration, or differences in hormone handling. In a cross-sectional study of 1,865 men, aromatase haplotypes were associated with estradiol and LH in opposite directions. The LH differences were strongest in men aged 65 or older.[232] High LH still records increased pituitary demand. The ratio gains meaning only beside symptoms, repeat measurements, fertility data, and testicular context.

Repeat testing and a review of the cause are more useful than immediate hormone escalation.

Pattern 6: high testosterone with suppressed LH and FSH

Exogenous androgen exposure commonly explains high testosterone with suppressed LH and FSH. Interpretation depends on timing relative to an injection, gel, oral product, or anabolic agent. Rare endogenous causes still require medical evaluation.

Ask directly about prescribed testosterone, underground products, prohormones, selective androgen-receptor modulators, shortened to SARMs, human chorionic gonadotropin, or hCG, fertility drugs, and contaminated supplements. Full disclosure prevents misclassification.

Pattern 7: valid total and free testosterone with persistent symptoms

When repeated measurements are appropriate and the androgen pattern remains normal, widen the diagnosis. Erectile symptoms may be vascular, neurological, medication-related, sleep-related, or psychological. Fatigue and low mood may come from thyroid disease, anemia, pain, depression, sleep disruption, inadequate food, or another illness.

The next test should follow the symptom. Forcing testosterone above an adequate physiological result does not identify the cause.

Prolactin

High prolactin can suppress GnRH and gonadal function. Pituitary adenoma, medication, hypothyroidism, kidney disease, and physiological stress all belong among the possible causes.[67]

A mild elevation often needs an unhurried repeat. When possible, avoid drawing immediately after sex, hard exercise, or a stressful venipuncture, and review medication and thyroid status.

Persistent elevation requires evaluation. Headache, visual change, galactorrhea, or other pituitary deficits make that evaluation more urgent. Dopamine agonists require a defined cause and medical management.

Measure prolactin and androgens when the pattern calls for them. Remove pornography during the restoration phase regardless of the prolactin result. Stop edging and review compulsive masturbation because the behavior can damage sexual function, sleep, and attention even when basal prolactin is normal.

Four patterns in real life

The underfed athlete. A man loses weight quickly, adds intervals, sleeps worse, loses libido, and gets a low testosterone result with low or inappropriately normal LH. The pattern points toward reduced central drive in an energy and recovery deficit. The first action is to restore energy availability and reduce load. A booster that pushes LH would leave the cause in place.

The man with obesity and sleep apnea. He has low total testosterone, low SHBG, preserved calculated free testosterone, loud snoring, and daytime sleepiness. The blood result partly reflects low binding protein. Adiposity and fragmented sleep remain the stronger upstream targets. He still needs a proper clinical interpretation because symptoms and free testosterone decide how much of the pattern is androgen-related.

The man with a testicular pattern. He has repeated low testosterone with high LH, a history of torsion, and a fertility goal. The pituitary is already sending a strong request. More LH-oriented stimulation cannot rebuild lost testicular tissue. Examination, follicle-stimulating hormone, semen analysis, and reproductive care take priority.

The man with normal androgen measurements and persistent symptoms. He has two valid testosterone results, appropriate free testosterone, and no abnormal gonadotropin pattern, yet erections and energy remain poor. The diagnostic branch widens to vascular health, medication, neuropathy, depression, sleep, pain, thyroid disease, relationship context, and other causes. Raising an already adequate testosterone result would test the wrong system.

12. Causes, exposures, and age

Foundational work must never delay evaluation of structural, genetic, medication-related, or serious disease.

Testicular causes

The relevant history includes undescended testes, delayed puberty, infertility, mumps orchitis, torsion, trauma, infection, testicular cancer, chemotherapy, pelvic or testicular radiation, and surgery. Examination may reveal small testes, asymmetry, varicocele, or a mass.[40]

Acute severe testicular pain is an emergency because torsion is time-sensitive. A painless mass also warrants prompt assessment.

Pituitary and hypothalamic causes

Secondary hypogonadism can arise from pituitary tumors, hyperprolactinemia, infiltrative disease, head trauma, cranial irradiation, genetic conditions, hemochromatosis, severe systemic disease, or medications.

A new severe headache, visual-field change, cranial nerve symptoms, vomiting with neurological change, or multiple pituitary deficits all require urgent attention. Lifestyle work comes later.

Medication and substance causes

Opioids are a major cause of gonadal suppression. A systematic review and meta-analysis estimated a high prevalence of hypogonadism among male users, although definitions and study results varied widely.[229] Management begins with medication review, coordination of pain care, and appropriate endocrine testing. Abrupt discontinuation may be unsafe.

Heavy or chronic alcohol exposure can suppress testosterone and damage sperm production through testicular, central, liver, sleep, and nutritional pathways.[233] Human findings at low or moderate intake are less consistent. Judge the exposure by its effect on sleep, liver function, nutrition, sexual function, and the hormone pattern rather than assuming one harmless dose fits every man.

Glucocorticoids, some antipsychotics, medications that raise prolactin, and other drugs can contribute. Finasteride, dutasteride, antidepressants, antihypertensives, alcohol, cannabis, and nicotine can affect sexual symptoms through pathways that may or may not involve serum testosterone.[40][67][217]

A complete medication list includes prescriptions, nonprescription drugs, supplements, injections, topical products used by a partner, and substances obtained outside medical care.

Environmental and occupational exposures

Environmental chemicals can interact with steroid synthesis, receptors, binding proteins, metabolism, and reproductive development. Human evidence varies widely with the chemical, dose, life stage, and outcome.

Recent meta-analyses associate higher exposure markers for some phthalates, bisphenol A, and per- and polyfluoroalkyl substances, or PFAS, with changes in testosterone, SHBG, or sperm outcomes.[234][235][236][237] Most contributing studies are observational. Urinary metabolites may represent a short exposure window, whereas serum concentrations of other chemicals can reflect long-term accumulation. Diet, occupation, adiposity, age, fertility status, and socioeconomic conditions can confound the results. Even compounds from the same chemical family may move an outcome in different directions.

The evidence supports targeted reduction of named exposures. Diagnose the chemical, source, and biological pattern before attributing symptoms to endocrine disruption. Commercial detox language skips all three.

Start with exposures that can be named and controlled:

  1. Identify occupational exposure to pesticides, solvents, plasticizers, metals, heat, radiation, or combustion products.

  2. Follow workplace controls, ventilation, protective equipment, and exposure monitoring.

  3. Avoid smoking and unnecessary combustion exposure.

  4. Store and heat food in materials designed for the temperature and use.

  5. Replace damaged food-contact containers and avoid an impossible pursuit of complete plastic elimination.

  6. Follow local fish, water, and contamination advisories when a specific exposure is known.

  7. Discuss biomonitoring with occupational or environmental medicine when the exposure is substantial and the result would change management.

Use low-cost household changes that reduce a named exposure. Treat their testosterone effect as secondary and keep major findings in priority order: high LH, a pituitary pattern, severe OSA, opioid exposure, and sustained underfueling come first.

Anabolic-androgenic steroids and testosterone

Anabolic-androgenic steroids, shortened to AAS, suppress LH and FSH. A systematic review found substantial and sometimes prolonged effects on testosterone, gonadotropins, sperm production, and fertility.[230] The pooled hormone comparisons were small, with 17 to 65 users depending on the outcome. Exposure, dose, assay, and follow-up varied, and most studies had an unclear risk of bias. The suppression is clear. The recovery clock remains specific to the exposure and the man.

Some former users continue to have lower testosterone and symptoms years after stopping.[238] A second systematic review found 168 cases that it attributed to AAS-induced hypogonadism. Complete outcomes were known for only 38, and four met its definition of full HPG-axis recovery, including two after drug treatment.[239] That is not a population recovery rate. The evidence set was dominated by selected cases, missing outcomes, mixed exposures, and likely publication bias.

The prospective HAARLEM study followed one hundred men before, during, and after a self-directed androgen cycle. Testosterone returned to the laboratory range within three months after cessation in most men, while sperm recovery took much longer. At the final follow-up, 11 percent still had low testosterone and 34 percent still had a total sperm count below 40 million.[240] The last visit occurred about one year after the cycle began, not one year after it ended. Most men used several underground products, and post-cycle treatment was not randomized.

Recovery depends on the compounds, dose, duration, age, baseline function, and time since cessation. The reviews and the prospective cohort show wide variation. An internet post-cycle template ignores the variables that determine recovery. hCG, selective estrogen-receptor modulators, aromatase inhibitors, and testosterone each alter the axis differently and require medical supervision.

Age

Do not assign a low testosterone result to age until reversible causes have been checked.

Over time, men often accumulate poor sleep, excess fat, diabetes, inactivity, medication exposure, illness, undernutrition, and testicular damage. Each can lower testosterone. In a Baltimore longitudinal cohort, age was no longer significant after the model included several health conditions.[241] A clinical review likewise found little decline before advanced age among men without obesity, adverse lifestyle, or opioid use.[242]

Some longitudinal studies find an additional independent decline, especially in bioavailable testosterone and at advanced age. That effect can coexist with reversible causes. Check the reversible causes first.

Classify the pattern at any age. Check sleep, body composition, disease, medication, LH, FSH, SHBG, prolactin, thyroid status, and testicular history.

Part III. Restore the system

13. The natural restoration plan

Follow the steps in order. Nothing later in the protocol can repair an invalid first measurement or compensate for an untreated structural cause.

Gate 1: Validate and classify

Begin by proving that the symptom and laboratory pattern are real. Record the change from baseline, its onset, the fertility goal, and every relevant exposure. Repeat a low testosterone result under comparable conditions. Add SHBG or a valid free-testosterone measure when needed, then read LH, FSH, and prolactin beside it.[40][197][67][225][227]

An unreliable assay, unmatched repeat, or incomplete exposure history leaves the pattern unclassified. Red flags, structural clues, and fertility threats go directly to clinical care.

Step 1. Complete the symptom and cause intake

Complete the opening intake, including the change from baseline, its onset, and what happened before it.[40][41]

Step 2. Standardize the first measurement

Use an accurate laboratory and test after representative sleep. For a conventional schedule, draw in the morning while fasting and outside acute illness. Record wake time, diet phase, training, medication, and androgen exposure.[40][50]

Step 3. Confirm persistence

Repeat any low result under comparable conditions, adding SHBG and valid free testosterone when needed.[40]

Step 4. Classify the layer

Add LH, FSH, and prolactin, then classify the pattern. When fertility matters, include reproductive history and semen analysis early.[197][67][225][227]

Gate result: A repeated, usable testosterone result has been classified as central, testicular, binding-related, prolactin-related, exogenous, or still unresolved. Red flags move directly to care.

Gate 2: Stabilize circadian rhythm and sleep

Once the baseline is usable, stabilize sleep and circadian timing. Track wake-time variation, sleep opportunity, awakenings, daytime sleepiness, snoring, nasal obstruction, light timing, and the main disruptor.[46][42][25][56][64][62]

The direction should be clear: steadier timing, fewer avoidable awakenings, better mornings, and less daytime sleepiness. Persistent insomnia, suspected apnea, unsafe sleepiness, or structural nasal obstruction needs its own clinical branch.

Step 5. Use a stable wake time

Choose a workable wake time and keep it stable when possible. Shift workers should protect complete sleep cycles within the most stable schedule their rotation permits.[44][50]

Step 6. Build day-night light contrast

Let outdoor light reach the eyes after waking when feasible. Keep the day bright, reduce blue-rich light near sleep, and keep the bedroom dark. Shift work and circadian disorders may require different timing.[42][43][64][54]

Step 7. Protect complete sleep cycles

Reserve enough time for complete cycles, protecting the slow-wave-rich early sleep period and the REM-rich later sleep period. Persistent insomnia deserves evidence-based care.[46][49][48][45][47]

Step 8. Screen sleep disruptors

Review snoring, apnea signs, nasal obstruction, allergies, pain, reflux, restless legs, caffeine, alcohol, nicotine, heat, and noise.[25][56][58][57]

Safe saline rinsing and nasal strips can help when they fit the nasal problem. Mouth taping has no place with obstruction or suspected apnea.

Gate result: Sleep has enough opportunity, a usable schedule, and a clear day-night light pattern. Persistent insomnia, apnea signs, or nasal obstruction has entered a specific diagnostic branch.[62][61][59]

Gate 3: Restore energetic and metabolic conditions

Next, match food and body composition to the starting problem. Track weight, waist, appetite, performance, recovery, sleep, libido, and the relevant laboratory values. The aim may be refeeding, gradual fat loss, or correction of a confirmed disease or deficiency.[74][83][84][1][77][242]

Continued involuntary loss, crash dieting, worsening recovery, uncontrolled gain, or no response means the plan is wrong or incomplete. Eating-disorder signs, malabsorption, anemia, iron overload, diabetes, thyroid disease, liver disease, and persistent abnormalities require the relevant clinician or dietitian.

Step 9. Reconstruct the energy history

Reconstruct the previous twelve months of weight, waist, dieting, training, illness, appetite, and food restriction. A low result after a prolonged cut starts with a different likely explanation from one that appeared during weight gain with severe insulin resistance.[74][83]

Step 10. Correct the energy state

When low energy availability is likely, increase food and reduce unnecessary expenditure. Build the diet from complete protein, tolerated carbohydrate, enough fat, and varied micronutrient sources.[74][76][77]

The body can make cholesterol from carbon supplied by carbohydrate, fat, and amino acids, so high fat is unnecessary for steroid substrate.[87][88]

Step 11. Reduce excess adiposity without creating a crash diet

When obesity and insulin resistance dominate the pattern, combine a sustainable energy deficit with resistance training, walking or aerobic work, adequate protein, and clinical obesity care when appropriate.[83][84]

Aim for better metabolic health without sacrificing recovery.

Step 12. Review minerals and correct defined needs

Investigate anemia, iron overload, vitamin D deficiency, diabetes, thyroid disease, liver disease, kidney disease, and malabsorption. Then review calcium, magnesium, potassium, sodium, iodine, selenium, zinc, copper, vitamins A, D, E, and K, and the B vitamins.[21][189][1][190][102]

For sodium, review sweat, heat, endurance work, diarrhea, food restriction, blood pressure, kidney and heart function, and medication. For thiamine, review food intake, alcohol, malabsorption, prolonged vomiting, high carbohydrate demand, diuretic use, neuropathic symptoms, and persistent constipation. Correct the identifiable constraint. Keep gram-dose thiamine and aggressive salt loading outside the default protocol.[90][92][93]

Use the supplement map in Section 5. Match magnesium form to elemental dose and bowel tolerance. Use iodine and selenium only after the thyroid and intake context are clear. Read zinc, P5P, and vitamin E as conditional prolactin tools rather than a universal anti-prolactin stack. Keep glycine and L-theanine in the sleep-support category. Keep TMG, TUDCA, D-chiro-inositol, methylene blue, Epithalon, Pinealon, Vilon, and disease-level doses outside the default stack.[103][108][97][152][158][162][117][122][126][116][98][163][161]

Reserve supplements for a defined need. Change one main input at a time and define the stop rule before starting. Orange juice, raw carrot salad, well-cooked white button mushrooms, or well-boiled bamboo shoots can be tested consistently when they fit the energy, estrogen, and bowel pattern.

Gate result: Food intake and weight change now fit the starting problem. Weight, waist, performance, sleep, and symptoms show whether refeeding, gradual fat loss, or correction of a defined deficiency is working.

Gate 4: Adjust training and remove suppressors

After food and sleep can support adaptation, make training recoverable and complete the exposure history. Track strength, work capacity, soreness, tissue tolerance, sleep, libido, medication, alcohol, nicotine, hormones, compulsive behavior, and active illness.[30][31][67][229][240][233]

Performance and recovery should improve as each suppressor receives a clear plan. Dependence, psychiatric risk, medication withdrawal, organ disease, bleeding, severe pain, and fertility risk require supervised care.

Step 13. Program training for adaptation

Use progressive resistance training with enough aerobic activity to improve fitness. Hard sessions must remain recoverable. Transient post-workout testosterone is not a useful program metric.[30][31][187][185]

Step 14. Match volume to recovery

When performance, mood, libido, sleep, and tissue tolerance decline together, reduce volume or intensity and reassess food and illness. If training load is the suspected stressor, a deload also serves as a diagnostic intervention.[186]

Step 15. Review drugs, hormones, and compulsive habits

Make a complete list of opioids, glucocorticoids, antipsychotics, antidepressants, finasteride or dutasteride, alcohol, cannabis, nicotine, testosterone, anabolic steroids, SARMs, prohormones, hCG, fertility drugs, and supplements.[67][229][230][233]

Treat an unexpectedly strong bodybuilding or sexual-enhancement supplement as a possible exposure to an undeclared drug until the product is verified.[38][39]

Remove pornography during the restoration phase. Stop edging and long compulsive sessions. Pause or reduce masturbation when it impairs sleep, attention, libido, erections, or partnered arousal. Keep partnered sex separate in the record because its physiological and relational context differs.[36][37][208][209]

Discuss medication changes with the relevant prescriber. Dependence-forming and psychiatric drugs should never be stopped abruptly without appropriate care.

Step 16. Treat active illness and gut disease

Investigate persistent pain, gastrointestinal disease, autoimmune disease, infection, dental disease, and organ dysfunction. Treat constipation, diarrhea, reflux, and inflammatory gut disease according to the cause. Vague symptoms cannot diagnose endotoxin or gut serotonin.[189][202][203][204][205]

Choose gut products by indication and exact preparation. Zinc L-carnosine, enteric-coated lactoferrin, riboflavin, microencapsulated sodium butyrate, S. boulardii CNCM I-745, H. coagulans GBI-30, 6086, and the named L. reuteri strains answer different questions.[130][132][133][140][141][129][131][135] Enterosgel and diosmectite remain short, indication-specific adsorbents.[149][150] Avoid live S. boulardii in the high-risk settings described in Section 5. Keep activated charcoal, bentonite, zeolite, and modified citrus pectin outside a daily restoration protocol.

Gate result: Training load is recoverable, known suppressors have a defined management plan, and active disease has been treated or referred. If function does not improve, retest and reconsider the classification with a specialist.

Gate 5: Retest, decide, and preserve options

Retest only after the intervention has had enough time to work. Compare the original symptom, matched testosterone testing, SHBG or free testosterone, LH, FSH, the abnormal cause-specific marker, and semen analysis when fertility is the goal.[40][67][241][240]

Function and the laboratory pattern should improve together without a new safety or fertility cost. No change, adverse effects, worsening fertility, or a mismatch between symptoms and laboratories means stop, change the hypothesis, or enter the appropriate clinical branch.

Step 17. Hold the intervention long enough

Match the interval to the biology and the intervention. Sleep, fat loss, recovery from underfeeding, thyroid treatment, medication changes, serum testosterone, and sperm do not share one response time. After AAS exposure, sperm production may recover much more slowly than serum testosterone.[74][77][190][240]

Keep tracking the symptoms named in Step 1. A better laboratory result without functional improvement gives only part of the answer.

Step 18. Repeat under matched conditions

Use the same laboratory and similar timing relative to sleep. Repeat total testosterone, SHBG or free testosterone, LH, FSH, and any abnormal cause-specific test.[40][50]

Before-and-after results become useful only when their sampling contexts are comparable.

Step 19. Escalate unresolved patterns

Persistent patterns and unclear causes warrant specialty care in endocrinology, urology, sleep medicine, or reproductive medicine. Escalate when fertility is threatened, prolactin stays high, LH is elevated, several pituitary hormones are abnormal, or structural disease is possible.[40][197][67]

Escalate immediately for acute testicular pain, a mass, severe headache with visual change, or severe systemic illness.

Step 20. Stop or choose a defined medical branch

Continue the natural plan while function and the laboratory pattern improve. Move to a defined medical branch when the cause proves structural, genetic, medication-related, or irreversible.

Every hormone under discussion needs a defined branch: T3 for verified thyroid disease, pregnenolone or progesterone for a defined upstream reason, DHT for a defined nonaromatizable androgen goal, and testosterone as final replacement. Every one can alter feedback and fertility.[85][200][243][244][224]

Gate result: Continue only when function and the matched laboratory pattern move in the intended direction without sacrificing fertility or safety. Otherwise stop, change the hypothesis, or enter a defined clinician-led branch.

The twenty-step natural testosterone protocol

Figure 12. Each later intervention depends on a credible result at the earlier gate.

14. Daily and weekly practice

The plan works through repeatable anchors. Use the schedule that fits the diagnosed problem and the person’s real sleep phase.

The daily routine

This routine begins after urgent causes have been screened. Adjust the clock to the person’s actual sleep schedule. The anchors matter more than a universal bedtime.

After waking

  • Record wake time and morning state when sleep is an active problem.

  • Get outdoor light when feasible. Keep the timing consistent with the intended circadian phase.

  • Eat according to the diagnosed energy state. A man recovering from underfeeding needs enough food. A man reducing excess fat needs a sustainable deficit.

  • Take prescribed treatment as directed. Do not add a hormone or booster to the routine without a defined indication.

During the day

  • Eat enough complete protein and total energy for the plan. Set carbohydrate and fat by tolerance, activity, body composition, and clinical context.

  • Train only on scheduled days. Use progressive work that can be recovered from.

  • Keep caffeine early enough that sleep remains intact.[25]

  • Use a bright daytime environment. A dim day followed by a bright screen at night weakens the day-night contrast.

Before sleep

  • Dim light and reduce bright screens near the face.

  • Leave enough sleep opportunity for complete cycles rather than forcing one fixed sleep time.

  • Manage the known disruptor. This may be congestion, apnea treatment, pain, reflux, heat, alcohol, restless legs, or noise.

  • Use saline rinse or a nasal strip only when it fits the nasal problem. Mouth tape never replaces an open airway or apnea care.[62][61][59]

  • Record only the outcomes needed for the current hypothesis. A long nightly scorecard will not improve adherence.

Daily routine for natural testosterone restoration

Figure 13A. Daily anchors create light contrast, adequate fuel, recoverable work, and protected sleep. The schedule follows the person’s sleep phase rather than a fixed clock time.

The weekly routine

Review trends once a week. Daily hormone interpretation creates noise.

  1. Compare wake-time range, sleep opportunity, awakenings, and daytime sleepiness.

  2. Review body-weight and waist direction without reacting to one reading.

  3. Check whether food intake matched the energy goal and whether protein remained adequate.

  4. Review training performance, total hard sets or endurance load, pain, and recovery.

  5. Record libido, spontaneous or morning erections, and the main functional outcome chosen at baseline.

  6. Check adherence to prescribed apnea, thyroid, allergy, or other cause-specific treatment.

  7. Review alcohol, nicotine, drugs, hormones, supplements, porn, edging, and compulsive masturbation.

  8. Adjust one active variable when possible. Keep the rest stable long enough to learn from the change.

  9. Escalate new red flags, persistent high prolactin, fertility concerns, or a worsening laboratory pattern.

Laboratory testing belongs at the interval required by the biology. It does not belong on a weekly schedule. Semen recovery, fat loss, thyroid treatment, and recovery after AAS follow different timelines.

Weekly review for natural testosterone restoration

Figure 13B. The weekly review compares trends, checks the main limiting layer, and changes one variable before the next review.

15. Monitor the result

Choose outcomes before changing the plan

Keep the record small enough to use consistently:

  • Sleep timing, duration, awakenings, and morning state.

  • Daytime sleepiness.

  • Libido and frequency of spontaneous or morning erections.

  • Erectile reliability in the relevant context.

  • Training performance and recovery.

  • Body weight and waist trajectory.

  • Mood or validated symptom measures when appropriate.

  • Semen parameters when fertility is the target.

  • Total testosterone, SHBG or free testosterone, LH, FSH, and cause-specific laboratories.

Summarize the record weekly. Sexual function, mood, and sleep fluctuate too much for one day to carry much meaning.

Separate process measures from outcome measures

Process measures show whether the action happened. Wake-time consistency, CPAP use, food intake, training volume, and weight trend belong here. Outcome measures show whether the target changed, such as testosterone, sleepiness, libido, sperm concentration, strength, or waist circumference.

Perfect adherence can still test the wrong idea.

Match the reassessment interval to the biology

Light timing may help within days or weeks. Recovery from underfeeding takes longer, and fat loss unfolds over months. Recovery after steroid exposure can be slow and uncertain. Sperm production also changes more slowly than a serum hormone result.

Keep measurement conditions comparable

A higher result after better sleep may partly reflect better sampling conditions, which itself shows that context mattered.

With every clinically important test, record wake time, fasting state, illness, training, medication timing, and androgen exposure. Use the same reliable laboratory when possible so the comparison remains meaningful.

Define success at several levels

Success can include:

  • A valid laboratory pattern moving toward normal.

  • Improvement in the symptom that justified the work.

  • Preservation of fertility goals.

  • Removal or control of the upstream cause.

  • A plan that can be sustained without escalating risk.

Partial success still carries information. Better sleep with unchanged testosterone points toward another limiting layer. Higher testosterone with unchanged fatigue shifts attention toward another cause of the fatigue.

Define failure before it happens

Failure means poor adherence, an unusable measurement, no result after enough time, adverse effects, worsening fertility, or discovery of a structural cause. Define it before starting.

The reason for failure determines the next move:

  • Fix adherence when exposure was inadequate.

  • Improve measurement when the comparison was invalid.

  • Extend time when the biology is slow and the direction is safe.

  • Change the hypothesis when the intervention was adequate and the outcome did not move.

  • Escalate care when the pattern suggests pituitary, testicular, systemic, or medication-related disease.

Each intervention should test one layer of the model.

16. Pattern-based troubleshooting

Troubleshooting tree for testosterone patterns

Figure 14. Troubleshooting begins with the pattern. Persistent symptoms with normal, valid androgen measurements require a broader diagnostic investigation.

Pattern A: low testosterone after poor sleep

First determine whether the result followed one unusual night or reflects a chronic pattern.

After an unusual night, restore the usual schedule and repeat the test. For a chronic pattern, distinguish among:

  • Insufficient opportunity.

  • Delayed or irregular circadian timing.

  • Insomnia.

  • OSA or another sleep disorder.

  • Caffeine, alcohol, nicotine, pain, reflux, or medication.

  • Shift work.

Treat the identified sleep problem, then repeat under representative conditions. High LH, markedly elevated prolactin, or structural clues point beyond sleep and need their own evaluation.

Pattern B: low total testosterone with obesity

First read the binding context. Measure SHBG, assess free testosterone, and add LH and FSH.

Low SHBG with preserved free testosterone shifts priority toward metabolic health and the symptom pattern. When both total and free testosterone are low alongside low or normal LH, functional central suppression becomes more likely, though pituitary and medication causes still need review. High LH means obesity alone cannot explain the primary pattern.

Screen for OSA. Review alcohol, opioids, diabetes, liver disease, and prior androgen use. Use a sustainable weight-loss plan and retest.

Pattern C: low testosterone during a cut

Reconstruct the deficit. Review its size and duration, the change in body fat, training load, sleep, illness, and dietary rigidity. Reduce the combined stress by raising intake, lowering expenditure, or doing both.

Preserve protein and restore enough carbohydrate and fat to make the diet complete. Give body weight, sleep, libido, and training performance time to recover before repeating the test.

Persistent high LH or a result that predates the cut points toward a different layer.

Pattern D: low testosterone with high LH

Treat this as a testicular pattern until the workup says otherwise. Confirm the result, include FSH, and arrange clinical evaluation. Review testicular history, fertility, infection, torsion, trauma, chemotherapy, radiation, genetic conditions, and examination findings.

Lifestyle can support general health while the testicular cause is being diagnosed.

Pattern E: low testosterone with low LH and high prolactin

Confirm prolactin and find the cause. Repeat it under appropriate conditions while reviewing medications, thyroid status, renal function, and symptoms. Marked or persistent elevation requires a search for the cause. Headache, visual change, galactorrhea, or other pituitary deficits make that search urgent.

Dopamine agonists require medical diagnosis and management.

Pattern F: normal testosterone with persistent symptoms

Confirm the androgen interpretation, then widen the diagnosis. First check free testosterone and SHBG.

For fatigue, consider sleep disorders, anemia, thyroid disease, depression, infection, cardiopulmonary disease, medication, underfueling, and overtraining.

For erectile dysfunction, consider vascular risk, blood pressure, diabetes, medication, pornography or stimulation patterns, anxiety, pelvic or neurological factors, and relationship context.

For low libido, consider mood, stress, medication, sleep, relationship factors, pain, prolactin, thyroid status, and estradiol context.

For poor training response, examine programming, technique, volume, food, protein, sleep, illness, and time.

A normal, valid androgen profile redirects the investigation without dismissing the symptoms.

Pattern G: high testosterone with suppressed LH and fertility concerns

Protect fertility before chasing the serum value. Document every androgen, SARM, prohormone, hCG, and fertility-drug exposure. Obtain a semen analysis and reproductive evaluation. Recovery after anabolic use varies and can be prolonged.

An internet post-cycle therapy protocol cannot account for the exposure, time course, testicular function, fertility timeline, and medical risks that should determine the plan.

Pattern H: numbers improve and function does not

Return to the original symptom. Reconsider whether the first attribution was correct.

An improved testosterone result settles only the androgen measurement. Persistent sleepiness, erectile dysfunction, depression, pain, infertility, or poor performance returns the investigation to the cause of that outcome.

Recognizing that mismatch prevents an endless sequence of higher doses and narrower explanations.

17. Where the natural approach ends

This article stops at endogenous production.

Sleep, food, training, body composition, thyroid care, airway treatment, and exposure reduction cannot rebuild destroyed testicular tissue or remove a pituitary tumor. Nor can they reverse every effect of chemotherapy, genetic disease, torsion, or prolonged steroid exposure.

The first article named thyroid hormone, progesterone, dopamine agonists, aromatase inhibitors, and other drugs. Their mechanisms belong in the map. The default natural protocol excludes them. Each drug needs a diagnosis, target, monitoring plan, fertility decision, and stopping rule.

Testosterone replacement therapy supplies the final hormone. It can normalize serum testosterone and improve selected outcomes in confirmed hypogonadism. It suppresses GnRH, LH, FSH, intratesticular testosterone, and sperm production. It is rational when clinically important androgen deficiency is confirmed and endogenous recovery is unavailable or inadequate. Apnea, pituitary disease, underfeeding, medication effects, and testicular disease remain separate treatment targets.[200][40]

hCG activates the LH receptor on Leydig cells. It can support intratesticular testosterone during gonadotropin suppression and is used in selected fertility and secondary-hypogonadism settings. Its action requires responsive Leydig cells and leaves FSH-dependent Sertoli function as a separate branch. Estradiol, symptoms, semen, and testicular response require monitoring.[200]

Clomiphene blocks estrogen feedback centrally and can raise endogenous LH, FSH, and testosterone when the hypothalamus, pituitary, and testes remain responsive. It is a mixture of enclomiphene and zuclomiphene and is used off label in men. It may preserve fertility better than testosterone, but semen responses vary and can worsen in a minority. It is a poor fit for primary testicular failure or a structural pituitary cause.[245]

Enclomiphene is the trans isomer of clomiphene. Trials in men with secondary hypogonadism found higher testosterone, LH, and FSH with preserved sperm counts compared with testosterone gel.[246] That is drug-driven stimulation of an intact axis. Continued sleep, obesity, medication, or pituitary causes can remain unresolved. Approval and availability vary by jurisdiction.

Enclomiphene should not be called a “side-effect-free natural testosterone booster.” It is a selective estrogen-receptor modulator that changes feedback. It belongs in a defined medical branch with monitoring.

Aromatase inhibitors reduce conversion of testosterone to estradiol and weaken estrogen feedback. In selected infertile or hypoandrogenic men with an appropriate testosterone-to-estradiol pattern, they can raise LH, FSH, testosterone, and some semen measures.[247] Estradiol is still required for bone, sexual function, and body composition. Broad suppression can create a new problem and does not treat every cause of high estradiol.

Dopamine agonists lower prolactin and can restore gonadal signaling when a defined hyperprolactinemic disorder is the cause. They are not treatments for pornography, a brief post-orgasm prolactin rise, or a vague low-dopamine theory. Pituitary imaging, medication review, adverse effects, and long-term management belong to the clinical branch.[67]

Thyroid hormone treats diagnosed thyroid disease. Restoring euthyroidism can improve SHBG, prolactin, sexual function, and testicular output when hypothyroidism is the limiting layer.[189][190] T3 is one medical option within thyroid care. Excess exposure can disturb rhythm, sleep, muscle, bone, and the heart. Thyroid hormone has no routine role as a testosterone booster in a euthyroid man.

Pregnenolone is the first steroid after cholesterol. It can feed progesterone, DHEA, corticosteroid, and neurosteroid branches. Taking it does not determine which branch receives the substrate, and it does not guarantee more testosterone.[85]

Progesterone is a normal male steroid intermediate and neurosteroid precursor. Sufficient exposure can suppress LH, FSH, and testosterone. Its use therefore requires a defined purpose and monitoring of the axis and fertility.[243]

DHT supplies a potent nonaromatizable androgen signal. It can act at target tissues while suppressing LH, testosterone, and estradiol. A long trial preserved many sexual measures while reducing spinal bone density.[244][224] DHT cannot supply estrogen-dependent effects or preserve endogenous fertility.

DHEA is an exogenous steroid precursor. Tissue enzymes can convert it toward androgens or estrogens. Controlled trials in men show no reliable restoration of testosterone, sexual function, strength, or broader clinical outcomes.[248][249] It still changes downstream exposure and laboratory interpretation.

Post-cycle drug stacks combine hCG, selective estrogen-receptor modulators, aromatase inhibitors, and sometimes other hormones after AAS or testosterone exposure. Each component pushes a different branch. The HAARLEM cohort observed self-selected post-cycle therapy rather than testing it as a randomized intervention.[240] Recovery depends on the compounds, exposure, baseline testicular capacity, time, and fertility goal. A stack can also obscure whether autonomous function has returned.

The separate HRT, ICT and PCT framework defines HRT as long-term hormone support, ICT as support during active AAS exposure, and PCT as assessment and recovery support after exposure has cleared. This guide does not tell readers to progress through them. A fully natural plan stops before hormone or fertility drugs. When a medical branch becomes necessary, define the failed layer and protect fertility before treatment begins.

The final decision rule

The first Testosterone Kabbalah had the right instinct. Testosterone belongs inside a network. The harder lesson is that every blood value leaves something out. Serum testosterone cannot show intratesticular testosterone, local DHT or estradiol, receptor action, fertility, or the cause of a symptom.

Start with a result worth interpreting. Read LH, FSH, SHBG, free testosterone when needed, prolactin, and the clinical context beside it. The pattern will usually point toward sleep, energy, metabolism, thyroid, medication, pituitary signaling, testicular function, transport, conversion, or a different cause of the symptom.

Natural restoration has a precise meaning. Repair the limiting branch while it can still recover. Retest under matched conditions. Stop self-experimenting when the pattern calls for medical treatment.

Protect fertility before changing the axis. The number should serve the diagnosis.

References

  1. Ananda S. Prasad et al. “Zinc Status and Serum Testosterone Levels of Healthy Adults.” Nutrition 12, no. 5 (1996): 344-348. DOI: 10.1016/S0899-9007(96)80058-X.

  2. Stephen J. Smith, Adrian L. Lopresti, Shaun Y. M. Teo, and Timothy J. Fairchild. “Examining the Effects of Herbs on Testosterone Concentrations in Men: A Systematic Review.” Advances in Nutrition 12, no. 3 (2021): 744-765. DOI: 10.1093/advances/nmaa134.

  3. Alexandre Morgado et al. “Do ‘Testosterone Boosters’ Really Increase Serum Total Testosterone? A Systematic Review.” International Journal of Impotence Research 36, no. 4 (2024): 348-364. DOI: 10.1038/s41443-023-00763-9.

  4. Musa T. Yakubu, Musbau A. Akanji, and Adenike T. Oladiji. “Aphrodisiac Potentials of the Aqueous Extract of Fadogia agrestis Stem in Male Albino Rats.” Asian Journal of Andrology 7, no. 4 (2005): 399-404. DOI: 10.1111/j.1745-7262.2005.00052.x.

  5. Musa T. Yakubu, Musbau A. Akanji, and Adenike T. Oladiji. “Effects of Oral Administration of Aqueous Extract of Fadogia agrestis Stem on Some Testicular Function Indices of Male Rats.” Journal of Ethnopharmacology 115, no. 2 (2008): 288-292. DOI: 10.1016/j.jep.2007.10.004.

  6. Musa T. Yakubu and Anthony J. Afolayan. “Reproductive Toxicologic Evaluations of Bulbine natalensis Baker Stem Extract in Albino Rats.” Theriogenology 72, no. 3 (2009): 322-332. DOI: 10.1016/j.theriogenology.2009.01.026.

  7. Anthony J. Afolayan and Musa T. Yakubu. “Effect of Bulbine natalensis Baker Stem Extract on the Functional Indices and Histology of the Liver and Kidney of Male Wistar Rats.” Journal of Medicinal Food 12, no. 4 (2009): 814-820. DOI: 10.1089/jmf.2008.0221.

  8. Vikas Sharma, Mayank Thakur, Nagendra S. Chauhan, and Vinod Kumar Dixit. “Effects of Petroleum Ether Extract of Anacyclus pyrethrum DC. on Sexual Behavior in Male Rats.” Journal of Chinese Integrative Medicine 8, no. 8 (2010): 767-773. DOI: 10.3736/jcim20100807.

  9. V. K. Neychev and V. I. Mitev. “The Aphrodisiac Herb Tribulus terrestris Does Not Influence the Androgen Production in Young Men.” Journal of Ethnopharmacology 101, nos. 1-3 (2005): 319-323. DOI: 10.1016/j.jep.2005.05.017.

  10. Carlos A. Santos Jr. et al. “Tribulus terrestris versus Placebo in the Treatment of Erectile Dysfunction: A Prospective, Randomized, Double-Blind Study.” Actas Urológicas Españolas 38, no. 4 (2014): 244-248. DOI: 10.1016/j.acuro.2013.09.014.

  11. José de Oliveira Vilar Neto et al. “Effects of Tribulus terrestris Supplementation on Erectile Dysfunction and Testosterone Levels in Men: A Systematic Review of Clinical Trials.” Nutrients 17, no. 7 (2025): 1275. DOI: 10.3390/nu17071275.

  12. W. Cherdshewasart and N. Nimsakul. “Clinical Trial of Butea superba, an Alternative Herbal Treatment for Erectile Dysfunction.” Asian Journal of Andrology 5, no. 3 (2003): 243-246.

  13. Jeff R. Cortés-González, Jorge A. Arratia-Maqueo, Lauro S. Gómez-Guerra, and Anders R. Holmberg. “The Use of Butea superba (Roxb.) Compared to Sildenafil for Treating Erectile Dysfunction.” BJU International 105, no. 2 (2010): 225-228. DOI: 10.1111/j.1464-410X.2009.08748.x.

  14. Kamon Chaiyasit and Viroj Wiwanitkit. “Hyperandrogenemia Due to Ingestion of Butea superba.” Indian Journal of Endocrinology and Metabolism 16, no. 3 (2012): 485-486. DOI: 10.4103/2230-8210.95756.

  15. Kristian Leisegang, Renata Finelli, Suresh C. Sikka, and Manesh Kumar Panner Selvam. “Eurycoma longifolia (Jack) Improves Serum Total Testosterone in Men: A Systematic Review and Meta-Analysis of Clinical Trials.” Medicina 58, no. 8 (2022): 1047. DOI: 10.3390/medicina58081047.

  16. Sasikala M. Chinnappan et al. “Effect of Eurycoma longifolia Standardised Aqueous Root Extract, Physta, on Testosterone Levels and Quality of Life in Ageing Male Subjects: A Randomised, Double-Blind, Placebo-Controlled Multicentre Study.” Food & Nutrition Research 65 (2021): 5647. DOI: 10.29219/fnr.v65.5647.

  17. Kai Quin Chan, Claire Stewart, Neil Chester, Sareena H. Hamzah, and Ashril Yusof. “The Effect of Eurycoma longifolia on the Regulation of Reproductive Hormones in Young Males.” Andrologia 53, no. 4 (2021): e14001. DOI: 10.1111/and.14001.

  18. Adrian L. Lopresti, Peter D. Drummond, and Stephen J. Smith. “A Randomized, Double-Blind, Placebo-Controlled, Crossover Study Examining the Hormonal and Vitality Effects of Ashwagandha in Aging, Overweight Males.” American Journal of Men’s Health 13, no. 2 (2019): 1557988319835985. DOI: 10.1177/1557988319835985.

  19. Sindre Lee-Ødegård, Thomas E. Gundersen, and Christian A. Drevon. “Effect of a Plant Extract of Fenugreek on Testosterone in Blood Plasma and Saliva in a Double-Blind Randomized Controlled Intervention Study.” PLOS ONE 19, no. 9 (2024): e0310170. DOI: 10.1371/journal.pone.0310170.

  20. S. Pandit et al. “Clinical Evaluation of Purified Shilajit on Testosterone Levels in Healthy Volunteers.” Andrologia 48, no. 5 (2016): 570-575. DOI: 10.1111/and.12482.

  21. Elisabeth Lerchbaum et al. “Vitamin D and Testosterone in Healthy Men: A Randomized Controlled Trial.” Journal of Clinical Endocrinology & Metabolism 102, no. 11 (2017): 4292-4302. DOI: 10.1210/jc.2017-01428.

  22. Alexander M. Sidlak et al. “Acute Salicylate Toxicity: A Narrative Review for Emergency Clinicians.” Cureus 17, no. 9 (2025): e91505. DOI: 10.7759/cureus.91505.

  23. Su Ling Young and Gus Gazzard. “The Adverse Effects of Oral Niacin/Nicotinamide: An Overview of Reviews.” Eye 39, no. 16 (2025): 2852-2859. DOI: 10.1038/s41433-025-04027-2.

  24. M. J. Stampfer et al. “Vitamin E Supplementation Effect on Human Platelet Function, Arachidonic Acid Metabolism, and Plasma Prostacyclin Levels.” American Journal of Clinical Nutrition 47, no. 4 (1988): 700-706. DOI: 10.1093/ajcn/47.4.700.

  25. Carissa Gardiner et al. “The Effect of Caffeine on Subsequent Sleep: A Systematic Review and Meta-Analysis.” Sleep Medicine Reviews 69 (2023): 101764. DOI: 10.1016/j.smrv.2023.101764.

  26. Geoffrey W. Melville, Jason C. Siegler, and Paul W. M. Marshall. “The Effects of D-Aspartic Acid Supplementation in Resistance-Trained Men over a Three-Month Training Period: A Randomised Controlled Trial.” PLOS ONE 12, no. 8 (2017): e0182630. DOI: 10.1371/journal.pone.0182630.

  27. Joel S. Finkelstein et al. “Gonadal Steroids and Body Composition, Strength, and Sexual Function in Men.” New England Journal of Medicine 369, no. 11 (2013): 1011-1022. DOI: 10.1056/NEJMoa1206168.

  28. Dongho Shin et al. “Efficacy and Safety of Maca in Patients with Symptoms of Late-Onset Hypogonadism: A Randomized, Double-Blind, Placebo-Controlled Clinical Trial.” World Journal of Men’s Health 41, no. 3 (2023): 692-700. DOI: 10.5534/wjmh.220112.

  29. Johann van der Merwe, Naomi E. Brooks, and Kathryn H. Myburgh. “Three Weeks of Creatine Monohydrate Supplementation Affects Dihydrotestosterone to Testosterone Ratio in College-Aged Rugby Players.” Clinical Journal of Sport Medicine 19, no. 5 (2009): 399-404. DOI: 10.1097/JSM.0b013e3181b8b52f.

  30. Gregory D. M. Potter et al. “Effects of Exercise Training on Resting Testosterone Concentrations in Insufficiently Active Men: A Systematic Review and Meta-Analysis.” Journal of Strength and Conditioning Research 36, no. 12 (2022): 3521-3528. DOI: 10.1519/JSC.0000000000004146.

  31. Daniel W. D. West et al. “Resistance Exercise-Induced Increases in Putative Anabolic Hormones Do Not Enhance Muscle Protein Synthesis or Intracellular Signalling in Young Men.” Journal of Physiology 587, no. 21 (2009): 5239-5247. DOI: 10.1113/jphysiol.2009.177220.

  32. Tillmann H. Krüger et al. “Orgasm-Induced Prolactin Secretion: Feedback Control of Sexual Drive?” Neuroscience & Biobehavioral Reviews 26, no. 1 (2002): 31-44. DOI: 10.1016/S0149-7634(01)00036-7.

  33. Tillmann H. Krüger et al. “Specificity of the Neuroendocrine Response to Orgasm during Sexual Arousal in Men.” Journal of Endocrinology 177, no. 1 (2003): 57-64. DOI: 10.1677/joe.0.1770057.

  34. Alonso Fernández-Guasti and Gabriela Rodríguez-Manzo. “Pharmacological and Physiological Aspects of Sexual Exhaustion in Male Rats.” Scandinavian Journal of Psychology 44, no. 3 (2003): 257-263. DOI: 10.1111/1467-9450.00343.

  35. Bryan V. Phillips-Farfán and Alonso Fernández-Guasti. “Endocrine, Neural and Pharmacological Aspects of Sexual Satiety in Male Rats.” Neuroscience & Biobehavioral Reviews 33, no. 3 (2009): 442-455. DOI: 10.1016/j.neubiorev.2008.11.003.

  36. Zisis Zacharopoulos et al. “Pornography Consumption and Male Sexual Dysfunction: A Systematic Review.” Advances in Experimental Medicine and Biology 1487 (2026): 297-304. DOI: 10.1007/978-3-032-03398-7_29.

  37. Beáta Bőthe et al. “Are Sexual Functioning Problems Associated with Frequent Pornography Use and/or Problematic Pornography Use? Results from a Large Community Survey Including Males and Females.” Addictive Behaviors 112 (2021): 106603. DOI: 10.1016/j.addbeh.2020.106603.

  38. Neil Campbell et al. “Adulteration of Purported Herbal and Natural Sexual Performance Enhancement Dietary Supplements with Synthetic Phosphodiesterase Type 5 Inhibitors.” Journal of Sexual Medicine 10, no. 7 (2013): 1842-1849. DOI: 10.1111/jsm.12172.

  39. Ryan M. Van Wagoner et al. “Chemical Composition and Labeling of Substances Marketed as Selective Androgen Receptor Modulators and Sold via the Internet.” JAMA 318, no. 20 (2017): 2004-2010. DOI: 10.1001/jama.2017.17069.

  40. Shalender Bhasin et al. “Testosterone Therapy in Men with Hypogonadism: An Endocrine Society Clinical Practice Guideline.” Journal of Clinical Endocrinology & Metabolism 103, no. 5 (2018): 1715-1744. DOI: 10.1210/jc.2018-00229.

  41. John E. Morley et al. “Validation of a Screening Questionnaire for Androgen Deficiency in Aging Males.” Metabolism 49, no. 9 (2000): 1239-1242. DOI: 10.1053/meta.2000.8625.

  42. Sat Bir S. Khalsa et al. “A Phase Response Curve to Single Bright Light Pulses in Human Subjects.” Journal of Physiology 549, no. 3 (2003): 945-952. DOI: 10.1113/jphysiol.2003.040477.

  43. Joshua J. Gooley et al. “Exposure to Room Light before Bedtime Suppresses Melatonin Onset and Shortens Melatonin Duration in Humans.” Journal of Clinical Endocrinology & Metabolism 96, no. 3 (2011): E463-E472. DOI: 10.1210/jc.2010-2098.

  44. Gary A. Wittert. “The Relationship Between Sleep Disorders and Testosterone in Men.” Asian Journal of Andrology 16, no. 2 (2014): 262-265. DOI: 10.4103/1008-682X.122586.

  45. Rafael Luboshitzky et al. “Relationship Between Rapid Eye Movement Sleep and Testosterone Secretion in Normal Men.” Journal of Andrology 20, no. 6 (1999): 731-737.

  46. Rafael Luboshitzky et al. “Disruption of Nocturnal Testosterone Rhythm by Sleep Fragmentation in Normal Men.” Journal of Clinical Endocrinology & Metabolism 86, no. 3 (2001): 1134-1139. DOI: 10.1210/jcem.86.3.7296.

  47. Yulia V. Ukraintseva et al. “Slow-Wave Sleep and Androgens: Selective Slow-Wave Sleep Suppression Affects Testosterone and 17α-Hydroxyprogesterone Secretion.” Sleep Medicine 48 (2018): 117-126. DOI: 10.1016/j.sleep.2018.04.012.

  48. Long Su et al. “Effect of Partial and Total Sleep Deprivation on Serum Testosterone in Healthy Males: A Systematic Review and Meta-Analysis.” Sleep Medicine 88 (2021): 267-273. DOI: 10.1016/j.sleep.2021.10.031.

  49. Rachel Leproult and Eve Van Cauter. “Effect of 1 Week of Sleep Restriction on Testosterone Levels in Young Healthy Men.” JAMA 305, no. 21 (2011): 2173-2174. DOI: 10.1001/jama.2011.710.

  50. Brittany N. Harding et al. “Changes in Melatonin and Sex Steroid Hormone Production among Men as a Result of Rotating Night Shift Work: The HORMONIT Study.” Scandinavian Journal of Work, Environment & Health 48, no. 1 (2022): 41-51. DOI: 10.5271/sjweh.3991.

  51. David I. Spratt et al. “Neuroendocrine-Gonadal Axis in Men: Frequent Sampling of LH, FSH, and Testosterone.” American Journal of Physiology 254, no. 5 Pt 1 (1988): E658-E666. DOI: 10.1152/ajpendo.1988.254.5.E658.

  52. Claude Gronfier and Gabrielle Brandenberger. “Ultradian Rhythms in Pituitary and Adrenal Hormones: Their Relations to Sleep.” Sleep Medicine Reviews 2, no. 1 (1998): 17-29. DOI: 10.1016/S1087-0792(98)90051-X.

  53. Li-Qiang Qin et al. “The Effects of Nocturnal Life on the Circadian Patterns of Sex Hormones in Young Healthy Men.” Journal of Health Science 51, no. 1 (2005): 33-40. DOI: 10.1248/jhs.51.33.

  54. Helen J. Burgess, Victoria L. Revell, and Charmane I. Eastman. “A Three Pulse Phase Response Curve to Three Milligrams of Melatonin in Humans.” Journal of Physiology 586, no. 2 (2008): 639-647. DOI: 10.1113/jphysiol.2007.143180.

  55. Alfred J. Lewy et al. “The Human Phase Response Curve to Melatonin Is about 12 Hours Out of Phase with the Phase Response Curve to Light.” Chronobiology International 15, no. 1 (1998): 71-83. DOI: 10.3109/07420529808998671.

  56. Bhanu Prakash Kolla et al. “The Impact of Alcohol on Breathing Parameters during Sleep: A Systematic Review and Meta-Analysis.” Sleep Medicine Reviews 42 (2018): 59-67. DOI: 10.1016/j.smrv.2018.05.007.

  57. John W. Winkelman et al. “Treatment of Restless Legs Syndrome and Periodic Limb Movement Disorder: An American Academy of Sleep Medicine Clinical Practice Guideline.” Journal of Clinical Sleep Medicine 21, no. 1 (2025): 137-152. DOI: 10.5664/jcsm.11390.

  58. Long Su et al. “Association between Obstructive Sleep Apnea and Male Serum Testosterone: A Systematic Review and Meta-Analysis.” Andrology 10, no. 2 (2022): 223-231. DOI: 10.1111/andr.13111.

  59. Kristina E. Hermelingmeier et al. “Nasal Irrigation as an Adjunctive Treatment in Allergic Rhinitis: A Systematic Review and Meta-Analysis.” American Journal of Rhinology & Allergy 26, no. 5 (2012): e119-e125. DOI: 10.2500/ajra.2012.26.3787.

  60. Jonathan S. Yoder et al. “Primary Amebic Meningoencephalitis Deaths Associated with Sinus Irrigation Using Contaminated Tap Water.” Clinical Infectious Diseases 55, no. 9 (2012): e79-e85. DOI: 10.1093/cid/cis626.

  61. Macario Camacho et al. “Nasal Dilators for Snoring and OSA: A Systematic Review and Meta-Analysis.” Pulmonary Medicine 2016 (2016): 4841310. DOI: 10.1155/2016/4841310.

  62. Jared Rhee et al. “Breaking Social Media Fads and Uncovering the Safety and Efficacy of Mouth Taping in Patients with Mouth Breathing, Sleep Disordered Breathing, or Obstructive Sleep Apnea: A Systematic Review.” PLOS ONE 20, no. 5 (2025): e0323643. DOI: 10.1371/journal.pone.0323643.

  63. Alfredo Cignarelli et al. “Effects of CPAP on Testosterone Levels in Patients with Obstructive Sleep Apnea: A Meta-Analysis Study.” Frontiers in Endocrinology 10 (2019): 551. DOI: 10.3389/fendo.2019.00551.

  64. Timothy M. Brown. “Melanopic Illuminance Defines the Magnitude of Human Circadian Light Responses under a Wide Range of Conditions.” Journal of Pineal Research 69, no. 1 (2020): e12655. DOI: 10.1111/jpi.12655.

  65. P. Michael Iuvone et al. “Light Stimulates Tyrosine Hydroxylase Activity and Dopamine Synthesis in Retinal Amacrine Neurons.” Science 202, no. 4370 (1978): 901-902. DOI: 10.1126/science.30997.

  66. Georgi Dinkov. “Lack of Light Exposure May Be the Main Cause of the Myopia Boom.” Official website, October 10, 2019.

  67. Shlomo Melmed et al. “Diagnosis and Treatment of Hyperprolactinemia: An Endocrine Society Clinical Practice Guideline.” Journal of Clinical Endocrinology & Metabolism 96, no. 2 (2011): 273-288. DOI: 10.1210/jc.2010-1692.

  68. M. Mikhaylova et al. “The Effects of Ladasten on Dopaminergic Neurotransmission and Hippocampal Synaptic Plasticity in Rats.” Neuropharmacology 53, no. 5 (2007): 601-608. DOI: 10.1016/j.neuropharm.2007.07.001.

  69. T. V. Grekhova et al. “Effect of Bromantane, a New Immunostimulating Agent with Psychostimulating Activity, on the Release and Metabolism of Dopamine in the Striatum of Freely Moving Rats: A Microdialysis Study.” Bulletin of Experimental Biology and Medicine 119, no. 3 (1995): 294-296. DOI: 10.1007/BF02445840.

  70. Yu. V. Vakhitova et al. “cDNA Macroarray Analysis of Gene Expression Changes in Rat Brain after a Single Administration of a 2-Aminoadamantane Derivative.” Molecular Biology 39, no. 2 (2005): 244-252. DOI: 10.1007/s11008-005-0035-7.

  71. Sergiy Oliynyk and Seikwan Oh. “The Pharmacology of Actoprotectors: Practical Application for Improvement of Mental and Physical Performance.” Biomolecules & Therapeutics 20, no. 5 (2012): 446-456. DOI: 10.4062/biomolther.2012.20.5.446.

  72. Daniele Santi et al. “Seasonal Changes of Serum Gonadotropins and Testosterone in Men Revealed by a Large Data Set of Real-World Observations Over Nine Years.” Frontiers in Endocrinology 10 (2019): 914. DOI: 10.3389/fendo.2019.00914.

  73. T. Zornitzki et al. “Seasonal Variation of Testosterone Levels in a Large Cohort of Men.” International Journal of Endocrinology 2022 (2022): 6093092. DOI: 10.1155/2022/6093092.

  74. Laura M. Rossow et al. “Natural Bodybuilding Competition Preparation and Recovery: A 12-Month Case Study.” International Journal of Sports Physiology and Performance 8, no. 5 (2013): 582-592. DOI: 10.1123/ijspp.8.5.582.

  75. Karsten Koehler et al. “Low Energy Availability in Exercising Men Is Associated with Reduced Leptin and Insulin but Not with Changes in Other Metabolic Hormones.” Journal of Sports Sciences 34, no. 20 (2016): 1921-1929. DOI: 10.1080/02640414.2016.1142109.

  76. Ivan Jurov et al. “Reducing Energy Availability in Male Endurance Athletes: A Randomized Trial with a Three-Step Energy Reduction.” Journal of the International Society of Sports Nutrition 19, no. 1 (2022): 179-195. DOI: 10.1080/15502783.2022.2065111.

  77. Alexiaa Sim, Hui Qing Tan, Yusuf Ali, and Stephen F. Burns. “Original Investigation: Manipulating Energy Availability in Male Endurance Runners: A Randomised Controlled Trial.” Applied Physiology, Nutrition, and Metabolism 49, no. 9 (2024): 1163-1174. DOI: 10.1139/apnm-2024-0037.

  78. Joseph Whittaker and Kexin Wu. “Low-Fat Diets and Testosterone in Men: Systematic Review and Meta-Analysis of Intervention Studies.” Journal of Steroid Biochemistry and Molecular Biology 210 (2021): 105878. DOI: 10.1016/j.jsbmb.2021.105878.

  79. Sahar Soltani et al. “The Effect of Low-Fat Diets Versus High-Fat Diet on Sex Hormones: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.” Journal of Food Science 90, no. 5 (2025): e70266. DOI: 10.1111/1750-3841.70266.

  80. Ray Peat. “Fatigue, Aging, and Recuperation.” RayPeat.com.

  81. Ray Peat. “Fats and Degeneration.” 2009. RayPeat.com.

  82. Ray Peat. “Gelatin, Stress, Longevity.” RayPeat.com.

  83. Mathis Grossmann. “Hypogonadism and Male Obesity: Focus on Unresolved Questions.” Clinical Endocrinology 89, no. 1 (2018): 11-21. DOI: 10.1111/cen.13723.

  84. Giovanni Corona et al. “Body Weight Loss Reverts Obesity-Associated Hypogonadotropic Hypogonadism: A Systematic Review and Meta-Analysis.” European Journal of Endocrinology 168, no. 6 (2013): 829-843. DOI: 10.1530/EJE-12-0955.

  85. Walter L. Miller and Richard J. Auchus. “The Molecular Biology, Biochemistry, and Physiology of Human Steroidogenesis and Its Disorders.” Endocrine Reviews 32, no. 1 (2011): 81-151. DOI: 10.1210/er.2010-0013.

  86. Barry R. Zirkin and Vassilios Papadopoulos. “Leydig Cells: Formation, Function, and Regulation.” Biology of Reproduction 99, no. 1 (2018): 101-111. DOI: 10.1093/biolre/ioy059.

  87. Federico Pietrocola et al. “Acetyl Coenzyme A: A Central Metabolite and Second Messenger.” Cell Metabolism 21, no. 6 (2015): 805-821. DOI: 10.1016/j.cmet.2015.05.014.

  88. Joseph L. Goldstein and Michael S. Brown. “Regulation of the Mevalonate Pathway.” Nature 343 (1990): 425-430. DOI: 10.1038/343425a0.

  89. Niels A. Graudal, Thorbjørn Hubeck-Graudal, and Gesche Jürgens. “Effects of Low Sodium Diet versus High Sodium Diet on Blood Pressure, Renin, Aldosterone, Catecholamines, Cholesterol, and Triglyceride.” Cochrane Database of Systematic Reviews 12 (2020): CD004022. DOI: 10.1002/14651858.CD004022.pub5.

  90. Ray Peat. “Salt, Energy, Metabolic Rate, and Longevity.” RayPeat.com.

  91. Angela X. Chen et al. “Dietary Sodium Intake and Cortisol Measurements.” Clinical Endocrinology 93, no. 5 (2020): 539-545. DOI: 10.1111/cen.14262.

  92. Derrick Lonsdale. “A Review of the Biochemistry, Metabolism and Clinical Benefits of Thiamin(e) and Its Derivatives.” Evidence-Based Complementary and Alternative Medicine 3, no. 1 (2006): 49-59. DOI: 10.1093/ecam/nek009.

  93. Cristian Díaz-Muñoz et al. “Genetic Dissection of Stool Frequency Implicates Vitamin B1 Metabolism and Other Actionable Pathways in the Modulation of Gut Motility.” Gut (2026). DOI: 10.1136/gutjnl-2025-337059.

  94. Georgi Dinkov. “Vitamin B1 (Thiamine) May Improve Gut Motility and Relieve Constipation/IBS.” Official website, May 24, 2026.

  95. Georgi Dinkov. “Increased Fat Oxidation (FAO) Sufficient to Cause Senescence/Aging/Disease.” Official website, November 1, 2024.

  96. Georgi Dinkov. “Low Energy Production (Glucose Metabolism) May Cause Andropause.” Official website, November 3, 2020.

  97. Wataru Yamadera et al. “Glycine Ingestion Improves Subjective Sleep Quality in Human Volunteers, Correlating with Polysomnographic Changes.” Sleep and Biological Rhythms 5, no. 2 (2007): 126-131. DOI: 10.1111/j.1479-8425.2007.00262.x.

  98. Amanda Bulman et al. “The Effects of L-Theanine Consumption on Sleep Outcomes: A Systematic Review and Meta-Analysis.” Sleep Medicine Reviews 81 (2025): 102076. DOI: 10.1016/j.smrv.2025.102076.

  99. Eunsoo Moon et al. “Melatonergic Agents Influence the Sleep-Wake and Circadian Rhythms in Healthy and Psychiatric Participants: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.” Neuropsychopharmacology 47, no. 8 (2022): 1523-1536. DOI: 10.1038/s41386-022-01278-5.

  100. N. D. Goncharova, B. Kh. Khavinson, and B. A. Lapin. “Regulatory Effect of Epithalon on Production of Melatonin and Cortisol in Old Monkeys.” Bulletin of Experimental Biology and Medicine 131, no. 4 (2001): 394-396. DOI: 10.1023/A:1017928925177.

  101. Szymon Kamil Araj et al. “Overview of Epitalon: Highly Bioactive Pineal Tetrapeptide with Promising Properties.” International Journal of Molecular Sciences 26, no. 6 (2025): 2691. DOI: 10.3390/ijms26062691.

  102. S. Maria O’Kane et al. “Micronutrients, Iodine Status and Concentrations of Thyroid Hormones: A Systematic Review.” Nutrition Reviews 76, no. 6 (2018): 418-431. DOI: 10.1093/nutrit/nuy008.

  103. Jessica Farebrother, Michael B. Zimmermann, and Maria Andersson. “Excess Iodine Intake: Sources, Assessment, and Effects on Thyroid Function.” Annals of the New York Academy of Sciences 1446, no. 1 (2019): 44-65. DOI: 10.1111/nyas.14041.

  104. Camilla Bøgelund Larsen et al. “Selenium Supplementation and Placebo Are Equally Effective in Improving Quality of Life in Patients with Hypothyroidism.” European Thyroid Journal 13, no. 1 (2024). DOI: 10.1530/ETJ-23-0175.

  105. Maurizio Nordio and Raffaella Pajalich. “Combined Treatment with Myo-Inositol and Selenium Ensures Euthyroidism in Subclinical Hypothyroidism Patients with Autoimmune Thyroiditis.” Journal of Thyroid Research 2013 (2013): 424163. DOI: 10.1155/2013/424163.

  106. Doaa El Amrousy et al. “Lactoferrin for Iron-Deficiency Anemia in Children with Inflammatory Bowel Disease: A Clinical Trial.” Pediatric Research 92, no. 3 (2022): 762-766. DOI: 10.1038/s41390-022-02136-2.

  107. Huma Bokkhim et al. “Physico-Chemical Properties of Different Forms of Bovine Lactoferrin.” Food Chemistry 141, no. 3 (2013): 3007-3013. DOI: 10.1016/j.foodchem.2013.05.139.

  108. Dominik Kappeler et al. “Higher Bioavailability of Magnesium Citrate as Compared to Magnesium Oxide Shown by Evaluation of Urinary Excretion and Serum Levels after Single-Dose Administration in a Randomized Cross-Over Study.” BMC Nutrition 3 (2017): 7. DOI: 10.1186/s40795-016-0121-3.

  109. Uwe Gröber et al. “Myth or Reality: Transdermal Magnesium?” Nutrients 9, no. 8 (2017): 813. DOI: 10.3390/nu9080813.

  110. Arman Arab et al. “The Role of Magnesium in Sleep Health: A Systematic Review of Available Literature.” Biological Trace Element Research 201, no. 1 (2023): 121-128. DOI: 10.1007/s12011-022-03162-1.

  111. Emma A. Vermeulen and Marc G. Vervloet. “Magnesium Administration in Chronic Kidney Disease.” Nutrients 15, no. 3 (2023): 547. DOI: 10.3390/nu15030547.

  112. Asagi Ito et al. “Menaquinone-4 Enhances Testosterone Production in Rats and Testis-Derived Tumor Cells.” Lipids in Health and Disease 10 (2011): 158. DOI: 10.1186/1476-511X-10-158.

  113. Stephen Schaffer, K. Takahashi, and Junichi Azuma. “Role of Osmoregulation in the Actions of Taurine.” Amino Acids 19, nos. 3-4 (2000): 527-546. DOI: 10.1007/s007260070004.

  114. Vladimir Khavinson et al. “EDR Peptide: Possible Mechanism of Gene Expression and Protein Synthesis Regulation Involved in the Pathogenesis of Alzheimer’s Disease.” Molecules 26, no. 1 (2021): 159. DOI: 10.3390/molecules26010159.

  115. Yi Wen et al. “Alternative Mitochondrial Electron Transfer as a Novel Strategy for Neuroprotection.” Journal of Biological Chemistry 286, no. 18 (2011): 16504-16515. DOI: 10.1074/jbc.M110.208447.

  116. R. R. Ramsay, C. Dunford, and P. K. Gillman. “Methylene Blue and Serotonin Toxicity: Inhibition of Monoamine Oxidase A Confirms a Theoretical Prediction.” British Journal of Pharmacology 152, no. 6 (2007): 946-951. DOI: 10.1038/sj.bjp.0707430.

  117. J. Néto et al. “Zinc: An Inhibitor of Prolactin Secretion in Humans.” Hormone and Metabolic Research 21, no. 4 (1989): 203-206. DOI: 10.1055/s-2007-1009191.

  118. Barbara Cellini et al. “Biochemical and Computational Approaches to Improve the Clinical Treatment of Dopa Decarboxylase-Related Diseases: An Overview.” Open Biochemistry Journal 6, no. 1 (2012): 131-138. DOI: 10.2174/1874091X01206010131.

  119. “Pyridoxine (B6) Suppresses the Rise in Prolactin and Increases the Rise in Growth Hormone Induced by Exercise.” New England Journal of Medicine 307, no. 7 (1982): 444-445. DOI: 10.1056/NEJM198208123070719.

  120. E. N. McIntosh. “Treatment of Women with the Galactorrhea-Amenorrhea Syndrome with Pyridoxine (Vitamin B6).” Journal of Clinical Endocrinology & Metabolism 42, no. 6 (1976): 1192-1195. DOI: 10.1210/jcem-42-6-1192.

  121. Allen M. Spiegel et al. “Effect of Intravenous Pyridoxine on Plasma Prolactin in Hyperprolactinemic Subjects.” Journal of Clinical Endocrinology & Metabolism 46, no. 4 (1978): 686-688. DOI: 10.1210/jcem-46-4-686.

  122. Raman Muhamad et al. “The Role of Vitamin B6 in Peripheral Neuropathy: A Systematic Review.” Nutrients 15, no. 13 (2023): 2823. DOI: 10.3390/nu15132823.

  123. Yue Zhao et al. “The Role of Retinoic Acid in Spermatogenesis and Its Application in Male Reproduction.” Cells 13, no. 13 (2024): 1092. DOI: 10.3390/cells13131092.

  124. María L. Pestalardo, Cecilia S. Bevilacqua, and Marcelo Fabián Amante. “Vitamin A Toxicity and Hepatic Pathology: A Comprehensive Review.” World Journal of Hepatology 17, no. 8 (2025): 107738. DOI: 10.4254/wjh.v17.i8.107738.

  125. Ray Peat. “Vitamin E: Estrogen Antagonist, Energy Promoter, and Anti-Inflammatory.” RayPeat.com.

  126. M. Yeksan et al. “Effect of Vitamin E Therapy on Sexual Functions of Uremic Patients in Hemodialysis.” International Journal of Artificial Organs 15, no. 11 (1992): 648-652. DOI: 10.1177/039139889201501105.

  127. Firoozeh Tarkesh et al. “Beneficial Health Effects of Menaquinone-7 on Body Composition, Glycemic Indices, Lipid Profile, and Endocrine Markers in Polycystic Ovary Syndrome Patients.” Food Science & Nutrition 8, no. 10 (2020): 5612-5621. DOI: 10.1002/fsn3.1837.

  128. Marie-Liesse Piketty et al. “High-Dose Biotin Therapy Leading to False Biochemical Endocrine Profiles: Validation of a Simple Method to Overcome Biotin Interference.” Clinical Chemistry and Laboratory Medicine 55, no. 6 (2017): 817-825. DOI: 10.1515/cclm-2016-1183.

  129. A. Mahmood et al. “Zinc Carnosine, a Health Food Supplement That Stabilises Small Bowel Integrity and Stimulates Gut Repair Processes.” Gut 56, no. 2 (2007): 168-175. DOI: 10.1136/gut.2006.099929.

  130. Tomoji Ono et al. “Potent Anti-Obesity Effect of Enteric-Coated Lactoferrin: Decrease in Visceral Fat Accumulation in Japanese Men and Women with Abdominal Obesity after 8-Week Administration of Enteric-Coated Lactoferrin Tablets.” British Journal of Nutrition 104, no. 11 (2010): 1688-1695. DOI: 10.1017/S0007114510002734.

  131. Lei Liu et al. “Riboflavin Supplementation Promotes Butyrate Production in the Absence of Gross Compositional Changes in the Gut Microbiota.” Antioxidants & Redox Signaling 38, nos. 4-6 (2023): 282-297. DOI: 10.1089/ars.2022.0033.

  132. T. Banasiewicz et al. “Microencapsulated Sodium Butyrate Reduces the Frequency of Abdominal Pain in Patients with Irritable Bowel Syndrome.” Colorectal Disease 15, no. 2 (2013): 204-209. DOI: 10.1111/j.1463-1318.2012.03152.x.

  133. Hania Szajewska and Marek Kołodziej. “Systematic Review with Meta-Analysis: Saccharomyces boulardii in the Prevention of Antibiotic-Associated Diarrhoea.” Alimentary Pharmacology & Therapeutics 42, no. 7 (2015): 793-801. DOI: 10.1111/apt.13344.

  134. C. Hennequin et al. “Possible Role of Catheters in Saccharomyces boulardii Fungemia.” European Journal of Clinical Microbiology & Infectious Diseases 19, no. 1 (2000): 16-20. DOI: 10.1007/s100960050003.

  135. H. Gang et al. “Impact of Heyndrickxia (Bacillus) coagulans GBI-30, 6086 (BC30) Probiotic on Gastrointestinal Function in Healthy Adults: A Randomised Controlled Trial.” Beneficial Microbes 17, no. 1 (2025): 29-46. DOI: 10.1163/18762891-bja00084.

  136. Theofilos Poutahidis et al. “Probiotic Microbes Sustain Youthful Serum Testosterone Levels and Testicular Size in Aging Mice.” PLOS ONE 9, no. 1 (2014): e84877. DOI: 10.1371/journal.pone.0084877.

  137. Lennart Ljunggren et al. “Effects of Probiotic Supplementation on Testosterone Levels in Healthy Ageing Men: A 12-Week Double-Blind, Placebo-Controlled Randomized Clinical Trial.” Contemporary Clinical Trials Communications 39 (2024): 101300. DOI: 10.1016/j.conctc.2024.101300.

  138. Masafumi Noda et al. “Effect of Probiotic Limosilactobacillus reuteri on a Serum Sex-Hormone- and Metabolic-Syndrome-Related Health Evaluation: A Single-Arm Open-Label Pilot Study.” Bioscience of Microbiota, Food and Health 45, no. 1 (2026): 42-50. DOI: 10.12938/bmfh.2025-020.

  139. Joon Lee et al. “Characterization of the Anti-Inflammatory Lactobacillus reuteri BM36301 and Its Probiotic Benefits on Aged Mice.” BMC Microbiology 16 (2016): 69. DOI: 10.1186/s12866-016-0686-7.

  140. G. Riezzo et al. “Randomised Double Blind Placebo Controlled Trial on Lactobacillus reuteri DSM 17938: Improvement in Symptoms and Bowel Habit in Functional Constipation.” Beneficial Microbes 9, no. 1 (2018): 51-60. DOI: 10.3920/BM2017.0049.

  141. Mitchell L. Jones et al. “Cholesterol-Lowering Efficacy of a Microencapsulated Bile Salt Hydrolase-Active Lactobacillus reuteri NCIMB 30242 Yoghurt Formulation in Hypercholesterolaemic Adults.” British Journal of Nutrition 107, no. 10 (2012): 1505-1513. DOI: 10.1017/S0007114511004703.

  142. Marziyeh Rahimiyan-Heravan et al. “The Potential Therapeutic Effects of Lactobacillus plantarum and Inulin on Serum and Testicular Reproductive Markers in Diabetic Male Rats.” Diabetology & Metabolic Syndrome 12 (2020): 53. DOI: 10.1186/s13098-020-00560-0.

  143. Gülay Çiftci and Elif Tuna. “Effects of Cholesterol and Lactobacillus acidophilus on Testicular Function.” Clinical and Experimental Reproductive Medicine 48, no. 3 (2021): 229-235. DOI: 10.5653/cerm.2020.04322.

  144. Fereshteh Dardmeh et al. “Lactobacillus rhamnosus PB01 (DSM 14870) Supplementation Affects Markers of Sperm Kinematic Parameters in a Diet-Induced Obesity Mice Model.” PLOS ONE 12, no. 10 (2017): e0185964. DOI: 10.1371/journal.pone.0185964.

  145. Heba Abdel-Aziz et al. “Mode of Action of Gingerols and Shogaols on 5-HT3 Receptors: Binding Studies, Cation Uptake by the Receptor Channel and Contraction of Isolated Guinea-Pig Ileum.” European Journal of Pharmacology 530, nos. 1-2 (2006): 136-143. DOI: 10.1016/j.ejphar.2005.10.049.

  146. Keng-Liang Wu et al. “Effects of Ginger on Gastric Emptying and Motility in Healthy Humans.” European Journal of Gastroenterology & Hepatology 20, no. 5 (2008): 436-440. DOI: 10.1097/MEG.0b013e3282f4b224.

  147. M. Kolahdooz et al. “Effects of Nigella sativa L. Seed Oil on Abnormal Semen Quality in Infertile Men: A Randomized, Double-Blind, Placebo-Controlled Clinical Trial.” Phytomedicine 21, no. 6 (2014): 901-905. DOI: 10.1016/j.phymed.2014.02.006.

  148. Shoukath M. Ali et al. “Thymoquinone with Metformin Decreases Fasting, Post Prandial Glucose, and HbA1c in Type 2 Diabetic Patients.” Drug Research 71, no. 6 (2021): 302-306. DOI: 10.1055/a-1388-5415.

  149. Carol Angela Howell et al. “Double-Blinded Randomised Placebo Controlled Trial of Enterosgel for the Treatment of IBS with Diarrhoea.” Gut 71, no. 12 (2022): 2430-2438. DOI: 10.1136/gutjnl-2022-327293.

  150. Faouzi Khediri et al. “Efficacy of Diosmectite in the Treatment of Acute Watery Diarrhoea in Adults: A Multicentre, Randomized, Double-Blind, Placebo-Controlled, Parallel Group Study.” Gastroenterology Research and Practice 2011 (2011): 783196. DOI: 10.1155/2011/783196.

  151. Tobias Zellner et al. “The Use of Activated Charcoal to Treat Intoxications.” Deutsches Ärzteblatt International 116 (2019): 311-317. DOI: 10.3238/arztebl.2019.0311.

  152. Marleen Kars et al. “Tauroursodeoxycholic Acid May Improve Liver and Muscle but Not Adipose Tissue Insulin Sensitivity in Obese Men and Women.” Diabetes 59, no. 8 (2010): 1899-1905. DOI: 10.2337/db10-0308.

  153. Alan L. Buchman et al. “Choline Deficiency Causes Reversible Hepatic Abnormalities in Patients Receiving Parenteral Nutrition: Proof of a Human Choline Requirement: A Placebo-Controlled Trial.” Journal of Parenteral and Enteral Nutrition 25, no. 5 (2001): 260-268. DOI: 10.1177/0148607101025005260.

  154. Umar Hayat et al. “The Effect of Coffee Consumption on Non-Alcoholic Fatty Liver Disease and Liver Fibrosis: A Meta-Analysis of 11 Epidemiological Studies.” Annals of Hepatology 20 (2021): 100254. DOI: 10.1016/j.aohep.2020.08.071.

  155. Emilia Zawieja et al. “Betaine Supplementation Improves CrossFit Performance and Increases Testosterone Levels, but Has No Influence on Wingate Power: Randomized Crossover Trial.” Journal of the International Society of Sports Nutrition 20, no. 1 (2023): 2231411. DOI: 10.1080/15502783.2023.2231411.

  156. Hamid Arazi et al. “Effects of Short-Term Betaine Supplementation on Muscle Endurance and Indices of Endocrine Function Following Acute High-Intensity Resistance Exercise in Young Athletes.” Journal of the International Society of Sports Nutrition 19, no. 1 (2022): 1-16. DOI: 10.1080/15502783.2022.2041988.

  157. Hadi Nobari et al. “The Effects of 14-Week Betaine Supplementation on Endocrine Markers, Body Composition and Anthropometrics in Professional Youth Soccer Players: A Double Blind, Randomized, Placebo-Controlled Trial.” Journal of the International Society of Sports Nutrition 18, no. 1 (2021): 20. DOI: 10.1186/s12970-021-00417-5.

  158. Ana Maria Grizales et al. “Metabolic Effects of Betaine: A Randomized Clinical Trial of Betaine Supplementation in Prediabetes.” Journal of Clinical Endocrinology & Metabolism 103, no. 8 (2018): 3038-3049. DOI: 10.1210/jc.2018-00507.

  159. Margreet R. Olthof et al. “Effect of Homocysteine-Lowering Nutrients on Blood Lipids: Results from Four Randomised, Placebo-Controlled Studies in Healthy Humans.” PLOS Medicine 2, no. 5 (2005): e135. DOI: 10.1371/journal.pmed.0020135.

  160. Joseph Larner, David L. Brautigan, and Michael O. Thorner. “D-Chiro-Inositol Glycans in Insulin Signaling and Insulin Resistance.” Molecular Medicine 16, no. 11-12 (2010): 543-552. DOI: 10.2119/molmed.2010.00107.

  161. Sandro Sacchi et al. “Modulation of Gonadotrophin Induced Steroidogenic Enzymes in Granulosa Cells by D-Chiroinositol.” Reproductive Biology and Endocrinology 14 (2016): 52. DOI: 10.1186/s12958-016-0189-2.

  162. Giovanni Monastra et al. “D-Chiro-Inositol, an Aromatase Down-Modulator, Increases Androgens and Reduces Estrogens in Male Volunteers: A Pilot Study.” Basic and Clinical Andrology 31 (2021): 13. DOI: 10.1186/s12610-021-00131-x.

  163. Maurizio Nordio et al. “D-Chiro-Inositol Improves Testosterone Levels in Older Hypogonadal Men with Low-Normal Testosterone: A Pilot Study.” Basic and Clinical Andrology 31 (2021): 28. DOI: 10.1186/s12610-021-00146-4.

  164. Aldo E. Calogero et al. “Myoinositol Improves Sperm Parameters and Serum Reproductive Hormones in Patients with Idiopathic Infertility: A Prospective Double-Blind Randomized Placebo-Controlled Study.” Andrology 3, no. 3 (2015): 491-495. DOI: 10.1111/andr.12025.

  165. Mohammad Reza Safarinejad and Shiva Safarinejad. “Efficacy of Selenium and/or N-Acetyl-Cysteine for Improving Semen Parameters in Infertile Men: A Double-Blind, Placebo Controlled, Randomized Study.” Journal of Urology 181, no. 2 (2009): 741-751. DOI: 10.1016/j.juro.2008.10.015.

  166. Ahmed Higazy et al. “Evaluation of Monotherapy of Coenzyme Q10, L-Carnitine or Combined Therapy on Semen Parameters in Idiopathic Male Infertility: A Placebo-Controlled Double Blind Randomized Clinical Trial.” Arab Journal of Urology 24, no. 1 (published online 2025): 68-74. DOI: 10.1080/20905998.2025.2509424.

  167. Sava Micic et al. “Double-Blind, Randomised, Placebo-Controlled Trial on the Effect of L-Carnitine and L-Acetylcarnitine on Sperm Parameters in Men with Idiopathic Oligoasthenozoospermia.” Andrologia 51, no. 6 (2019): e13267. DOI: 10.1111/and.13267.

  168. Anne Z. Steiner et al. “The Effect of Antioxidants on Male Factor Infertility: The Males, Antioxidants, and Infertility Randomized Clinical Trial.” Fertility and Sterility 113, no. 3 (2020): 552-560.e3. DOI: 10.1016/j.fertnstert.2019.11.008.

  169. N. N. Sevostianova et al. “Immunomodulating Effects of Vilon and Its Analogue in the Culture of Human and Animal Thymus Cells.” Bulletin of Experimental Biology and Medicine 154, no. 4 (2013): 562-565. DOI: 10.1007/s10517-013-2000-0.

  170. Iris Erlund et al. “Plasma Kinetics and Urinary Excretion of the Flavanones Naringenin and Hesperetin in Humans after Ingestion of Orange Juice and Grapefruit Juice.” Journal of Nutrition 131, no. 2 (2001): 235-241. DOI: 10.1093/jn/131.2.235.

  171. Y. C. Kao et al. “Molecular Basis of the Inhibition of Human Aromatase (Estrogen Synthetase) by Flavone and Isoflavone Phytoestrogens: A Site-Directed Mutagenesis Study.” Environmental Health Perspectives 106, no. 2 (1998): 85-92. DOI: 10.1289/ehp.9810685.

  172. Katie M. Edmunds et al. “The Effects of Dietary Phytoestrogens on Aromatase Activity in Human Endometrial Stromal Cells.” Reproduction Nutrition Development 45, no. 6 (2005): 709-720. DOI: 10.1051/rnd:2005055.

  173. Lan Ye et al. “The Citrus Flavanone Hesperetin Inhibits Growth of Aromatase-Expressing MCF-7 Tumor in Ovariectomized Athymic Mice.” Journal of Nutritional Biochemistry 23, no. 10 (2012): 1230-1237. DOI: 10.1016/j.jnutbio.2011.07.003.

  174. Ray Peat. “Natural Estrogens.” RayPeat.com.

  175. J. Robertson et al. “The Effect of Raw Carrot on Serum Lipids and Colon Function.” American Journal of Clinical Nutrition 32, no. 9 (1979): 1889-1892. DOI: 10.1093/ajcn/32.9.1889.

  176. Elisabeth Wisker et al. “Fibre-Mediated Physiological Effects of Raw and Processed Carrots in Humans.” British Journal of Nutrition 72, no. 4 (1994): 579-599. DOI: 10.1079/BJN19940061.

  177. Sherwood L. Gorbach and Barry R. Goldin. “Diet and the Excretion and Enterohepatic Cycling of Estrogens.” Preventive Medicine 16, no. 4 (1987): 525-531. DOI: 10.1016/0091-7435(87)90067-3.

  178. S. J. Lewis et al. “Lower Serum Oestrogen Concentrations Associated with Faster Intestinal Transit.” British Journal of Cancer 76, no. 3 (1997): 395-400. DOI: 10.1038/bjc.1997.397.

  179. Baiba J. Grube et al. “White Button Mushroom Phytochemicals Inhibit Aromatase Activity and Breast Cancer Cell Proliferation.” Journal of Nutrition 131, no. 12 (2001): 3288-3293. DOI: 10.1093/jn/131.12.3288.

  180. Shiuan Chen et al. “Anti-Aromatase Activity of Phytochemicals in White Button Mushrooms (Agaricus bisporus).” Cancer Research 66, no. 24 (2006): 12026-12034. DOI: 10.1158/0008-5472.CAN-06-2206.

  181. Przemyslaw Twardowski et al. “A Phase I Trial of Mushroom Powder in Patients with Biochemically Recurrent Prostate Cancer: Roles of Cytokines and Myeloid-Derived Suppressor Cells for Agaricus bisporus-Induced Prostate-Specific Antigen Responses.” Cancer 121, no. 17 (2015): 2942-2950. DOI: 10.1002/cncr.29421.

  182. V. Schulzová et al. “Influence of Storage and Household Processing on the Agaritine Content of the Cultivated Agaricus Mushroom.” Food Additives and Contaminants 19, no. 9 (2002): 853-862. DOI: 10.1080/02652030210156340.

  183. Eun-Jin Park and Deok-Young Jhon. “Effects of Bamboo Shoot Consumption on Lipid Profiles and Bowel Function in Healthy Young Women.” Nutrition 25, nos. 7-8 (2009): 723-728. DOI: 10.1016/j.nut.2009.01.007.

  184. Guillermo Federico Padilla-González et al. “Cyanogenic Derivatives as Chemical Markers for the Authentication of Commercial Products of Bamboo Shoots.” Journal of Agricultural and Food Chemistry 69, no. 34 (2021): 9915-9923. DOI: 10.1021/acs.jafc.1c02947.

  185. Joshua C. Pelland et al. “The Resistance Training Dose Response: Meta-Regressions Exploring the Effects of Weekly Volume and Frequency on Muscle Hypertrophy and Strength Gains.” Sports Medicine 56, no. 2 (2026): 481-505. DOI: 10.1007/s40279-025-02344-w.

  186. Anthony C. Hackney. “Hypogonadism in Exercising Males: Dysfunction or Adaptive-Regulatory Adjustment?” Frontiers in Endocrinology 11 (2020): 11. DOI: 10.3389/fendo.2020.00011.

  187. Jan Stutz, Reto Eiholzer, and Christina Spengler. “Effects of Evening Exercise on Sleep in Healthy Participants: A Systematic Review and Meta-Analysis.” Sports Medicine 49, no. 2 (2019): 269-287. DOI: 10.1007/s40279-018-1015-0.

  188. Ray Peat. “TSH, Temperature, Pulse Rate, and Other Indicators in Hypothyroidism.” RayPeat.com.

  189. Gerasimos E. Krassas, Kris Poppe, and Daniel Glinoer. “Thyroid Function and Human Reproductive Health.” Endocrine Reviews 31, no. 5 (2010): 702-755. DOI: 10.1210/er.2009-0041.

  190. Jayakumar S. Ambigapathy et al. “Effect of Thyroxine Replacement on Leydig Cell and Sertoli Cell Function in Men with Hypothyroidism.” Indian Journal of Endocrinology and Metabolism 24, no. 3 (2020): 265-269. DOI: 10.4103/ijem.IJEM_69_20.

  191. Luigi Bartalena and Jacob Robbins. “Variations in Thyroid Hormone Transport Proteins and Their Clinical Implications.” Thyroid 2, no. 3 (1992): 237-245. DOI: 10.1089/thy.1992.2.237.

  192. Antonio C. Bianco et al. “Biochemistry, Cellular and Molecular Biology, and Physiological Roles of the Iodothyronine Selenodeiodinases.” Endocrine Reviews 23, no. 1 (2002): 38-89. DOI: 10.1210/edrv.23.1.0455.

  193. W. Edward Visser, Edith C. H. Friesema, Jurgen Jansen, and Theo J. Visser. “Thyroid Hormone Transport in and Out of Cells.” Trends in Endocrinology & Metabolism 19, no. 2 (2008): 50-56. DOI: 10.1016/j.tem.2007.11.003.

  194. Jacques Young et al. “Effects of Human Recombinant Luteinizing Hormone and Follicle-Stimulating Hormone in Patients with Acquired Hypogonadotropic Hypogonadism: Study of Sertoli and Leydig Cell Secretions and Interactions.” Journal of Clinical Endocrinology & Metabolism 85, no. 9 (2000): 3239-3244. DOI: 10.1210/jcem.85.9.6811.

  195. K. Skorupskaite, J. T. George, and R. A. Anderson. “The Kisspeptin-GnRH Pathway in Human Reproductive Health and Disease.” Human Reproduction Update 20, no. 4 (2014): 485-500. DOI: 10.1093/humupd/dmu009.

  196. J. T. George et al. “Kisspeptin-10 Is a Potent Stimulator of LH and Increases Pulse Frequency in Men.” Journal of Clinical Endocrinology & Metabolism 96, no. 8 (2011): E1228-E1236. DOI: 10.1210/jc.2011-0089.

  197. Frederick C. W. Wu et al. “Characteristics of Secondary, Primary, and Compensated Hypogonadism in Aging Men: Evidence from the European Male Ageing Study.” Journal of Clinical Endocrinology & Metabolism 95, no. 4 (2010): 1810-1818. DOI: 10.1210/jc.2009-1796.

  198. Ray Peat. “Menopause and Its Causes.” RayPeat.com, 1997.

  199. Melanie Y. Roth et al. “Serum LH Correlates Highly with Intratesticular Steroid Levels in Normal Men.” Journal of Andrology 31, no. 2 (2010): 138-145. DOI: 10.2164/jandrol.109.008391.

  200. Andrea D. Coviello et al. “Low-Dose Human Chorionic Gonadotropin Maintains Intratesticular Testosterone in Normal Men with Testosterone-Induced Gonadotropin Suppression.” Journal of Clinical Endocrinology & Metabolism 90, no. 5 (2005): 2595-2602. DOI: 10.1210/jc.2004-0802.

  201. Veeravich Jaruvongvanich et al. “Testosterone, Sex Hormone-Binding Globulin and Nonalcoholic Fatty Liver Disease: A Systematic Review and Meta-Analysis.” Annals of Hepatology 16, no. 3 (2017): 382-394. DOI: 10.5604/16652681.1235481.

  202. Dan Li et al. “3β-Hydroxysteroid Dehydrogenase Expressed by Gut Microbes Degrades Testosterone and Is Linked to Depression in Males.” Cell Host & Microbe 30, no. 3 (2022): 329-339.e5. DOI: 10.1016/j.chom.2022.01.001.

  203. Henry B. Bosmann et al. “Acute In Vivo Inhibition of Testosterone by Endotoxin Parallels Loss of Steroidogenic Acute Regulatory (StAR) Protein in Leydig Cells.” Endocrinology 137, no. 10 (1996): 4522-4525. DOI: 10.1210/endo.137.10.8828518.

  204. Kelton Tremellen, Natalie McPhee, and Karma Pearce. “Metabolic Endotoxaemia Related Inflammation Is Associated with Hypogonadism in Overweight Men.” Basic and Clinical Andrology 27 (2017): 5. DOI: 10.1186/s12610-017-0049-8.

  205. Na Liu et al. “The Mechanism of Secretion and Metabolism of Gut-Derived 5-Hydroxytryptamine.” International Journal of Molecular Sciences 22, no. 15 (2021): 7931. DOI: 10.3390/ijms22157931.

  206. Jessica M. Yano et al. “Indigenous Bacteria from the Gut Microbiota Regulate Host Serotonin Biosynthesis.” Cell 161, no. 2 (2015): 264-276. DOI: 10.1016/j.cell.2015.02.047.

  207. Juan C. Tinajero, Angelo Fabbri, and Maria L. Dufau. “Regulation of Corticotropin-Releasing Factor Secretion from Leydig Cells by Serotonin.” Endocrinology 130, no. 4 (1992): 1780-1788. DOI: 10.1210/endo.130.4.1312425.

  208. Stuart Brody and Tillmann H. C. Krüger. “The Post-Orgasmic Prolactin Increase Following Intercourse Is Greater than Following Masturbation and Suggests Greater Satiety.” Biological Psychology 71, no. 3 (2006): 312-315. DOI: 10.1016/j.biopsycho.2005.06.008.

  209. Nicoletta Cera et al. “How Relevant Is the Systemic Oxytocin Concentration for Human Sexual Behavior? A Systematic Review.” Sexual Medicine 9, no. 4 (2021): 100370. DOI: 10.1016/j.esxm.2021.100370.

  210. Michael S. Carmichael et al. “Plasma Oxytocin Increases in the Human Sexual Response.” Journal of Clinical Endocrinology & Metabolism 64, no. 1 (1987): 27-31. DOI: 10.1210/jcem-64-1-27.

  211. Maria Elena Hernandez-Gonzalez et al. “A Study of the Prostate, Androgens and Sexual Activity of Male Rats.” Reproductive Biology and Endocrinology 5 (2007): 11. DOI: 10.1186/1477-7827-5-11.

  212. G. Magrini et al. “New Aspects of Androgens, Prolactin, and ACTH Interaction in Men.” Archives of Andrology 2, no. 2 (1979): 141-155. DOI: 10.3109/01485017908987306.

  213. M. Takeyama et al. “Stimulatory Effect of Prolactin on Luteinizing Hormone-Induced Testicular 5 Alpha-Reductase Activity in Hypophysectomized Adult Rats.” Endocrinology 118, no. 6 (1986): 2268-2275. DOI: 10.1210/endo-118-6-2268.

  214. Paula Banca et al. “Novelty, Conditioning and Attentional Bias to Sexual Rewards.” Journal of Psychiatric Research 72 (2016): 91-101. DOI: 10.1016/j.jpsychires.2015.10.017.

  215. Valerie Voon et al. “Neural Correlates of Sexual Cue Reactivity in Individuals with and without Compulsive Sexual Behaviours.” PLOS ONE 9, no. 7 (2014): e102419. DOI: 10.1371/journal.pone.0102419.

  216. Tim Jacobs et al. “Associations Between Online Pornography Consumption and Sexual Dysfunction in Young Men: Multivariate Analysis Based on an International Web-Based Survey.” JMIR Public Health and Surveillance 7, no. 10 (2021): e32542. DOI: 10.2196/32542.

  217. Sarah Whirledge and John A. Cidlowski. “Glucocorticoids, Stress, and Fertility.” Minerva Endocrinologica 35, no. 2 (2010): 109-125.

  218. Georgi Dinkov. “Salt Restriction Promotes Stress by Elevating Cortisol.” Official website, June 6, 2024.

  219. Ronald S. Swerdloff et al. “Dihydrotestosterone: Biochemistry, Physiology, and Clinical Implications of Elevated Blood Levels.” Endocrine Reviews 38, no. 3 (2017): 220-254. DOI: 10.1210/er.2016-1067.

  220. Lina Schiffer, Wiebke Arlt, and Karl-Heinz Storbeck. “Intracrine Androgen Biosynthesis, Metabolism and Action Revisited.” Molecular and Cellular Endocrinology 465 (2018): 4-26. DOI: 10.1016/j.mce.2017.08.016.

  221. Lina Schiffer et al. “Human Steroid Biosynthesis, Metabolism and Excretion Are Differentially Reflected by Serum and Urine Steroid Metabolomes: A Comprehensive Review.” Journal of Steroid Biochemistry and Molecular Biology 194 (2019): 105439. DOI: 10.1016/j.jsbmb.2019.105439.

  222. James L. Mohler, Mark A. Titus, and Elizabeth M. Wilson. “Potential Prostate Cancer Drug Target: Bioactivation of Androstanediol by Conversion to Dihydrotestosterone.” Clinical Cancer Research 17, no. 18 (2011): 5844-5849. DOI: 10.1158/1078-0432.CCR-11-0644.

  223. Stephanie T. Page et al. “Dihydrotestosterone Administration Does Not Increase Intraprostatic Androgen Concentrations or Alter Prostate Androgen Action in Healthy Men: A Randomized-Controlled Trial.” Journal of Clinical Endocrinology & Metabolism 96, no. 2 (2011): 430-437. DOI: 10.1210/jc.2010-1865.

  224. Gideon A. Sartorius, Lam P. Ly, and David J. Handelsman. “Male Sexual Function Can Be Maintained Without Aromatization: Randomized Placebo-Controlled Trial of Dihydrotestosterone in Healthy, Older Men for 24 Months.” Journal of Sexual Medicine 11, no. 10 (2014): 2562-2570. DOI: 10.1111/jsm.12550.

  225. Niels Jørgensen et al. “Compensated Reduction in Leydig Cell Function Is Associated with Lower Semen Quality Variables: A Study of 8182 European Young Men.” Human Reproduction 31, no. 5 (2016): 947-957. DOI: 10.1093/humrep/dew021.

  226. Katrine Bay et al. “Insulin-Like Factor 3 Serum Levels in 135 Normal Men and 85 Men with Testicular Disorders: Relationship to the Luteinizing Hormone-Testosterone Axis.” Journal of Clinical Endocrinology & Metabolism 90, no. 6 (2005): 3410-3418. DOI: 10.1210/jc.2004-2257.

  227. Ravinder Anand-Ivell et al. “Insulin-Like Peptide 3 as an Indicator of Leydig Cell Insufficiency in Middle-Aged and Older Men with Hypogonadism: Reference Range and Threshold.” Aging Male 27, no. 1 (2024): 2346322. DOI: 10.1080/13685538.2024.2346322.

  228. Jon Jarløv Rasmussen et al. “Serum Insulin-Like Factor 3 Levels Are Reduced in Former Androgen Users, Suggesting Impaired Leydig Cell Capacity.” Journal of Clinical Endocrinology & Metabolism 106, no. 7 (2021): e2664-e2672. DOI: 10.1210/clinem/dgab129.

  229. Femke de Vries et al. “Opioids and Their Endocrine Effects: A Systematic Review and Meta-Analysis.” Journal of Clinical Endocrinology & Metabolism 105, no. 3 (2020): 1020-1029. DOI: 10.1210/clinem/dgz022.

  230. Maria A. Christou et al. “Effects of Anabolic Androgenic Steroids on the Reproductive System of Athletes and Recreational Users: A Systematic Review and Meta-Analysis.” Sports Medicine 47, no. 9 (2017): 1869-1883. DOI: 10.1007/s40279-017-0709-z.

  231. Thomas Ahern et al. “Elevated Luteinizing Hormone Despite Normal Testosterone Levels in Older Men: Natural History, Risk Factors and Clinical Features.” Clinical Endocrinology 88, no. 3 (2018): 479-490. DOI: 10.1111/cen.13524.

  232. Bu B. Yeap et al. “A 5α-Reductase (SRD5A2) Polymorphism Is Associated with Serum Testosterone and Sex Hormone-Binding Globulin in Men, While Aromatase (CYP19A1) Polymorphisms Are Associated with Oestradiol and Luteinizing Hormone Reciprocally.” Clinical Endocrinology 90, no. 2 (2019): 301-311. DOI: 10.1111/cen.13885.

  233. Ylenia Duca et al. “Substance Abuse and Male Hypogonadism.” Journal of Clinical Medicine 8, no. 5 (2019): 732. DOI: 10.3390/jcm8050732.

  234. Xuanxuan Li et al. “Association of Di(2-ethylhexyl) Phthalate Exposure with Reproductive Hormones in the General Population and the Susceptible Population: A Systematic Review and Meta-Analysis.” Environment & Health 2, no. 11 (2024): 750-765. DOI: 10.1021/envhealth.4c00046.

  235. Lin Sang et al. “Association between Per- and Polyfluoroalkyl Substances and Sex Hormone Levels in Males Based on Human Studies.” Ecotoxicology and Environmental Safety 271 (2024): 115998. DOI: 10.1016/j.ecoenv.2024.115998.

  236. Lijun Lü et al. “Bisphenol A Exposure Interferes with Reproductive Hormones and Decreases Sperm Counts: A Systematic Review and Meta-Analysis of Epidemiological Studies.” Toxics 12, no. 4 (2024): 294. DOI: 10.3390/toxics12040294.

  237. Dimitra Bliatka et al. “Effect of Endocrine Disruptors on Male Reproduction in Humans: Why the Evidence Is Still Lacking.” Andrology 5, no. 3 (2017): 404-407. DOI: 10.1111/andr.12339.

  238. Jørgen J. Rasmussen et al. “Former Abusers of Anabolic Androgenic Steroids Exhibit Decreased Testosterone Levels and Hypogonadal Symptoms Years after Cessation: A Case-Control Study.” PLOS ONE 11, no. 8 (2016): e0161208. DOI: 10.1371/journal.pone.0161208.

  239. José de Oliveira Vilar Neto et al. “Anabolic Androgenic Steroid-Induced Hypogonadism, a Reversible Condition in Male Individuals? A Systematic Review.” Andrologia 53, no. 7 (2021): e14062. DOI: 10.1111/and.14062.

  240. Diederik L. Smit et al. “Disruption and Recovery of Testicular Function During and After Androgen Abuse: The HAARLEM Study.” Human Reproduction 36, no. 4 (2021): 880-890. DOI: 10.1093/humrep/deaa366.

  241. Catherine A. Carto et al. “Association Between Comorbidities and Longitudinal Changes in Total Testosterone among Men from the Baltimore Longitudinal Study of Aging.” Journal of Sexual Medicine 20, no. 5 (2023): 605-611. DOI: 10.1093/jsxmed/qdad025.

  242. Gary Wittert and Mathis Grossmann. “Obesity, Type 2 Diabetes, and Testosterone in Ageing Men.” Reviews in Endocrine and Metabolic Disorders 23, no. 6 (2022): 1233-1242. DOI: 10.1007/s11154-022-09746-5.

  243. Brendan M. Brady et al. “Demonstration of Progesterone Receptor-Mediated Gonadotrophin Suppression in the Human Male.” Clinical Endocrinology 58, no. 4 (2003): 506-512. DOI: 10.1046/j.1365-2265.2003.01751.x.

  244. Anne Cailleux-Bounacer et al. “Impact Level of Dihydrotestosterone on the Hypothalamic-Pituitary-Leydig Cell Axis in Men.” International Journal of Andrology 32, no. 1 (2009): 57-65. DOI: 10.1111/j.1365-2605.2007.00818.x.

  245. Manou Huijben et al. “Clomiphene Citrate for Male Infertility: A Systematic Review and Meta-Analysis.” Andrology 11, no. 6 (2023): 987-996. DOI: 10.1111/andr.13388.

  246. Edward D. Kim, Andrew McCullough, and Jed Kaminetsky. “Oral Enclomiphene Citrate Raises Testosterone and Preserves Sperm Counts in Obese Hypogonadal Men, Unlike Topical Testosterone.” BJU International 117, no. 4 (2016): 677-685. DOI: 10.1111/bju.13337.

  247. Francesco Del Giudice et al. “A Systematic Review and Meta-Analysis of Clinical Trials Implementing Aromatase Inhibitors to Treat Male Infertility.” Asian Journal of Andrology 22, no. 4 (2020): 360-367. DOI: 10.4103/aja.aja_101_19.

  248. Alvaro Morales et al. “Androgens and Sexual Function: A Placebo-Controlled, Randomized, Double-Blind Study of Testosterone versus Dehydroepiandrosterone in Men with Sexual Dysfunction and Androgen Deficiency.” Aging Male 12, no. 4 (2009): 104-112. DOI: 10.3109/13685530903294388.

  249. K. Sreekumaran Nair et al. “DHEA in Elderly Women and DHEA or Testosterone in Elderly Men.” New England Journal of Medicine 355, no. 16 (2006): 1647-1659. DOI: 10.1056/NEJMoa054629.

This Substack is reader-supported. To receive new posts and support my work, consider becoming a free or paid subscriber.

]]><![CDATA[PCT, ICT and HRT for Men: A Mechanistic Framework]]>https://articles.berbarianwizard.com/p/pct-ict-and-hrt-for-men-a-mechanistic-frameworkhttps://articles.berbarianwizard.com/p/pct-ict-and-hrt-for-men-a-mechanistic-frameworkThu, 06 Aug 2026 12:18:54 GMT

Complete guide structure

  • Opening. The separate goals of ICT, PCT, fertility recovery and long-term HRT

  • Block I. Endocrine foundations and steroid pathways

  • Part I. How the hypothalamus, pituitary, Leydig cells and Sertoli cells coordinate male function

    • GnRH pulses, daylight and sleep timing, sampling variation, LH demand, FSH action, intratesticular testosterone and INSL3

    • Why LH and hCG can produce different testicular signals

  • Part II. Every major route from cholesterol to androgens, estrogens, neurosteroids and corticosteroids

    • Mitochondrial cholesterol entry, the Δ5 and Δ4 routes and classical testosterone formation

    • Progesterone through the complete backdoor route to DHT

    • Progesterone routes to allopregnanolone, cortisol and aldosterone

  • Part III. How tissues activate, recycle and clear steroid hormones

    • The 5α-reductase network and practical ways to assess reduced-steroid flux

    • DHT, reversible diols, aromatase, estrogen metabolites and prostate intracrinology

    • SHBG, TBG, liver clearance, conjugation and microbial reactivation

    • Reduced-androgen control of estrogen, DHEA oxygenation, progesterone metabolites and the narrower 6-OXO branch

  • Block II. Exogenous anabolic-androgenic steroid exposure

  • Part IV. Parent drugs, active metabolites and endocrine effects across the major AAS families

    • Names, oral survival, route, ester, depot persistence and the difference between active and analytical metabolites

    • Testosterone, Δ1, 19-nor, DHT-lineage, heterocyclic and designer steroids

    • AR, PR, ER and GR activity, aromatization, anti-aromatase effects, thyroid effects, SHBG and TBG

    • Historical anabolic-to-androgenic numbers beside an evidence-graded recovery comparison

    • Product substitution, concentration errors and uncertain exposure

  • Block III. Locating the failed step

  • Part V. The hierarchy of suppression from active exposure to measured hormone output

    • Depot and metabolite persistence, estradiol, androgen and progesterone feedback

    • Central suppression, Leydig under-response, Sertoli impairment and metabolic limits

  • Part VI. Ten post-AAS patterns that require different decisions

    • Residual exposure, central suppression, primary or compensated Leydig dysfunction and mixed failure

    • Fertility-dominant, thyroid-metabolic, estrogen-prolactin, tissue-signaling and measurement patterns

  • Part VII. Building an interpretable assessment before treatment

    • Exposure history, valid sampling, endocrine tests, thyroid and metabolic context and semen analysis

  • Part VIII. Defining recovery through output, pituitary demand, fertility and durability

    • LH beside testosterone, INSL3, semen and stable function after temporary support clears

  • Block IV. Intervention during exposure, after exposure and during long-term support

  • Part IX. ICT during active AAS use

    • The function to preserve, pregnenolone dose logic and reduced-pathway assessment

    • Protection of blood pressure, cardiac structure, blood count, lipids, vessels, liver, kidneys, glucose handling, fertility, prostate, sleep and mental state

    • Food, supplements, prescription drugs and peptide bioregulators arranged by evidence, target and product identity

    • Current liquid hormone and micronutrient formats mapped to the correct protocol branch

  • Part X. Estrogen control, temporary pituitary recruitment and final-resort fertility rescue

    • LHCGR stimulation, SERM response, raloxifene for breast tissue, low-dose exemestane and specialist gonadotropin care

  • Part XI. Post-clearance recovery selected by suppression phenotype

    • Thyroid-limited, central, Leydig, fertility, reduced-androgen and upstream-steroid branches

    • T3, DHT, pregnenolone, DHEA and progesterone with direct review conditions

  • Part XII. Fertility recovery through Leydig, Sertoli and germ-cell function

    • Intratesticular testosterone, Sertoli-cell fuel, zinc status, semen interpretation and the time required for spermatogenesis

  • Part XIII. HRT after metabolic readiness, diagnosis and fertility are settled

    • Conditional T3, DHT, precursor and testosterone branches with route-specific monitoring

  • Block V. Decision and feedback

  • Part XIV. A phenotype-first ICT, PCT and HRT decision system

    • Active exposure, credible clearance, fertility priority, suppression phenotype and one measured treatment test

  • Part XV. Six response patterns that identify success, failure, dependence or a wrong target

  • Reference material

  • Steroidogenesis and enzyme atlases, AAS dossier template, pattern index, intervention index and references

Read more

]]><![CDATA[Anavar-Only Cycle Experiment and Guide: Why Most “Anavar” Isn’t Oxandrolone]]>https://articles.berbarianwizard.com/p/anavar-only-cycle-experiment-andhttps://articles.berbarianwizard.com/p/anavar-only-cycle-experiment-andTue, 21 Apr 2026 23:21:41 GMTAbstract

Oxandrolone is a DHT-derived oral anabolic steroid with a distinct pharmacological profile. It does not aromatize, shows relatively low androgenicity, and exerts part of its effect through anti-catabolic mechanisms. Clinical data supports measurable improvements in lean mass, recovery, and strength at low doses, often with moderate changes in liver enzymes and lipids.

Developed in the early 1960s by G. D. Searle & Company and commercialized as Anavar, oxandrolone was initially used in clinical settings for muscle wasting, burn recovery, and post-surgical weight loss before becoming a restricted, limited-availability pharmaceutical.

Modern reports frequently describe oxandrolone as weak or ineffective. This contrasts with older clinical data and earlier bodybuilding accounts. On paper, its anabolic-to-androgenic ratio (~322–630 : 24) corresponds to roughly 3× to 6× more anabolic activity per milligram than testosterone, with lower androgenicity. The discrepancy is consistent with widespread substitution of oxandrolone by other oral steroids in the current market.

This article examines the structure, pharmacology, clinical evidence, and real-world use of oxandrolone, then addresses the gap between expected and observed effects.

Read more

]]><![CDATA[The Ultimate Guide for Hard Gainers - Appetite, Digestion, Training Design and Lean Mass Gain]]>https://articles.berbarianwizard.com/p/the-ultimate-guide-for-hard-gainershttps://articles.berbarianwizard.com/p/the-ultimate-guide-for-hard-gainersTue, 21 Apr 2026 12:58:30 GMTIntroduction - Energy balance and main constraints

Bodyweight increases when daily intake is higher than total expenditure and this is maintained over time.

If intake does not exceed expenditure, nothing changes. If expenditure rises with intake, nothing changes.

Food has to be eaten in sufficient quantity and repeated daily. Meals have to be completed. The stomach has to empty fast enough to allow the next meal. Digestion should not create symptoms that reduce the following intake. Nutrients have to be absorbed. At the same time, expenditure has to stay below intake. Training, daily movement and stress all increase it, sometimes more than expected.

The process can be written as:

intake → meal completion → gastric emptying → digestion → absorption → net energy → recovery → partitioning

Net energy equals intake minus expenditure.
If this is not positive, the rest does not matter.

Constraint hierarchy and impact levels

Everything is handled in order. The first unstable part sets the limit.

Tier I - Intake, expenditure, recovery and training stimulus

This is where most issues sit.

  • Low appetite or meals ending too early

  • High expenditure from training, daily activity or stress

  • Poor sleep affecting both appetite and recovery

  • Training that creates fatigue but no clear growth signal

  • Low carbohydrate intake reducing performance

When something here is off, changing digestion or supplements does not move bodyweight.

Tier II - Digestion speed and meal tolerance

Here the problem is not hunger, but keeping intake consistent.

  • Meals staying too long in the stomach

  • High fat or high fiber meals increasing fullness

  • Food intolerance causing bloating or pressure

  • Fluid intake interfering with digestion

Intake may look fine on some meals but drops over the day.

Tier III - Absorption and nutrient availability

At this point food is eaten and tolerated, but not fully used.

  • Incomplete absorption despite sufficient intake

  • Micronutrient deficiencies affecting energy and appetite

  • Unstable digestion reducing consistency

  • Low enzymatic capacity

Bodyweight stays flat even when intake seems adequate.

Tier IV - Targeted corrections

These only make sense when a specific issue is clear.

  • Digestive support when breakdown is incomplete

  • Gut support when digestion is unstable

  • Sleep support when recovery is low

Without a clear problem, they do very little.

Tier V - Pharmacological interventions

These act directly on appetite or signaling.

  • Central appetite agents

  • Ghrelin related compounds

They can increase intake, but they do not fix the underlying limitation.

Using the model

The sequence matters.

If intake is low, digestion is not the issue.
If digestion limits intake, adding calories does not help.
If expenditure cancels intake, improving digestion does not change weight.
If recovery is poor, more training increases fatigue.

Start where it actually breaks. Fix that. Keep it stable.

Chapter 1 - Intake, expenditure and meal completion

The first limitation is almost always here.

Weight gain depends on how much energy enters and how much leaves. Intake and expenditure have to be considered together. Looking at one without the other leads to wrong conclusions.

Low intake is not always obvious. Some people simply do not feel hungry enough to reach the required calories. Others feel hungry but stop eating early because meals become uncomfortable. In both cases, total intake stays below what is needed.

Early fullness is a separate issue. Hunger can be present, but meals end too quickly. This reduces calories per meal and forces a higher meal frequency that is not always achievable. Over a full day, intake remains low without being noticed.

Expenditure can cancel intake even when food seems sufficient. This happens with high training volume, high daily movement, or constant stress. Some people increase activity without noticing when they eat more, which keeps bodyweight stable.

At this stage, digestion is often blamed too early. If meals are not completed or repeated, digestion is not the main problem. Intake has to be stable before moving further.

What limits intake in practice

The most common pattern is a combination of low appetite and early satiety.

  • Low appetite reduces the number of meals and the size of each meal

  • Early fullness stops meals before enough calories are reached

  • Food choice makes this worse when meals are bulky or hard to eat

Dry foods, high fiber meals, and low palatability reduce intake without effort. Liquid calories and softer textures usually solve part of the problem immediately.

Meal structure also matters. Large meals with long gaps between them increase the pressure on each feeding. When one meal fails, total intake drops for the entire day.

What increases expenditure without being noticed

Energy loss is not limited to training sessions.

  • High training volume increases both expenditure and fatigue

  • Unconscious movement increases with higher intake in some individuals

  • Stress raises baseline energy use and reduces appetite at the same time

Cardio is often added without adjusting intake. In a hard gainer context, it usually reduces net energy unless it replaces something else.

Training itself can become a problem when volume is too high. Performance drops, appetite decreases, and recovery becomes inconsistent. This creates a situation where more effort produces less result.

What to fix first

At this level, the objective is simple.

  • Meals have to be completed

  • Intake has to be repeatable across the day

  • Expenditure has to stay below intake

If one of these is not true, nothing below this level changes the outcome.

Chapter 2 - Appetite regulation and early satiety mechanisms

Appetite and early satiety control how much food is eaten before digestion becomes a factor. Hunger can be present, but intake still stays low if meals end too quickly.

Hunger is influenced by energy availability, sleep, and daily rhythm. When energy is low and recovery is stable, hunger usually rises. When stress is high or sleep is poor, hunger often drops even if energy needs are high.

Early satiety is different. It is driven by mechanical and digestive signals during the meal. The stomach stretches, pressure increases, and the meal is stopped before enough calories are consumed. This can happen even when hunger is still present.

What reduces appetite

Low appetite is often linked to energy balance and nervous system state.

  • Poor sleep lowers hunger and reduces meal frequency

  • High stress shifts the body away from feeding and toward alertness

  • Low carbohydrate intake reduces training output and appetite over time

In this state, meals are skipped or delayed without effort. Intake stays low without any clear digestive issue.

What causes early satiety

Early satiety is mainly mechanical.

  • High volume meals stretch the stomach quickly

  • High fiber increases bulk and slows intake

  • High fat delays gastric emptying and prolongs fullness

The combination of volume and slow digestion keeps the stomach full longer than expected. The next meal is delayed or reduced.

This is why food choice matters. Two meals with the same calories can produce very different levels of fullness.

Meal structure and its effect

Meal structure determines how easily calories are consumed.

Dense and easy to eat meals increase total intake.
Bulky and slow meals reduce it.

Liquid calories reduce mechanical satiety. They pass through the stomach faster and do not create the same level of pressure. This allows higher intake without increasing discomfort.

Spacing also matters. Large gaps between meals increase the reliance on each meal. If one meal is small, the entire day is affected.

What to adjust

At this stage, the goal is to increase total intake without increasing effort.

  • Reduce unnecessary volume

  • Limit fiber that does not contribute to calories

  • Keep fat low enough to avoid slowing digestion

  • Use liquid calories when needed

These changes affect appetite and satiety directly. They do not depend on supplements or advanced strategies.

Chapter 3 - High carbohydrate low fat structure and its effect on intake and digestion

Meal composition changes how fast food moves through the stomach, how long fullness lasts, and how easily intake can be repeated. A high carbohydrate low fat structure keeps digestion faster and reduces the time between meals.

Fat slows gastric emptying. When fat intake is high, meals stay longer in the stomach, fullness lasts longer, and the next meal is delayed. This reduces total intake over the day even when calories per meal look adequate.

Carbohydrates move through the stomach faster and support repeated feeding. They also maintain glycogen, which keeps training performance stable. When carbohydrate intake is low, performance drops and the body relies more on stress responses to maintain energy output.

Effect on meal turnover

With lower fat intake, meals clear faster. This allows:

  • Shorter time between meals

  • Less residual fullness from the previous meal

  • More opportunities to eat during the day

With higher fat intake, the opposite happens. Meals overlap in the stomach, fullness carries into the next feeding, and intake drops without effort.

Effect on satiety

Fat increases satiety beyond its calorie content. This is useful in a deficit, but counterproductive when the goal is to increase intake.

Fiber adds volume and further increases satiety. In combination with fat, it creates meals that are both slow and bulky. This is one of the most common reasons intake stays low in hard gainers.

Carbohydrates, especially in less fibrous forms, provide calories with less mechanical and digestive resistance.

Effect on training and recovery

High carbohydrate intake supports glycogen levels. This keeps training output stable and reduces the need for stress driven energy production.

When carbohydrates are insufficient, performance declines and fatigue increases. This often leads to higher perceived effort, lower appetite, and reduced recovery.

Keeping carbohydrates high while controlling fat intake maintains both intake and performance.

Effect on fat gain

In practice, excess dietary fat is stored efficiently. Carbohydrate conversion to fat is limited under normal conditions and requires sustained surplus conditions.

A high carbohydrate low fat structure tends to direct more energy toward glycogen storage and immediate use, especially when training is present.

This does not eliminate fat gain, but it reduces unnecessary storage when compared to mixed high fat high carbohydrate meals.

Practical structure

The goal is not to remove fat completely, but to keep it low enough that digestion stays fast and intake stays high.

  • Carbohydrates form the base of meals

  • Fat is kept moderate to low to avoid slowing digestion

  • Fiber is controlled to avoid unnecessary volume

  • Liquid carbohydrates are used when solid intake is limited

This structure increases total intake without increasing discomfort.

Chapter 4 - Meal design and food selection for consistent intake

At this stage the problem is not knowledge. It is execution. Intake depends on how food is presented and how easy it is to eat repeatedly.

Foods that require long chewing, create dryness, or increase volume reduce intake without effort. Foods that are soft, moist, and easy to swallow increase intake with less resistance. The difference shows up over a full day, not in a single meal.

Texture matters as much as composition. Dense foods that go down easily allow higher calories before fullness appears. Bulky foods fill the stomach early and delay the next meal.

Palatability also changes intake. When meals are easy to eat, they are finished. When they are not, portions shrink over time even if the plan stays the same on paper.

What improves meal completion

  • Soft, moist foods are easier to finish than dry foods

  • Mixed textures reduce monotony within a meal

  • Warm meals are often easier to eat than cold meals

  • Salt improves palatability and helps maintain intake

These are simple changes, but they directly affect how much is eaten.

What reduces intake without being noticed

  • Dry meals increase chewing time and fatigue

  • Very high volume foods create early fullness

  • Repetitive meals reduce willingness to eat over time

These factors do not appear in calorie tracking, but they control whether targets are reached.

Role of liquid calories

Liquid intake reduces mechanical satiety. It passes through the stomach faster and requires no chewing. This allows calories to be added without increasing meal size.

Liquid carbohydrates are the easiest way to increase intake when solid meals become limiting. They can be placed between meals or alongside them without interfering with appetite as much as solid food.

Meal spacing and structure

Spacing should allow digestion to proceed without overlap. If meals are too close, fullness carries into the next one. If meals are too far apart, total intake depends too much on each feeding.

Smaller, repeatable meals are more reliable than large meals that fail. Consistency over the day matters more than the size of any single meal.

Protein in meal structure

Protein should not limit meal completion.

A practical range is 1.2 to 1.6 g per kilogram of bodyweight per day.

Higher intake increases satiety and slows meals without improving results in this context.

When appetite is limited, protein stays moderate and does not dominate the meal.

Lean sources are preferred to avoid adding fat and slowing digestion.

Practical direction

Meals should be:

  • Easy to eat

  • Easy to repeat

  • Low in unnecessary volume

If a meal regularly feels difficult to finish, it is not well structured for this goal.

Chapter 5 - Removing factors that suppress appetite and reduce intake

At this stage the objective is not to add more food. It is to remove what reduces intake without being obvious.

Several factors lower appetite or end meals early without being recognized as a problem. They act through volume, gastric pressure, or nervous system state.

Fiber and meal volume

Fiber increases bulk without increasing calories. Large amounts of fiber stretch the stomach quickly and bring fullness forward in the meal.

This is useful when the goal is to reduce intake. Here it limits how much can be eaten before discomfort appears.

The effect is cumulative. A single high fiber meal may be tolerated, but repeated meals slow intake across the day.

Carbonation and gastric pressure

Carbonated drinks introduce gas into the stomach. This increases pressure and creates a sense of fullness that is not related to energy intake.

When used around meals, carbonation reduces how much food can be eaten before stopping.

Stimulants and appetite suppression

Stimulants reduce hunger. The effect varies, but it is consistent enough to matter when intake is already limited.

Caffeine is the most common example. It can delay meals, reduce portion size, and shift intake later in the day. In some cases this leads to missed calories rather than compensation.

Nicotine has a similar effect, often stronger.

Fluid timing

Large amounts of fluid taken before or during meals increase gastric volume without adding calories. This accelerates fullness and reduces intake.

Hydration is necessary, but timing matters. Spreading fluid intake away from meals improves meal completion.

Combined effects

These factors often appear together. A high fiber meal, combined with fluid intake and caffeine, creates a situation where appetite is reduced and fullness arrives early.

Individually each factor seems small. Together they significantly reduce total intake.

Practical direction

  • Keep fiber at a level that does not limit intake

  • Avoid carbonation around meals

  • Limit stimulants when they reduce appetite

  • Separate large fluid intake from meals

Removing these constraints increases intake without adding complexity.

Chapter 6 - Sleep, circadian rhythm and their effect on appetite and recovery

Sleep affects both sides of the system. It changes appetite and it changes expenditure.

When sleep is consistent, hunger tends to appear at regular times. Meals are easier to start and easier to finish. Training output is more stable and recovery is more predictable.

When sleep is irregular or insufficient, appetite often drops. Meals are delayed or skipped. At the same time, fatigue increases and training becomes less efficient. This combination reduces intake and increases energy loss.

Circadian rhythm sets the timing of these effects. Light exposure, especially late in the day, shifts sleep later and shortens total sleep time. Irregular timing produces the same result even if total hours look acceptable.

Effect on appetite

Reduced sleep lowers hunger during the day. Meals become smaller or are pushed later. In some cases, intake shifts to late hours where it is less consistent.

This is not a digestion issue. It is a regulation issue.

Effect on recovery and training

Poor sleep reduces training output. Effort increases while performance decreases. This raises fatigue without improving the stimulus.

Over time this leads to lower appetite, inconsistent intake and slower progress.

Effect on daily expenditure

Sleep disruption increases baseline activity in some cases and reduces it in others. The more consistent effect is increased stress and reduced efficiency.

Energy is used less effectively, and recovery requires more input to produce the same result.

What matters in practice

Regular timing matters more than isolated long nights.
Light exposure early in the day helps set the rhythm.
Light exposure late at night delays sleep.

Small changes here often affect appetite more than diet adjustments.

Practical direction

  • Keep sleep timing consistent

  • Reduce light exposure late in the day

  • Maintain a stable wake time

These changes improve appetite and recovery without changing food intake directly.

Chapter 7 - Supporting sleep and recovery when baseline is not sufficient

When sleep timing and light exposure are already controlled, some people still have low sleep quality or wake up without recovery. In that situation, appetite stays low and training output does not improve.

The goal here is not sedation. It is to improve the transition into sleep and reduce night time disruption so that recovery becomes consistent.

Glycine and night time downregulation

Glycine acts on inhibitory pathways and reduces neural activation before sleep. Taken in the evening, it shortens the time needed to fall asleep and improves perceived recovery the next day.

It also has an anti catabolic effect during periods of stress or low intake. This becomes relevant when training is present and energy availability is borderline.

Magnesium and nervous system stability

Magnesium supports relaxation and reduces excessive neural activity. Deficiency is common and often shows as poor sleep quality, muscle tension, or difficulty staying asleep.

Correcting it improves sleep depth and reduces night time awakenings.

Cyproheptadine in context

Cyproheptadine reduces serotonin signaling and produces a sedative effect. In low doses it can improve sleep onset and increase appetite the following day.

The effect is direct. Sleep becomes deeper, appetite increases, and intake often improves without forcing food.

It is not required when sleep is already stable, but it is effective when both appetite and sleep are low.

Peptide based approaches

Compounds such as epithalon or pinealon are used to influence sleep regulation and circadian rhythm. Their effect is less immediate than classical sedatives, but they aim at improving rhythm stability over time.

They are not first line tools, but can be used when sleep remains inconsistent despite basic corrections.

Practical direction

  • Use glycine in the evening to improve sleep onset and recovery

  • Correct magnesium if sleep is light or fragmented

  • Use stronger agents only when both sleep and appetite are limiting

The objective is stable recovery. When sleep improves, appetite and training usually follow.

Chapter 8 - Gastric function and digestion as a limiter of intake

At this stage intake is present, but meals are difficult to repeat. The limiting factor is how fast the stomach empties and how the meal is handled during the first phase of digestion.

Food remains in the stomach until it is reduced to a form that can pass into the small intestine. When this process is slow, fullness lasts longer than expected and the next meal is delayed. Over a full day, intake drops without any conscious restriction.

When gastric emptying is slow

The usual pattern is persistent fullness after meals.

  • Meals feel heavy for several hours

  • The next meal is delayed or reduced

  • Appetite does not return at the expected time

This is often interpreted as low appetite, but the issue is mechanical. The stomach is still processing the previous meal.

Meal composition plays a direct role here. Fat slows emptying. Large volumes increase the time needed to process the meal. Certain foods create additional delay when they are harder to break down.

Role of stomach acid

Protein digestion begins in the stomach. Adequate acidity helps break down food and prepares it for the next phase. When this step is inefficient, digestion slows and meals remain longer in the stomach.

The effect is not always obvious. It appears as heaviness, slow digestion, or reduced appetite at the next meal rather than acute discomfort.

Interaction with meal structure

Large meals with mixed macronutrients are slower to process. Fat combined with volume increases this effect. Fiber adds bulk and further delays emptying.

In contrast, meals built around easily digestible carbohydrates with moderate protein and controlled fat clear faster and allow more frequent feeding.

Liquid intake moves faster than solid food. This is why it is often used to increase calories when solid meals become limiting.

Common patterns

Slow digestion is rarely isolated. It usually appears with one or more of the following:

  • High fat intake slowing the entire meal

  • High fiber increasing volume and retention

  • Large meals creating mechanical delay

  • Irregular meal timing reducing digestive rhythm

These patterns reinforce each other and reduce total intake across the day.

Practical direction

  • Keep fat low enough to avoid slowing gastric emptying

  • Control meal volume to avoid excessive fullness

  • Favor foods that are easy to digest and quick to clear

  • Use liquid calories when solid meals become limiting

The objective is not to increase appetite directly, but to remove the delay that prevents the next meal.

Chapter 9 - Increasing digestion speed and reducing post meal discomfort

Once gastric emptying is identified as the limiter, the objective is to keep food moving at a steady pace and avoid the buildup of pressure after meals.

Post meal discomfort usually appears as heaviness, bloating or a drop in appetite before the next meal. These signals are enough to reduce intake even when calories are planned correctly.

Keeping digestion moving

Digestion speed is strongly influenced by what the meal contains and how it is structured.

  • Lower fat reduces the time food stays in the stomach

  • Easily digestible carbohydrates move through faster

  • Moderate protein avoids unnecessary delay

When these are in place, meals clear with less overlap and appetite returns at predictable times.

Role of motility

Motility refers to the movement of food through the digestive tract. When it slows down, food accumulates and symptoms appear even if the meal itself is not excessive.

Ginger is commonly used to support motility. Its effect is not to increase digestion capacity, but to help move food forward and reduce stagnation.

This becomes useful when meals are correctly structured but still feel slow to clear.

Managing post meal symptoms

Some symptoms reduce intake without being linked to a clear cause.

  • Bloating creates pressure that limits the next meal

  • Reflux or discomfort reduces willingness to eat again

  • Persistent fullness delays feeding

These are often tied to food combinations, volume or timing rather than a single ingredient.

Interaction with meal timing

Meals that are too close together create overlap. Meals that are too far apart increase the pressure on each feeding.

A stable rhythm allows digestion to complete before the next meal begins. This reduces symptoms and keeps intake consistent.

Practical direction

  • Keep meals simple and easy to digest

  • Use ginger when digestion feels slow despite correct structure

  • Adjust meal timing to avoid overlap

When digestion speed improves, appetite often increases without direct intervention.

Chapter 10 - Managing reflux, bloating and intolerance without reducing intake

At this stage, intake is limited by symptoms rather than appetite or meal size. Food is eaten, but certain meals create discomfort that reduces the next one. Over a full day, total intake drops.

The goal is not to remove foods blindly. The goal is to keep calories high while reducing the specific triggers that create symptoms.

Reflux and upper digestive discomfort

Reflux appears when pressure in the stomach increases or when food remains too long. It is often linked to meal size, fat content and timing.

Large mixed meals with high fat are more likely to produce this effect. Reducing fat and simplifying meals often removes the problem without lowering calories.

Fluid intake around meals can also increase pressure and worsen symptoms.

Lactose and dairy tolerance

Dairy is a dense and practical calorie source, but lactose intolerance can limit its use.

Symptoms appear when lactose is not fully broken down. This leads to gas, bloating and discomfort.

This does not require removing dairy entirely.

  • Lactase can be used when dairy is consumed

  • Lactose free options maintain intake without symptoms

  • Tolerance varies with dose and timing

The objective is to keep dairy in the diet when possible, not to remove it at the first symptom.

Starch, gluten and fermentation

Some carbohydrate sources ferment more than others. This creates gas and pressure, which reduces the next meal.

Starch that is poorly digested or consumed in large amounts can contribute to this. In some cases, gluten containing foods are also associated with symptoms, though this varies between individuals.

The issue is not the category itself, but the individual response.

When fermentation is high, intake drops because meals feel heavier and less repeatable.

Butyrate and gas production

Butyrate is produced during fermentation. It has beneficial roles in the gut, but the process that produces it also generates gas.

In individuals prone to bloating, increasing fermentable substrates can worsen symptoms even if the underlying mechanism is considered beneficial.

Maintaining intake while reducing symptoms

Removing too many foods reduces calories and creates new limitations. Adjustments should keep intake stable.

  • Replace problematic foods rather than removing entire categories

  • Adjust portion size and timing instead of full exclusion

  • Keep calorie dense foods in the diet whenever possible

The objective is stable digestion that allows consistent intake.

Chapter 11 - Carbohydrate selection and liquid calories for higher intake

Carbohydrates are the main driver of repeatable intake in this context. They move through the stomach faster than fat, support training output, and can be consumed in liquid form without increasing meal size.

The question is not whether to use carbohydrates, but which forms allow intake to stay high without creating symptoms.

Simple and complex sources

Easily digested carbohydrates allow faster gastric emptying and reduce the time between meals. Sources that are slow to digest or that ferment heavily tend to create fullness and delay the next feeding.

This is why two meals with similar calories can behave differently. One clears quickly and allows another meal. The other creates residual fullness and reduces intake later in the day.

Glucose based sources are usually well tolerated when digestion is stable. Fructose can be used in combination, but tolerance varies and depends on dose and context.

Liquid carbohydrates

Liquid intake reduces mechanical satiety. It requires no chewing and creates less pressure in the stomach. This allows calories to be added without affecting meal completion.

This is useful when solid meals are already at their limit. Liquid carbohydrates can be placed between meals or around training without reducing appetite as much as additional solid food.

They also support training directly by maintaining blood glucose during the session.

Timing and distribution

Carbohydrates can be distributed across the day to keep energy availability stable.

Large amounts in a single meal can increase fullness and reduce the next feeding. Spreading intake allows more frequent meals with less discomfort.

Around training, carbohydrates help maintain output and reduce fatigue. This indirectly supports appetite by keeping performance stable.

Tolerance and adjustment

Not all carbohydrate sources are tolerated equally.

  • Some produce little to no digestive stress

  • Others increase gas or discomfort depending on the individual

Adjustments are made based on response, not on category labels. The objective is to keep carbohydrates high enough to support intake and training without creating symptoms that reduce total intake.

Practical direction

  • Use easily digestible carbohydrate sources as the base of meals

  • Add liquid carbohydrates when solid intake is limited

  • Adjust sources based on tolerance rather than fixed rules

Carbohydrates support both intake and performance when they are selected and distributed correctly.

Chapter 12 - Recognizing absorption issues and nutrient limitations

At this point intake is in place and meals are tolerated, but bodyweight still does not move. The question shifts from how much is eaten to how much is actually used.

Absorption issues are less common than intake or digestion problems, but when they are present they block progress completely.

When intake does not translate into weight

The pattern is simple. Calories are consistent, digestion feels acceptable, but bodyweight stays flat over time.

In some cases there are visible signs. In others, the only signal is the lack of progress.

Common observations:

  • Stable or high intake with no weight increase

  • Energy levels that do not match intake

  • Inconsistent digestion over time

These do not confirm a single cause, but they indicate that intake is not fully converted into usable energy.

Digestion versus absorption

Digestion and absorption are often grouped together, but they are not the same.

Digestion breaks food down into smaller components.
Absorption transfers those components into circulation.

Digestion can appear normal while absorption is incomplete. In that case, part of the intake does not contribute to energy or tissue.

Micronutrient limitations

Micronutrients affect how energy is used.

Low levels can reduce appetite, limit energy production and affect training performance. This creates a situation where intake is present but the system does not respond as expected.

Iron, B12, magnesium and zinc are commonly involved. Their role is not limited to deficiency symptoms. They influence the overall efficiency of the system.

Gut stability and consistency

Absorption is not only about capacity, but also about consistency.

If digestion varies from day to day, absorption also varies. Intake may be sufficient on average, but inconsistent absorption prevents steady progress.

This often appears as alternating periods of normal digestion and periods of discomfort or irregularity.

Enzymatic capacity

Enzymes are required to complete digestion. When their activity is low, part of the meal remains incompletely processed.

This reduces the amount of nutrients available for absorption, even when intake is high.

The effect is gradual and often overlooked because it does not always produce strong symptoms.

Practical direction

  • Confirm that intake is stable before assuming an absorption issue

  • Look for consistency rather than isolated symptoms

  • Address micronutrient status when progress does not match intake

Absorption becomes relevant only after intake and digestion are stable. When it is limiting, increasing calories does not solve the problem.

Chapter 13 - Electrolytes, hydration and their effect on digestion and performance

Electrolytes and fluid balance influence how food moves through the stomach, how nutrients are absorbed, and how well training is supported. They do not change intake directly, but they affect how the system handles that intake.

Sodium and fluid handling

Sodium supports fluid absorption and maintains blood volume. When intake is low, fluid handling becomes less efficient. This can affect digestion by slowing the movement of food and altering gastric function.

Higher sodium intake usually improves palatability and makes meals easier to finish. It also supports performance by maintaining circulation during training.

Low sodium often appears as fatigue, low appetite or reduced training output rather than clear digestive symptoms.

Potassium and cellular function

Potassium is involved in cellular activity, including muscle contraction and energy use. When intake is low, performance and recovery are affected.

This does not directly reduce appetite, but it reduces the effectiveness of training and can indirectly limit progress.

Fluid balance and timing

Hydration affects both digestion and meal completion.

Large amounts of fluid taken around meals increase stomach volume and accelerate fullness. This reduces how much can be eaten in that meal.

When fluid intake is spread away from meals, digestion is more stable and meal completion improves.

Interaction with training

During training, fluid and electrolyte balance influence performance and fatigue.

When sodium and fluids are sufficient, output remains stable. When they are not, fatigue appears earlier and the session becomes less effective.

This indirectly affects appetite by changing how demanding training feels and how recovery is handled.

Practical direction

  • Keep sodium intake sufficient to support fluid balance and meal completion

  • Maintain potassium through regular food intake

  • Separate large fluid intake from meals when it reduces appetite

Electrolytes and hydration support the system, but they do not replace intake or digestion. They become relevant when those are already in place.

Chapter 14 - Gut stability, microbiome and the effect of antibiotics

At this point intake, digestion and basic absorption are in place, but consistency is not. Some days feel normal, others reduce appetite or create symptoms. The limiting factor is not a single meal, but how stable digestion is over time.

The microbiome influences this stability. When it is balanced, digestion remains predictable. When it is disrupted, symptoms appear even if meal structure is unchanged.

Effect of antibiotics

Antibiotics reduce bacterial populations broadly. This can remove pathogenic strains, but it also affects organisms that support digestion.

After a course of antibiotics, it is common to see:

  • Increased bloating or gas with foods that were previously tolerated

  • Less predictable digestion from one day to the next

  • Reduced appetite due to discomfort rather than low energy needs

These effects are not always immediate. They can appear gradually as intake increases again.

Instability and intake

When digestion is inconsistent, intake becomes inconsistent. A meal that is tolerated one day may reduce appetite the next day.

This makes it difficult to maintain a steady surplus. Even if average intake looks correct, fluctuations prevent steady weight gain.

S. boulardii

S. boulardii is a non bacterial organism used to stabilize digestion after disruption. It does not colonize in the same way as typical probiotics. Its role is to limit overgrowth of undesirable strains and reduce symptoms such as bloating or irregularity.

It is often used after antibiotics or when digestion is unstable despite correct meal structure.

L. reuteri

L. reuteri is used to support microbiome balance and improve tolerance to certain foods. Its effects are more gradual and depend on context.

In some individuals it improves digestion and appetite. In others the effect is limited. It is not a universal solution, but it can help restore stability when imbalance is present.

Lactoferrin and bacterial control

Lactoferrin binds iron and limits its availability to certain bacteria. This can reduce the growth of strains that depend on free iron.

The effect is indirect. By limiting these strains, overall balance can improve, which reduces symptoms that interfere with intake.

Practical direction

  • Use targeted support when digestion is unstable, not as a default

  • Focus on restoring consistency rather than adding multiple strains at once

  • Maintain intake while adjusting, instead of removing too many foods

Gut stability matters because it allows intake to stay consistent across days. Without that, even a good diet structure does not translate into progress.

Chapter 15 - Digestive enzymes and when to use them

Enzymes are relevant when food is eaten and tolerated, but digestion remains incomplete. They do not increase appetite. They do not replace proper meal structure. Their role is limited to improving the breakdown of specific nutrients.

Use them when there is a clear mismatch between intake and how the meal is handled.

When enzymes are useful

Look for a consistent pattern rather than isolated symptoms.

  • Dairy leads to gas or discomfort even in moderate amounts

  • Meals feel heavy despite correct composition and portion size

  • Intake is stable but digestion is not consistent from one day to the next

In these cases, enzyme support can remove a specific bottleneck and make intake easier to repeat.

Lactase

Lactase breaks down lactose in dairy. When endogenous lactase is low, lactose reaches the colon and ferments. This produces gas and pressure that reduce the next meal.

Using lactase with dairy allows intake to remain high without removing a dense calorie source. The effect is immediate and easy to evaluate.

Pancreatic enzymes

Pancreatic enzymes support the breakdown of protein, fat and carbohydrates. They are useful when meals are correctly structured but still feel slow or incomplete.

The goal is not to compensate for poor diet design. It is to improve digestion when structure is already appropriate.

Alpha galactosidase

This enzyme targets specific carbohydrates that tend to ferment. It is used when certain foods consistently produce gas and reduce intake later in the day.

It does not change overall digestion, only the handling of those specific components.

Limitations

Enzymes do not fix slow gastric emptying caused by high fat or large meal volume. They do not increase appetite when intake is limited by hunger. They do not compensate for high expenditure.

When used without a clear indication, they do not change the outcome.

Practical direction

  • Use enzymes for specific foods that consistently create symptoms

  • Keep meal structure correct before adding support

  • Remove them if no clear effect is observed

They are tools for precision, not a base strategy.

Chapter 16 - Training design for hard gainers

Training has to provide a strong enough stimulus to build muscle without increasing fatigue to the point where appetite, recovery and total intake are affected.

In this context, more volume often works against progress. The objective is to get a clear hypertrophy signal while keeping systemic stress low enough to maintain appetite and recovery.

The approach below follows that logic.

Intensity versus volume

Resistance training programs vary widely in how they distribute workload. Some approaches rely on high weekly volume with many sets per muscle group. Others focus on fewer sets performed with very high effort.

The approach I use falls into the second category. It is largely inspired by the training philosophy associated with Mike Mentzer and later Dorian Yates, who emphasized high-intensity work with relatively low total volume.

The central idea is straightforward. A muscle does not require dozens of sets to receive a growth stimulus. What it requires is a set performed with sufficient mechanical tension and effort to recruit a large proportion of available motor units.

When a set is taken close to muscular failure, high-threshold motor units are progressively recruited as fatigue accumulates. These motor units contain the largest muscle fibers and contribute significantly to hypertrophy.

Multiple low-effort sets often produce less stimulus than a smaller number of highly demanding sets.

A high-intensity approach therefore attempts to maximize the quality of stimulus per set rather than the total number of sets performed.

Judging failure

Failure is the point where a full repetition can no longer be completed with the same execution.

A repetition still counts only if the range of motion and control stay consistent with the previous ones. When the bar speed slows but the movement is still controlled and reaches the same positions, the set is not finished. When the repetition shortens, the path changes, or momentum is used to complete it, failure has already been reached.

In practice, the last valid repetition is the last one that looks like the ones before it, just slower. The next attempt either does not move, stops halfway, or requires a change in execution. That is the end of the set.

Partials can be used after that point, but they extend the set. They are not used to redefine where failure occurs.

This keeps the stimulus consistent and makes progression measurable from one session to the next.

Why lower volume fits this context

Training volume directly influences systemic stress.

Very high weekly volume accumulates fatigue in the nervous system, connective tissue and endocrine system. When recovery capacity is exceeded, performance drops, sleep becomes less stable and appetite tends to decrease.

For someone trying to maintain a consistent surplus, this becomes a problem. The cost of training starts to interfere with the ability to eat and recover.

A lower-volume approach with carefully executed sets provides a strong hypertrophic stimulus while keeping overall fatigue manageable.

The objective is not to minimize effort. It is to avoid unnecessary fatigue that does not contribute to growth.

Weekly structure

Training is organized over four sessions per week using a modified push–pull split that separates upper and lower body movements.

Upper push
Chest, front deltoids, lateral deltoids, biceps

Lower push
Quadriceps and adductors

Upper pull
Back, rear deltoids, triceps

Lower pull
Hamstrings, glutes, abductors

This structure allows each muscle group to be trained with focus while leaving enough time for recovery before the next exposure.

Frequency remains moderate. Intensity remains high.

Exercise selection

For each muscle group, two exercises are usually enough.

One movement emphasizes tension in the stretched position, where the muscle is lengthened under load. The other emphasizes tension in the contracted position, where peak contraction occurs.

Both contribute to hypertrophy through different mechanisms. Tension in the stretched position is mechanically demanding. Peak contraction improves recruitment and local fatigue.

The order depends on priority.

When a muscle group is lagging, starting with the contraction-focused movement improves control and activation early in the session. Otherwise, starting with the stretch-focused movement is usually more efficient.

Set execution

Each exercise is built around one main working set taken to muscular failure.

Failure is defined as the point where no further full repetition can be completed with proper form.

After reaching this point, the set can be extended slightly.

Partials can be performed in the strongest portion of the movement once full repetitions are no longer possible.
Rest–pause can be used by taking a short break and attempting a few additional repetitions with the same load.

These techniques increase the density of the set without increasing total volume.

Machines versus free weights

Machines are often preferred in this context.

They provide more consistent resistance across the movement and reduce the need for stabilization. This allows the target muscle to be loaded more directly.

It also makes it safer to approach failure and to use techniques such as partials or rest–pause.

Free weights are still useful, but they are not required to achieve a strong hypertrophic stimulus.

Range of motion and tension

Range of motion should include the part of the movement where tension is highest.

For example, in pressing movements, the highest tension often occurs in the stretched position near the bottom. Short repetitions at the top miss that stimulus.

Partials can be used to extend a set, but they should not replace full range work.

The muscle needs to experience meaningful tension for growth to occur.

Example sessions

Upper push

Decline chest press machine
Pec deck machine
Incline dumbbell front raises
Machine lateral raises
Preacher curl machine
Cable reverse curl

Decline pressing reduces shoulder dominance and increases chest involvement in some structures.

Lateral raise machines maintain tension through the full movement, which makes them effective for the middle deltoid.

Lower push

Leg extension
Hack squat or unilateral leg press
Adductor machine

Leg extensions load the quadriceps strongly in the contracted position. Hack squats or unilateral leg press load them in the stretched position.

Upper pull

Chest-supported T-bar row
Reverse-grip lat pulldown
Rear delt machine
Triceps pushdown
Overhead triceps cable extension

If lat activation is poor, starting with a pullover variation improves recruitment before compound pulling movements.

Lower pull

RDL machine
Seated leg curl
Abductor machine

If glute activation is limited, starting with hip thrusts improves engagement for the rest of the session.

Chapter 17 - Recovery management, deloads and maintaining performance

Training adds stress that has to be absorbed and resolved. When recovery is sufficient, performance holds or improves and appetite remains stable. When recovery is not sufficient, performance drops and intake becomes less consistent.

Fatigue builds over time even when sessions look manageable. The first signs are small. Repetitions drop at the same load, rest periods extend, sessions feel heavier than expected. Sleep can become lighter and appetite less reliable.

If this continues, training stops producing a useful stimulus. More effort is required for the same output, and the cost in fatigue increases.

Recognizing accumulated fatigue

Look for changes across several sessions rather than a single day.

  • Performance trends down at the same loads

  • Sessions feel harder without a change in programming

  • Rest periods extend without improving output

  • Sleep becomes less stable

  • Appetite becomes less consistent

These signs usually appear together.

Deloads

A deload reduces fatigue so performance can return to baseline.

This can be done by lowering volume, lowering load, or both. The exact method matters less than the effect. The goal is to reduce stress enough for recovery to catch up.

A short period is usually sufficient. When done early, the interruption is minimal. When delayed, the time needed to recover increases.

Maintaining intake during recovery

When training volume is reduced, it is common to reduce food intake at the same time. This removes the conditions needed for recovery.

Energy intake should remain stable. Glycogen needs to be restored and the organism needs enough energy to repair tissue.

Reducing intake during a deload often extends the recovery period instead of shortening it.

Return to full training

After fatigue is reduced, performance should return to baseline. From there, training can resume with the same structure.

If fatigue returns quickly, volume is still too high or recovery is still limited.

Progressive overload

Strength has to increase over time for muscle to increase. If performance on the same movements does not improve under the same conditions, growth is limited.

Each exercise uses one working set taken to failure. The set must be comparable from one session to the next. Range of motion, control and execution stay the same. If execution changes, the comparison is not valid.

Use a fixed rep range. For most movements, 6 to 10 repetitions is appropriate. Start with a load that allows at least 6 clean repetitions.

Keep the load constant and increase repetitions across sessions. When 10 clean repetitions are reached, increase the load at the next session. The increase should be small enough to stay within the range.

A repetition counts only if it matches the previous ones. Same range, same control, same path. When the movement shortens, slows to the point where positions are not reached, or requires momentum, the set is finished.

Progression is tracked per exercise. Keep the same movements long enough to observe a trend. Changing exercises too often removes the ability to measure progress.

If repetitions increase at the same load, no change is needed.

If performance is stable for one or two sessions, repeat the same load. Small fluctuations are normal.

If performance does not improve across several sessions, check intake, bodyweight trend, sleep and fatigue. In most cases, the issue is insufficient recovery or insufficient surplus.

If performance drops across multiple sessions under stable conditions, reduce training stress temporarily. Lower the load slightly or stop short of failure for a short period. When performance stabilizes, return to full effort.

Adding more sets is not used as a first adjustment. Higher volume increases fatigue and can reduce recovery and intake.

If an exercise does not progress over time despite stable conditions, replace it with a similar movement and restart progression from the lower end of the range.

Bodyweight and performance should increase together. If performance improves without bodyweight increase, intake is not sufficient. If bodyweight increases without performance improvement, the stimulus or execution is not sufficient.

Progress comes from repeating the same movements with slightly higher output over time.

Practical direction

  • Monitor performance trends, not single sessions

  • Reduce training stress when performance declines consistently

  • Keep food intake stable during recovery periods

Recovery is not separate from training. It determines whether training produces progress or just fatigue.

Chapter 18 - Intra workout nutrition and total calorie accounting

Resistance training relies on glucose. When sessions are demanding, glycogen is used quickly and blood glucose can drop. If this is not supported, performance declines during the session and recovery is affected after it.

Intra workout carbohydrates provide a steady source of glucose during training. This keeps output more stable and reduces the need to rely on stress driven energy production.

Effect during the session

When carbohydrates are available during training, performance is more consistent from the first set to the last. Fatigue still accumulates, but the drop in output is smaller.

Without this support, repetitions fall faster, effort increases, and the session becomes less productive.

Effect on recovery

Maintaining blood glucose during training reduces the stress response associated with falling energy levels. This makes recovery more predictable and reduces the impact of the session on appetite.

When sessions are less stressful, intake after training is easier to maintain.

Liquid form and absorption

Carbohydrates are used in liquid form during training because they are absorbed quickly and do not interfere with movement.

Sodium can be added to improve fluid absorption and maintain performance. This becomes more relevant as session length increases.

Calorie accounting

Intra workout intake is often not counted as part of daily calories. This creates an error.

On training days, a portion of total intake comes from intra workout carbohydrates. On rest days, this portion is missing. If it is not replaced, total daily intake drops.

Over a week, this reduces the average surplus and slows weight gain.

Maintaining consistency

Calories consumed during training need to be accounted for and replaced on days without training.

If intake is high only on training days and low on rest days, progress becomes inconsistent.

Practical direction

  • Use liquid carbohydrates during training to support performance

  • Include these calories in total daily intake

  • Replace them on rest days to keep intake stable

Intra workout nutrition supports both performance and total intake when it is accounted for correctly.

Chapter 19 - Rest days, energy expenditure and maintaining a surplus

Rest days remove the training session, but they do not remove energy expenditure. Total intake often drops while expenditure stays similar. Over a week, this reduces the average surplus.

A common pattern is higher intake on training days and lower intake on rest days. Part of this comes from missing intra workout carbohydrates. Part comes from reduced appetite when there is no session.

If the difference is large enough, the weekly balance moves toward maintenance.

Non exercise activity

Daily movement outside of training can offset intake without being noticed. This includes walking, posture changes, and general activity.

Some people increase this activity when they eat more. Others maintain a high level regardless of intake. In both cases, part of the surplus is used without contributing to weight gain.

This is not visible in training logs, but it affects the result.

Cardio

Cardio adds expenditure without contributing to hypertrophy. In a hard gainer context, it usually needs to be limited or adjusted.

When cardio is present, intake has to account for it. If not, it reduces the net surplus.

Rest day intake

Intake should not depend on the presence of a training session. The body still requires energy to recover and to maintain a positive balance.

When intake drops on rest days, recovery slows and weekly intake becomes inconsistent.

Keeping the balance stable

The objective is to keep net energy positive across the week, not only on training days.

  • Maintain similar intake on rest days

  • Account for calories that are only present during training

  • Limit unnecessary expenditure when intake is already difficult

Practical direction

  • Keep daily intake stable across the week

  • Adjust for cardio and daily activity

  • Avoid large drops in calories on rest days

Consistency over multiple days determines the outcome, not a single high intake day.

Chapter 20 - Nutrient partitioning and directing calories toward muscle

At this stage, intake is sufficient and repeatable, digestion is stable, and energy balance is positive. The remaining variable is how that energy is used.

Partitioning refers to where calories go once they are available. They can support muscle, be stored as fat, or be dissipated through stress related processes. The same intake can produce different outcomes depending on this environment.

Role of training

Resistance training increases the demand for energy in muscle tissue. This creates a local environment where nutrients are directed toward repair and growth.

When the stimulus is clear and recovery is adequate, more of the available energy is used for muscle rather than stored.

If training is weak or inconsistent, this signal is reduced. Energy is then distributed more broadly, with a larger portion going to storage.

Carbohydrate availability and glycogen

Carbohydrates replenish glycogen in muscle. When glycogen stores are low, incoming carbohydrates are directed toward restoration. When stores are adequate and training is present, they support ongoing performance.

This cycle keeps energy moving through the system instead of accumulating in storage.

Low carbohydrate intake reduces this effect. Training output declines and the demand for glycogen decreases, which changes how nutrients are used.

Insulin sensitivity

Insulin directs nutrients into cells. When sensitivity is high, nutrients are taken up efficiently by muscle tissue.

Training improves this locally. Consistent carbohydrate intake supports it systemically.

When sensitivity is low, more energy remains in circulation and is more likely to be stored.

Stress and energy use

Stress changes how energy is handled. When stress is high, more energy is used to maintain basic functions and less is available for growth.

This appears as stable or rising intake with limited progress. The issue is not intake, but how that intake is used.

Sleep and recovery are the main variables here.

Practical direction

  • Keep training consistent and focused on high effort

  • Maintain sufficient carbohydrate intake to support glycogen and performance

  • Keep recovery stable to limit stress related energy loss

When these conditions are in place, a larger share of intake supports muscle rather than being lost or stored inefficiently.

Chapter 21 - Compounds that increase appetite and override satiety

These are used when intake remains limited after food structure, digestion and sleep have been corrected. They act on central signals that control hunger or on pathways that increase the drive to eat.

They increase intake, but they do not correct the reason intake was low. If the underlying limitation is still present, the effect is partial or short lived.

Cyproheptadine

Cyproheptadine reduces serotonin signaling and produces a clear increase in appetite. It also has a sedative effect, which can improve sleep quality when sleep is part of the problem.

The result is usually a higher meal size and more consistent intake across the day. The effect is direct and easy to evaluate.

Sedation can be limiting if the dose is too high or timing is not controlled. In that case, appetite may increase but daily activity becomes less productive.

Tolerance can develop with continuous use. The appetite effect may decrease over time, especially with daily use. Short breaks or intermittent use help maintain its effect.

MK-677

Raises ghrelin and increases hunger. Appetite rises quickly.

Limits and risks:

  • Insulin resistance over time with continuous use

  • Water retention that masks true weight gain

  • Fatigue and lethargy in some cases

  • Possible increase in prolactin in some individuals

  • No improvement in digestion, tolerance or gastric emptying

It increases hunger without improving how food is handled or where calories go. This makes fat gain more likely if intake is not controlled.

Position:

  • Not recommended as a base tool

  • Avoid when other constraints are not fully solved

  • Use only if low appetite remains after correcting sleep and diet, and even then with caution

GH and IGF-1 context

Growth hormone is often overestimated in this context.

Higher GH does not replace intake. It does not improve digestion, and it does not correct low appetite when the issue is mechanical or behavioral.

GH secretagogues can increase hunger, but they do not improve how food is handled or how nutrients are partitioned. Without sufficient intake and proper training, the effect remains limited to water retention and minor changes in body composition.

The limiting factors remain intake, digestion, recovery and training.

Mirtazapine

Mirtazapine acts centrally and increases appetite. It also has a strong sedative effect.

This combination can be useful when both sleep and intake are low. The effect is similar to cyproheptadine but generally stronger.

Sedation and daytime lethargy can limit its use, especially if training quality is affected.

Dopamine related compounds

Some individuals do not have a strong drive to eat even when energy needs are high. In these cases the limitation is not hunger itself, but the initiation of eating.

Compounds that increase dopamine signaling can change this. They can make it easier to start meals and maintain routine when motivation is low.

  • Cabergoline

  • Pramipexole

  • Selegiline

The response is not predictable. In some cases appetite improves through increased drive. In others, appetite decreases because dopamine also suppresses feeding signals. These are not reliable tools for increasing intake and are not required when the rest of the system is stable.

Cannabinoids

THC increases appetite through central pathways and can make meals easier to start. The effect is noticeable and often immediate.

However, the context matters. The increase in appetite comes with a change in how energy is handled and how behavior is organized.

  • Reduced focus and lower training quality

  • Less structured eating patterns over time

  • Tendency toward low quality food choices when appetite is driven centrally

In practice, this often leads to inconsistent intake and poorer partitioning. Calories increase, but the structure that directs those calories toward muscle is reduced.

This makes it a poor tool for this context. Appetite increases, but the outcome is not controlled.

Limits of this approach

These compounds increase intake, but they do not fix:

  • Slow gastric emptying

  • Food intolerance

  • High expenditure

  • Poor training structure

If one of these is the limiting factor, appetite can increase without a meaningful change in bodyweight.

Chapter 22 - Compounds that improve digestion and reduce gastrointestinal friction

These are used when intake is present but digestion limits how often meals can be repeated. The goal is to reduce delay and discomfort so that intake stays consistent.

They do not replace meal structure. If meals are too large, too high in fat, or poorly selected, these tools have limited effect.

Ginger and motility

Ginger supports the movement of food through the digestive tract. It does not increase capacity, but it reduces stagnation when meals feel slow to clear.

This is useful when meals are correctly structured but still produce a sense of heaviness that delays the next feeding.

The effect is usually subtle but noticeable over multiple meals.

Digestive enzymes in context

Enzymes are used when breakdown is incomplete.

Lactase allows dairy to be used without symptoms when lactose digestion is limited.
Pancreatic enzymes support mixed meals when digestion feels slow despite correct structure.
Alpha galactosidase reduces fermentation from specific carbohydrates.

The role is targeted. They remove a specific friction point rather than improving digestion in general.

Glycine and indirect effects

Glycine does not act as a digestive agent, but it reduces stress and improves sleep. This has an indirect effect on digestion.

When the nervous system is less activated, digestion tends to be more stable. Meals are processed with fewer symptoms and appetite is more consistent.

This is more noticeable when stress or poor sleep is already present.

Lysine and its effect on appetite and stress

Lysine is not a primary driver, but it can be useful in specific situations.

It interacts with stress pathways. In some individuals, it reduces the stress response and improves appetite indirectly. When appetite is low due to stress or tension rather than digestion, this can make meals easier to start and finish.

It also supports protein balance. When intake is high in carbohydrates and lower in protein, lysine ensures that protein quality is not limiting. This is more relevant when dairy or animal protein intake is inconsistent.

The effect is not strong enough to fix low intake on its own. It works when the limiting factor is mild stress or suboptimal protein quality, not when appetite is suppressed by poor sleep or digestion issues.

Betaine HCl

Protein digestion begins in the stomach and depends on adequate acidity. When stomach acid is low, meals feel heavier and take longer to process even when their composition is correct.

Betaine HCl is used in this context. It improves the initial breakdown of food and can reduce the feeling that meals “sit” for too long. This allows appetite to return at a more predictable time.

It is not required when digestion is already fast and comfortable. Its role is limited to cases where low stomach acid is part of the problem.

Taurine

Taurine supports bile flow and helps with fat digestion. When fat is not handled efficiently, meals feel slower and less comfortable, which reduces the next feeding.

In this context, taurine can make meals easier to process without changing their composition. The effect is indirect but noticeable when fat digestion is a limitation.

It does not increase appetite directly, but it reduces friction in the system.

Limitations

These tools do not fix:

  • High fat intake slowing gastric emptying

  • Excessive meal volume

  • Poor meal timing

  • High energy expenditure

If these are not addressed, improvements remain limited.

Practical direction

  • Use motility support when meals feel slow despite correct structure

  • Use enzymes for specific foods that consistently create symptoms

  • Use glycine when stress and sleep are affecting digestion

They are used to remove specific points of resistance so that intake can be repeated without interruption.

Chapter 23 - Compounds that support absorption and gut integrity

These are used when intake is stable and digestion is acceptable, but results are inconsistent. The objective is to make absorption more reliable and reduce variability from one day to the next.

They are not required when progress is already steady.

Zinc and basic support

Zinc affects appetite, taste perception and general metabolic function. Low levels reduce food intake and make meals less appealing.

Correcting it often improves appetite slightly and makes intake easier to maintain. The effect is not immediate, but it becomes noticeable over time.

Zinc carnosine

Zinc carnosine is used for local support of the gut lining. When irritation or instability is present, it helps reduce symptoms and improves tolerance to food.

This becomes relevant when meals are correct but still produce discomfort that limits intake.

Lactoferrin

Lactoferrin binds iron and limits its availability to certain bacteria. This can reduce the growth of strains that contribute to instability.

The effect is indirect. As the balance shifts, digestion becomes more predictable and symptoms that reduce intake appear less often.

Butyrate

Butyrate supports the gut lining, but it is linked to fermentation. In some individuals it improves stability. In others it increases gas and pressure.

The response determines its use. If symptoms increase, it does not help intake even if the mechanism is considered beneficial.

Probiotics

Probiotics aim to improve microbiome balance. Effects vary between individuals and depend on the starting point.

Some strains improve tolerance and reduce symptoms. Others have little effect.

S. boulardii is often used for stability after disruption. L. reuteri is used to support balance over time.

Adding multiple strains at once makes it difficult to identify what works.

B vitamins

B vitamins support energy production, but thiamine is the most relevant in this context.

Thiamine is required for carbohydrate metabolism. When intake is high in carbohydrates, the demand for thiamine increases. If it is not sufficient, glucose is not used efficiently. This shows as lower energy, reduced training output and a gradual drop in appetite.

Thiamine also has a role at the gut level. It supports motility and helps maintain a stable digestive rhythm. When levels are low, digestion can feel slower, meals sit longer, and fermentation tends to increase. This creates bloating and reduces the next meal.

In this situation, the issue is not intake itself but how food is processed and moved through the system. Appetite decreases because digestion becomes less predictable.

Correcting thiamine improves both sides. Energy production becomes more efficient and digestion becomes more stable. Meals clear faster, appetite returns at expected times and intake becomes easier to maintain.

Other B vitamins still matter, but their effect is less direct. Thiamine is the one that most closely links carbohydrate intake, gut function and appetite.

BPC-157

BPC-157 is used for tissue repair, including the gastrointestinal lining. In this context, it is considered when digestion is unstable despite correct food structure.

The expected effect is improved tolerance to food. Meals that previously caused irritation or discomfort become easier to handle. This can allow intake to remain consistent across days.

The effect is not immediate and not always consistent. It does not increase appetite directly and does not affect gastric emptying in a reliable way. Its role is limited to situations where irritation or instability is suspected.

It is not required when digestion is already stable. It does not replace adjustments in meal composition or structure.

Limitations

These compounds do not increase intake directly. They do not fix slow gastric emptying or high expenditure.

They are used when inconsistency in digestion or absorption is the limiting factor.

Practical direction

  • Correct basic deficiencies first

  • Introduce one compound at a time

  • Keep only what produces a clear effect

The objective is stable absorption that allows intake to translate into progress.

Chapter 24 - Compounds that support performance, recovery and nutrient use

These are used once intake and digestion are stable. The role here is to make training more effective and to support how nutrients are used, not to increase appetite.

Creatine

Creatine increases the availability of rapid energy in muscle. This improves performance on repeated efforts and helps maintain output across sets.

With more consistent output, the training stimulus becomes more reliable. This supports muscle retention and growth when energy intake is sufficient.

It also increases intracellular water in muscle, which is often seen as a small increase in bodyweight. This is not the primary goal, but it reflects increased storage within muscle tissue.

Electrolytes in performance context

Sodium and potassium support muscle contraction and fluid balance. When they are adequate, performance remains stable across the session.

When they are low, fatigue appears earlier and output drops. This reduces the effectiveness of training and can indirectly reduce appetite by making sessions more demanding.

Electrolytes do not increase intake, but they help maintain the conditions where intake can be used effectively.

Interaction with recovery

Better performance increases the quality of the stimulus, but it also increases the need for recovery.

When intake is sufficient, this leads to adaptation. When intake is borderline, the additional demand can increase fatigue.

This is why these compounds are placed after intake and digestion are stable.

Limitations

These do not fix low appetite, poor digestion or high expenditure. They do not replace food.

Their effect is only visible when the rest of the system is already in place.

Practical direction

  • Use creatine to stabilize performance across sessions

  • Maintain electrolyte balance to support output

  • Ensure intake matches the increased demand

They improve how training translates into growth, but only when energy is available.

Chapter 25 - Low priority and situational compounds

These are often added early, but they rarely change the outcome. They can have effects, but those effects are small compared to intake, digestion, sleep, and training.

They are considered only after the main constraints are stable.

Fenugreek

Fenugreek is used for appetite or metabolic effects. In practice the response is variable.

Some individuals notice a small increase in hunger. Others see no change. The effect is not strong enough to compensate for low intake caused by poor meal structure or digestion.

It can be used if a mild increase in appetite is needed, but it does not solve a limiting problem.

General “gut health” stacks

These combine multiple ingredients with the aim of improving digestion or microbiome balance.

The issue is not the concept, but the lack of precision. When several compounds are introduced at once, it becomes difficult to identify what works.

If digestion is already stable, these do not improve intake. If digestion is unstable, targeted approaches are more effective.

Other minor interventions

Many supplements fall into this category. They may influence one part of the system slightly, but the effect is not large enough to change bodyweight or performance.

When used without a clear reason, they add complexity without improving results.

Practical direction

  • Use these only after higher impact variables are stable

  • Avoid adding multiple low impact compounds at the same time

  • Remove them if no clear effect is observed

They can be used as adjustments, not as solutions.

Chapter 26 - Building a minimal effective system

At this point all variables have been covered. Most of them are not required at the same time.

The system works when a small number of conditions are met and kept stable. Adding more elements does not improve results if these conditions are not already in place.

Base structure

A minimal setup is built around a few points.

  • Intake is high enough and repeated daily

  • Meals are easy to finish and do not create residual fullness

  • Carbohydrates form the base of intake, fat is kept low enough to avoid slowing digestion

  • Training is performed with high effort and controlled volume

  • Sleep is stable and allows recovery

When these are in place, bodyweight and performance increase without additional tools.

Adjustments when needed

If progress stops, the adjustment depends on what changed.

If intake drops, meal structure is the first variable to check.
If meals become harder to repeat, digestion is the next step.
If intake is stable but weight does not move, expenditure is usually the cause.
If performance drops, recovery or training volume needs to be adjusted.

Each change is linked to a specific constraint. Adding unrelated variables does not help.

Avoiding unnecessary complexity

Most issues come from trying to fix several levels at once.

Adding supplements, changing diet structure and increasing training at the same time makes it difficult to identify what works. It also increases fatigue and reduces consistency.

A simpler system is easier to maintain and easier to adjust.

Practical direction

  • Keep the base structure stable

  • Change one variable at a time

  • Remove what does not produce a clear effect

The objective is not to use every tool. It is to remove the limiting factor with the smallest effective change.

Chapter 27 - Scaling intake while maintaining digestion and appetite

Once a baseline intake is established, increasing calories has to be done without disrupting digestion or reducing appetite. Rapid increases often create fullness, slow gastric emptying, and make meals harder to repeat. Intake becomes inconsistent and total calories drop over the week.

Progress is more reliable when intake is increased in small steps that the system can absorb without changing how meals feel.

How to increase intake

Add calories where they create the least resistance.

  • Increase carbohydrates before increasing fat

  • Add liquid calories before increasing meal size

  • Distribute additional intake across meals instead of concentrating it

These adjustments keep digestion stable while total intake rises.

When increases fail

If a small increase reduces appetite or creates fullness, the issue is not the number of calories. It is how they are added.

Large additions to a single meal increase pressure and delay the next feeding. Increasing fat slows the entire process. Adding volume without density creates early satiety.

In these cases, the increase has to be redistributed rather than reduced.

Monitoring response

The response to an increase is seen over several days.

  • Meals should feel similar to before

  • Appetite should return at expected times

  • Bodyweight should trend upward over time

If meals become harder to finish or appetite drops, the increase is too aggressive or poorly placed.

Maintaining digestion

Digestion should remain stable as intake increases.

If symptoms appear, the first step is to adjust structure, not to reduce calories immediately. Changing the source or timing of the added calories often resolves the issue.

Practical direction

  • Increase intake gradually

  • Prioritize changes that do not affect meal comfort

  • Keep digestion stable while calories rise

Scaling intake is not about pushing as much food as possible. It is about increasing calories while keeping the system unchanged.

Chapter 28 - Troubleshooting plateaus and common issues

When progress stops, the cause is usually simple but not always visible. The same symptoms can come from different points in the system, so the first step is to check what actually changed.

A plateau is defined by stable intake and stable bodyweight over time. If intake is not stable, it is not a plateau.

No weight gain despite eating enough

When intake looks sufficient but weight does not move, the issue is often on the expenditure side.

  • Daily activity increased without being noticed

  • Training volume increased and raised total expenditure

  • Rest day intake dropped compared to training days

If intake and digestion are stable, this is the first place to look.

Meals becoming harder to finish

When meals feel heavier or appetite drops, the issue is usually related to digestion or meal structure.

  • Fat intake increased and slowed gastric emptying

  • Meal volume increased too quickly

  • Food selection changed and reduced tolerance

Reducing volume or redistributing calories often restores intake.

Digestive discomfort appearing over time

When digestion becomes inconsistent, intake follows the same pattern.

  • Food that was tolerated becomes harder to process

  • Bloating or pressure reduces the next meal

  • Meal timing becomes irregular due to symptoms

This points to digestion speed, tolerance or gut stability rather than intake itself.

Performance dropping in training

When output decreases, appetite often follows.

  • Accumulated fatigue from excessive volume

  • Insufficient recovery or poor sleep

  • Low carbohydrate availability

Reducing training stress or improving recovery usually restores both performance and intake.

Excess fat gain

When weight increases too quickly and body composition changes unfavorably, the issue is not intake alone but how it is structured.

  • Fat intake is too high relative to carbohydrates

  • Total surplus is larger than required

  • Training stimulus is not sufficient to direct nutrients

Adjusting composition and stimulus corrects this without reducing intake excessively.

Practical approach

Check intake first.
Then check digestion and meal structure.
Then check expenditure and recovery.

Only after these are stable should other variables be considered.

Plateaus are rarely complex. They are usually a missed change in one of the main constraints.

High intake example day

This is a working structure built to reach high intake without relying on large meals.

Most calories come from liquids and dense carbohydrates placed between meals.
Meals stay simple so they do not interfere with the next one.

Morning

Start without creating fullness.

Coffee with 300 to 400 ml skim milk, lactose-free if needed.
Add 20 to 30 g sugar or honey.

Drink 400 to 600 ml orange juice or apple juice alongside it.

This starts intake early without slowing digestion.

First meal

Keep it predictable.

White rice, around 70 to 90 g dry weight.
Lean protein, around 100 to 150 g.
Salt added.

Rice is used because it is easier to repeat than potatoes and creates less fullness for the same calories.

If the meal feels heavy, reduce protein slightly before touching carbohydrates.

Between meals

This is where most intake is built.

Drink 500 to 700 ml chocolate milk.
Lactose-free if digestion is not perfect.
Drink it quickly.

Add 80 to 120 g dried fruit such as dates or raisins.

If needed, add 5 to 10 g candied ginger during the day when food starts to sit longer than expected.

This block alone can add over 150 g carbohydrates without affecting the next meal.

Second meal

Same structure.

White rice or low-fiber pasta.
Lean protein.
Low fat.

Keep portions similar to the first meal.

If appetite drops here, it usually means the previous block was too heavy or too slow.

Pre training

Keep it light.

300 ml juice or a small cola.
If needed, add a small portion of rice cakes or low-fat cereal.

No fat and no large meal.

During training

30 to 50 g carbohydrates in liquid form.
Juice, dextrose or similar.

Add salt to support fluid absorption.

This keeps output stable without increasing stress.

Post training

Keep digestion fast.

400 to 600 ml juice or chocolate milk.
Add a low-fat protein source if needed.

Avoid fat here. The next meal should not be delayed.

Evening meal

Same structure again.

Rice, bread or pasta.
Lean protein.
Low fat.

If intake is still low, add something easy at the end.

Sorbet or low-fat ice cream works because it adds calories without slowing digestion.

Late intake

If total intake is still below target, add another liquid block.

Juice, cola or milk.

This is usually enough to reach 700 to 800 g carbohydrates without increasing meal size.

Daily intake range

Carbohydrates typically fall between 650 and 850 g depending on portions.

Protein stays moderate.
Fat remains low.

The structure allows scaling without changing the meals.

Minimal stack

Used only when a limitation appears.

Betaine HCl, 300 to 600 mg with meals if digestion feels slow.
Candied ginger, 5 to 10 g during the day if food sits too long.

Lactoferrin, 100 to 200 mg, or butyrate, 300 to 600 mg, when digestion is unstable.

Glycine, 3 to 5 g before sleep.
Lysine, 1 to 2 g if appetite is affected by stress.

Creatine, 3 to 5 g daily.

Cyproheptadine, 0.5 to 1 mg before sleep.

Execution

Liquids are consumed quickly, not sipped.

Meals stay simple.
If one meal delays the next, it is too heavy.

If intake is too low, add another liquid block before increasing meal size.

If digestion slows, reduce fat and protein before reducing carbohydrates.

Weekly Check and Adjustment System

Evaluate once every 7 days under the same conditions.

What to track

Bodyweight

  • Weigh daily under the same conditions

  • Use the weekly average

Meal completion

  • Count missed or incomplete meals

Digestion

  • Note recurring issues such as heaviness, bloating or delayed hunger

Training performance

  • Use the same exercises and execution

  • Track repetitions at a fixed load

1. Bodyweight

  • If the weekly average did not increase, move to intake

  • If it increased, move to performance

2. Intake

If meals were not completed

  • Do not increase calories

  • Reduce meal volume

  • Reduce fat per meal

  • Add liquid calories

  • Adjust meal timing

If meals were completed

  • Increase intake by +200 to +300 kcal per day

  • Keep structure unchanged

3. Performance

If performance is increasing

  • No change

If performance is flat or decreasing

  • Keep calories unchanged

  • Lower load slightly

  • Or stop 1–2 reps before failure

  • Or reduce total exercises

4. Digestion

If digestion limits intake

  • Reduce fat per meal

  • Simplify meals

  • Control fiber and volume

  • Separate fluids from meals

  • Use liquid carbohydrates

Do not increase calories until meals are repeatable

5. Rules

Do not change calories and training in the same week
Do not react to a single day
Do not increase calories if meals are not completed
Do not reduce food when fatigue increases
Do not add volume as a first adjustment

Make one change per week

6. Target

Bodyweight should increase slowly and consistently
Performance should increase over time

If performance increases without bodyweight increase

  • Increase intake

If bodyweight increases without performance increase

  • Reduce fatigue

Final

When progress stops, check in order

Meal completion
Intake level
Digestion
Recovery
Training stress

Fix the first limiting factor and keep the rest unchanged

Conclusion - What actually determines progress

Progress depends on a small number of variables that have to stay stable over time.

Intake has to be high enough and repeatable.
Expenditure has to stay below intake.
Digestion has to allow meals to be repeated without discomfort.
Recovery has to support training.
Training has to provide a clear stimulus without excessive fatigue.

When these conditions are met, bodyweight and performance increase. When one of them is unstable, progress stops.

Most of the system is built around removing friction. Meals become easier to finish. Digestion becomes predictable. Training becomes repeatable. Intake stays consistent across days.

Additional tools only matter when they remove a specific limitation. Without that, they do not change the result.

The structure does not need to be complex. It needs to be stable.

Once the main constraints are handled, progress becomes a matter of time and consistency.

This Substack is reader-supported. To receive new posts and support my work, consider becoming a free or paid subscriber.

]]><![CDATA[Beyond Calories : The Complete Metabolic Guide to Sustainable Fat Loss - Part III — Pharmacology of Fat Loss]]>https://articles.berbarianwizard.com/p/beyond-calories-fat-loss-guide-part-3https://articles.berbarianwizard.com/p/beyond-calories-fat-loss-guide-part-3Mon, 09 Mar 2026 10:49:08 GMTIntroduction : Optional Tools, Not Necessary Ones

You can get lean without any of the compounds in this article. If you have not read Part I and Part II, start there. They explain the foundations you cannot replace with shortcuts.

I wrote this part for a narrow situation. You already built a working diet. You already train in a way that preserves muscle. You already optimized your sleep. Then you hit the zone where fat loss slows down and the usual levers create more stress than progress. In that case, you may start looking at optional accelerators.

Keep a clear frame. These are tools. They come with a price. If you use them, you pay somewhere. The only question is whether you understand the trade and whether the trade makes sense for your current body composition, stress level, and goals.

Fat Loss Is Already Possible With Nutrition and Training Alone

Fat loss works when you create a steady negative energy balance while keeping your metabolism stable and your muscle intact. You can do that with food, training, walking, sleep, and a sane routine. That is why Part I and Part II exist. They are the base layer that makes everything else optional.

If your basics are weak, adding drugs tends to create a false sense of progress. You see the scale move. You lose water. You lose glycogen. You lose sleep. You lose patience. Then you lose muscle and rebound. That cycle looks like “fat loss” in the short term, then looks like confusion in the mirror.

The leaner you get, the more you need to think like a systems engineer. You do not “push harder” forever. You manage constraints.

Why Some People Still Look for Additional Levers

You will see 2 profiles.

The first profile wants a shortcut while sitting above 15% body fat. They want a pill to compensate for inconsistent diet, poor sleep, low daily movement, and weak training. That profile does not need an accelerator. They need the foundations, and they need time. If you are in that zone, read Part I and Part II, apply them for weeks, then reassess.

The second profile already did the boring work. They built muscle, improved insulin sensitivity, fixed food quality, and learned how to diet without chaos. They are often already lean. They can lose fat, but the last stretch starts demanding disproportionate sacrifice. That is where people start investigating compounds, usually to reduce the stress cost of continued fat loss or to overcome stubborn areas that resist normal approaches.

The Purpose of This Article: Mechanisms, Context, and Risks

This is a physiology-first piece. You will see mechanisms, expected effects, common failure points, and risk tradeoffs. I will keep coming back to a single rule because it prevents most mistakes.

Always think “benefit to risk ratio” Not the hype. Not the fear. Not the forum folklore. The ratio.

You will also see my personal bias clearly. I lean Peat in worldview. I care about thyroid function, stress hormones, sleep quality, and long-term metabolic stability. At the same time, I accept rapid short fat loss in a narrow context when you manage stress well and you already sit below 15% body fat. That context matters more than the compound.

From Metabolism to Fat Burners

What Part I Explained About Energy Metabolism

Part I explains how fuel selection, stress hormones, and dietary structure shape fat loss outcomes. It also frames why “calories” often fail as a complete explanation when your metabolism adapts and your behavior changes with restriction. If you skip that base, you will misinterpret what these compounds are doing.

What Part II Explained About Training and Lifestyle

Part II shows you how training protects muscle, improves nutrient partitioning, and supports fat loss without forcing you into endless cardio. It also covers how daily habits steer stress and recovery, which directly changes your ability to keep losing fat without breaking down. If you do not train correctly, many “fat loss” approaches simply become muscle loss dressed as progress.

Why This Article Is Only About Optional Accelerators

You do not need this part to get lean. You read this because you want to understand what these compounds do, why they sometimes work, why they often backfire, and how to judge them without emotion.

If you want a simple takeaway, keep this in mind.

If you are above 15% body fat, you do not need accelerators. You need fundamentals. That is why Part I and Part II come first.

Who This Article Is For

Already Lean Individuals Trying to Get Leaner

Once you get lean, the body defends harder. Hunger rises. Sleep becomes fragile. Libido can drop. Training feels heavier. Your brain looks for relief. If you push the wrong way, you lose muscle and you keep the same “look” because the physique depends on muscle fullness and proportions, not only scale weight.

At this stage, you care less about speed and more about control.

Athletes Near Single Digit Body Fat

If you are pushing toward single digits, you enter a zone where tradeoffs become unavoidable. You can do it, but you need to plan the cost and limit the duration. That is why I will keep repeating the idea of short mini-cuts later in this article. Long runs at extreme leanness degrade performance and mood in most people.

People With a Healthy Metabolism and Thyroid Function

If your thyroid function is weak, your sleep is unstable, and you live under chronic stress, most accelerators amplify chaos. You can “force” weight loss while degrading your system, then rebound or end up with a worse baseline. Fixing the baseline gives you a better body with less drama.

If you are unsure, return to Part I and Part II first.

Who Should Never Use These Compounds

Individuals Above 12–15% Body Fat

If you are above 15% body fat, your best fat loss returns come from the basics. You can lose fat fast already. You do not need extra stress, extra heart strain, extra sleep disruption, or appetite chaos. You also do not need a mindset that trains you to seek shortcuts instead of building competence.

A simple rule keeps you safe.

If you are not already lean, do not use rapid fat loss drugs.

People With Poor Sleep or High Stress

Many fat burners work by raising catecholamines or by forcing higher energy turnover. Both tend to collide with sleep. Once sleep breaks, fat loss quality breaks. Your cravings rise. Your training degrades. Your mood shifts. The cut stops being clean.

You cannot “out-supplement” poor sleep. That is why Part II matters.

People With Thyroid or Metabolic Dysfunction

If your metabolism already struggles, pushing stimulants or thyroid without structure often creates a short-term illusion followed by long-term dysfunction. You may “lose weight” while feeling worse, then regain. That outcome is common because the intervention does not address the baseline. It attacks symptoms.

Return to Part I and fix the metabolic layer first.

People Looking For Effortless Fat Loss

Effortless fat loss tends to mean one of 2 things.

You suppress appetite so hard you eat less without noticing, then you pay with fatigue, nausea, or muscle loss.

You force energy expenditure up, then you pay with stress, sleep disruption, or heat intolerance.

Either way, the cost shows up.

The First Warning : Rapid Fat Loss Comes With Real Costs

The Difference Between Fat Loss and Weight Loss

The scale moves for multiple reasons. Water shifts. Glycogen shifts. Gut content changes. Inflammation changes. Fat loss is slower and more stable. When you add aggressive tools, weight can fall faster than fat.

A useful frame is simple.

Your goal is fat loss while maintaining muscle. You care about the mirror, strength, and how you function. The scale is data, not a verdict.

The Hidden Cost of Aggressive Fat Loss

Aggressive fat loss often increases stress hormones. That can accelerate weight loss in the short term, then degrade recovery and muscle retention. People confuse the early speed with effectiveness. They forget to measure the cost.

The cost usually shows up as some combination of poor sleep, irritability, cold extremities, reduced training performance, weaker libido, or hair shedding. That is your system telling you it is paying.

Why Stress Hormones Can Drive Short-Term Fat Loss

Adrenaline mobilizes fuel. Cortisol keeps blood glucose stable under perceived threat. When dieting feels like threat, these signals rise. They can help you lose weight fast. They can also push you into a state where you do not recover and you do not build.

Cortisol, Adrenaline and Muscle Loss

Muscle is expensive tissue. When stress stays high and calories stay low, your body looks for ways to lower the bill. You can protect muscle with training and protein, but stress can still tilt the balance.

That is why I keep anchoring the conversation in benefit to risk ratio. If a compound helps fat loss but pushes chronic adrenaline, your physique can worsen even as the scale improves.

Why Rapid Fat Loss Is Only Appropriate For Already Lean Individuals

How Fat Loss Physiology Changes at Low Body Fat

When body fat drops, the physiology of fat loss changes. Your body does not treat the first 10 kilograms of fat the same way it treats the last 3. Early fat loss often happens easily because the body still has abundant energy reserves and hormonal signals remain stable. As you get leaner, the system becomes defensive.

Leptin drops. Thyroid output can fall. Hunger signals increase. Stress hormones rise more easily. The body begins to treat continued fat loss as a threat to stability.

You notice the shift in simple ways. Your appetite increases even when calories remain adequate. Sleep becomes lighter. Training sessions require more focus to maintain performance. The body becomes efficient at conserving energy.

At that stage, fat loss is no longer a simple calorie calculation. It becomes a hormonal and metabolic negotiation.

This is why aggressive tools are sometimes discussed in already lean individuals. They can temporarily bypass some of the defensive adaptations that appear when fat levels are low.

The context matters. The goal is not permanent reliance. The goal is a short controlled phase where fat loss continues without excessive metabolic slowdown.

Hormonal Risks When Body Fat Is Still High

When body fat is still elevated, the body does not need aggressive interventions to lose fat. The system already has sufficient energy reserves and fat oxidation can increase simply through dietary changes and training.

Using powerful fat loss compounds at that stage often introduces unnecessary stress.

A stimulant that raises adrenaline may reduce appetite and increase energy expenditure, but if the same fat loss could be achieved with a moderate calorie deficit and increased activity, the stimulant provides little benefit while adding physiological strain.

The same logic applies to thyroid manipulation or mitochondrial uncoupling. These mechanisms can accelerate energy expenditure, but when body fat is still high the metabolic system rarely requires that level of intervention.

The cost then outweighs the benefit.

This is why individuals above roughly 12–15% body fat should focus entirely on the fundamentals described in Part I and Part II.

Why These Compounds Are Not Designed For Obesity

Many compounds discussed in fat loss circles originate from bodybuilding, sports physiology, or metabolic research models. They were not designed as casual tools for people beginning a fat loss journey.

In bodybuilding contexts, the compounds often appear during the final phase of preparation when body fat is already low and the goal is to refine conditioning.

In metabolic research, compounds are often studied to understand how cells regulate energy expenditure, insulin sensitivity, or mitochondrial efficiency.

The purpose is not convenience. The purpose is mechanistic intervention.

Using those tools while the metabolic basics remain unresolved produces inconsistent outcomes. The person may lose weight quickly but without improving the underlying metabolic environment.

When the compound is removed, the system returns to the same conditions that produced fat gain originally.

Understanding this distinction protects you from a common trap. Fat loss drugs can move weight quickly. They do not fix the metabolic environment that determines long-term body composition.

Short Mini-Cuts vs Long-Term Use

Why Short Aggressive Cuts Can Be Useful

A mini-cut is a short period of aggressive fat loss designed to remove a small amount of fat quickly while preserving muscle mass.

The time frame is usually limited. A few weeks rather than months.

This strategy appears frequently in athletes and physique competitors. The reason is simple. Prolonged dieting often produces cumulative stress. Hormones shift. Sleep deteriorates. Training intensity drops.

Short aggressive phases can sometimes reduce total stress because the intervention ends before major metabolic slowdown develops.

In that context, certain compounds may support the process by increasing energy expenditure, mobilizing stubborn fat, or maintaining metabolic rate.

The key element is duration. The goal is temporary acceleration, followed by a return to normal eating and training patterns.

Why Chronic Use of Fat Loss Drugs Is a Bad Strategy

Long-term reliance on stimulants or metabolic drugs often creates adaptation.

Adrenergic receptors downregulate. Thyroid signaling becomes dysregulated. Appetite hormones fluctuate. The nervous system becomes more sensitive to stress.

When the compounds are removed, energy expenditure drops while hunger remains elevated. The result is often rapid weight regain.

Many individuals interpret that rebound as a personal failure. In reality it reflects physiological adaptation.

The body adapts to repeated pharmacological stress just as it adapts to repeated caloric restriction.

Short cycles limit that adaptation. Long cycles amplify it.

The Metabolic Damage of Long-Term Stimulant Use

Chronic stimulant use affects multiple systems simultaneously.

The nervous system remains in a state of elevated sympathetic activation. Heart rate increases. Sleep quality decreases. Cortisol can remain elevated.

When sleep deteriorates, insulin sensitivity declines and appetite signals increase. The same compound that initially assisted fat loss begins to interfere with the process.

This pattern appears frequently in people who rely on stimulants throughout extended dieting phases. The early results feel promising. Later stages become difficult because recovery, mood, and sleep degrade.

This is another example of benefit versus risk ratio.

A short intervention may produce a positive tradeoff. Long-term use usually reverses it.

The Second Warning : Fat Burners Do Not Replace Fundamentals

Nutrition and Training Remain the Primary Drivers of Fat Loss

Fat burners operate on top of an existing metabolic environment. They modify energy expenditure, lipolysis, or hormonal signaling.

They do not create fat loss in isolation.

If caloric intake remains excessive or if training fails to stimulate muscle retention, the compound cannot compensate indefinitely. At best it temporarily masks the underlying imbalance.

This is why the foundations described in Part I and Part II remain essential.

Why Metabolic Health Must Be Addressed First

Metabolic health determines how your body responds to energy intake, stress, and training.

Individuals with stable blood glucose regulation, good sleep quality, and adequate thyroid function typically respond well to moderate dieting strategies.

Individuals with metabolic dysfunction often experience the opposite. Hunger remains elevated, fatigue appears quickly, and fat loss becomes inconsistent.

Adding aggressive compounds in that state tends to amplify symptoms rather than solve them.

Improving metabolic health often reduces the need for additional tools. Many people discover that once sleep, diet quality, and training are optimized, fat loss proceeds at a sustainable pace.

Thyroid Function and Fat Oxidation

Thyroid hormones regulate metabolic rate and influence how efficiently cells use oxygen to produce energy.

Low thyroid activity often correlates with reduced metabolic rate, increased fatigue, and difficulty maintaining body temperature. Fat loss becomes slower because cellular energy turnover decreases.

Maintaining adequate thyroid function supports the body’s ability to oxidize fat while preserving muscle.

This is one reason why extreme calorie restriction frequently backfires. Severe energy restriction can suppress thyroid output, lowering metabolic rate and increasing fatigue.

Understanding thyroid physiology prevents many dieting mistakes.

Sleep and Circadian Rhythm Control Fat Loss

Sleep influences almost every hormonal signal involved in fat loss.

Insulin sensitivity declines when sleep becomes fragmented. Appetite hormones such as ghrelin increase. Leptin decreases. Cortisol rises earlier in the morning and remains elevated throughout the day.

These changes increase hunger while reducing metabolic efficiency.

Circadian rhythm disruption produces similar effects. Exposure to artificial light late at night, irregular sleep schedules, and chronic stress can all alter metabolic signaling.

This is why improving sleep often produces visible changes in body composition without any pharmacological intervention.

When sleep remains unstable, aggressive fat loss compounds often magnify the problem.

How Fat Burners Actually Work

Energy Balance at the Cellular Level

Energy balance ultimately occurs inside cells. Nutrients enter metabolic pathways, generating ATP that fuels cellular processes.

When energy intake exceeds expenditure, excess energy is stored. When expenditure exceeds intake, stored energy is mobilized.

Fat burners modify this balance by altering how cells handle fuel. Some increase energy expenditure. Others increase fat mobilization from adipose tissue. Some change cellular signaling pathways that regulate metabolism.

Understanding these mechanisms allows you to evaluate compounds logically rather than emotionally.

ATP Production and Energy Efficiency

Cells produce ATP primarily through mitochondrial oxidative phosphorylation.

In this process, electrons travel through the electron transport chain, creating a proton gradient across the inner mitochondrial membrane. That gradient drives ATP synthesis through ATP synthase.

The system normally operates efficiently. Most energy from nutrients becomes usable ATP.

Certain compounds interfere with this efficiency. They allow protons to leak across the membrane without producing ATP.

The result is increased fuel consumption. Cells burn more substrate to generate the same usable energy.

This phenomenon forms the basis of mitochondrial uncoupling, a mechanism that appears frequently in discussions of fat loss compounds.

Increasing Energy Expenditure Without Eating Less

When mitochondrial efficiency decreases, the body must oxidize more fuel to maintain the same level of ATP production.

Energy expenditure rises. Heat production increases. Fat oxidation often increases as well.

In theory, this allows fat loss without reducing caloric intake.

In practice, the body still adapts. Appetite may increase to compensate for higher energy expenditure. Heat tolerance becomes a factor. Electrolyte balance becomes more important.

Understanding these physiological responses prevents unrealistic expectations.

Why Stubborn Fat Exists

Alpha-2 vs Beta Adrenergic Receptors

Not all fat tissue behaves the same way. Some areas release fat easily when you diet. Other areas resist even when your overall body fat is already low. That phenomenon is commonly called stubborn fat, and it has a physiological explanation.

Fat cells respond to catecholamines such as adrenaline and noradrenaline through adrenergic receptors. These receptors regulate lipolysis, the process that releases fatty acids from adipose tissue.

Two receptor families matter most.

Beta adrenergic receptors stimulate lipolysis. When they are activated, fat cells release stored fatty acids into circulation where they can be oxidized for energy.

Alpha-2 adrenergic receptors inhibit lipolysis. When they dominate the signal, fat cells resist releasing fatty acids.

Different fat depots contain different ratios of these receptors. Areas with a higher density of alpha-2 receptors respond weakly to the same hormonal signals that trigger fat release in other regions.

That is why fat loss does not occur uniformly across the body. The abdomen, lower back, hips, and lower body often contain higher alpha-2 receptor density, making those areas slower to respond during dieting.

Blood Flow Differences in Fat Tissue

Blood flow also influences how easily fat can leave a particular depot.

Adipose tissue with strong circulation receives more oxygen and more hormonal signaling. Fatty acids released from those cells enter circulation efficiently and can be oxidized by muscles and other tissues.

Stubborn fat areas often display reduced blood flow, especially under conditions of low calorie intake and elevated stress hormones. When circulation decreases, mobilized fatty acids remain trapped locally rather than entering the bloodstream efficiently.

Cold extremities during dieting provide a simple example of this phenomenon. Reduced circulation reflects sympathetic nervous system activation and peripheral vasoconstriction.

In stubborn fat depots, similar microvascular patterns can reduce fat mobilization efficiency.

Some stubborn fat strategies have historically attempted to improve adipose blood flow during fat loss phases.

Vasodilatory compounds such as niacin or nitric-oxide–promoting nutrients have occasionally been discussed in this context.

The theoretical goal is to increase circulation within adipose tissue so that mobilized fatty acids can enter systemic circulation more efficiently.

In practice, however, the metabolic impact of these approaches appears modest compared with the adrenergic mechanisms discussed earlier.

Hormonal Sensitivity of Stubborn Fat Areas

Hormones influence fat distribution as well.

Estrogen, cortisol, insulin, and catecholamines all shape where fat accumulates and how easily it leaves.

For example, elevated insulin blocks lipolysis regardless of adrenergic receptor signaling. Cortisol can shift fat storage patterns toward visceral regions. Estrogen influences fat distribution in the lower body.

These hormonal influences interact with receptor density and blood flow. The result is a system where some fat depots respond quickly to diet while others require more time or stronger signals to mobilize.

Understanding this model explains why some compounds target alpha-2 receptor antagonism or catecholamine signaling.

They attempt to change the balance between inhibitory and stimulatory signals in stubborn fat regions.

The Stubborn Fat Model

Adrenergic Control of Lipolysis

Lipolysis depends heavily on adrenergic signaling.

When catecholamines bind to beta receptors, cyclic AMP increases inside fat cells. This activates hormone sensitive lipase and other enzymes responsible for releasing fatty acids from triglycerides.

Those fatty acids then leave the fat cell and circulate through the bloodstream.

From there, tissues capable of oxidation such as skeletal muscle can use them as fuel.

The process looks simple on paper. In reality it competes with opposing signals.

Alpha-2 receptor activation suppresses cyclic AMP production, reducing lipolysis even when catecholamines are present. High insulin levels also suppress lipolysis by activating phosphodiesterase enzymes that degrade cyclic AMP.

The balance between these signals determines whether fat leaves the cell.

Why Insulin Blocks Fat Mobilization

Insulin is a powerful regulator of nutrient storage.

When insulin levels rise, the body interprets that signal as an environment of nutrient availability. Under those conditions, lipolysis slows down and fatty acid release decreases.

This mechanism protects the body from excessive circulating fatty acids after meals.

During fat loss phases, however, elevated insulin can interfere with stubborn fat mobilization. If insulin remains high, alpha-2 receptor dominance becomes even stronger, making lipolysis less responsive.

This explains why some stubborn fat strategies emphasize fasted conditions, where insulin levels remain low and adrenergic signaling can operate more freely.

Fasted Conditions and Fat Burning

Fasted states alter several hormonal variables simultaneously.

Insulin levels drop. Catecholamine activity increases slightly. Blood flow to fat tissue may improve during movement such as walking or low intensity activity.

Under those conditions, lipolysis can proceed more efficiently.

This model influenced many traditional stubborn fat protocols described in bodybuilding literature. Strategies often involve fasting periods combined with targeted compounds that modify adrenergic signaling.

The goal is to create a short window where lipolysis proceeds more easily before carbohydrate intake raises insulin again.

Understanding the physiology clarifies why certain compounds appear repeatedly in fat loss discussions.

The Four Metabolic Levers of Fat Loss

Fat-loss compounds influence metabolism through several distinct physiological mechanisms. Understanding these categories makes it easier to evaluate any compound logically instead of relying on marketing claims.

Most fat-loss drugs and supplements ultimately operate through one of four metabolic levers.

Catecholamine-Driven Lipolysis

Some compounds increase catecholamine signaling or modify adrenergic receptor activity.

By increasing adrenaline signaling or blocking alpha-2 receptors, these compounds promote lipolysis in adipose tissue. Fatty acids leave the fat cell more easily and become available for oxidation.

Examples include yohimbine, ephedrine, and beta-agonists such as clenbuterol or salbutamol.

Because these compounds directly stimulate the sympathetic nervous system, they often produce noticeable side effects such as elevated heart rate, anxiety, and sleep disruption.

Thyroid-Driven Metabolic Acceleration

Thyroid hormones regulate basal metabolic rate.

Higher thyroid signaling increases oxygen consumption, mitochondrial activity, and cellular energy turnover. When metabolic rate increases, the body burns more fuel continuously throughout the day.

Some fat-loss strategies involve manipulating thyroid hormones directly or indirectly.

Unlike catecholamine stimulants that primarily affect lipolysis, thyroid hormones influence the entire metabolic system.

Mitochondrial Uncoupling

Uncouplers act directly at the mitochondrial level.

Instead of allowing the proton gradient to generate ATP efficiently, they allow protons to leak across the mitochondrial membrane. As a result, mitochondria must oxidize more fuel to maintain cellular energy production.

The excess energy is released as heat rather than stored as ATP. This increases total energy expenditure independently of adrenergic stimulation.

Metabolic Signaling and Nutrient Partitioning

Some compounds influence metabolic signaling pathways rather than directly stimulating the nervous system.

These pathways include mechanisms such as cAMP signaling, AMPK activation, mitochondrial enzyme regulation, and glucose metabolism control.

The resulting effects can include improved insulin sensitivity, better glucose utilization, and changes in how nutrients are partitioned between storage and oxidation.

Compared with stimulants or thyroid hormones, these mechanisms tend to produce more subtle but potentially more sustainable metabolic effects.

The Evolution of Fat Loss Drugs

Early Thermogenic Stimulants

Early pharmacological fat loss strategies focused primarily on stimulants.

Compounds that increased catecholamine signaling elevated heart rate, body temperature, and energy expenditure. These effects often produced noticeable weight loss but also introduced cardiovascular and neurological stress.

Many early weight loss medications followed this pattern.

During the supplement boom of the early 2000s, compounds such as DMAA (1,3-dimethylamylamine) briefly appeared in fat-burner and pre-workout products.

These stimulants produced strong sympathetic activation but were later removed from most markets due to safety concerns.

While they temporarily gained popularity in sports nutrition, their mechanisms were largely nonspecific stimulant effects rather than targeted metabolic interventions.

The Bodybuilding Era of Beta-Agonists

As sports pharmacology evolved, beta-adrenergic agonists gained popularity within bodybuilding communities.

These compounds stimulated beta receptors directly, increasing lipolysis and sometimes influencing muscle tissue as well.

Some beta-agonists originally developed for asthma treatment later became known for their fat loss effects when used at higher doses.

Their popularity grew because they could increase fat loss while maintaining or even improving training performance in certain contexts.

Thyroid Hormones and Metabolic Acceleration

Thyroid hormones became another tool within advanced dieting strategies.

Because thyroid hormones regulate metabolic rate, manipulating them can increase energy expenditure and accelerate fat loss.

However, improper use can also increase muscle breakdown and disrupt hormonal balance. This approach therefore requires careful context and duration.

The Underground Era of Uncouplers

Mitochondrial uncouplers attracted attention due to their powerful effect on energy expenditure.

By forcing the body to waste energy as heat, uncouplers can produce dramatic fat loss under controlled conditions.

At the same time, improper dosing introduces significant risks because excessive heat production can overwhelm thermoregulation.

This balance between effectiveness and danger defines the historical reputation of uncouplers.

Modern Metabolic Research Compounds

More recent research has explored compounds that influence metabolic signaling rather than simple stimulation.

These include molecules that alter mitochondrial efficiency, improve insulin sensitivity, or activate specific metabolic pathways.

Many of these compounds remain experimental. Their long-term safety profiles and human dosing protocols remain uncertain.

The gap between promising laboratory data and practical human use remains large.

How This Article Evaluates Fat Burners

To keep the discussion grounded, each compound category will be evaluated through the same lens.

Mechanism of Action

Understanding how a compound interacts with cellular physiology helps determine what results to expect and what side effects may appear.

Mechanism provides context for both benefits and risks.

Established Protocols From Research and Literature

Where available, dosing strategies from research literature or historical use will be mentioned.

These protocols provide a starting point for understanding how the compound has been used previously.

Personal Experience When Applicable

In some cases, personal experimentation provides useful context regarding real-world effects.

Physiological responses vary between individuals, but personal experience can illustrate how a compound behaves outside controlled laboratory settings.

Benefit vs Risk Ratio

Every compound ultimately falls into a spectrum defined by benefit relative to risk.

Some provide modest benefits with minimal downside. Others produce powerful effects with narrow safety margins.

Understanding that ratio allows you to judge whether the compound fits your current goals and context.

Category 1 : Catecholamine-Driven Lipolysis

Yohimbine

Yohimbine belongs to the class of compounds that influence adrenergic signaling, specifically through α2-adrenergic receptor antagonism. As explained earlier in the stubborn fat model, α2 receptors inhibit lipolysis. When these receptors dominate in a fat depot, fatty acids remain trapped even when catecholamines are present.

Blocking those receptors shifts the balance.

When α2 signaling is reduced, catecholamine stimulation through β receptors becomes more effective. The fat cell releases fatty acids more easily, increasing the availability of fuel for oxidation during activity.

This mechanism explains why yohimbine repeatedly appears in discussions of stubborn fat mobilization.

In practical contexts, stubborn fat areas often contain a higher density of α2 receptors. The lower abdomen, lower back, hips, and related abdominal depots tend to display this pattern. When α2 signaling dominates, lipolysis remains suppressed even during caloric deficit.

By blocking those receptors, yohimbine attempts to restore responsiveness.

This is the main reason it became popular in physique circles. The appeal is not simply “more fat loss” in the abstract. The appeal is the possibility of helping spot-reduce stubborn body fat deposits around the lower back and abs during a contest prep or cutting phase, especially when the individual is already lean and the remaining fat becomes disproportionately resistant.

However, the compound also increases sympathetic nervous system activity, which explains the psychological and cardiovascular side effects frequently reported.

A Peaty Perspective

From a Ray Peat–inspired metabolic perspective, yohimbine is not an obviously “Peaty” compound.

Its primary real-world effect is increasing sympathetic nervous system activity by enhancing norepinephrine signaling. In practical terms that means more adrenergic tone, higher stress signaling, increased heart rate, and often poorer sleep quality. Chronic adrenergic activation tends to move physiology toward the same stress-driven metabolic state associated with elevated cortisol and adrenaline, which Ray Peat generally viewed as metabolically damaging when sustained over time.

So from that standpoint alone, yohimbine does not fit naturally into a Peat-style strategy focused on lowering stress hormones, stabilizing energy metabolism, and protecting sleep and nervous system calm.

However, the pharmacology of yohimbine is more complex than simply “raising adrenaline”

Beyond α2-adrenergic antagonism, yohimbine interacts with several serotonin receptors. It has been shown to act as an antagonist at 5-HT1B receptors, and it also displays partial agonist activity at 5-HT1A receptors in some models. These serotonergic interactions mean that the compound can influence central neurotransmission in ways that are not purely stimulatory.

Some experimental work has shown that yohimbine can reduce cortical serotonin release while increasing catecholaminergic signaling. From a Peaty viewpoint (where excess serotonin is often seen as metabolically suppressive) this aspect of the pharmacology introduces a small theoretical nuance. The compound is still strongly adrenergic, but its interaction with serotonergic pathways is not entirely straightforward.

Another interesting nuance appears in metabolic research examining glucose handling.

In a study on type-II diabetic rats, yohimbine administration improved oral glucose tolerance, reduced circulating glucose concentrations, and increased insulin levels following glucose intake. The researchers concluded that α2-adrenergic blockade enhanced glucose-induced insulin secretion from pancreatic beta cells and improved the metabolic handling of glucose loads.

In other words, by blocking α2 receptors (which normally inhibit insulin release) yohimbine allowed pancreatic cells to respond more strongly to glucose. This resulted in improved glucose disposal and higher insulin secretion in response to carbohydrate intake.

The implication is that α2-adrenergic signaling may normally act as a brake on insulin release and glucose utilization, and blocking that signal can enhance glucose metabolism under certain conditions.

From a metabolic perspective this is interesting, because improved glucose oxidation and insulin responsiveness can theoretically support a more oxidative metabolic state. However, this observation comes primarily from animal models, and the overall physiological impact in humans remains uncertain.

So the honest conclusion remains fairly simple.

While yohimbine has some mechanistic features that may intersect with metabolic pathways (such as α2-mediated insulin regulation and serotonergic receptor interactions) its dominant physiological effect in real-world use is still strong sympathetic activation.

For that reason, even though the compound can clearly mobilize stubborn fat, it does not align well with the broader metabolic philosophy that prioritizes low stress signaling, stable sleep, and calm energy metabolism.

The mechanism may be interesting. The metabolic nuance may exist. But the overall physiological signal remains fundamentally adrenergic rather than metabolic-supportive.

Importance of Fasted Conditions

One important limitation of yohimbine involves insulin.

Insulin strongly suppresses lipolysis by activating phosphodiesterase enzymes that degrade cyclic AMP. Even when α2 receptors are blocked, elevated insulin signaling can still prevent fat release.

For this reason, most protocols recommend using yohimbine in fasted conditions.

When insulin remains low:

• Catecholamine signaling becomes more effective
• lipolysis increases
• Fatty acids can leave adipocytes more easily

This is why yohimbine is often combined with fasted walking or low-intensity cardio.

Even relatively small carbohydrate intake can significantly blunt its fat-mobilizing effect.

Dosing Protocols in Literature

Several dosing strategies appear in fat loss literature.

Read more

]]><![CDATA[Beyond Calories : The Complete Metabolic Guide to Sustainable Fat Loss - Part II — Muscle, Movement & Daily Habits]]>https://articles.berbarianwizard.com/p/beyond-calories-fat-loss-guide-part-2https://articles.berbarianwizard.com/p/beyond-calories-fat-loss-guide-part-2Wed, 04 Mar 2026 15:19:46 GMT

Before you read this part:

This article is Part II of the guide. It builds directly on the nutritional principles explained in Part I. If you haven’t read it yet, you should start there first, otherwise some of the concepts discussed here won’t make full sense.

Read Part I here: Beyond Calories, The Complete Metabolic Guide to Sustainable Fat Loss : Part I — Nutrition

PROLOGUE

Movement as a Metabolic Regulator

In Part I, we established that fat loss depends on fuel partitioning, hormonal environment, thyroid function, and substrate competition. Energy balance exists, but the body dynamically adjusts expenditure according to perceived energy availability and tissue needs.

Part II addresses the second layer: movement and daily physiological signals.

Muscle tissue, mechanical activity, circadian alignment, and recovery all influence how nutrients are handled. They determine whether incoming energy is directed toward glycogen storage, muscle repair, fat storage, or oxidation. They also determine whether metabolic rate is maintained or gradually suppressed.

Adipose tissue has a very low metabolic rate. Skeletal muscle has a high one. That difference alone changes long-term body composition.

In the resting state, skeletal muscle relies largely on fatty acid oxidation. The larger the pool of metabolically active tissue, the greater the baseline demand for energy substrate. Muscle also acts as the primary reservoir for glycogen, buffering post-prandial glucose and lowering the need for prolonged insulin elevation.

Loss of muscle reduces resting energy expenditure, reduces glucose disposal capacity, and increases the likelihood that excess substrate will be directed toward fat storage.

This becomes increasingly relevant with aging. Progressive loss of muscle mass is consistently associated with increased fat mass and reduced metabolic resilience. The shift is structural and hormonal.

If someone attempts fat loss exclusively through caloric restriction while allowing muscle mass to decline, future fat loss becomes harder. The body now has less active tissue to oxidize fatty acids and less glycogen storage capacity to stabilize glucose. Energy expenditure drops, and stress signaling increases.

Movement, particularly resistance training, changes this equation.

Resistance training increases muscle protein synthesis, improves insulin sensitivity, increases GLUT4 translocation independent of insulin, enhances mitochondrial density over time, and improves nutrient partitioning. Walking influences substrate use differently, favoring fat oxidation at low intensity with minimal stress hormone activation. Sunlight and sleep regulate hormonal rhythms that govern appetite, thyroid output, cortisol timing, and growth hormone secretion.

These signals interact.

A person who maintains or increases muscle mass while dieting retains a higher metabolic rate. A person who walks regularly increases fat oxidation without adding systemic fatigue. A person who aligns circadian rhythm improves insulin sensitivity and reduces cortisol variability. A person who sleeps deeply preserves growth hormone pulses and limits stress-driven hunger.

None of these mechanisms are abstract. They alter measurable physiology.

The objective of Part II is to show how to structure training, movement, and daily habits in a way that preserves metabolic rate while fat mass decreases. The goal is to maintain tissue quality and substrate flexibility while gradually reducing stored fat.

We begin with muscle, because without sufficient metabolically active tissue, every other strategy becomes less effective.

This Substack is reader-supported. To receive new posts and support my work, consider becoming a free or paid subscriber.

Chapter 1

Muscle: The Organ That Burns Fat

When fat loss is discussed in popular fitness culture, muscle is often treated as secondary. The focus goes to calorie deficits, cardio routines, or various dietary manipulations. Yet from a metabolic standpoint, skeletal muscle plays a central role in determining how the body handles energy.

Muscle tissue consumes energy continuously. Even at rest, skeletal muscle relies heavily on fatty acids as a fuel source. The metabolic rate of muscle tissue is significantly higher than that of adipose tissue, which functions primarily as a passive storage depot.

Ray Peat summarized this relationship clearly:

“In the resting state, muscles consume mainly fats, so maintaining relatively large muscles is important for preventing the accumulation of fats.”

This observation reflects a simple physiological principle. The more metabolically active tissue present in the body, the greater the baseline demand for energy substrates. Muscle increases this demand.

Adipose tissue behaves very differently. Fat cells store energy efficiently and expend relatively little. When body composition shifts toward a higher proportion of adipose tissue and lower muscle mass, resting energy expenditure decreases. The system becomes more prone to storing energy rather than oxidizing it.

This difference becomes increasingly relevant during dieting.

When someone attempts fat loss purely through caloric restriction, muscle tissue is often lost alongside fat mass. Protein breakdown increases, glycogen stores shrink, and muscle protein synthesis decreases. The result is a reduction in metabolically active tissue.

Ray Peat addressed this dynamic directly:

“Since fat has a very low rate of metabolism, people who lose muscle by fasting are going to have increasing difficulty in losing weight, since they will have less active tissue to consume fat.”

Loss of muscle therefore changes the metabolic environment in several ways simultaneously.

First, resting energy expenditure declines because muscle tissue requires more energy to maintain than fat tissue.

Second, the capacity for glucose disposal decreases. Skeletal muscle is the largest site of insulin-mediated glucose uptake in the body. When muscle mass decreases, blood glucose remains elevated longer after meals, increasing the likelihood that excess substrate will be directed toward fat storage.

Third, glycogen storage capacity decreases. Muscle glycogen functions as a buffer for incoming carbohydrates. Reduced storage capacity increases glycemic variability and increases the reliance on stress hormones to stabilize blood sugar between meals.

These changes create a metabolic environment that favors fat regain after dieting. The individual who has lost muscle during a crash diet often finds that maintaining a lower body weight becomes progressively harder.

Resistance training directly counteracts this process.

Mechanical tension applied to muscle fibers stimulates a cascade of cellular events that increase muscle protein synthesis. Over time, this leads to hypertrophy: an increase in the cross-sectional area of muscle fibers.

The structural consequences of hypertrophy extend beyond appearance. Increased muscle mass improves insulin sensitivity, increases glycogen storage capacity, and increases the amount of tissue capable of oxidizing fatty acids during rest and low-intensity activity.

Peat again emphasized the relevance of muscle development:

“Some muscle-building resistance exercise might help to increase the anabolic ratio, reducing the belly fat.”

The phrase anabolic ratio refers to the balance between tissue-building signals and tissue-breaking signals. Resistance training shifts this balance toward anabolism by stimulating protein synthesis, increasing local androgen signaling, and improving insulin sensitivity in muscle tissue.

These changes alter nutrient partitioning.

When carbohydrates are consumed in the presence of well-trained muscle tissue, a greater proportion of glucose is directed toward glycogen storage in muscle rather than toward lipogenesis in adipose tissue. The body becomes more capable of handling carbohydrate intake without excessive insulin elevation or fat accumulation.

Muscle tissue also influences metabolic flexibility.

Metabolic flexibility describes the ability to transition efficiently between glucose oxidation and fat oxidation depending on substrate availability and activity demands. Individuals with greater muscle mass and higher mitochondrial density tend to exhibit greater metabolic flexibility. They can oxidize glucose efficiently during intense activity and oxidize fatty acids during rest or low-intensity movement.

Reduced muscle mass limits this adaptability.

The relationship between muscle mass and fat accumulation becomes even more evident with aging. Sarcopenia, the gradual loss of skeletal muscle that occurs with age, correlates strongly with increases in fat mass and declines in metabolic rate.

Ray Peat described this structural shift in simple terms:

“Failure to renew cells and tissues leads to loss of function and substance. Bones and muscles get weaker and smaller with aging… It’s also common for fat cells to increase, as muscle cells disappear.”

This pattern highlights an important point: fat gain is not always the result of increased caloric intake alone. Structural changes in tissue composition influence how energy is handled over time.

Preserving or increasing muscle mass therefore functions as a protective factor against fat accumulation.

Muscle also contributes to lymphatic circulation and vascular health. Each contraction of skeletal muscle compresses surrounding blood vessels and lymphatic channels, promoting fluid movement through tissues. This mechanical pumping effect improves circulation, supports immune function, and helps prevent the stagnation associated with prolonged sedentary behavior.

For individuals attempting fat loss, this means that building muscle improves multiple physiological systems simultaneously.

It increases resting energy demand.
It improves carbohydrate handling.
It increases glycogen storage capacity.
It improves metabolic flexibility.
It supports circulation and lymphatic flow.

These changes do not produce instant results on the scale. They change the long-term metabolic trajectory of the organism.

Fat loss becomes easier when the body contains more tissue capable of oxidizing fatty acids. Resistance training builds that tissue.

For this reason, resistance training should not be considered optional during a fat-loss phase. Even a small number of weekly sessions can preserve muscle mass and maintain metabolic rate during caloric restriction.

The next question then becomes practical: who can realistically build muscle while losing fat ?

The answer depends on training history, body composition, and physiological context. Several groups of individuals can experience simultaneous fat loss and muscle gain under the right conditions.

That is the subject of the next chapter.

Chapter 2

Re-composition: Who Can Build Muscle While Losing Fat

In most discussions about fat loss, a strict separation is made between two phases. One phase for building muscle, another phase for losing fat. The idea usually presented is simple: muscle gain requires a caloric surplus, fat loss requires a deficit, therefore both cannot occur at the same time.

This model describes what tends to happen in advanced lifters who are already lean and close to their genetic ceiling. For a large portion of the population, the situation looks different.

Simultaneous fat loss and muscle gain, often referred to as body re-composition, occurs under several common conditions. The mechanism behind it is straightforward.

When a strong anabolic stimulus appears in a system that previously lacked it, muscle tissue can grow even while overall energy balance is slightly negative.

The first case is the true beginner.

Someone who has never trained with resistance is introducing a completely new mechanical stimulus to the organism. Muscle fibers that previously had no reason to adapt now experience repeated tension, metabolic stress, and microtrauma. Protein synthesis increases sharply. Neural efficiency improves. Motor units that were previously underutilized begin to recruit.

In this context, the body has a strong incentive to build muscle tissue. At the same time, if caloric intake is controlled and protein intake is sufficient, stored fat can supply a portion of the energy required for this adaptation.

The result is a gradual shift in body composition. Fat mass decreases while lean mass increases.

Beginners often underestimate how powerful this phase can be. During the first year of proper training, muscle gains can occur relatively quickly. Neural adaptations account for a portion of early strength increases, but structural hypertrophy also develops.

The second case involves individuals returning to training after a long interruption.

Muscle tissue exhibits a phenomenon known as muscle memory. When muscle fibers grow through hypertrophy, they acquire additional myo-nuclei. These nuclei are retained even after periods of detraining when muscle size decreases. When training resumes, these pre-existing nuclei allow protein synthesis to increase rapidly.

In practical terms, this means that regaining previously lost muscle is much faster than building it for the first time.

A person who trained seriously in the past and returns after several years can often regain muscle mass while losing fat at the same time. The biological infrastructure for muscle growth already exists; the training stimulus simply reactivates it.

The third situation occurs in individuals with higher body fat levels.

Adipose tissue represents stored energy. When body fat levels are elevated, the body has access to a large internal reserve of substrate that can support anabolic processes during training. If protein intake is adequate and resistance training is consistent, some of this stored energy can be redirected toward muscle growth while total body fat gradually decreases.

This scenario is particularly common in people beginning a structured training program after years of sedentary lifestyle.

In all three cases, the same principle applies. The body reallocates available resources when the right signals appear.

Resistance training provides a clear signal that muscle tissue is required. Adequate protein provides the structural material for repair and growth. Stored fat provides energy.

None of this requires extreme caloric restriction.

In fact, excessively aggressive deficits tend to impair this process. When energy availability becomes too low, cortisol rises, recovery declines, and muscle protein synthesis becomes harder to sustain.

A moderate caloric deficit combined with consistent resistance training is usually far more effective for re-composition than severe restriction.

The presence of muscle mass also changes how carbohydrates are handled.

Muscle tissue acts as a large sink for glucose. When glycogen stores are depleted during training, incoming carbohydrates after meals are preferentially directed toward replenishing muscle glycogen. This reduces the amount of circulating glucose that must be cleared through other pathways.

Improved glucose disposal reduces the likelihood that excess substrate will be converted into fat. It also stabilizes energy levels throughout the day by limiting large fluctuations in blood glucose.

The practical implication is simple. Resistance training improves the body’s ability to use food productively.

Even in cases where simultaneous muscle gain and fat loss do not occur, preserving existing muscle mass during dieting remains essential. Muscle loss during caloric restriction lowers resting energy expenditure and reduces future metabolic flexibility.

For this reason, resistance training should remain part of the weekly routine even when fat loss is the primary goal.

The frequency required for this stimulus is often overestimated. Many people assume that effective resistance training demands six days per week in the gym. In reality, the minimum effective dose can be much lower.

Two to three well-structured sessions per week can maintain muscle mass and stimulate gradual improvement, especially when the training intensity is high and recovery is adequate.

Consistency matters more than complexity.

The next barrier many people encounter is not physiology but psychology. A significant number of individuals avoid resistance training entirely because they feel uncomfortable in gym environments. Others assume that specialized equipment is necessary to build muscle effectively.

Neither assumption holds.

Muscle responds to mechanical tension regardless of where that tension is generated. A well-designed home setup or a simple calisthenics routine can provide a sufficient stimulus for hypertrophy when applied correctly.

The next chapter addresses this issue directly. Resistance training does not require expensive equipment or crowded gyms. In many cases, a minimal setup can provide everything needed to build and maintain muscle.

Chapter 3

If You Don’t Want to Go to the Gym

The Psychological Barrier

For many people the main obstacle to resistance training is not physiology or lack of time. It is discomfort with the gym environment.

Beginners often imagine that experienced lifters are watching them, judging their technique, or evaluating their physique. This perception keeps many people away from resistance training entirely.

In practice, gym environments rarely function this way.

Most individuals training in a gym are focused on their own sets, breathing, and fatigue. During demanding sets of resistance exercise, attention narrows significantly. Cognitive resources are directed toward completing repetitions, maintaining form, and managing discomfort. External observation becomes secondary.

From a practical perspective, very little attention is paid to other people in the room.

For someone entering the gym for the first time, a simple strategy often removes this barrier: wear loose clothing, follow a basic plan, and focus on executing exercises quietly and consistently. Progress occurs gradually and often without attracting attention.

Many experienced lifters began in exactly this way.

The important point is that resistance training does not require public performance. It requires consistent exposure to mechanical tension.

Muscle Does Not Know Where the Tension Comes From

Skeletal muscle responds to mechanical tension, metabolic stress, and repeated contraction. It does not distinguish between a commercial gym machine, a barbell in a garage, or bodyweight resistance.

If sufficient tension is applied to a muscle fiber repeatedly, adaptive processes begin.

Protein synthesis increases. Satellite cells activate. Structural proteins are repaired and strengthened. Over time the muscle fiber increases in cross-sectional area.

This process can occur in many environments.

For individuals who prefer to avoid gyms entirely, a simple home setup can provide the necessary stimulus.

A Minimal Home Setup

A very small number of tools can allow full-body resistance training.

A pull-up bar allows vertical pulling movements that train the lats, upper back, and biceps.

Parallel dip bars allow pushing movements that train the chest, shoulders, and triceps.

Resistance bands allow progressive resistance for many accessory movements including curls, lateral raises, face pulls, and triceps extensions.

A weighted vest can increase resistance during bodyweight exercises such as dips, pull-ups, push-ups, and squats.

For lower body training, single-leg movements can create significant mechanical tension even without heavy equipment. Pistol squats, Bulgarian split squats, and step-ups can challenge the quadriceps and glutes effectively when performed with control.

The unilateral nature of these exercises increases the load per leg, allowing meaningful intensity even when external weight is limited.

This minimal setup fits easily in a small room or garage and allows a complete resistance training routine.

Calisthenics and Street Lifting

Another viable approach is calisthenics, sometimes referred to as street lifting.

This style of training relies primarily on bodyweight exercises performed on outdoor bars or simple equipment. Pull-ups, dips, push-ups, and variations of squats form the foundation.

As strength increases, additional load can be introduced with a weighted vest or belt.

Many individuals develop impressive strength and muscular development using primarily calisthenic exercises. The physiological mechanisms remain identical: mechanical tension, progressive overload, and recovery.

Outdoor training also offers an additional advantage: exposure to natural light and fresh air, both of which influence circadian rhythm and mood.

The location of the training stimulus matters far less than the consistency with which it is applied.

Building Quietly and Consistently

Progress in resistance training often occurs slowly enough that dramatic changes are not immediately visible.

This gradual progression works in favor of individuals who prefer to train privately. Muscle develops over months and years of repeated stimulus rather than days.

The strategy becomes simple. Choose a training method that feels sustainable. Apply progressive overload gradually. Maintain consistency week after week.

Over time, structural changes accumulate. Muscle mass increases, strength improves, posture often improves, and metabolic capacity expands.

From a fat-loss perspective, these changes alter the baseline physiology of the organism. The body contains more metabolically active tissue and becomes better equipped to handle energy substrates.

The environment where the training occurs is secondary.

The next step is understanding how to structure resistance training in a way that produces strong stimulus while keeping overall fatigue manageable. There are many possible training styles, but the system that fits most naturally with the metabolic framework described in Part I is a high-intensity, low-volume approach.

The following chapter explains how this approach works and why it aligns well with long-term metabolic health.

Chapter 4

My HIT Blueprint (Mentzer/Yates Inspired)

Intensity Versus Volume

Resistance training programs vary widely in how they distribute workload. Some approaches rely on high weekly volume with many sets per muscle group. Others focus on fewer sets performed with very high effort.

The approach I use falls into the second category. It is largely inspired by the training philosophy associated with Mike Mentzer and later Dorian Yates, who emphasized high-intensity work with relatively low total volume.

The central idea is straightforward. A muscle does not require dozens of sets to receive a growth stimulus. What it requires is a set performed with sufficient mechanical tension and effort to recruit a large proportion of available motor units.

When a set is taken close to muscular failure, high-threshold motor units are progressively recruited as fatigue accumulates. These motor units contain the largest muscle fibers and contribute significantly to hypertrophy.

Multiple low-effort sets often produce less stimulus than a smaller number of highly demanding sets.

A high-intensity approach therefore attempts to maximize the quality of stimulus per set rather than the total number of sets performed.

Why Lower Volume Fits a Metabolic Approach

Training volume influences systemic stress.

Very high weekly volume can accumulate significant fatigue in the nervous system, connective tissue, and endocrine system. When recovery capacity is exceeded, cortisol tends to rise, sleep quality declines, and performance decreases.

For individuals already maintaining a caloric deficit during fat loss, recovery resources are somewhat reduced. Excessive training volume can therefore create unnecessary strain.

A lower-volume approach with carefully executed sets can deliver a strong hypertrophic stimulus while keeping overall systemic fatigue manageable.

This aligns well with the metabolic principles discussed in Part I. The objective is to maintain muscle mass and metabolic rate without generating chronic stress signals that interfere with recovery and hormonal balance.

My Weekly Training Structure

Personally, I train four times per week using a modified push–pull split that separates upper and lower body movements.

The structure looks like this:

Upper Push
Chest, front deltoids, lateral deltoids, biceps

Lower Push
Quadriceps and adductors

Upper Pull
Back, rear deltoids, triceps

Lower Pull
Hamstrings, glutes, abductors

This arrangement allows each muscle group to receive focused attention while providing sufficient recovery time before the next session targeting the same region.

Training frequency remains moderate while the intensity of individual sets remains high.

Exercise Selection

For each muscle group I usually select two exercises.

The goal is to expose the muscle to tension in different parts of its strength curve.

One exercise emphasizes tension in the stretched position, where the muscle is lengthened under load.

The second exercise emphasizes tension in the contracted position, where the muscle is shortened and peak contraction occurs.

Both positions can contribute to hypertrophy through slightly different mechanisms. Stretch-mediated tension may stimulate mechanical signaling pathways associated with muscle growth, while strong peak contraction can enhance fiber recruitment and mind–muscle connection.

The order of these exercises can change depending on priorities.

When a muscle group is a weak point, I often begin with the contraction-focused movement. This allows greater neural focus and control early in the session.

Otherwise, I typically start with the stretch-focused exercise.

Set Execution

Each exercise receives one primary working set taken beyond muscular failure.

Reaching true muscular failure requires pushing until no further full repetition can be completed with proper form.

After this point I often extend the set slightly using partial repetitions in the strongest portion of the movement. These partials allow additional high-threshold motor unit recruitment once full-range repetitions are no longer possible.

Occasionally I also use rest–pause techniques.

In this method the set is taken to failure, followed by a short rest of approximately ten to fifteen seconds. After this brief pause, a few additional repetitions are attempted with the same weight.

This extends the stimulus of a single set without requiring a full additional set.

These techniques increase the intensity of the working set while keeping total volume low.

Machines Versus Free Weights

Whenever possible I prefer well-designed machines for many exercises.

This preference is not ideological. It is based on practical considerations.

Machines often provide more consistent resistance curves that maintain tension across the entire movement. They also reduce the need for stabilizing muscles that can limit performance in free-weight exercises.

Reduced stabilization demands allow greater focus on the target muscle and make it safer to approach muscular failure.

Machines also allow techniques such as forced negatives or extended partials to be applied more safely than with heavy free weights.

Free weights remain useful for certain movements, particularly when machines are unavailable. However, when the goal is maximal stimulation of a specific muscle with minimal injury risk, machines can be very effective tools.

Range of Motion and Tension

Range of motion should always include the portion of the movement where mechanical tension on the target muscle is highest.

For example, during chest pressing movements, the highest tension typically occurs when the chest muscles are in a stretched position near the bottom of the movement. Performing only short repetitions near the top would miss this stimulus.

Advanced lifters sometimes experiment with partial ranges of motion focused specifically on the high-tension region of the movement. In some cases this can intensify the stimulus on the target muscle.

However, these methods require careful execution and should generally follow a foundation of full-range training.

The principle remains simple: the muscle must experience meaningful tension for growth to occur.

Example Session: Upper Push

An example of my upper push session might look like the following:

Decline chest press machine
Pec deck machine
Incline dumbbell front raises
Machine lateral raises
Preacher curl machine
Cable reverse curl

Decline pressing works well for me because my shoulders tend to dominate flat pressing movements. The decline angle helps emphasize the chest.

Lateral raise machines allow continuous tension through the movement, which makes them useful for targeting the middle deltoid.

Example Session: Lower Push

Lower body push movements focus primarily on the quadriceps.

Leg extension
Hack squat or unilateral leg press
Adductor machine

Leg extensions create strong tension in the contracted position of the quadriceps. Hack squats or unilateral leg presses load the quads heavily in the stretched position.

Example Session: Upper Pull

Upper pulling movements emphasize the back and posterior shoulder.

Wide-grip chest-supported T-bar row
Reverse-grip lat pulldown
Rear delt machine
Triceps pushdown
Overhead triceps cable extension

If someone struggles to feel their lat muscles during pulling exercises, beginning the session with a machine pullover or cable pullover can improve activation before compound pulling movements.

Example Session: Lower Pull

Lower-body pulling movements target the posterior chain.

RDL machine
Seated leg curl
Abductor machine

For individuals who have difficulty activating their glutes, beginning the session with hip thrusts can improve engagement during subsequent exercises.

Chapter 5

Why You Don’t Burn Fat While Lifting

The Primary Fuel of Resistance Training

During high-intensity resistance exercise, the dominant fuel source is glucose, not fat.

When a set approaches muscular failure, the muscle fibers involved require rapid ATP production. The fastest way for cells to produce ATP under these conditions is through glycolysis, the metabolic pathway that converts glucose into energy.

Fat oxidation cannot supply ATP quickly enough to sustain maximal muscular contractions. Fatty acids must first be transported into mitochondria through the carnitine shuttle and then undergo beta-oxidation before entering the Krebs cycle. This process is efficient but relatively slow.

High-intensity muscular contractions demand energy immediately.

As a result, the body relies primarily on stored glycogen in muscle tissue and circulating glucose during demanding resistance training.

This is a basic physiological constraint.

Attempts to force the body to rely on fat during high-intensity lifting usually result in reduced performance rather than increased fat loss.

Glycogen as the Immediate Energy Reservoir

Muscle glycogen acts as a localized energy reserve.

When resistance training begins, glycogen stored inside the muscle fibers is broken down into glucose and enters glycolysis to produce ATP. This process allows repeated contractions during a set and across successive exercises.

Once glycogen availability declines, performance decreases rapidly. Strength drops, repetition capacity falls, and fatigue increases.

This relationship explains why athletes performing high-intensity training generally maintain sufficient carbohydrate intake.

Adequate glycogen availability allows training intensity to remain high, which preserves the stimulus required for muscle maintenance or growth.

What Happens When Glucose Is Insufficient

When glucose availability becomes limited during high-intensity activity, the body must maintain blood sugar through other mechanisms.

The primary mechanism is gluconeogenesis, a process where the liver produces glucose from non-carbohydrate substrates such as amino acids.

This process is regulated largely by cortisol and glucagon.

Cortisol mobilizes amino acids from skeletal muscle tissue, particularly alanine and glutamine, which can then be converted into glucose by the liver. While this helps stabilize blood glucose temporarily, it also increases muscle protein breakdown.

During repeated training sessions with inadequate carbohydrate availability, this pattern can lead to increased catabolism.

In practical terms, performance decreases while muscle tissue becomes harder to maintain. For individuals attempting to lose fat while preserving muscle mass, this is not an ideal scenario.

The Role of Intra-Workout Carbohydrates

One strategy that can support both performance and muscle preservation is the use of intra-workout carbohydrates.

Consuming a small amount of rapidly absorbed carbohydrates during training helps maintain blood glucose levels and reduces the need for stress-mediated glucose production.

This has several effects.

Blood glucose remains stable during demanding sets.
Cortisol release associated with falling blood sugar is reduced.
Muscle glycogen depletion slows.
Training intensity remains higher.

The result is improved performance during the session and reduced muscle breakdown afterward.

In practice, this can be as simple as consuming 20–40 grams of fast carbohydrates during training.

Diluted orange juice, dextrose, or cyclic dextrin are common options. Adding a small amount of sodium improves fluid absorption and supports muscular contraction.

The objective is not to consume large quantities of sugar. The objective is to provide a steady supply of glucose so the body does not rely on stress hormones to maintain blood sugar.

Resistance Training as a Muscle-Preservation Signal

Resistance training serves a specific physiological role during fat loss.

The mechanical tension applied to muscle fibers signals that this tissue remains necessary. When sufficient protein and recovery are available, the body attempts to preserve or rebuild these structures even during periods of reduced caloric intake.

Without this signal, the body has fewer reasons to maintain muscle tissue.

During aggressive dieting combined with minimal resistance training, muscle loss can occur alongside fat loss. This reduces resting metabolic rate and decreases the body’s ability to oxidize fatty acids later.

Resistance training interrupts this process.

It tells the organism that muscle tissue must remain functional.

Training Performance as a Metabolic Indicator

Performance in the gym often reflects underlying metabolic conditions.

When glycogen stores are adequate and recovery is sufficient, strength levels remain stable or gradually increase. Sets feel strong, coordination remains sharp, and muscular contraction feels efficient.

When glycogen availability declines or stress hormones increase chronically, performance tends to deteriorate.

Repetition capacity decreases.
Strength plateaus or declines.
Recovery between sessions becomes slower.

These changes often occur before significant shifts appear on the scale.

Monitoring performance during resistance training therefore provides indirect information about metabolic status.

Consistent strength during a fat-loss phase usually indicates that muscle tissue is being preserved effectively.

Fat Loss Happens Outside the Set

The physiological reality of resistance training sometimes surprises people.

During a demanding set of squats, presses, or rows, the body is relying heavily on glucose metabolism. The primary role of the session is not fat oxidation.

The role of the session is muscle stimulation.

Fat loss occurs across the entire day through a combination of basal metabolism, low-intensity activity, and periods where insulin levels decline and lipolysis resumes.

Resistance training supports this process by preserving metabolically active tissue and improving nutrient partitioning.

In other words, lifting weights prepares the metabolic environment where fat loss becomes easier. The fat itself is often oxidized later, during rest or lower-intensity activity.

This leads naturally to the next topic.

Low-intensity movement, especially walking, relies much more heavily on fatty acid oxidation and can increase daily energy expenditure without imposing significant recovery demands.

Understanding how this form of movement interacts with resistance training is essential for designing a sustainable fat-loss strategy.

The next chapter examines the physiological effects of resistance training beyond the muscle fiber itself and explains how lifting weights alters hormonal signaling and nutrient partitioning throughout the body.

Chapter 6

Hormonal and Cellular Effects of Resistance Training

Muscle as a Glucose Sink

Skeletal muscle plays a central role in glucose metabolism. After a carbohydrate-containing meal, a significant portion of circulating glucose is directed toward muscle tissue where it can be stored as glycogen.

Resistance training improves this process through several mechanisms.

Repeated muscular contractions stimulate the movement of GLUT4 transporters to the surface of muscle cells. GLUT4 is the primary transporter responsible for moving glucose from the bloodstream into muscle fibers.

This process can occur independently of insulin during and after exercise. Muscle contraction itself triggers intracellular signaling pathways that allow glucose to enter the cell.

As a result, trained muscle tissue becomes highly efficient at clearing glucose from circulation.

Over time, this improves insulin sensitivity. For the same amount of carbohydrate intake, less insulin is required to move glucose into cells. Blood sugar stabilizes more quickly, and nutrient partitioning improves.

In practical terms, individuals with greater muscle mass often tolerate carbohydrates better because the glucose has somewhere to go.

Glycogen Storage Capacity

Muscle tissue also determines the total storage capacity for glycogen.

Each kilogram of muscle can store a substantial amount of glycogen. The more muscle tissue present, the larger the available glycogen reservoir.

This capacity influences metabolic stability throughout the day.

When glycogen stores are well filled, blood glucose tends to remain stable between meals. The body has an internal reserve that can release glucose gradually as needed.

When glycogen stores are chronically depleted, the body relies more heavily on stress hormones to maintain blood sugar. Cortisol and adrenaline stimulate gluconeogenesis and glycogen breakdown to keep glucose available for the brain.

Resistance training increases glycogen storage capacity over time. Larger muscles provide more space for carbohydrate storage and reduce the need for stress-mediated glucose production.

Nutrient Partitioning

Resistance training alters how nutrients are distributed throughout the body.

When muscle tissue receives repeated mechanical loading, several adaptations occur:

  • Increased insulin sensitivity in muscle cells

  • Increased glycogen storage capacity

  • Increased protein synthesis

  • Increased mitochondrial density over time

These adaptations influence nutrient partitioning, the process that determines where incoming nutrients are directed.

After training, muscle tissue becomes more receptive to amino acids and glucose. Protein synthesis increases in response to amino acid availability, and glycogen synthesis increases when carbohydrates are consumed.

Because muscle tissue is actively repairing and replenishing energy stores, a larger portion of nutrients is directed toward muscle rather than adipose tissue.

This shift can occur even when total caloric intake remains moderate.

Androgen Signaling and Muscle Adaptation

Resistance training also influences androgen signaling within muscle tissue.

Shortly after intense resistance exercise, small increases in circulating testosterone and growth hormone can occur. These acute hormonal changes are relatively modest and short-lived, but they coincide with a local increase in androgen receptor activity within muscle cells.

Increased androgen receptor density enhances the responsiveness of muscle tissue to circulating androgens. Over time this contributes to hypertrophic adaptation.

The local signaling environment created by resistance exercise therefore promotes muscle repair and growth even without dramatic systemic hormone changes.

Mitochondrial Adaptations

Although resistance training is primarily associated with hypertrophy, it can also influence mitochondrial function.

Repeated muscular contractions stimulate cellular signaling pathways that encourage the formation of new mitochondria within muscle fibers. This process increases the capacity of the cell to generate ATP through oxidative metabolism.

Greater mitochondrial density improves metabolic flexibility.

Muscle tissue becomes more capable of switching between glucose oxidation and fatty acid oxidation depending on substrate availability and activity level.

During periods of rest or low-intensity activity, fatty acids can be oxidized efficiently. During high-intensity activity, glycolysis can rapidly provide ATP from glucose.

This adaptability supports overall metabolic resilience.

Muscle Contraction and Circulation

Muscle contraction affects circulation beyond energy metabolism.

Each contraction compresses nearby blood vessels and lymphatic channels, promoting the movement of blood and lymph through tissues. This mechanical pumping effect improves nutrient delivery, removes metabolic byproducts, and supports fluid balance.

Sedentary behavior limits this circulation. When movement decreases, lymphatic flow slows and tissue fluid can accumulate.

Regular resistance training and walking maintain this mechanical circulation and help prevent stagnation in the vascular and lymphatic systems.

Structural Adaptation Over Time

Many of the metabolic benefits associated with resistance training emerge gradually.

Initial improvements in strength are often driven by neural adaptations. Motor unit recruitment becomes more efficient, and coordination improves.

Structural changes follow with consistent training.

Muscle fibers enlarge. Glycogen storage increases. Mitochondrial density increases. Connective tissues strengthen. Insulin sensitivity improves.

These changes collectively alter the metabolic baseline of the organism.

A trained body handles nutrients differently than an untrained one. Glucose disposal improves, fatty acid oxidation becomes more efficient during rest, and the overall capacity for energy turnover increases.

The Interaction with Fat Loss

During a fat-loss phase, these adaptations become especially valuable.

Muscle tissue maintained through resistance training continues to consume energy and oxidize fatty acids during rest and low-intensity activity. At the same time, improved glucose disposal reduces metabolic stress after carbohydrate-containing meals.

The result is a more stable metabolic environment where fat can gradually decrease without large swings in blood glucose or stress hormone production.

Resistance training therefore acts as a stabilizing influence during dieting.

The body retains metabolically active tissue, maintains higher energy expenditure, and handles incoming nutrients more effectively.

Movement Beyond the Gym

Resistance training provides a powerful anabolic stimulus, but it represents only a small portion of daily activity.

Most hours of the day occur outside the gym.

The type of movement performed during these hours influences substrate utilization in a different way. Low-intensity activity tends to rely more heavily on fatty acid oxidation and places minimal stress on recovery systems.

Among these activities, walking stands out as one of the simplest and most sustainable forms of movement.

The next chapter examines how walking and other forms of low-intensity movement contribute to fat oxidation, circulation, and overall metabolic stability.

Chapter 7

Walking and Cardiovascular Activity

Movement Outside the Gym

Resistance training provides a strong stimulus for muscle preservation and growth, but most of the day is spent outside the gym.

The body continues to metabolize substrates during these hours. Basal metabolism, low-intensity activity, and spontaneous movement contribute significantly to total daily energy expenditure.

Among these activities, walking occupies a unique position. It is simple, accessible, and places very little stress on recovery systems. Yet it plays an important role in energy metabolism and circulation.

Low-intensity movement relies primarily on fatty acid oxidation. During walking, the demand for ATP remains moderate, and energy can be supplied through oxidative metabolism without requiring rapid glycolysis.

This contrasts with high-intensity resistance exercise, where glucose becomes the dominant fuel source.

Because walking occurs at a lower intensity, the body can rely more heavily on fatty acids released from adipose tissue and circulating in the bloodstream.

Fat Oxidation During Low-Intensity Activity

Fat oxidation increases when energy demand is modest and oxygen availability remains sufficient for mitochondrial metabolism.

Walking falls within this range for most individuals.

During prolonged low-intensity movement, fatty acids are transported into mitochondria and oxidized through beta-oxidation. The resulting acetyl-CoA enters the Krebs cycle, producing ATP through oxidative phosphorylation.

This process is slower than glycolysis but highly efficient when sustained over time.

As a result, walking can increase the proportion of energy derived from fat without requiring large hormonal stress responses.

Minimal Recovery Cost

One of the advantages of walking compared to more demanding cardiovascular exercise is the low recovery cost.

Intense cardiovascular sessions can generate significant fatigue, elevate stress hormones, and interfere with recovery from resistance training. When performed excessively, they may also increase appetite and make caloric restriction harder to maintain.

Walking does not create the same systemic strain.

Heart rate increases modestly, circulation improves, and energy expenditure rises without substantial disruption to the nervous system or connective tissues.

Because the recovery cost remains low, walking can be performed frequently without compromising strength training sessions.

Cardiovascular Health and Circulation

Walking also supports cardiovascular function.

Regular low-intensity movement improves endothelial function, increases blood flow through peripheral tissues, and enhances capillary density over time.

These changes improve oxygen delivery and nutrient transport throughout the body.

Muscle contractions during walking also contribute to venous return and lymphatic circulation. Each step compresses blood vessels and lymphatic channels, helping move fluids through tissues and preventing stagnation.

For individuals who spend long periods sitting during work, walking becomes especially important for maintaining circulation.

Walking and Insulin Sensitivity

Low-intensity movement after meals can also influence glucose metabolism.

A short walk following a meal increases muscular glucose uptake and helps stabilize blood sugar levels. Muscle contractions stimulate glucose transport into cells, reducing the amount of circulating glucose that must be cleared by insulin.

Over time, regular walking improves overall insulin sensitivity and metabolic flexibility.

These effects accumulate gradually with consistent practice.

Practical Integration

Walking does not require rigid structure to be effective.

Many people attempt to follow strict step-count targets such as ten thousand steps per day. While step counts can provide a rough guideline, obsessively tracking numbers often adds unnecessary complexity.

A more practical approach is to integrate walking naturally into daily routines.

Walking to nearby places instead of driving, taking a brief walk after meals, or choosing stairs instead of elevators can increase daily movement without requiring dedicated workout sessions.

Some individuals enjoy longer walks in natural environments or hiking trails. Others prefer short walks spread throughout the day.

For people working from home, a walking pad can provide an easy way to accumulate movement while reading or working on a computer.

The objective is consistent movement rather than strict numerical targets.

High-Intensity Cardio and Recovery

High-intensity interval training, often referred to as HIIT, has become popular as a time-efficient form of cardiovascular exercise.

HIIT sessions typically involve repeated bursts of maximal effort separated by short recovery periods. Sprint intervals on a bicycle, treadmill, or running track are common examples.

These sessions can elevate heart rate rapidly and increase short-term energy expenditure.

However, they also generate significant fatigue and stress on joints, connective tissues, and the nervous system.

For individuals who are already performing intense resistance training, additional high-intensity cardio can create recovery conflicts.

Heavy lifting sessions already place considerable demand on the nervous system and muscular structures. Adding repeated sprint intervals may increase fatigue without providing proportional benefits.

For this reason, I rarely include traditional HIIT sessions in my routine.

The intensity applied during resistance training already provides a substantial stimulus. Prioritizing recovery allows those sessions to remain productive.

Walking provides cardiovascular movement with minimal interference in recovery. It supports circulation and fat oxidation without placing additional strain on joints or connective tissue.

Some individuals enjoy HIIT and tolerate it well. In those cases it can be used occasionally, provided recovery remains adequate. The key factor is balancing total training stress with the body’s ability to recover.

A Sustainable Form of Movement

Walking has another advantage: it is sustainable over long periods of time.

Many exercise routines fail because they rely on methods that are difficult to maintain consistently. Walking rarely creates this problem.

It can be performed alone or socially. It can occur outdoors or indoors. It does not require specialized equipment or scheduling.

Over months and years, this consistency produces meaningful effects on metabolic health.

Walking supports circulation, increases daily energy expenditure, improves insulin sensitivity, and encourages fat oxidation during low-intensity activity.

In combination with resistance training, it forms a balanced movement pattern that supports both muscle preservation and gradual fat loss.

Movement also influences another physiological system that often receives little attention: the lymphatic network.

Unlike the cardiovascular system, the lymphatic system does not possess a central pump. Its circulation depends largely on muscular contraction and physical movement.

Understanding this system helps explain why regular movement can influence fluid balance and tissue health.

The next chapter examines how movement supports lymphatic flow and why sedentary behavior can disrupt this process.

Chapter 8

The Lymphatic System and Mechanical Circulation

A Circulatory System Without a Pump

The lymphatic system receives far less attention than the cardiovascular system, yet it plays an essential role in fluid balance, immune function, and tissue maintenance.

Unlike the circulatory system, which relies on the heart as a central pump, the lymphatic system does not have a dedicated organ that drives its flow. Lymph moves through vessels primarily through mechanical forces generated by movement.

Muscle contractions compress lymphatic vessels and push fluid through the network of channels that return it to the bloodstream.

Breathing movements also contribute. Each expansion and contraction of the rib cage alters pressure gradients in the thoracic cavity, helping draw lymph upward through the thoracic duct.

When the body moves regularly, these mechanical forces maintain a continuous circulation of lymph. When movement becomes limited, lymphatic flow slows.

Sedentary Behavior and Fluid Stagnation

Long periods of sitting reduce muscular contraction and diminish the mechanical pumping action that normally drives lymphatic circulation.

This can lead to stagnation of interstitial fluid in tissues. Mild swelling, feelings of heaviness in the limbs, and slower removal of metabolic byproducts can occur when lymph movement becomes sluggish.

While the body possesses compensatory mechanisms, regular physical movement remains the most effective way to maintain normal lymphatic circulation.

Walking and resistance training both support this process.

Each step taken during walking compresses muscles in the legs and pelvis, pushing lymph upward toward the torso. Resistance training produces stronger contractions that further stimulate fluid movement.

These mechanical forces contribute to maintaining tissue health and circulation.

Movement as a Natural Lymph Pump

Because lymphatic vessels run alongside muscles and connective tissues, physical activity acts as a natural pumping mechanism.

This effect becomes particularly noticeable during lower-body movement. The large muscles of the legs contract repeatedly during walking, cycling, or squatting movements. These contractions compress surrounding lymphatic channels and encourage the movement of fluid through the system.

In addition to supporting immune surveillance, lymph circulation also helps remove cellular waste products and inflammatory mediators from tissues.

Regular movement therefore contributes indirectly to tissue recovery and metabolic stability.

Manual Methods That Support Lymph Flow

Beyond physical movement, certain manual techniques can assist lymphatic circulation.

Massage is one of the most commonly used methods. Gentle compression and rhythmic pressure applied to tissues can stimulate lymphatic vessels and encourage fluid movement.

Professional lymphatic drainage massage is designed specifically to guide lymph flow toward major drainage points in the body.

Some individuals also use practices such as dry brushing, where a soft brush is moved across the skin toward lymphatic drainage regions. The mechanical stimulation of the skin may encourage superficial lymphatic movement.

Another traditional approach involves the use of herbs historically associated with lymphatic support.

One example is cleavers (Galium Aparine), a plant that has been used in traditional herbal medicine as a mild lymphatic tonic. While modern clinical evidence remains limited, cleavers have long been used to support lymphatic circulation and fluid balance.

These methods are supportive rather than essential. The primary driver of lymph movement remains physical activity.

Movement Over Extreme Interventions

In recent years, practices such as extreme cold exposure have gained popularity as tools for recovery and metabolic health.

While cold exposure can produce short-term physiological responses, it also activates significant stress responses in the body, including increases in adrenaline and other catecholamines.

For individuals already managing training stress and caloric restriction, repeated activation of stress pathways may not always be beneficial.

Moderate approaches that emphasize regular movement, adequate circulation, and recovery often provide more sustainable support for metabolic health.

Walking, resistance training, and consistent daily activity maintain lymphatic flow without introducing additional systemic stress.

Circulation, Recovery, and Fat Loss

Efficient circulation contributes indirectly to fat loss by supporting recovery and metabolic stability.

Improved lymphatic flow helps remove metabolic byproducts from tissues, maintain fluid balance, and support immune function. These processes allow the body to recover more efficiently between training sessions.

Recovery capacity influences how consistently an individual can train and maintain activity levels.

When circulation and recovery remain strong, training quality improves and metabolic activity remains higher across time.

Movement therefore affects more than immediate energy expenditure. It influences the internal environment that determines how the body responds to training, diet, and recovery.

The Role of Daily Activity

The lymphatic system reinforces an idea that appears repeatedly in physiology: the body is designed to move regularly.

Small amounts of daily movement accumulated across the day often contribute more to long-term health than occasional extreme efforts.

Walking, standing, stretching, and periodic resistance training collectively maintain circulation, support lymphatic flow, and sustain metabolic activity.

These activities require no extreme protocols or specialized interventions.

Consistent movement provides the mechanical signals the body evolved to expect.

Movement and circulation interact closely with another fundamental physiological regulator: light exposure.

Sunlight influences hormonal rhythms, circadian timing, and even aspects of metabolic function. Its effects extend beyond vitamin D production and contribute to broader regulation of biological systems.

The next chapter examines how sunlight affects metabolism, hormones, and even the visual appearance of body composition.

Chapter 9

Sunlight, Circadian Signals, and Metabolic Regulation

Light as a Biological Signal

Human physiology evolved under predictable cycles of daylight and darkness. For most of human history, exposure to natural sunlight occurred daily, and the timing of light exposure provided the body with consistent information about the time of day.

Modern indoor lifestyles have altered this pattern significantly. Many people spend most of the day inside artificial environments with limited exposure to natural light. This shift affects several biological systems, including circadian rhythm, hormone secretion, sleep quality, and metabolic regulation.

Sunlight functions as an environmental signal that synchronizes internal clocks throughout the body. Specialized cells in the retina detect light intensity and wavelength and transmit signals to the suprachiasmatic nucleus in the hypothalamus. This region acts as the central circadian regulator.

Once activated by light, the suprachiasmatic nucleus coordinates rhythms in hormone secretion, body temperature, sleep-wake cycles, and metabolic activity.

Regular exposure to natural light during the day helps maintain stable circadian rhythms.

Circadian Alignment and Hormonal Rhythms

Several hormones involved in metabolism follow circadian patterns.

Cortisol, for example, normally peaks in the early morning hours. This rise helps mobilize energy substrates and supports alertness after waking. As the day progresses, cortisol levels gradually decline.

Disruption of circadian rhythm can alter this pattern. Irregular light exposure, nighttime screen use, and inconsistent sleep schedules may shift cortisol release later into the evening. Elevated nighttime cortisol can interfere with sleep quality and alter glucose metabolism.

Sunlight exposure early in the day reinforces the natural timing of these hormonal rhythms. Morning light signals to the brain that daytime activity has begun. This cue strengthens the alignment between internal biological clocks and the external environment.

Over time, this alignment supports stable sleep cycles, improved energy levels, and more consistent metabolic function.

Vitamin D and Endocrine Function

Sunlight also stimulates the production of vitamin D in the skin.

Ultraviolet B radiation converts a cholesterol-derived molecule in the skin into vitamin D₃, which is later activated through metabolic processes in the liver and kidneys.

Vitamin D acts as a hormone that influences many physiological systems. Receptors for vitamin D are present in muscle tissue, immune cells, and endocrine organs.

Adequate vitamin D levels correlate with improved immune function, better bone health, and improved muscle function.

Some studies have also observed associations between vitamin D status and testosterone levels in men. While these relationships remain complex and influenced by multiple factors, adequate sunlight exposure often supports overall hormonal balance.

For individuals who spend long periods indoors, sunlight provides a natural source of vitamin D that supports several aspects of metabolic health.

Nitric Oxide and Circulatory Effects

Sunlight influences circulation through another mechanism as well.

Ultraviolet radiation can trigger the release of nitric oxide from stores in the skin. Nitric oxide is a signaling molecule that causes blood vessels to relax and widen.

This process, known as vasodilation, improves blood flow through peripheral tissues. Improved circulation supports nutrient delivery, oxygen transport, and waste removal from tissues.

These vascular effects occur independently of vitamin D production and represent another pathway through which sunlight influences physiology.

Sunlight and Mood Regulation

Light exposure also influences neurotransmitter systems involved in mood and motivation.

Sunlight stimulates retinal pathways that influence dopamine and serotonin signaling in the brain. These neurotransmitters affect alertness, mood stability, and motivation.

Regular exposure to daylight often improves subjective energy levels and mental clarity.

Improved mood indirectly supports metabolic health as well. When individuals feel mentally stable and energetic, they are more likely to maintain consistent physical activity, structured eating habits, and regular sleep patterns.

The psychological effects of sunlight therefore interact with behavioral factors that influence long-term health.

Visual Effects on Body Composition

Sunlight can also influence how body composition appears visually.

Exposure to sunlight increases skin pigmentation through melanin production. Tanned skin tends to create stronger visual contrast between muscles and surrounding tissue.

This contrast can enhance the appearance of muscle definition.

Additionally, sunlight exposure often promotes mild fluid shifts through increased circulation and sweating. These temporary changes can make the body appear slightly leaner or “drier” under natural lighting.

While these effects do not change actual body fat levels, they can influence visual perception of physique.

Practical Sunlight Exposure

The goal of sunlight exposure is not prolonged sunbathing or excessive ultraviolet exposure.

Moderate, regular exposure to natural daylight is generally sufficient to support circadian alignment and vitamin D synthesis.

Spending time outdoors during the morning or early afternoon can provide meaningful benefits. Walking outside, training outdoors, or simply sitting in natural light for short periods during the day can reinforce circadian rhythms.

The duration required varies depending on latitude, season, and skin pigmentation. Consistency often matters more than intensity. Short daily exposure to natural light can provide strong signals to the body’s circadian system.

Light and Sleep

Sunlight exposure during the day also affects nighttime sleep.

When the circadian system receives strong daylight signals, the body produces melatonin more reliably in the evening. Melatonin promotes sleep onset and helps coordinate nighttime recovery processes.

Without sufficient daylight exposure, melatonin rhythms can become irregular. Sleep onset may become delayed, and sleep quality may decline.

Because sleep influences hormone regulation, glucose metabolism, and appetite control, disruptions in circadian rhythm can indirectly affect body composition.

Daily sunlight exposure therefore contributes to several interconnected systems that influence metabolic health.

A Natural Environmental Signal

Sunlight represents one of the simplest environmental inputs affecting physiology.

It regulates circadian rhythm, supports vitamin D synthesis, influences circulation through nitric oxide signaling, and improves mood and alertness.

These mechanisms operate continuously when natural light exposure remains consistent.

In combination with resistance training and regular movement, sunlight contributes to a stable internal environment that supports metabolic health.

Another physiological factor plays an even larger role in recovery, hormone regulation, and fat metabolism: sleep.

Sleep governs growth hormone release, cortisol rhythms, and the restoration of neural and muscular systems after daily activity.

The next chapter examines the physiology of sleep and explains how improving sleep quality can support fat loss, recovery, and metabolic stability.

Chapter 10

Sleep, Recovery, and Nighttime Metabolism

Sleep as a Metabolic Process

Sleep is often treated as a passive state where the body simply shuts down for several hours. Physiologically, the opposite occurs. During sleep the organism performs many of the processes required for recovery, hormonal regulation, and tissue repair.

Several hormones that influence metabolism follow circadian patterns closely tied to sleep quality and timing. Growth hormone, cortisol, melatonin, and insulin sensitivity all change across the sleep–wake cycle.

Disruptions in sleep affect these systems simultaneously.

When sleep becomes irregular or insufficient, the body often shows measurable changes in glucose metabolism, appetite regulation, and stress hormone activity. Over time, these changes can influence body composition and recovery from training.

Growth Hormone and Lipolysis

One of the most important hormonal events during sleep is the release of growth hormone (GH).

Growth hormone secretion occurs primarily during deep sleep, particularly during the early phases of the night. These pulses of GH support tissue repair and influence substrate metabolism.

Growth hormone promotes lipolysis, the process by which stored triglycerides in adipose tissue are broken down into free fatty acids and glycerol. These fatty acids can then be oxidized for energy.

During nighttime fasting, this mechanism helps supply energy to the body while glycogen stores are partially depleted.

Sleep therefore contributes to the gradual mobilization of stored fat.

When sleep quality declines or deep sleep becomes fragmented, the magnitude of growth hormone release often decreases. This can reduce the efficiency of nighttime recovery and alter metabolic signaling.

Sleep Deprivation and Glucose Regulation

Sleep restriction also influences glucose metabolism.

Studies consistently show that insufficient sleep can reduce insulin sensitivity. After even a few nights of restricted sleep, glucose tolerance may decline and higher insulin levels may be required to regulate blood sugar.

This shift can increase metabolic stress after meals and alter nutrient partitioning.

Sleep deprivation also affects appetite-regulating hormones.

Levels of ghrelin, a hormone associated with hunger, often increase when sleep is restricted. At the same time, levels of leptin, a hormone associated with satiety and energy sufficiency, may decrease.

These hormonal changes can increase food intake and make dietary adherence more difficult. Maintaining adequate sleep therefore supports both metabolic regulation and appetite control.

Cortisol and Circadian Rhythm

Cortisol normally follows a predictable daily pattern.

Levels rise during the early morning hours, helping mobilize energy and prepare the body for activity after waking. Cortisol then gradually declines throughout the day and reaches its lowest levels during the late evening.

When sleep schedules become irregular or nighttime light exposure increases, this rhythm can shift. Elevated evening cortisol can delay sleep onset and interfere with recovery processes that occur during the night.

Consistent sleep timing helps reinforce the natural cortisol rhythm and reduces unnecessary activation of stress pathways.

Circadian Alignment

The timing of sleep interacts with circadian signals generated by the brain.

Exposure to daylight during the morning and reduced light exposure during the evening help synchronize the circadian clock with the external environment.

When sleep occurs at consistent times each night, hormone release patterns stabilize. Body temperature cycles become predictable, and the timing of melatonin secretion aligns with the onset of darkness.

These patterns support deeper and more restorative sleep.

Irregular schedules, late-night screen exposure, and frequent shifts in bedtime can disrupt this alignment.

Even when total sleep duration remains adequate, circadian misalignment may reduce sleep quality.

Environmental Factors That Affect Sleep

Several environmental conditions influence sleep quality.

Room temperature plays a significant role. Slightly cooler environments often promote deeper sleep because body temperature naturally declines during the night.

Noise can fragment sleep cycles even when it does not fully wake the individual. Consistent background noise or quiet sleeping environments tend to improve sleep continuity.

Light exposure is another important factor. Bright artificial light during the evening can suppress melatonin production and delay the onset of sleepiness.

Reducing screen exposure or using dimmer lighting during the hours before bedtime can help maintain natural melatonin rhythms.

Sleep Apnea and Breathing During Sleep

Breathing patterns during sleep can also influence sleep quality.

One common condition affecting sleep is obstructive sleep apnea. In this disorder, the airway becomes partially or fully obstructed during sleep, causing repeated interruptions in breathing.

These interruptions fragment sleep cycles and reduce the amount of deep sleep obtained during the night.

Symptoms of sleep apnea may include loud snoring, frequent awakenings, morning headaches, and persistent daytime fatigue.

Individuals who suspect sleep apnea should consider seeking medical evaluation. Diagnosis typically involves sleep studies that monitor breathing patterns, oxygen levels, and sleep stages.

Effective treatment can dramatically improve sleep quality and overall health.

Nasal Breathing and Airflow

Breathing through the nose during sleep supports stable airflow and helps maintain open airways.

The nose warms, humidifies, and filters incoming air before it reaches the lungs. Nasal passages also produce nitric oxide, which contributes to improved oxygen delivery in the lungs.

A useful analogy helps explain nasal airflow:

Think of the nose like an automatic air conditioner. When air flows through it regularly, the passages stay open. When it is not used and breathing occurs through the mouth, the nasal passages tend to become more congested.

If nasal congestion occurs, forcing nasal breathing may be uncomfortable. In these situations it can help to restore airflow gradually.

A saline nasal rinse can help clean and calm irritated nasal passages. Nasal strips can mechanically open the nasal valve area and improve airflow during sleep.

Once air begins to move through the nose again, nasal breathing tends to maintain openness naturally.

Some individuals also use mouth tape during sleep to encourage nasal breathing, although this approach should only be considered when nasal airflow is already adequate.

Nutritional and Supplemental Support

Certain nutrients and compounds can support sleep quality when used appropriately.

Glycine and gelatin contain amino acids that may promote relaxation and improve sleep onset in some individuals.

Magnesium participates in many neurological processes and may support muscle relaxation and nervous system balance.

Certain spices, such as cardamom, have traditionally been used in small amounts to support digestion and relaxation.

Some individuals also use medications such as cyproheptadine under medical guidance. Cyproheptadine influences serotonin and histamine signaling and can have sedative effects. Because it is a pharmacological compound, its use should be approached cautiously and under appropriate supervision.

Carbohydrates consumed in the evening can also support sleep by replenishing liver glycogen. Stable liver glycogen reduces the likelihood that cortisol will rise during the night to maintain blood glucose.

When blood sugar remains stable, sleep tends to remain deeper and less fragmented.

Sleep as a Foundation for Recovery

Sleep integrates many of the physiological systems discussed throughout this guide.

Growth hormone release supports tissue repair and fat mobilization. Stable cortisol rhythms reduce metabolic stress. Improved insulin sensitivity supports nutrient partitioning. Adequate sleep also supports cognitive function, mood stability, and consistent training performance.

Without sufficient sleep, the benefits of training and nutrition become harder to maintain.

Fat loss strategies that ignore sleep often encounter unexpected obstacles, including fatigue, increased hunger, and slower recovery from exercise.

For this reason, improving sleep quality often produces noticeable improvements in both physical performance and metabolic health.

Daily habits also influence the ability to maintain dietary consistency.

Food environments, particularly restaurants and social eating patterns, can introduce hidden variables that interfere with fat-loss strategies.

The next chapter examines why controlling food environments remains important during fat-loss phases and how restaurant habits can influence metabolic outcomes.

Chapter 11

Restaurants, Food Environments, and Hidden Variables

Control of Ingredients

When preparing food at home, the ingredients and cooking methods remain under direct control. Oils, portion sizes, seasoning, and cooking temperatures can be adjusted precisely.

Restaurants operate under a different set of priorities. The objective is to maximize flavor, consistency, and customer satisfaction while maintaining efficiency in food preparation.

To achieve these goals, restaurant kitchens frequently rely on ingredients that increase palatability and shelf stability. Large quantities of cooking oils, sauces, refined starches, and sugar are commonly used. Many of these ingredients are added during preparation in ways that are not visible to the customer.

Even meals that appear relatively simple can contain substantial amounts of added fats or sugars. This does not imply that restaurants deliberately create unhealthy meals. Their focus lies in producing food that tastes appealing and can be prepared quickly for many customers.

However, the lack of control over ingredients introduces uncertainty when someone is attempting to manage body composition carefully.

Hidden Fats and Cooking Oils

One of the most common hidden variables in restaurant meals is the amount and type of fat used during cooking.

Vegetables, meats, and grains are often prepared with generous amounts of oil to prevent sticking and enhance flavor. Frying, sautéing, and finishing dishes with oils or butter are common practices in commercial kitchens.

Because oils contain a high energy density, even moderate amounts can significantly increase the caloric content of a meal.

The challenge is that these additions are rarely visible once the dish is served.

A grilled piece of fish, for example, may have been cooked with several tablespoons of oil during preparation. A stir-fried dish may contain oil incorporated throughout the cooking process.

Without direct knowledge of how the food was prepared, estimating intake becomes difficult.

Alcohol and Appetite Regulation

Restaurant meals are also frequently associated with alcohol consumption.

Alcohol influences appetite regulation in several ways. It can lower inhibition and increase the likelihood of overeating. It also contributes additional energy that the body tends to metabolize preferentially before other substrates.

While moderate alcohol consumption does not necessarily prevent fat loss, frequent intake can interfere with dietary consistency.

Alcohol also affects sleep quality when consumed in the evening. Although it may initially produce a sedative effect, alcohol can fragment sleep later in the night and disrupt normal sleep architecture.

Given the importance of sleep for metabolic regulation and recovery, frequent late-evening alcohol intake can indirectly affect body composition.

Portion Size and Eating Pace

Restaurant portions are often larger than typical home-prepared meals.

Large portions encourage faster eating and can make it more difficult to recognize satiety signals. Meals are often consumed in social environments where conversation and distraction reduce attention to hunger and fullness cues.

Under these conditions, energy intake may increase without deliberate intention.

Eating at home allows greater control over portion size and pacing of meals. Food can be prepared in quantities that match individual needs more closely.

Environmental Cues

Food environments influence behavior in subtle ways.

Bright lighting, menus with highly palatable options, and the social context of dining out can encourage larger food intake. Multiple courses, desserts, and beverages often accompany restaurant meals, creating additional opportunities for increased energy consumption.

These environmental cues operate largely at a subconscious level.

When the goal is gradual fat loss, reducing exposure to environments that promote overeating can simplify the process considerably.

Strategic Use of Restaurants

Avoiding restaurants entirely is not necessary for most people. Social events, travel, and occasional dining experiences are normal parts of life.

However, frequent restaurant meals introduce variability that makes dietary consistency more difficult.

When restaurants are used occasionally rather than daily, their impact becomes easier to manage. Choosing simpler menu items, avoiding heavily fried dishes, and limiting alcohol intake can help maintain better control over nutrient intake.

The key concept is frequency.

Meals prepared at home most of the time allow consistent control over ingredients and portion sizes. Occasional restaurant meals become manageable exceptions rather than the norm.

Consistency Over Perfection

Fat loss does not require eliminating every restaurant meal or social gathering.

The goal is simply to minimize the number of hidden variables that can interfere with dietary consistency.

Home cooking provides transparency and control. Restaurant meals introduce uncertainty.

When most meals are prepared at home, the overall nutritional pattern remains stable. Small variations introduced by occasional restaurant visits have limited impact on long-term progress.

The Importance of Small Daily Habits

Large lifestyle changes often receive the most attention in discussions about fat loss and health. Training programs, diet plans, and supplementation protocols are frequently emphasized.

However, small daily behaviors accumulate over time and influence metabolic health in meaningful ways.

Short walks, choosing stairs instead of elevators, spending time outdoors, and maintaining regular sleep schedules may appear insignificant individually. Over months and years, these habits shape the physiological environment in which fat loss and metabolic health occur.

The final chapter examines how these small behaviors contribute to long-term metabolic stability and body composition.

Chapter 12

Small Habits That Compound Over Time

The Accumulation of Daily Movement

Human metabolism responds to repeated patterns more than isolated actions.

One intense training session does not determine body composition, just as one high-calorie meal does not determine fat gain. What matters is the pattern of behavior repeated day after day.

Small movements accumulated across the day contribute significantly to total daily energy expenditure.

Walking short distances instead of driving, standing periodically during work, or choosing stairs instead of elevators increases movement frequency without requiring additional workout sessions.

These actions stimulate circulation, engage skeletal muscle, and increase energy turnover gradually.

Over long periods of time, these small increases in activity contribute to meaningful differences in metabolic output.

Walking as Transportation

Many daily tasks involve distances short enough to walk.

Walking to nearby shops, visiting a local market on foot, or simply choosing to walk for short errands introduces regular movement into daily routines.

These short walks provide the same physiological benefits described earlier: improved circulation, mild increases in energy expenditure, and enhanced fat oxidation during low-intensity activity.

Because these walks are integrated into normal routines, they rarely require additional motivation or scheduling.

Post-Meal Movement

Short periods of movement after meals can influence glucose metabolism.

A brief walk after eating increases muscular glucose uptake and helps stabilize blood sugar levels. Muscle contractions stimulate glucose transport into cells, reducing the burden on insulin to clear circulating glucose.

Over time, this habit can contribute to improved insulin sensitivity and more stable energy levels throughout the day.

The duration required does not need to be long. Even ten minutes of walking after a meal can produce measurable metabolic effects.

Light Exposure and Daily Rhythm

Daily exposure to natural light reinforces circadian rhythms.

Spending time outdoors during daylight hours helps synchronize biological clocks that regulate hormone release, sleep timing, and metabolic processes.

Combining walking with daylight exposure amplifies these effects.

A morning walk outdoors provides both movement and circadian signals that support alertness during the day and sleep quality at night.

Long-Term Perspective

Habits that appear minor on a daily basis often accumulate into meaningful physiological differences over time.

Regular resistance training preserves muscle mass. Walking supports circulation and fat oxidation. Sunlight exposure regulates circadian rhythms. Consistent sleep restores hormonal balance. Home-prepared meals reduce dietary uncertainty.

Together, these behaviors create an internal environment that favors metabolic stability.

Fat loss then occurs gradually as stored energy is mobilized and oxidized over time.

The Structural Approach

A sustainable approach to fat loss focuses on structure rather than short-term intensity.

Training provides the stimulus that preserves muscle tissue. Daily movement supports energy turnover. Sunlight and sleep regulate hormonal rhythms. Consistent eating environments reduce dietary variability.

When these elements align, fat loss becomes a predictable physiological process rather than a constant struggle.

The body adapts to the signals it receives repeatedly.

Provide the signals that maintain metabolic activity, preserve muscle mass, and support recovery, and the system gradually shifts toward improved body composition.

Conclusion

For most people, Part I and Part II are enough.

If nutrition is structured correctly, muscle mass is maintained through resistance training, daily movement is present, sleep is optimized, and basic habits are aligned, reaching around ~12% body fat becomes a very achievable and sustainable outcome.

These two parts form the foundation. Without them, no supplement, drug, stimulant, or protocol will produce lasting fat loss. At best, those tools create temporary results while the underlying metabolic environment remains unfavorable.

In other words, if someone has not yet reached roughly 12% body fat, the solution is usually not more complexity. The solution is simply applying the principles from Part I and Part II consistently.

Only once someone is already relatively lean does the situation change.

In Part III, we will discuss more advanced tools sometimes used to push body fat even lower. This includes pharmacological approaches, stimulants, thyroid manipulation, and other strategies often referred to as “dark Peating”

These methods interact directly with metabolic pathways and require careful consideration. But again, without the foundations covered in Part I and Part II, they rarely lead to sustainable results.

This Substack is reader-supported. To receive new posts and support my work, consider becoming a free or paid subscriber.

]]><![CDATA[Beyond Calories : The Complete Metabolic Guide to Sustainable Fat Loss - Part I — Nutrition]]>https://articles.berbarianwizard.com/p/beyond-calories-fat-loss-guidehttps://articles.berbarianwizard.com/p/beyond-calories-fat-loss-guideSun, 01 Mar 2026 06:35:08 GMTPROLOGUE

Why Most Fat Loss Advice Fails

If fat loss were as simple as “eat less, move more” most people would not be struggling. The formula sounds clean. Reduce calories. Increase activity. The body burns stored fat to make up the difference. End of story.

And yet, in reality, something else happens.

People diet hard for weeks. The scale moves. Then it stalls. Energy drops. Sleep worsens. Hunger increases. Training performance declines. They feel colder. More irritable. Sometimes softer, not leaner. Eventually they either give up or push harder (cutting calories further, adding more cardio) and paradoxically make the situation worse.

What went wrong?

The problem is not that thermodynamics is false. The human body does obey the laws of physics.

The problem is that the body is not a static machine that burns fuel at a fixed rate. It is a dynamic, adaptive biological system governed by hormones, feedback loops, stress signals, fuel partitioning, enzyme activity, mitochondrial function, and survival mechanisms that evolved over hundreds of thousands of years.

When you reduce calories, your body does not simply “burn fat” It interprets the situation. It decides whether conditions are safe for reproduction and growth or whether they resemble famine and stress. That decision changes everything.

Fat loss is not triggered by a number on a calorie app.
It is permitted by the hormonal environment.

This distinction is the foundation of this entire guide.

Most mainstream advice collapses metabolism into a single variable: calorie balance. But fat storage and fat burning are regulated processes. They are controlled by hormones like insulin, glucagon, cortisol, thyroid hormone, leptin, adrenaline, and many others. These hormones determine not just how much energy you expend, but what type of fuel you burn, where fat is stored, and whether your metabolic rate increases or decreases.

Two diets can contain the same number of calories and produce completely different results.

Two people can eat the same calories and respond differently.

The question is not just “how many calories” but:

  • What fuels are being oxidized ?

  • What fuels are being stored ?

  • What hormones are dominant ?

  • Is metabolism being supported or suppressed ?

  • Is the body in a growth state or a stress state ?

When you understand these questions, fat loss stops being mysterious. It becomes logical.

There is another reason most advice fails.

It treats fat loss as a temporary intervention instead of a metabolic condition.

Crash diets can make someone lighter. They do not make someone metabolically healthy. They often suppress thyroid function, reduce leptin, elevate cortisol, and lower energy expenditure. The result is predictable: weight regain.

If your fat loss strategy destroys your metabolic rate, you did not solve the problem. You postponed it.

This guide is not about losing 5 kilograms in 4 weeks.

It is about building a nutritional foundation that allows someone to reach sub 15% body fat (sustainably) without chronic fatigue, hormonal suppression, or rebound weight gain.

Part 2 and 3 are coming soon. Subscribe to be notified first and support my work.

But before we discuss strategy, we need to understand calories and thermodynamics are, what macronutrients are, how fat is stored, how fuels compete, how hormones decide whether fat leaves or stays.

Without that foundation, every “fat loss tip” is guesswork. With that foundation, everything makes sense.

There is a final misconception we must clear before moving forward.

Many people believe that questioning “calories in, calories out” means denying physics. It does not.

The first law of thermodynamics always applies.

But what is rarely discussed is that in living organisms, “calories out” is not fixed. It changes depending on hormonal state, nutrient status, stress levels, thyroid function, sleep quality, and fuel type.

If you cut calories aggressively, your body may reduce energy expenditure to match. If you improve metabolic function, it may increase energy expenditure without increasing activity.

The body is not passive. It adapts.

The entire purpose of this guide is to teach you how to influence that adaptation.

Before You Read Further

This is 10 years of trial and error.

I’ve tried running 10 km daily, doing 30 minutes of HIIT every day, programs like Shortcut to Shred (Jim Stoppani) with cardio between lifting sets, strict ketogenic diets under 20 grams of carbs, intermittent fasting, a 7-day water fast, extreme aggressive deficits around 1,500 calories, and even peating without respecting the Randle cycle.

Some approaches made me fatter. Some worked temporarily but weren’t sustainable. Others came with side effects like low energy, low libido, hair shedding, and poor sleep.

I kept asking myself how some people could eat a lot, have high energy, and stay lean. Instead of jumping to another protocol, I decided to understand metabolism itself.

This guide is the result of that process.

Chapter 1

What a Calorie Actually Is

A calorie is a unit of energy.

More precisely, in nutrition we use the kilocalorie (kcal), which is the amount of energy required to raise the temperature of one kilogram of water by one degree Celsius. When a food label says “200 calories” it technically means 200 kilocalories.

That definition comes from physics. It is measured using a device called a bomb calorimeter, where food is combusted and the heat released is measured. The total heat output becomes its caloric value.

That method is clean. Precise. Repeatable.

But your body is not a sealed steel chamber where food is burned in a single, complete combustion reaction.

Inside your body, food is digested, absorbed, transported, metabolized, stored, converted, oxidized, re-esterified, excreted, and sometimes even lost through inefficiencies. Different tissues use different fuels. Hormones decide which pathway is prioritized. Mitochondria regulate how efficiently energy is extracted. Stress signals can reduce or increase total expenditure.

So while calories measure potential energy, they do not tell us how that energy will be handled biologically.

That distinction matters.

The First Law of Thermodynamics And Its Limits in Biology

The first law of thermodynamics states that energy cannot be created or destroyed. It can only change form.

In the context of fat loss, this is often simplified to:

If you consume fewer calories than you expend, you must lose weight.

Technically, this is true. But here is the missing piece:

Your body controls energy expenditure.

It can increase it.
It can decrease it.
It can shift which fuels are burned.
It can store efficiently.
It can become inefficient.

And it does all of this based on hormonal and metabolic signals.

So when someone says “calories in, calories out” they are not wrong, but they are incomplete. They assume “calories out” is a stable number. It is not.

Why “Calories Out” Is Not a Fixed Variable

Total daily energy expenditure (TDEE) is typically divided into:

  1. Basal metabolic rate (BMR)

  2. Activity expenditure

  3. Thermic effect of food (TEF)

  4. Non-exercise activity thermogenesis (NEAT)

Each of these is influenced by metabolic state.

Basal metabolic rate is heavily influenced by thyroid hormone (T3), sympathetic nervous system tone, mitochondrial function, and lean mass.

NEAT, the unconscious movement you do throughout the day, can vary by hundreds of calories between individuals, and even within the same individual depending on diet and hormonal state.

The thermic effect of food differs between macronutrients. Protein digestion is energetically expensive. Fat digestion is not.

Even spontaneous activity drops during prolonged dieting. People move less without realizing it.

When calories are chronically restricted, the body adapts:

  • Thyroid hormone drops.

  • Leptin falls.

  • Cortisol may rise.

  • Reproductive hormones decline.

  • Resting energy expenditure decreases.

This is not failure. It is survival biology. Your body is designed to resist famine.

If you cut calories aggressively and weight loss stalls, it is not because thermodynamics stopped working. It is because your metabolism adjusted.

That is the trap of oversimplification.

Why We Can’t Precisely Calculate “Calories Out”

Many apps and calculators attempt to estimate daily energy needs using formulas based on height, weight, age, and activity level. These are estimates.

They do not account for:

  • Adaptive thermogenesis

  • Thyroid fluctuations

  • Hormonal stress responses

  • Sleep quality

  • Nutrient deficiencies

  • Changes in mitochondrial efficiency

  • Differences in gut microbiome

  • Changes in spontaneous movement

Two people of the same size can differ by several hundred calories per day in expenditure. The same person can differ by several hundred calories depending on metabolic state.

This is why some individuals can maintain weight at 2,500 calories during one phase of life, and gain weight at the same intake later.

Energy balance exists, but it is dynamic.

Calories Matter But Context Determines Outcome

None of this means calories are irrelevant. If someone consumes an extreme surplus, fat will accumulate. If someone consumes a sustained deficit, weight will decrease.

But the composition of that weight change (fat vs muscle vs water) and the sustainability of that change depend on how metabolism responds.

You can lose weight while suppressing your thyroid, increasing cortisol, and damaging long-term metabolic health.

Or you can lose fat while maintaining energy, stable hormones, and performance.

The difference lies in fuel selection, hormonal signaling, and metabolic flexibility, topics we will explore in detail.

Chapter 2

Macronutrients : What You’re Actually Eating

Before we discuss fat loss, fuel competition, or hormones, we need something more basic: You need to understand what you are putting into your body. Most people don’t.

They eat “healthy. They eat “clean” They eat “low calorie”

But they do not actually know how many grams of fat, carbohydrates, or protein they are consuming. They do not know how those macros behave metabolically. And they often underestimate hidden fats, especially in restaurant food.

Fat loss without macro awareness is like trying to manage finances without knowing your income or expenses.

Let’s fix that.

The Three Macronutrients

All calorie-containing foods are made of three primary macronutrients: Protein, Carbohydrates, Fat

Each has a different structure, different metabolic fate, and different thermic cost.

Protein

4 kcal per gram

Protein is made of amino acids. It is primarily used for:

  • Muscle repair and growth

  • Enzyme production

  • Hormone synthesis

  • Immune function

It is not a preferred energy source. The body can convert protein to glucose (via gluconeogenesis), but this is energetically costly. Protein has the highest thermic effect of food : about 20–30% of its calories are lost during digestion and processing.

This means if you eat 100 kcal of protein, only about 70–80 kcal are available for usable energy.

Protein is structurally important. It is not an efficient fat-storage nutrient.

Carbohydrates

4 kcal per gram

Carbohydrates are broken down into glucose. Glucose can:

  • Be oxidized immediately for energy

  • Be stored as glycogen in the liver and muscles

  • Be converted to fat (via de novo lipogenesis, which we will discuss later)

Carbohydrates are the body’s preferred fuel for high-intensity activity. They are oxidized rapidly and support thyroid function and metabolic rate when used correctly.

Contrary to popular belief, carbohydrates are not inherently fattening. Their storage pathway is more complex than dietary fat.

Fat

9 kcal per gram

Dietary fat is energy-dense. It is absorbed as fatty acids and reassembled into triglycerides. These triglycerides can be:

  • Oxidized for energy

  • Stored directly in adipose tissue

The key detail:

Dietary fat is stored extremely efficiently.

Unlike carbohydrates, fat does not need to be converted into another form before storage. It is already in storage-ready form.

This is one of the most important concepts in this entire book.

Alcohol Is Not a Macronutrient But It Changes the Equation

Alcohol provides energy (7 kcal per gram), but it is not stored or oxidized like carbohydrates, fat, or protein.

When alcohol is consumed, the liver prioritizes metabolizing it immediately. This temporarily suppresses fat oxidation and shifts the NAD+/NADH balance in a way that favors fat storage. Even if total calories are controlled, alcohol changes how fuels are handled.

In addition, alcohol impairs sleep quality, increases next-day cortisol, reduces insulin sensitivity, and can subtly reduce spontaneous activity. This is why fat loss often stalls even when macros appear accurate.

Alcohol is not just “extra calories” It alters fuel hierarchy and hormonal regulation.

Why Energy Density Matters

Fat contains more than twice the calories per gram compared to carbs or protein. That means small errors in fat intake can significantly alter total calorie intake.

For example:

  • 10 grams of fat = 90 kcal

  • 10 grams of carbs = 40 kcal

If someone “eyeballs” their fat intake and underestimates by 30 grams, that’s 270 extra calories, enough to eliminate a moderate deficit.

Fat is easy to overconsume.

How to Read a Nutrition Label Properly

Most people look only at calories. That’s a mistake. You must look at:

  1. Serving size

  2. Grams of fat

  3. Grams of carbohydrates

  4. Grams of protein

  5. Ingredient list

Let’s break this down.

1. Serving Size

Food labels are deceptive.

If a bag says “150 calories” but the serving size is 30 grams and the bag contains 90 grams, you are consuming 450 calories if you eat the whole bag.

Always multiply by actual consumption.

2. Total Fat (and Type of Fat)

Look at total fat in grams. Then look at the ingredient list. Hidden fats are common in:

  • Sauces

  • Restaurant meals

  • Processed snacks

  • “Healthy” granola

  • Nut butters

  • Salad dressings

Especially in restaurants, seed oils are widely used. You cannot control fat quantity or quality when you eat outside frequently.

For fat loss, cooking your own food is not optional. It is control.

3. Carbohydrates

Carbs are often broken down into:

  • Total carbohydrates

  • Fiber

  • Sugars

Fiber reduces net carbohydrate absorption slightly, but total carb intake still matters metabolically.

You should know whether your carbs come from:

  • Fruit

  • Potatoes

  • Rice

  • Processed flour

  • Added sugars

Quality influences digestion speed and satiety, but quantity still matters.

4. Protein

Most people overestimate protein intake. You need to actually measure it.

If your goal is body re-composition, insufficient protein undermines muscle retention.

But excessive protein is unnecessary and can displace carbohydrates that support thyroid function.

Moderation matters.

Why You Must Cook Your Own Food

This is non-negotiable for serious fat loss.

When you cook:

  • You control fat quantity.

  • You control ingredients.

  • You eliminate hidden oils.

  • You eliminate guesswork.

When you eat out frequently:

  • Oils are invisible.

  • Portions are inconsistent.

  • Sauces contain hidden fats.

  • Macros are estimates at best.

You cannot manage fat intake precisely without control.

For someone who is serious about reaching sub 15% body fat sustainably, this is foundational.

Should You Track Calories and Macros?

Tracking is a tool. Not a religion. Using apps like FatSecret or Cronometer can educate you about:

  • Portion sizes

  • Hidden fats

  • Your true macro distribution

But long-term, you should develop intuitive awareness. The goal is education first, then competence. Tracking for 4–8 weeks can completely change your understanding of food.

After that, you may not need constant logging, but you will know what you’re eating.

Chapter 3

What Happens to Fat, Carbohydrates, and Protein Inside the Body

Now we move from labels to physiology. Because reading macros is only useful if you understand what the body does with them.

Fat loss is not about “eating less.”
It is about what gets stored and what gets oxidized.

Each macronutrient follows a different metabolic pathway. They are not interchangeable. If you understand their fate, you understand energy partitioning, and once you understand energy partitioning, fat loss becomes predictable.

Dietary Fat : The Most Efficient Storage Nutrient

When you eat fat, it is broken down into fatty acids and absorbed through the intestine. These fatty acids are packaged into chylomicrons and transported through the bloodstream.

From there, they have two primary fates:

  1. Immediate oxidation (burning for energy)

  2. Storage in adipose tissue

Here is the critical point: Dietary fat is already in storage-ready form.

To store dietary fat, the body does not need to convert it into something else. It simply re-esterifies it into triglycerides and deposits it into fat cells.

This process is highly efficient.

Research consistently shows that approximately 90–98% of excess dietary fat can be stored directly with minimal energetic cost.

The thermic effect of fat is low : roughly 2–3%. That means if you consume 100 kcal of fat, about 97–98 kcal are available for storage or use.

There is no major “conversion penalty”. This does not mean dietary fat automatically makes you fat. It means:

If there is a surplus of dietary fat and the body does not need to oxidize it immediately, storage is easy.

Carbohydrates : Oxidize First, Store as Glycogen

Carbohydrates are metabolized very differently.

When you consume carbs, they are broken down into glucose. Glucose enters the bloodstream and triggers insulin release. Glucose has priority use.

It can be:

  • Burned immediately for energy

  • Stored as glycogen in the liver

  • Stored as glycogen in skeletal muscle

  • Converted to fat (de novo lipogenesis, or DNL)

The body prefers to oxidize glucose first. Why?

Because glucose oxidation is rapid. It produces ATP efficiently and supports high-energy demand. It also produces carbon dioxide (CO₂), which has regulatory and stabilizing effects on cellular metabolism.

Before the body converts carbohydrates to fat, it must first fill glycogen stores.

Approximate glycogen storage capacity:

  • Liver: ~80–120 grams

  • Muscle: ~300–600 grams (depending on size and training status)

That’s roughly 400–700 grams total storage capacity, or 1,600–2,800 kcal worth of carbohydrates.

Only when glycogen stores are saturated and carbohydrate intake remains excessive does the body increase de novo lipogenesis.

And here is the crucial detail: Under normal dietary conditions, DNL in humans is extremely low.

Most studies show:

  • Less than 1% of carbohydrate intake is converted into fat under normal feeding.

  • Even in high-carb overfeeding, DNL often stays around 1–3%.

  • Fat conversion from carbs occurs mainly when glycogen is full and calories are massively excessive over multiple days.

Unlike dietary fat, carbohydrates require a metabolically expensive conversion process before they can be stored as fat. This conversion “wastes” energy. The body does not prefer it.

Protein : Structurally Important, Metabolically Costly

Protein has a different fate. Amino acids are primarily used for:

  • Tissue repair

  • Muscle synthesis

  • Enzyme production

  • Hormone production

If protein intake exceeds structural needs, amino acids can:

  • Be oxidized for energy

  • Be converted into glucose (gluconeogenesis)

Converting protein into fat is extremely inefficient and uncommon under normal conditions.

The thermic effect of protein is high : approximately 20–30%. If you eat 100 kcal of protein, only 70–80 kcal are available after digestion and processing.

This is why high-protein diets often increase satiety and slightly raise total energy expenditure.

Protein is metabolically “expensive”. Fat is metabolically “cheap”. Carbohydrates are conditionally efficient : depending on glycogen status and metabolic health.

The Thermic Effect of Food : Why Macros Aren’t Equal

Let’s compare the thermic cost:

  • Protein: ~20–30%

  • Carbohydrates: ~5–10%

  • Fat: ~2–3%

This means two diets with equal calories but different macro composition can produce different net energy availability.

1,000 kcal from fat is not metabolically identical to 1,000 kcal from protein. The body processes them differently. This alone already complicates simplistic calorie arithmetic.

Chapter 4

The Randle Cycle : Why Fuel Competition Determines Fat Storage

At this point, you understand something most people don’t:

  • Dietary fat is easily stored.

  • Carbohydrates are oxidized first and stored as glycogen before meaningful fat conversion occurs.

  • Protein is metabolically costly and rarely becomes fat directly.

Now we introduce the mechanism that connects all of this:

The Randle cycle. Also known as the glucose–fatty acid cycle, it describes how fat and glucose compete as fuels inside the body.

This competition determines:

  • Which fuel gets burned

  • Which fuel gets stored

  • How insulin sensitivity changes

  • Whether energy production feels stable or sluggish

Understanding this is essential.

The Basic Principle

The Randle cycle states:

When fatty acid oxidation (FAO) is high, glucose oxidation is inhibited.
When glucose oxidation is high, fat oxidation is inhibited.

But here’s the crucial nuance most people never hear:

The inhibition is asymmetrical.

Fatty acid oxidation inhibits glucose oxidation more strongly than glucose inhibits fat oxidation.

This asymmetry changes everything.

When Fat Oxidation Is High

When you consume a high-fat diet, or when fatty acids are elevated in the bloodstream (from dietary fat or body fat), fatty acid oxidation increases.

As fatty acids are oxidized in the mitochondria, they generate metabolic intermediates (like acetyl-CoA and citrate) that inhibit key enzymes involved in glucose oxidation.

Specifically:

  • Pyruvate dehydrogenase (PDH) activity decreases

  • Glucose oxidation slows

  • The cell becomes more reliant on fat

This means that elevated fatty acid oxidation reduces glucose utilization.

In practical terms:

High fat availability → reduced glucose oxidation → reduced insulin sensitivity (at least acutely).

This is why mixing high fat and high carbohydrate intake can create metabolic friction. Both fuels are present. Both compete. The system becomes less efficient.

When Glucose Oxidation Is High

Now let’s examine the opposite scenario.

When carbohydrate intake is high and fat intake is low, glucose oxidation increases.

Glucose metabolism produces malonyl-CoA, which inhibits CPT-1 : the enzyme responsible for transporting fatty acids into mitochondria for oxidation.

This reduces fat oxidation.

But here is the key difference:

This inhibition is localized and reversible. When glucose availability falls, fat oxidation resumes quickly.

Glucose is oxidized much faster than fat. This is important for metabolic rate and acute energy demands.

Fat oxidation is slower and more dependent on stress hormones when carbohydrate availability is low.

The asymmetry matters. Fat oxidation strongly suppresses glucose oxidation. Glucose oxidation suppresses fat oxidation more gently.

The Three Dietary Scenarios

Now we can analyze the three major macro combinations.

1. High Fat + High Carb

This is the worst metabolic scenario for fat loss. Both fuels are abundant. Fatty acids inhibit glucose oxidation. Glucose elevates insulin. Dietary fat is easily stored.
Glucose oxidation is impaired.

Energy production can feel unstable. Fat storage becomes easier.

This combination is common in modern processed food:

  • Pizza

  • Pastries

  • Fried carbs

  • Desserts with added oils

It is hyper-palatable and metabolically inefficient.

2. High Fat + Low Carb

This is the ketogenic approach.

In this scenario:

  • Insulin remains low

  • Fat oxidation increases

  • The body adapts to using fat and ketones

Many people lose fat on this approach, especially if they were previously metabolically inflexible. However, maintaining blood glucose under low-carb conditions often requires elevated stress hormones:

  • Adrenaline

  • Cortisol

  • Glucagon

These hormones stimulate gluconeogenesis to maintain necessary blood sugar levels. This approach can work, but it relies more heavily on stress pathways. For some individuals, this is sustainable.

For others, it leads to:

  • Lower thyroid output

  • Higher cortisol

  • Reduced performance

  • Lower carbohydrate tolerance long-term

We will discuss this in more detail later.

3. High Carb + Low Fat

In this scenario:

  • Glucose oxidation is prioritized

  • Glycogen is replenished

  • Fat intake is too low to be stored in large quantities

  • Thyroid function tends to remain more stable

  • Insulin sensitivity can improve (if fat intake is low)

Because dietary fat is limited, even if insulin rises temporarily after carb intake, there is minimal fat available to store.

Carbohydrates are:

  • Burned

  • Stored as glycogen

  • Only minimally converted to fat under normal conditions

This is why high-carb, low-fat diets can produce steady fat loss when total intake is controlled. They align with the asymmetry of the Randle cycle.

Are All Fats Equal Within the Randle Framework?

Not all fats behave identically in the context of fuel competition.

Most of the Randle cycle research focuses on long-chain fatty acids : the types found in typical dietary fats such as beef fat, seed oils, pork fat, and high-fat dairy. These fatty acids require the carnitine shuttle (via CPT-1) to enter the mitochondria. When oxidized in high amounts, they generate metabolic intermediates that strongly inhibit pyruvate dehydrogenase (PDH), suppressing glucose oxidation.

Short- and medium-chain fatty acids behave differently.

Medium-chain fats (such as caprylic and capric acid found in coconut oil and MCT oil) enter mitochondria more directly and are oxidized rapidly, particularly in the liver. Because they are cleared quickly and are less likely to accumulate as circulating free fatty acids, they tend to interfere less with glucose oxidation compared to long-chain fats.

They are still fats. They still provide energy. They are not metabolically neutral. But within the context of fuel competition, they are generally less disruptive than high intakes of long-chain fatty acids.

This distinction matters when structuring a high-carb, low-fat approach.

Insulin Sensitivity and the Randle Cycle

One of the most misunderstood points in nutrition is insulin sensitivity. Eating more carbohydrates does not automatically reduce insulin sensitivity.

In fact, studies show that increasing carbohydrate intake while keeping fat low can improve insulin sensitivity in metabolically healthy individuals.

Why?

Because reducing fat intake reduces circulating fatty acids.

Lower fatty acids → less inhibition of glucose oxidation → improved glucose utilization.

This is consistent with the asymmetry of the Randle cycle. Fatty acid overload is often a stronger driver of insulin resistance than carbohydrate intake alone.

Why This Matters for Fat Loss

Fat loss is not just about reducing calories. It is about creating conditions where:

  • Fat can be mobilized

  • Fat can be oxidized

  • Metabolism remains high

  • Hormones remain stable

If you combine high fat and high carbohydrate intake, you increase the probability that dietary fat will be stored.

If you reduce fat intake while allowing carbohydrates to fuel activity and maintain thyroid function, you create a different metabolic environment.

This does not mean carbohydrates are magic. It means fuel competition is real. And when you understand it, you stop randomly mixing macros without strategy.

Chapter 5

Glucose Oxidation vs Fat Oxidation : What Really Powers Your Metabolism

Now we move inside the cell. Because fat loss is not just about storage. It is about oxidation.

You cannot lose fat unless fatty acids are:

  1. Released from adipose tissue (lipolysis)

  2. Transported to tissues

  3. Oxidized in mitochondria

And oxidation is not automatic. It is regulated.

To understand how to create a metabolism that burns fat efficiently without suppressing itself, we need to understand how the two primary fuels (glucose and fatty acids) are oxidized.

Glucose Oxidation : The High-Speed Fuel

When you consume carbohydrates, glucose enters the bloodstream and is transported into cells. Inside the cell, glucose undergoes:

  1. Glycolysis

  2. Conversion to pyruvate

  3. Entry into the mitochondria

  4. Oxidation via the Krebs cycle

  5. Electron transport chain (ETC) activity

  6. ATP production

The key gateway enzyme is pyruvate dehydrogenase (PDH). PDH converts pyruvate into acetyl-CoA, which enters the Krebs cycle.

If PDH is functioning properly, glucose is efficiently oxidized. If PDH is inhibited, glucose is diverted toward lactate production instead of mitochondrial oxidation.

This distinction matters for energy quality.

Nutrients Required for Proper Glucose Oxidation

Glucose oxidation is not automatic. It requires:

  • Vitamin B1 (thiamine) : essential for PDH activation

  • Magnesium : required for ATP stability

  • Vitamin B3 (niacinamide) : supports NAD+ pools

  • Adequate thyroid hormone (T3) : increases mitochondrial respiration

  • Adequate oxygen delivery

  • Proper mitochondrial integrity

If these factors are impaired, glucose oxidation becomes inefficient.

Energy production drops. Fatigue increases. Lactate accumulates. Stress hormones rise.

Carbohydrates are not the problem in that scenario. Impaired oxidation is.

Why Glucose Oxidation Supports Metabolic Rate

Glucose oxidation produces: ATP, CO₂, Water

CO₂ is not just a waste gas. Carbon dioxide stabilizes proteins, reduces excitability, improves oxygen delivery (Bohr effect), and opposes stress signaling.

Efficient glucose oxidation tends to:

  • Support thyroid function

  • Lower cortisol

  • Support performance

  • Increase metabolic rate

Glucose is oxidized quickly. This is why high-intensity exercise depends on glycolysis : fat oxidation is too slow to meet rapid ATP demand.

Fat Oxidation : Slower, Stress-Sensitive Fuel

Fat oxidation occurs when fatty acids enter the mitochondria through CPT-1 and undergo beta-oxidation. This produces acetyl-CoA, which enters the Krebs cycle.

Fat oxidation:

  • Produces ATP efficiently

  • Is slower than glucose oxidation

  • Generates more reactive oxygen species (ROS) per unit of ATP

  • Is often elevated during fasting or low-carb states

Fat oxidation is not inherently harmful. But when carbohydrate availability is low, maintaining blood glucose requires: Cortisol, Adrenaline, Glucagon

These hormones stimulate gluconeogenesis. This is why prolonged low-carb dieting can increase stress hormone reliance in some individuals.

The body must maintain blood glucose, especially for the brain.

What Happens After Oxidation?

Oxidation determines whether fat mass decreases. If fatty acids are released but not oxidized, they can be:

  • Re-esterified back into triglycerides

  • Stored again

This is why lipolysis alone does not guarantee fat loss. Fat must be oxidized.

If someone has high fatty acid release but low oxidation capacity (due to low thyroid function, mitochondrial impairment, or sedentary behavior), fat loss may stall.

Oxidation is the bottleneck.

Fuel Switching : What Determines Which Fuel Is Used?

The body switches between glucose and fat oxidation based on:

  • Insulin levels

  • Glycogen availability

  • Thyroid hormone

  • Stress hormones

  • Fat availability

  • Activity level

High insulin suppresses lipolysis. Low insulin allows lipolysis. But insulin is not the only regulator.

Elevated circulating fatty acids can suppress glucose oxidation. Low thyroid function reduces overall oxidation capacity. Cortisol increases fatty acid release but may impair glucose tolerance.

This is a coordinated system.

Metabolic Flexibility

Metabolic flexibility refers to the ability to switch efficiently between glucose and fat oxidation.

A metabolically flexible individual:

  • Burns glucose efficiently when carbs are available

  • Burns fat efficiently during fasting or low-intensity activity

  • Maintains stable energy

Metabolic inflexibility looks like:

  • Poor glucose tolerance

  • High fasting fatty acids

  • Constant fatigue

  • High stress hormones

  • Reduced thyroid output

Fat loss is easier when metabolic flexibility is intact. And flexibility is influenced by diet composition.

Chapter 6

Insulin, Lipolysis, and the Hormonal Control of Fat Storage

Up until now, we have discussed fuel handling in mechanical terms:

  • What gets stored

  • What gets oxidized

  • How fuels compete

Now we move to the control layer. Because fat does not leave a fat cell simply because you ate fewer calories.

It leaves because hormones allow it to leave. And it stays because hormones tell it to stay.

Lipolysis : The Gatekeeper of Fat Loss

Fat stored in adipose tissue exists as triglycerides. For fat loss to occur, those triglycerides must be broken down into: Free fatty acids, Glycerol

This breakdown process is called lipolysis. The key enzyme responsible for initiating lipolysis is Hormone-Sensitive Lipase (HSL).

If HSL is inactive, fat remains stored. If HSL is activated, fatty acids are released into circulation. But release does not equal loss. Release must be followed by oxidation.

Still, lipolysis is the first gate. And insulin directly controls that gate.

Insulin : Not Evil, But Powerful

Insulin is often portrayed as the villain in fat loss discussions. That is an oversimplification.

Insulin is a storage hormone. Its primary roles include:

  • Promoting glucose uptake

  • Promoting glycogen storage

  • Inhibiting lipolysis

  • Promoting fat storage in the presence of excess fuel

When insulin is elevated, HSL is inhibited. That means lipolysis slows down. If insulin remains chronically elevated, fat mobilization becomes difficult.

But here is the nuance:

Insulin rises in response to carbohydrates : yes. But insulin also rises in response to protein. And insulin elevation alone does not cause fat gain. Fat gain requires energy surplus and available fat substrate.

If dietary fat is low, even in the presence of insulin, fat storage potential is limited.

Insulin blocks fat release. It does not magically create fat from nothing.

The Insulin–Glucagon Ratio

Insulin does not operate alone. It works in opposition to glucagon.

When insulin is high: Storage is favored. When glucagon is high: Mobilization is favored.

During fasting or between meals, insulin drops and glucagon rises. This allows lipolysis to occur.

But lipolysis is also influenced by: Adrenaline, Noradrenaline, Cortisol

These are stress hormones. They increase lipolysis. However, chronically elevated cortisol can also impair insulin sensitivity and alter fat distribution.

Which brings us to an important point.

Where Fat Is Stored : Hormonal Influence on Distribution

Fat storage is not random. Different hormones influence different fat depots.

  • Cortisol tends to increase visceral fat accumulation.

  • Estrogen influences gluteofemoral fat distribution.

  • Insulin resistance promotes central fat storage.

  • Low testosterone in men can increase abdominal fat.

So when someone says, “I’m in a deficit but I’m storing belly fat” the answer may lie in stress hormones and insulin sensitivity, not just calorie count.

Hormonal environment determines partitioning.

Insulin Sensitivity : The Missing Variable

Two people can eat identical meals. One will store more fat. The other will oxidize more glucose. The difference is insulin sensitivity.

If muscle tissue is insulin sensitive:

  • Glucose is directed into muscle

  • Glycogen is replenished

  • Energy is used efficiently

If muscle tissue is insulin resistant:

  • Glucose lingers in circulation

  • Insulin remains elevated longer

  • Fat storage probability increases

Insulin resistance is often associated with:

  • Elevated circulating fatty acids

  • Chronic inflammation

  • Sedentary lifestyle

  • High-fat overfeeding

  • Sleep deprivation

It is not caused by carbohydrates alone. Remember the Randle cycle: Excess fatty acid oxidation inhibits glucose oxidation.

Chronically elevated fatty acids can impair glucose handling. This is one reason why high fat + high carb is metabolically problematic.

The Switch Between Fat and Glucose Oxidation

Fat oxidation increases when:

  • Insulin is low

  • Glycogen is low

  • Stress hormones rise

  • Activity is low-intensity

  • During sleep

Glucose oxidation increases when:

  • Carbohydrates are consumed

  • Glycogen is being replenished

  • Activity is high-intensity

  • Thyroid hormone is adequate

The body constantly shifts between fuels. The goal is not to “never spike insulin” The goal is to create a system where:

  • Insulin rises when appropriate

  • Lipolysis resumes when appropriate

  • Oxidation capacity remains high

  • Metabolism is not suppressed

This requires balance.

Why Chronic Low Calories Backfire

If someone reduces calories aggressively for weeks:

  • Leptin drops

  • Thyroid hormone (T3) drops

  • Cortisol rises

  • Energy expenditure decreases

Lipolysis may increase temporarily. But oxidation capacity may decrease. Eventually, fat loss stalls. Not because thermodynamics stopped working, but because the body adapted.

When the body senses prolonged energy scarcity, it shifts into conservation mode. And conservation mode reduces metabolic rate. This is why fat loss strategy must consider hormonal adaptation.

Chapter 7

Calories In, Calories Out : Where the Model Breaks Down

By now, you should see the pattern. Calories matter. Hormones matter. Fuel type matters. Metabolic rate matters.

But the common fat loss model reduces everything to:

Create a deficit and fat loss will happen.

On paper, that is correct. In biology, it is incomplete. Let’s rebuild the model properly.

What “Calories In” Really Means

Calories in refers to the total energy you consume from food. That part is measurable, with some margin of error: You can weigh food. You can track macros. You can calculate intake.

But even here, variability exists:

  • Food labels can be off by 10–20%.

  • Fiber reduces absorbed energy slightly.

  • Gut microbiome differences affect extraction.

  • Cooking methods change caloric availability.

Still, intake is relatively controllable. The real problem is not “calories in” It is “calories out”

What “Calories Out” Really Includes

Total energy expenditure is not just exercise. It includes:

  • Basal metabolic rate (BMR)

  • Non-exercise activity (NEAT)

  • Thermic effect of food

  • Exercise energy expenditure

  • Adaptive thermogenesis

Most calorie calculators assume BMR is relatively fixed. It is not. BMR is strongly influenced by:

  • Thyroid hormone (especially T3)

  • Sympathetic nervous system tone

  • Lean mass

  • Mitochondrial efficiency

  • Hormonal status

  • Sleep quality

When calories are chronically restricted, the body lowers energy expenditure to preserve survival. This is adaptive thermogenesis. It can reduce daily expenditure by several hundred calories.

That reduction is not voluntary. It is biological.

Adaptive Thermogenesis : The Survival Mechanism

When you diet aggressively:

  • Leptin drops.

  • T3 decreases.

  • Resting energy expenditure declines.

  • Spontaneous movement decreases.

  • Reproductive hormones may decline.

  • Hunger signals increase.

Your body does not know you are dieting for aesthetics. It interprets a deficit as potential famine. The response is conservation.

This is why many people experience:

  • Initial rapid weight loss

  • Followed by a plateau

  • Followed by increasing fatigue

They reduce calories further. The body reduces expenditure further. The gap closes. The deficit shrinks. Fat loss stalls. The model of “just eat less” fails because the body adapts.

The Illusion of Precision

Online calculators give specific numbers:

  • “Your maintenance is 2,346 calories”

  • “Eat 1,846 calories to lose 1 pound per week”

These numbers create false confidence. In reality:

Your maintenance can fluctuate by hundreds of calories depending on:

  • Sleep

  • Stress

  • Carb intake

  • Thyroid output

  • Training volume

  • Fatigue

The body is dynamic. Energy expenditure is responsive. This is the trap of oversimplification.

Energy Partitioning vs Energy Arithmetic

Instead of thinking only in terms of deficit, a better framework is:

Energy balance determines total mass change. Energy partitioning determines whether that change is fat, muscle, or water.

Two people can both lose 1 kilogram.

One loses:

  • Mostly fat

  • Preserves muscle

  • Maintains metabolic rate

The other loses:

  • Muscle

  • Glycogen

  • Water

  • With suppressed metabolism

Same calorie deficit. Different hormonal environment. Different outcome.

Why Some People Lose Fat at Higher Calories

You may have seen this phenomenon:

Someone increases carbohydrates, raises total calories slightly, and suddenly fat loss resumes. How ? Because metabolism increased.

Higher carbs can:

  • Restore glycogen

  • Increase leptin

  • Raise T3

  • Lower cortisol

  • Increase training performance

  • Increase NEAT

If expenditure rises more than intake rises, net fat loss can resume. This is not magic. It is metabolic restoration.

The Correct Way to Think About Energy Balance

Energy balance is real. But it is dynamic.

Instead of asking: “How low can I cut calories?”. The better question is: “How can I maintain the highest sustainable metabolic rate while creating a moderate deficit?”

This shifts the strategy entirely. It favors:

  • Supporting thyroid function

  • Supporting glucose oxidation

  • Managing stress hormones

  • Avoiding excessive fat intake

  • Using strategic refeeds

  • Preserving muscle mass

Fat loss becomes a metabolic optimization problem, not a starvation contest.

Chapter 8

Why I Prefer High-Carb, Low-Fat for Sustainable Fat Loss

At this point, we’ve built the foundation. You understand:

  • Dietary fat is easily stored.

  • Carbohydrates are preferentially oxidized and stored as glycogen before meaningful fat conversion occurs.

  • The Randle cycle makes high fat + high carb metabolically inefficient.

  • Chronic calorie restriction lowers thyroid, leptin, and metabolic rate.

  • Energy expenditure adapts.

Now we can answer the practical question: If the goal is to reach sub ~15% body fat sustainably (without suppressing metabolism) what macro structure makes the most sense ?

For me, and for many metabolically functional individuals, the answer is: High carbohydrate, low fat.

This is not ideology. It is a conclusion drawn from fuel physiology. Let’s build the case clearly.

1. Dietary Fat Is Easily Stored

This is the most straightforward argument. Dietary fat requires minimal processing before storage. It enters circulation, is reassembled into triglycerides, and can be deposited into adipose tissue efficiently.

The storage efficiency is extremely high : often 90–98%. There is almost no metabolic penalty.

Carbohydrates, on the other hand, must:

  • Fill glycogen stores first

  • Then undergo de novo lipogenesis (DNL) to become fat

And DNL in humans is low under normal conditions : typically under 1% of carbohydrate intake in energy-balanced states, and often only 1–3% even during overfeeding.

This means: If fat intake is low, there is very little direct substrate available for fat storage. That changes the entire partitioning equation.

2. The Randle Cycle Favors Low Fat with High Carbs

Remember the asymmetry: High fatty acid oxidation strongly inhibits glucose oxidation. High glucose oxidation only mildly inhibits fat oxidation.

When fat intake is low, circulating fatty acids drop. This reduces inhibition of glucose oxidation. Insulin sensitivity improves. Glucose is handled efficiently. Energy production remains stable.

When fat intake is high alongside carbs:

  • Fat inhibits glucose oxidation.

  • Insulin remains elevated.

  • Fat is easily stored.

This is why high fat + high carb is metabolically problematic. High carb + low fat avoids this fuel conflict.

3. Higher Carbohydrate Intake Supports Thyroid Function

Thyroid hormone (especially T3) is critical for maintaining metabolic rate. Chronic low carbohydrate intake can reduce T3 levels in some individuals.

Low T3 leads to:

  • Reduced resting energy expenditure

  • Lower body temperature

  • Slower gut motility

  • Increased fatigue

Carbohydrates help maintain:

  • Liver glycogen

  • Leptin levels

  • T3 conversion

When liver glycogen is full, cortisol does not need to rise to maintain blood glucose. Lower cortisol means less stress signaling and less water retention. Supporting thyroid function is central to sustainable fat loss.

4. You Look and Perform Better on Carbs

Glycogen stored in muscle binds water. Roughly 3 grams of water are stored with every gram of glycogen.

This means:

  • Muscles look fuller.

  • Strength improves.

  • Training performance increases.

Higher performance allows:

  • Greater training stimulus.

  • Greater energy expenditure.

  • Better muscle retention.

Low-carb diets often flatten muscle glycogen, making people look smaller and softer, even if fat mass hasn’t changed significantly.

Full muscles are not just aesthetic. They are metabolically active tissue.

5. The Brain Requires Glucose

The brain relies heavily on glucose. It can use ketones to some degree, but it cannot eliminate glucose requirements entirely.

When carbohydrate intake is low, the body must maintain blood glucose via:

  • Gluconeogenesis

  • Amino acid breakdown

  • Stress hormone activation

This can increase reliance on cortisol. Carbohydrates reduce that burden.

Stable glucose often means:

  • Better mood

  • Better sleep

  • Lower stress hormones

Which indirectly supports fat loss.

6. Carbohydrates Are Muscle-Sparing

During energy restriction, muscle loss is a risk. Carbohydrates help spare muscle by:

  • Reducing cortisol

  • Maintaining training intensity

  • Supporting insulin-mediated anti-catabolic effects

When carbs are adequate, protein can be used for repair rather than converted into glucose. This can allow moderate protein intake without excessive breakdown.

7. More Calories Can Be Tolerated

Because of:

  • Lower fat storage efficiency

  • Higher thermic effect compared to fat

  • Greater support of metabolic rate

High-carb, low-fat diets often allow slightly higher calorie intake while still achieving fat loss. This improves sustainability. The goal is not starvation. The goal is controlled partitioning with a preserved metabolic rate.

Inflammation, Aromatase, and Hormonal Environment

High dietary fat (especially when combined with excess body fat) is associated with increased inflammatory signaling. Adipose tissue itself produces cytokines such as IL-6. Chronically elevated IL-6 is associated with increased aromatase activity, the enzyme that converts testosterone into estrogen.

Higher aromatase activity shifts the hormonal environment toward estrogen dominance. Elevated estrogen can increase prolactin, suppress thyroid signaling, and promote additional fat storage, reinforcing the very state someone is trying to escape.

This does not mean dietary fat directly “causes estrogen” It means that in a metabolically impaired or inflamed state, higher fat availability combined with adiposity can amplify inflammatory signaling and hormonal conversion pathways.

A high-carb, controlled-fat approach reduces direct fat storage efficiency, improves glucose oxidation, and (when paired with fat loss) helps lower inflammatory signaling over time. The result is not just weight loss, but a more favorable hormonal environment.

Do You Need Dietary Fat to Produce Testosterone?

One of the most frequent objections to a high-carb, low-fat approach is the belief that dietary fat is required to produce testosterone.

The reasoning usually goes like this: testosterone is made from cholesterol, cholesterol comes from fat, therefore low fat must lower testosterone.

That logic sounds intuitive, but it’s incomplete.

Cholesterol is produced endogenously in the liver through the mevalonate pathway. The raw material for this process is acetyl-CoA. Acetyl-CoA does not come exclusively from dietary fat. It can be generated from glucose oxidation, fatty acid oxidation, or amino acid metabolism. When carbohydrate intake is adequate and glucose oxidation is functioning properly, acetyl-CoA production is not limited.

In fact, carbohydrate metabolism plays a central role in supporting cholesterol synthesis. The process requires NADPH, a reducing equivalent largely generated through the pentose phosphate pathway, which is directly fueled by glucose metabolism. In other words, carbohydrate oxidation contributes both the substrate and the reducing power required for cholesterol synthesis.

Steroid hormone production depends primarily on energy availability, thyroid function, and mitochondrial health, not on consuming large amounts of dietary fat.

This does not mean dietary fat is useless. It means that high dietary fat is not a prerequisite for steroidogenesis.

If anything, inadequate energy intake, suppressed thyroid function, chronic stress, or low micronutrient status are far more likely to impair testosterone production than moderate fat intake.

One micronutrient worth mentioning in this context is vitamin A in its active form (retinol, not beta-carotene). Retinol supports steroidogenic enzyme expression and proper hormonal signaling. This is a biochemical detail often overlooked when people reduce the discussion to “eat more fat for testosterone.”

The body is not dependent on large dietary fat intake to produce cholesterol or testosterone. It is dependent on adequate metabolic energy and proper enzymatic support.

Understanding this distinction removes one of the biggest misconceptions about high-carb, low-fat nutrition.

A Brief Note on Fruit vs Starch

Both fruit and starch can support a high-carbohydrate approach. But fruit has unique metabolic advantages worth mentioning.

Fruit contains both glucose and fructose. While glucose replenishes muscle glycogen, fructose preferentially replenishes liver glycogen. Adequate liver glycogen plays a central role in lowering cortisol and stabilizing blood glucose between meals. When liver glycogen is consistently repleted, the body relies less on stress hormones to maintain blood sugar.

Fruit is also naturally rich in potassium, which supports glycogen storage, insulin function, and fluid balance. For many individuals, fruit is easier to digest than large quantities of starch, especially in states of impaired gut motility.

This does not mean starch is problematic. Potatoes and rice can be excellent carbohydrate sources. But strategically incorporating fruit can improve liver glycogen buffering and stress regulation, which indirectly supports fat loss.

Strategic Carbohydrate Timing

Carbohydrates are not just about total daily intake. Timing matters.

Around training, carbohydrates are strategic. High-intensity resistance training depends primarily on glycolysis, the rapid breakdown of glucose to produce ATP. Fat oxidation is too slow to meet that demand. Consuming carbohydrates before and even during training supports performance, reduces cortisol rise, preserves muscle glycogen, and limits catabolism.

Carbohydrates before sleep serve a different purpose. During the night, the liver must maintain stable blood glucose for the brain. If liver glycogen is low, cortisol rises to compensate. A moderate carbohydrate intake in the evening helps refill liver glycogen, reduce nighttime stress hormone release, and improve sleep quality and recovery.

This does not mean fat oxidation “stops” when you eat carbs. Fuel use is dynamic. Fat oxidation increases during sleep, low-intensity movement, between meals, and on lower-carb days. The goal is not to eliminate fat oxidation, it is to structure fuel use intelligently.

Strategic carbohydrate placement supports performance when energy demand is high and allows fat oxidation to occur naturally when demand is low.

Important Clarification

This does not mean:

  • Everyone must eat extremely high carb.

  • Fat must be eliminated completely.

  • Keto cannot work.

It means that for many metabolically functional individuals seeking sustainable fat loss with stable energy, high-carb, low-fat aligns well with:

  • Fuel physiology

  • Randle asymmetry

  • Thyroid support

  • DNL inefficiency

  • Muscle performance

It is a strategic alignment, not dogma.

Chapter 9

When Fat Oxidation Happens on a High-Carb, Low-Fat Diet

One of the most common objections to a high-carb, low-fat (HCLF) approach is this:

“If insulin rises after carbs, and insulin blocks fat burning, how can you possibly lose fat while eating carbohydrates daily ?”

The confusion comes from assuming that insulin remains elevated 24/7 and that fat oxidation is an all-or-nothing switch.

It isn’t. Fat oxidation is rhythmic. It rises and falls across the day depending on:

  • Time since last meal

  • Glycogen status

  • Activity level

  • Hormonal state

  • Total energy balance

You do not need zero insulin to lose fat. You need periods where fat oxidation exceeds fat storage across a 24-hour cycle. Let’s walk through how that actually happens.

Fat Oxidation Is Not Constant, It Cycles

Even on a high-carb diet, insulin does not stay elevated continuously.

After a carbohydrate-containing meal:

  • Insulin rises.

  • Glucose is oxidized.

  • Glycogen is replenished.

  • Lipolysis temporarily decreases.

Several hours later:

  • Insulin falls.

  • Glucagon rises.

  • Lipolysis resumes.

  • Fatty acids are released and oxidized.

This is a normal physiological oscillation. The body is constantly switching between glucose and fat oxidation depending on immediate availability.

The mistake is thinking that eating carbohydrates permanently “shuts off” fat burning. It does not. It temporarily shifts the dominant fuel source. Over 24 hours, both fuels are used.

Fat Oxidation During Sleep

Sleep is one of the most overlooked fat-burning windows.

During sleep:

  • Insulin is low.

  • Growth hormone rises.

  • Lipolysis increases.

  • The body shifts toward greater fat oxidation.

If glycogen stores are adequate, cortisol remains stable. If glycogen is depleted, cortisol may rise to maintain blood glucose.

This is one reason why extremely low-carb dieting can increase nighttime stress hormones in some individuals.

On a well-structured HCLF diet:

  • Carbs consumed earlier in the day replenish glycogen.

  • Fat intake remains low.

  • During sleep, the body draws more heavily from stored fat.

Fat oxidation still happens. It just happens in rhythm.

Fat Oxidation During Low-Intensity Activity

Walking, standing, daily movement, these rely heavily on fat oxidation. Low-intensity movement does not require rapid ATP production.

Fat oxidation is slower but sufficient.

This means someone on a high-carb diet can:

  • Use carbohydrates during training.

  • Use fat during walking, daily activity, and sleep.

The body is flexible when metabolic health is intact.

Total Energy Balance Still Matters

If someone eats:

  • 400g carbohydrates

  • 40g fat

  • 150g protein

And total intake is slightly below expenditure, fat loss can occur because:

  • Fat intake is low.

  • Carbs replenish glycogen.

  • Insulin fluctuates normally.

  • Fat oxidation occurs during low-insulin periods.

  • Metabolic rate remains high.

Fat loss is not determined by a single insulin spike. It is determined by net substrate balance over time.

If dietary fat is limited and overall intake is controlled, fat mass can decrease even with daily carbohydrate consumption.

The Importance of Glycogen

Glycogen is not the enemy. It is a buffer.

When liver glycogen is adequate:

  • Cortisol remains lower.

  • Blood sugar remains stable.

  • Stress signaling is reduced.

When liver glycogen is chronically depleted:

  • Cortisol rises.

  • Gluconeogenesis increases.

  • Stress hormones dominate.

High-carb intake supports glycogen. Low fat intake limits storage substrate.

This creates a dynamic where:

  • Carbs fuel performance.

  • Fat oxidation occurs between meals and during sleep.

  • Metabolism remains high.

The Big Picture

Fat loss is not about eliminating carbohydrates. It is about managing fuel competition and hormonal environment.

On HCLF:

  • Insulin rises and falls appropriately.

  • Fat intake is low, reducing storage potential.

  • Thyroid function remains supported.

  • Stress hormones remain moderate.

  • Fat oxidation occurs during low-insulin windows.

Chapter 10

Carb Cycling and Refeeds : Restoring Metabolism Without Gaining Fat

At some point during a fat loss phase, something almost always happens.

Progress slows. Energy drops. Workouts feel flat. Sleep worsens. Libido declines.
The scale stops moving, or even goes up slightly.

Most people respond by cutting calories further. That is usually the wrong move.

Because what’s often happening at this stage is not a lack of discipline. It’s metabolic adaptation.

What Happens During Prolonged Caloric Restriction

When someone eats low calories (let’s say 1,800 kcal daily) for several weeks, especially with moderate to high activity, the body adapts.

Several things occur simultaneously:

  • Leptin decreases

  • T3 (active thyroid hormone) decreases

  • Reverse T3 may increase

  • Resting energy expenditure declines

  • Spontaneous movement decreases

  • Cortisol increases

  • Water retention may increase

Leptin is a hormone produced by fat cells. It signals energy sufficiency to the brain. When calories drop, leptin falls quickly, often within days.

Low leptin tells the hypothalamus:

“Energy availability is low”

In response:

  • Thyroid conversion slows.

  • Metabolic rate decreases.

  • Hunger increases.

  • Reproductive hormones may decline.

The Role of Liver Glycogen and Cortisol

Low-carb or prolonged calorie restriction often depletes liver glycogen.

When liver glycogen is low:

  • The body must maintain blood glucose via cortisol-driven gluconeogenesis.

  • Cortisol increases.

  • Water retention increases.

  • Energy feels unstable.

This is why someone can be losing fat but still look “softer”. High cortisol increases aldosterone. Aldosterone increases sodium retention. Sodium retention increases water retention. The scale lies.

Why a High-Carb Refeed Works

A properly structured refeed is not a cheat day. It is a metabolic signal. When you consume a high-carbohydrate, low-fat refeed:

  1. Liver glycogen is replenished.
    Cortisol drops because blood sugar no longer requires stress-mediated support.

  2. Leptin temporarily increases.
    Even short-term carb overfeeding can increase leptin, which signals energy sufficiency.

  3. T3 conversion improves.
    Thyroid output increases when carbohydrate availability rises.

  4. Training performance improves.
    Muscle glycogen increases. Strength increases.

  5. Water retention from stress hormones can drop.
    The “whoosh effect” often follows.

Fat loss may appear to “restart” not because the refeed burned fat directly, but because it restored metabolic rate and lowered stress.

Why Fat Must Stay Low During a Refeed

This is critical. High carb + high fat is metabolically inefficient.

During a high-carb refeed:

  • Insulin rises.

  • Glycogen stores are replenished.

  • Glucose oxidation increases.

If dietary fat is high at the same time:

  • Fat is easily stored.

  • The Randle cycle creates fuel competition.

  • Storage probability increases.

If dietary fat is kept low:

  • Most carbohydrate goes to glycogen.

  • DNL remains minimal under normal conditions.

  • Fat storage remains limited.

This is why refeeds should be: High carb. Low fat. Adequate protein. Not pizza and donuts.

Can You Go Very High in Carbs?

In metabolically healthy individuals, yes, temporarily.

Because:

  • DNL in humans is low.

  • Glycogen storage capacity is large.

  • Glucose oxidation increases with intake.

  • Thermogenesis increases.

Studies show that even during high-carb overfeeding, only a small percentage of carbohydrate is converted into fat unless glycogen is fully saturated and intake remains excessive for several days.

Short-term carb overfeeding behaves differently than fat overfeeding.

Most fat gain during refeed-style overfeeding comes from dietary fat, not carbohydrate conversion.

Refeed Frequency

There is no universal rule. But common indicators that a refeed may be beneficial:

  • Fat loss stalls for 1–2 weeks.

  • Training performance declines.

  • Body temperature drops.

  • Libido declines.

  • Sleep worsens.

  • Persistent fatigue.

Lean, active individuals typically require refeeds more often. Higher body fat individuals may need them less frequently.

The goal is not to eat more randomly. The goal is to restore metabolic function strategically.

Carb Cycling

Carb cycling builds on this principle. Instead of constant intake daily, you alternate:

  • Higher-carb days on training or high-activity days.

  • Lower-carb days on rest or low-activity days.

Lower-carb days:

  • Increase fat oxidation.

  • Lower insulin exposure.

Higher-carb days:

  • Restore glycogen.

  • Raise leptin.

  • Support thyroid.

  • Improve performance.

This creates metabolic rhythm without chronic suppression.

The Psychological Benefit

Refeeds are not just physiological. They reduce: Binge risk. Diet fatigue. Obsession. Restriction mentality.

When structured properly, they support sustainability. And sustainability determines whether you reach sub 15% body fat, not just whether you lose 2 kg quickly.

Chapter 11

Water Retention : Cortisol, Sodium, Glycogen, and the “Whoosh Effect”

One of the biggest psychological traps during fat loss is confusing water with fat.

The scale goes up 1.5 kg overnight. The mirror looks softer. Abs look blurred. Panic begins. Calories get cut further.

But in many cases, what changed was not fat mass.

It was water. Understanding water retention is essential if you want to avoid sabotaging your own progress.

Glycogen and Water : The Basic Mechanism

Every gram of glycogen stored in muscle binds approximately 3 grams of water.

If you refill 400 grams of glycogen during a high-carb refeed, you may retain 1–1.5 kg of water.

This is not fat. It is stored carbohydrate and its associated hydration.

This is why:

  • Low-carb diets make people look flatter and lighter quickly.

  • High-carb refeeds make people look fuller but heavier temporarily.

Neither change reflects actual fat mass in the short term.

Aldosterone and Sodium Retention

When insulin drops during prolonged dieting (especially low-carb dieting) sodium excretion increases.

The body compensates by raising aldosterone, a hormone that retains sodium. Elevated aldosterone causes water retention.

If sodium intake remains inconsistent or too low, aldosterone stays elevated. This leads to:

  • Persistent water retention

  • Feeling “puffy” despite dieting

Paradoxically, adequate sodium intake often reduces water retention over time because it lowers aldosterone signaling.

Under-salting while dieting can keep you watery.

Cortisol : The Stress Hormone Behind the “Soft Look”

Cortisol rises when:

  • Liver glycogen is depleted.

  • Calories are chronically low.

  • Sleep is insufficient.

  • Stress is high.

  • Training volume is excessive.

Cortisol increases gluconeogenesis and mobilizes fatty acids.

But it also:

  • Increases water retention.

  • Raises blood glucose.

  • Impairs insulin sensitivity when chronically elevated.

This creates the illusion of stalled fat loss. Someone can be losing fat while looking softer due to cortisol-driven water retention.

When a high-carb refeed restores liver glycogen:

  • Cortisol drops.

  • Aldosterone normalizes.

  • Water retention decreases.

This is often called the “whoosh effect” : sudden visible tightening after a refeed. The fat loss was happening gradually. The water masked it. The refeed revealed it.

Potassium : The Forgotten Mineral

Sodium retains water outside cells. Potassium regulates water inside cells.

Adequate potassium supports:

  • Glycogen storage

  • Insulin sensitivity

  • Proper fluid balance

  • Nerve function

  • Muscle contraction

Low potassium can worsen fatigue and fluid imbalance. Foods like potatoes, fruit, and orange juice are naturally high in potassium and align well with a high-carb, low-fat structure.

Gut Motility and Water Retention

Constipation or poor bowel movement frequency can also distort scale weight. Low thyroid function slows gut motility. Low-carb dieting can reduce fiber variety.

Dehydration alters stool volume. Gut content weight can fluctuate significantly. Sometimes what appears to be fat gain is simply slowed elimination. Metabolism and digestion are intertwined.

How to Interpret Scale Changes

Short-term weight changes reflect: Glycogen, Sodium, Hydration, Gut content, Inflammation.

They rarely reflect immediate fat gain. Fat gain requires sustained surplus over time. A single refeed does not produce significant fat gain if fat intake is controlled.

This is why progress should not be measured by daily scale weight alone. Which brings us to monitoring.

How to Monitor Fat Loss Properly

Relying solely on body weight is misleading.

Instead, monitor:

  • Waist circumference (consistent measurement location)

  • Visual changes in the mirror

  • Progress photos under consistent lighting

  • Training performance

  • Body temperature and pulse (for metabolic health)

A high-carb approach will often increase glycogen and water initially. Waist size is more informative than total body weight.

If waist circumference decreases while weight stays similar, fat loss is occurring. Muscle fullness and glycogen mask scale-based interpretation.

Chapter 12

PUFA Release During Fat Loss : Inflammation, Oxidative Stress, and the Role of Vitamin E

When people think about fat loss, they imagine adipose tissue as inert storage, like a passive warehouse of energy.

It isn’t. Adipose tissue stores triglycerides composed of different fatty acids:

  • Saturated fats

  • Monounsaturated fats

  • Polyunsaturated fats (PUFAs)

When you lose fat, you don’t selectively burn only the “good” fats. You mobilize what is stored. And in modern populations, a significant portion of stored fat contains polyunsaturated fatty acids from years of dietary seed oil intake.

This matters because PUFAs are chemically unstable.

What Happens When Stored Fat Is Released

During lipolysis, triglycerides are broken down into:

  • Free fatty acids

  • Glycerol

These fatty acids circulate in the bloodstream bound to albumin. If oxidation capacity is sufficient, they are burned for energy. If oxidation is impaired, they may be re-esterified and stored again.

When PUFAs are mobilized, they are more prone to:

  • Lipid peroxidation

  • Reactive oxygen species (ROS) generation

  • Inflammatory signaling

PUFAs contain multiple double bonds, which are structurally vulnerable to oxidation. When oxidized, they form lipid peroxides and reactive aldehydes. This can increase systemic oxidative stress.

Why This Matters During Fat Loss

As fat mass decreases, PUFA release increases proportionally. In individuals with high historical seed oil intake, adipose tissue PUFA content can be significant.

During aggressive fat loss:

  • Circulating PUFA levels rise.

  • Oxidative stress may increase.

  • Inflammation may temporarily increase.

Some people experience: Fatigue, Irritability, Brain fog, Joint discomfort

Part of this may be related to increased free fatty acid circulation and oxidative stress. This does not mean fat loss is harmful. It means fat loss is metabolically active. And protection mechanisms matter.

Vitamin E : A Protective Antioxidant

Vitamin E is a fat-soluble antioxidant that protects lipids from peroxidation. It integrates into cell membranes and neutralizes lipid radicals before chain reactions propagate. During periods of increased fat mobilization, vitamin E intake becomes more relevant.

It helps:

  • Reduce lipid peroxidation

  • Protect cellular membranes

  • Reduce oxidative burden

This is particularly relevant in individuals transitioning away from high-PUFA diets. Over time, as adipose tissue composition shifts toward more saturated and monounsaturated fats, this issue becomes less pronounced.

But during active fat loss (especially after years of high seed oil intake) antioxidant protection is worth considering.

The Goal Is Not Fear : It Is Context

The solution is not to fear fat loss. The solution is to:

  • Avoid excessive PUFA intake during fat loss

  • Support antioxidant defenses

  • Avoid extreme crash dieting that overwhelms oxidation capacity

Moderate, controlled fat loss with adequate nutrition is not inflammatory by default. Aggressive starvation combined with poor nutrient intake can increase stress. As with everything in metabolism, context determines outcome.

Chapter 13

How to Monitor Fat Loss Correctly : Beyond the Scale

If you take nothing else from this section, remember this:

The scale is the noisiest metric in fat loss.

It reflects: Fat mass, Muscle mass, Glycogen, Water retention, Sodium intake, Inflammation, Gut content

It does not tell you which of those changed. If you rely only on body weight, you will misinterpret normal physiological fluctuations as failure.

And that leads people to:

  • Cut calories unnecessarily

  • Abandon refeeds

  • Add excessive cardio

  • Panic-adjust a working plan

Monitoring correctly is what separates strategic dieting from emotional dieting.

Why Weight Alone Is Misleading

Let’s say you begin a high-carb, low-fat approach. Within days:

  • Glycogen increases.

  • Water retention increases.

  • Body weight may increase 1–2 kg.

Have you gained fat? No. You have restored glycogen.

Conversely, on low-carb dieting:

  • Glycogen drops.

  • Water drops.

  • Weight drops rapidly.

Have you lost mostly fat? Not necessarily.

Early weight changes are often water shifts. Fat loss is slower. Roughly 7,700 kcal equates to 1 kg of fat. You cannot gain 2 kg of fat in two days without an extreme surplus. Most rapid changes are fluid.

Better Metrics for Fat Loss

1. Waist Circumference

This is one of the most reliable tools. Measure:

  • At the same location (e.g., at navel level)

  • In the morning

  • Under similar hydration conditions

  • Once or twice per week

Waist circumference reflects abdominal fat changes more reliably than scale weight. If waist size decreases over weeks, fat loss is occurring, even if weight fluctuates.

2. Progress Photos

Lighting matters. Time of day matters. Hydration matters. Take photos:

  • Same time of day

  • Same lighting

  • Same posture

  • Same distance from camera

Weekly or biweekly comparisons reveal trends better than daily mirror checks.

3. The Mirror (With Context)

The mirror is useful : but only if:

  • You avoid daily emotional interpretation.

  • You understand glycogen fullness changes appearance.

High-carb days may make you look fuller. Low-carb days may make you look flatter. Neither necessarily reflects fat mass change. Trend over weeks matters.

4. Training Performance

If: Strength is stable or improving. Pumps are good. Recovery is solid. Then metabolism is likely intact.

If: Strength drops sharply. Energy collapses. Sleep worsens. Metabolic suppression may be occurring.

Performance is a metabolic indicator.

5. Body Temperature and Pulse (Advanced Monitoring)

Because thyroid function influences metabolic rate, tracking:

  • Waking temperature (around 36.6–36.8°C / 97.8–98.2°F)

  • Resting pulse (around 75–85 bpm in calm state)

Can provide insight into metabolic status.

Consistently low temperature and low pulse during dieting may indicate metabolic suppression. Fat loss should not require chronic cold intolerance and fatigue.

What to Expect During HCLF Fat Loss

On high-carb, low-fat:

  • Initial weight may increase due to glycogen.

  • Waist may decrease slowly.

  • Muscles look fuller.

  • Performance improves.

The scale may move slower than expected. But the composition shift can be superior. Fat loss is not linear. Water shifts will obscure short-term progress. Your job is to detect trend, not react to noise.

The 2-Week Rule

Never judge fat loss based on a single week. Evaluate trends over 2–3 weeks.

If after two consistent weeks:

  • Waist is stable.

  • Weight is stable.

  • Energy is stable.

Then adjust. If weight fluctuates but waist decreases, continue.

Chapter 14

The Non-Negotiables : Control, Cooking, and Eliminating Hidden Variables

Everything we’ve discussed so far (fuel partitioning, the Randle cycle, insulin sensitivity, refeeds, thyroid support, oxidation capacity) assumes one thing:

You know what you are eating. If you don’t control input, none of the theory matters.

You cannot outsmart hidden fat. You cannot compensate for invisible oils. You cannot calculate around unknown variables.

Fat loss requires structure. And structure requires control.

Why Eating Out Is the Silent Fat-Loss Killer

Restaurants optimize for taste, not metabolic efficiency.

That usually means:

  • Generous amounts of seed oils

  • Butter added after cooking

  • Hidden dressings

  • Sugary sauces

  • Large, inconsistent portion sizes

Even “healthy” options often contain:

  • 20–40 grams of hidden fat

  • Oils you cannot see

  • Macro distributions that are impossible to estimate accurately

If someone eats out frequently and claims they are in a strict deficit, the margin of error can easily erase that deficit.

A single underestimated 30 grams of fat equals ~270 calories. Do that several times per week and the math changes dramatically.

If you are serious about reaching sub 15% body fat sustainably: Frequent restaurant eating must decrease.

Cooking Is Not Optional, It Is Strategic

When you cook:

  • You measure fat.

  • You choose fat type.

  • You control portion sizes.

  • You eliminate hidden oils.

  • You reduce variability.

Control creates consistency. Consistency reveals trends. Trends allow intelligent adjustment. Without control, every week is guesswork.

Read Ingredient Lists, Not Just Macros

Even when buying packaged foods, the ingredient list matters.

Look for:

  • Seed oils (soybean, corn, canola, sunflower)

  • Hidden added fats

  • Emulsifiers and additives that may affect digestion

This is especially relevant during fat loss, when:

  • PUFA release increases.

  • Oxidative stress may increase.

  • Inflammation may distort fluid balance.

Reducing unnecessary dietary PUFA during fat loss is strategic.

Macro Awareness, Not Macro Obsession

You do not need to weigh every gram of food forever.

But during an active fat-loss phase, you must:

  • Know your fat intake.

  • Know your carb intake.

  • Estimate protein intake accurately.

For a high-carb, low-fat approach, that usually means:

  • Fat kept relatively low and consistent.

  • Carbs adjusted based on activity and refeeds.

  • Protein moderate and sufficient.

Without awareness, fat intake often drifts upward unnoticed. And because fat is easily stored, this drift matters.

Consistency Beats Perfection

You do not need:

  • Perfect macros every day.

  • Identical meals daily.

  • Obsessive rigidity.

You need:

  • Controlled fat intake.

  • Adequate carbs.

  • Strategic refeeds.

  • Stable sleep.

  • Reasonable stress.

Fat loss is a long-term signal. Small daily fluctuations do not matter. Uncontrolled patterns do.

The Discipline That Prevents Yo-Yo Dieting

Most yo-yo cycles follow this pattern:

  1. Aggressive restriction.

  2. Metabolic suppression.

  3. Psychological burnout.

  4. Rebound overeating.

  5. Fat regain.

The solution is not stricter restriction. It is metabolic stability.

A high-carb, low-fat structure with carb cycling and refeeds:

  • Preserves thyroid output.

  • Preserves performance.

  • Reduces cortisol spikes.

  • Reduces binge pressure.

  • Allows sustainable deficit.

Sustainability is not weakness. It is long-term dominance over your environment.

Chapter 15

The Complete Practical Blueprint : Weekly Structure, Full Days, Refeeds & Carb Cycling Strategy

Everything up to this point was theory. Now we translate it into execution.

This blueprint is designed for:

  • Sustainable fat loss toward sub ~15% body fat

  • Preserved metabolic rate

  • Preserved training performance

  • Controlled fat intake

  • Strategic carbohydrate cycling

Step 1 : Establish Your Baseline Macros

Instead of giving arbitrary numbers, we’ll use ranges based on bodyweight.

Protein

Protein should be sufficient to preserve muscle, not excessive.

Target range:

  • 1.6–2.2 g per kg bodyweight

Examples:

  • 70 kg → 110–155g protein

  • 80 kg → 130–175g

  • 95 kg → 150–210g

Going above this is rarely necessary and may displace carbohydrates that support thyroid function.

Calcium, Phosphorus, and Stress Signaling (Dairy vs Meat) :

Another overlooked factor is the calcium-to-phosphorus ratio of the diet. Muscle meats are rich in phosphorus, and modern diets often contain far more phosphorus than calcium. When phosphorus intake is chronically high relative to calcium, parathyroid hormone (PTH) rises to maintain mineral balance. Elevated PTH increases intracellular calcium, raises stress signaling, and is associated with reduced metabolic efficiency and increased fat storage over time.

Adequate calcium intake (particularly from dairy when tolerated) lowers PTH and supports a more favorable metabolic environment. The goal is not to eliminate phosphorus, but to balance it. A diet centered around fruit, dairy, and moderate protein naturally improves this ratio compared to a diet dominated by muscle meat alone.

Fat

Fat must be controlled carefully. For HCLF fat loss:

Target range:

  • 0.4–0.6 g per kg bodyweight

Examples:

  • 70 kg → 28–42g

  • 80 kg → 32–48g

  • 95 kg → 38–57g

This keeps dietary fat low enough to minimize easy storage while still supporting essential fatty acid requirements.

Carbohydrates

Carbs fill the remaining calories. Training days will be higher. Rest days slightly lower.

Typical training-day range:

  • 3.5–6 g per kg bodyweight

Examples:

  • 70 kg → 250–420g

  • 80 kg → 280–480g

  • 95 kg → 330–570g

Refeed days may exceed this.

Sodium & Potassium Targets

Sodium:

  • 3–5g sodium per day (not salt, sodium)

  • Equivalent to ~7–12g salt

Potassium:

  • 3,000–4,500 mg daily minimum

  • From potatoes, fruit, orange juice

Mineral balance prevents unnecessary aldosterone-driven water retention.

Step 2 : Example: 80 kg Male (Training Day)

Goal: ~2,550 kcal
Protein: 160g
Fat: 23g
Carbs: ~400g

Morning

Breakfast:

  • 400 ml orange juice

  • 200g low-fat Greek yogurt

  • 1 banana

  • 1 tbsp honey

  • Salt added to OJ

Macros:
~85–90g carbs
~22g protein
~2g fat

Why:

  • Replenish liver glycogen

  • Lower morning cortisol

  • Provide potassium

  • Minimal fat to avoid Randle conflict

Mid-Morning

  • 350g boiled or air-fried potatoes

  • 150g egg whites + 1 whole egg

  • Salt

~60g carbs
~22g protein
~5g fat

Pre-Workout (60–90 min before)

  • 450 ml orange juice

  • 30g whey isolate (optional)

  • Pinch of salt

~40g carbs
~25g protein
~1g fat

Intra-Workout

This is critical for high-intensity training.

In high-resistance training, glucose is the primary and preferential fuel source (especially for fast-twitch glycolytic fibers) and if adequate glucose isn’t available, cortisol rises to drive gluconeogenesis, pulling amino acids (alanine, glutamine, BCAAs) from muscle tissue to maintain blood sugar, increasing catabolism and impairing recovery.

Consuming intra-workout carbs maintains blood glucose, lowers the cortisol response, reduces muscle protein breakdown, preserves glycogen, sustains power output, and acts as a direct anti-catabolic buffer during intense sessions.

Intra drink:

  • 20–40g fast carbs (dextrose, cyclic dextrin, or diluted OJ)

  • 1g sodium (salt)

  • Optional: 5g creatine

Why:

  • Maintain blood glucose

  • Reduce cortisol rise

  • Improve performance

  • Support glycolysis

High-intensity training depends on glucose. Fat oxidation is too slow to meet rapid ATP demand.

Post-Workout

  • ~500g boiled potatoes OR ~110g uncooked white rice

  • 150g lean beef or chicken breast

  • Fruit

  • Salt

~85–90g carbs
~40g protein
~8g fat

This refills glycogen quickly.

Dinner

  • ~100g uncooked white rice

  • 150g lean fish

  • Cooked vegetables

  • Fruit

~80g carbs
~35g protein
~5g fat

Before Bed

  • 500ml skim milk OR

  • 1 cup low-fat cottage cheese

  • 1 tbsp honey

~40–45g carbs
~20g protein

Carbs before sleep help lower cortisol overnight.

Step 3 : Low-Carb Rest Day Example (80 kg)

Calories slightly lower: ~2,300–2,400 kcal
Protein same (~160g)
Fat slightly higher (50g max)
Carbs reduced (~200–250g)

Meals include:

  • Eggs

  • Lean meats

  • Potatoes (smaller portions)

  • Fruit

  • Dairy optional

Why lower carb on rest days?

  • Increase fat oxidation windows

  • Lower total weekly calories

  • Maintain insulin sensitivity

Still not keto. Still metabolically supported.

Step 4 : Refeed Day Example

Calories: ~3,200–3,500 kcal
Fat: ≤30g
Protein: ~150g
Carbs: 500–650g

Meals centered around:

  • Potatoes

  • Rice

  • Orange juice

  • Fruit

  • Low-fat dairy

  • Lean meats

Fat remains very low. Why ? High carb + high fat promotes storage.

High carb + low fat prioritizes:

  • Glycogen refill

  • Increased leptin

  • Increased T3

  • Increased thermogenesis

DNL remains minimal in short-term refeeding.

Step 5 : Example Weekly Structure

Monday : High carb (training)
Tuesday : Moderate carb
Wednesday : High carb (training)
Thursday : Lower carb
Friday : High carb (training)
Saturday : Refeed (if needed)
Sunday : Moderate carb

Adjust frequency based on:

  • Energy

  • Training performance

  • Fat loss rate

You now understand

  • What calories are and why arithmetic alone fails.

  • How macronutrients are processed.

  • Why dietary fat is easily stored.

  • Why de novo lipogenesis is limited under normal conditions.

  • How the Randle cycle shapes fuel competition.

  • Why high fat + high carb is problematic.

  • How glucose and fat oxidation differ.

  • How hormones control fat storage.

  • Why chronic deficits suppress metabolism.

  • How refeeds restore leptin and T3.

  • Why water retention masks progress.

  • Why PUFA release matters during fat loss.

  • How to monitor progress properly.

  • Why food control is non-negotiable.

If you apply this structure correctly, reaching sub ~15% body fat is not extreme. It is repeatable. It is sustainable.

It does not require starvation. It does not require chronic fatigue. It does not require metabolic self-destruction. It requires understanding.

What This Blueprint Achieves ?

  • Supports glucose oxidation

  • Limits direct fat storage

  • Maintains thyroid output

  • Maintains training performance

  • Reduces cortisol reliance

  • Allows refeeds without fat gain

In Part II, we will expand this foundation to include:

  • Training strategy

  • Walking vs cardio

  • Daily habits

  • Small behavioral leverage points

  • How movement influences fuel partitioning

And in Part III, we will address advanced strategies for those who want to push below 10% body fat, including supplements and pharmacological tools and their risks.

But none of that works without Part I. Nutrition is the base. Without it, everything else is compensation. With it, everything else becomes leverage.

Part 2 and Part 3 are coming soon. To receive them and support my work, consider becoming a free or paid subscriber.

Thanks for reading ! This post is public so feel free to share it.

Share

]]>